No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2aanA, 0.7699, 2.03, 0.190, 123, 121, AURACYANIN A: A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUMCHLOROFLEXUS AURANTIACUS
2, 1azcA, 0.7698, 2.29, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
3, 1azbA, 0.7697, 2.28, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
4, 1azbB, 0.7691, 2.28, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
5, 1azcB, 0.7688, 2.28, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
6, 1aizB, 0.7684, 2.30, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
7, 1aizA, 0.7683, 2.32, 0.169, 129, 124, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
8, 2azaB, 0.7682, 2.35, 0.169, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
9, 2azaA, 0.7682, 2.37, 0.169, 129, 124, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
10, 1uriA, 0.7664, 2.22, 0.163, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
11, 1ov8A, 0.7661, 2.18, 0.194, 139, 124, AURACYANIN B STRUCTURE IN SPACE GROUP P65
12, 1ov8C, 0.7660, 2.19, 0.202, 139, 124, AURACYANIN B STRUCTURE IN SPACE GROUP P65
13, 1ov8B, 0.7658, 2.19, 0.202, 139, 124, AURACYANIN B STRUCTURE IN SPACE GROUP P65
14, 1ov8D, 0.7657, 2.19, 0.202, 139, 124, AURACYANIN B STRUCTURE IN SPACE GROUP P65
15, 1dz0A, 0.7652, 2.23, 0.154, 129, 123, REDUCED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
16, 1dyzA, 0.7648, 2.23, 0.154, 129, 123, OXIDISED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
17, 1qhqA, 0.7647, 2.21, 0.194, 139, 124, AURACYANIN A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUM CHLOROFLEXUS AURANTIACUS
18, 1a4aA, 0.7646, 2.40, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
19, 1uriB, 0.7645, 2.33, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
20, 1rkrA, 0.7645, 2.36, 0.153, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
21, 1rkrC, 0.7642, 2.38, 0.153, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
22, 2ccwA, 0.7641, 2.23, 0.154, 129, 123, CRYSTAL STRUCTURE OF AZURIN II AT ATOMIC RESOLUTION (1.13 ANGSTROM)
23, 1rkrD, 0.7639, 2.37, 0.153, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
24, 1a4aB, 0.7638, 2.38, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
25, 1nwpA, 0.7628, 2.23, 0.163, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
26, 1rkrB, 0.7627, 2.38, 0.153, 129, 124, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
27, 1a4bA, 0.7623, 2.37, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
28, 1cuoA, 0.7622, 2.32, 0.169, 129, 124, CRYSTAL STRUCTURE ANALYSIS OF ISOMER-2 AZURIN FROM METHYLOMONAS J
29, 2tsbA, 0.7615, 2.21, 0.139, 128, 122, AZURIN MUTANT M121A-AZIDE
30, 4hz1D, 0.7606, 2.25, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
31, 2tsbD, 0.7602, 2.22, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
32, 2tsaA, 0.7602, 2.22, 0.139, 128, 122, AZURIN MUTANT M121A
33, 3azuA, 0.7600, 2.23, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
34, 3iboC, 0.7598, 2.27, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
35, 2h47C, 0.7598, 2.31, 0.146, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 1)
36, 6mjtB, 0.7593, 2.36, 0.146, 128, 123, AZURIN 122F/124W/126RE 
37, 2oj1A, 0.7593, 2.30, 0.138, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
38, 1nwpB, 0.7593, 2.27, 0.163, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
39, 1a4cC, 0.7592, 2.31, 0.163, 129, 123, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
40, 2oj1B, 0.7589, 2.31, 0.138, 128, 123, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
41, 1nwoA, 0.7589, 2.29, 0.163, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
42, 1a4cA, 0.7588, 2.45, 0.153, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
43, 2tsaD, 0.7587, 2.22, 0.131, 128, 122, AZURIN MUTANT M121A
44, 1jzjA, 0.7586, 2.30, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
45, 1a4cD, 0.7585, 2.43, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
46, 4ko6C, 0.7583, 2.31, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
47, 1nwoB, 0.7582, 2.30, 0.154, 128, 123, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
48, 4ko6B, 0.7580, 2.32, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
49, 1a4bB, 0.7580, 2.42, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
50, 1xb8A, 0.7579, 2.24, 0.139, 127, 122, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
51, 1jziA, 0.7579, 2.35, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
52, 1jzeA, 0.7579, 2.36, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(BPY)2(IM)(HIS83)
53, 1a4cB, 0.7578, 2.34, 0.161, 129, 124, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
54, 4ko5B, 0.7575, 2.30, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
55, 3azuD, 0.7574, 2.22, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
56, 2iaaC, 0.7574, 2.34, 0.146, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 2)
57, 2h3xC, 0.7573, 2.33, 0.146, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
58, 1e5zC, 0.7573, 2.37, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
59, 2h3xF, 0.7572, 2.33, 0.146, 128, 123, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
60, 2i7sD, 0.7571, 2.32, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
61, 1gr7B, 0.7571, 2.15, 0.149, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
62, 6gyiC, 0.7570, 2.37, 0.146, 128, 123, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
63, 1jzhA, 0.7570, 2.35, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RU(TPY)(BPY)(HIS83)
64, 4ko5A, 0.7568, 2.33, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
65, 4hz1A, 0.7568, 2.24, 0.139, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
66, 6gyiB, 0.7567, 2.21, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
67, 1e65D, 0.7567, 2.24, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
68, 3ugeA, 0.7566, 2.41, 0.138, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
69, 3ugeD, 0.7565, 2.23, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
70, 2tsbC, 0.7565, 2.25, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
71, 1etjD, 0.7565, 2.22, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
72, 1gr7C, 0.7563, 2.16, 0.149, 125, 121, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
73, 1etjC, 0.7563, 2.24, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
74, 1etjA, 0.7563, 2.25, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
75, 3fswB, 0.7562, 2.41, 0.130, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
76, 1e65C, 0.7562, 2.38, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
77, 2i7sC, 0.7561, 2.33, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
78, 1e5zD, 0.7561, 2.24, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
79, 5azuC, 0.7560, 2.38, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
80, 1xb3A, 0.7560, 2.33, 0.138, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
81, 1e5zB, 0.7559, 2.28, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
82, 1e5yD, 0.7559, 2.23, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
83, 1e5yC, 0.7559, 2.41, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
84, 5azuD, 0.7558, 2.24, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
85, 6mjsA, 0.7556, 2.34, 0.146, 128, 123, AZURIN 122W/124W/126RE 
86, 2tsaC, 0.7556, 2.26, 0.139, 128, 122, AZURIN MUTANT M121A
87, 1jvoE, 0.7556, 2.24, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
88, 1i53A, 0.7556, 2.38, 0.146, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
89, 4ko9D, 0.7555, 2.39, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
90, 3azuC, 0.7555, 2.25, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
91, 4kobD, 0.7554, 2.35, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
92, 3ugeC, 0.7554, 2.39, 0.146, 128, 123, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
93, 2idfB, 0.7554, 2.36, 0.146, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
94, 4kobA, 0.7553, 2.34, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
95, 3jt2A, 0.7553, 2.25, 0.139, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
96, 1jziB, 0.7553, 2.37, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
97, 1jvoD, 0.7553, 2.24, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
98, 1jvoA, 0.7553, 2.25, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
99, 1e65A, 0.7553, 2.24, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
100, 1ag0B, 0.7553, 2.36, 0.138, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
101, 3iboB, 0.7552, 2.35, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
102, 2idfA, 0.7552, 2.37, 0.146, 128, 123, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
103, 1vlxC, 0.7552, 2.40, 0.146, 128, 123, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
104, 1jvoJ, 0.7552, 2.24, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
105, 1ilsC, 0.7552, 2.41, 0.138, 128, 123, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
106, 1i53B, 0.7552, 2.35, 0.146, 128, 123, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
107, 1aznB, 0.7552, 2.24, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
108, 1ag0A, 0.7552, 2.36, 0.138, 128, 123, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
109, 6iavA, 0.7551, 2.22, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
110, 1azrC, 0.7551, 2.39, 0.146, 128, 123, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
111, 4ko9C, 0.7550, 2.37, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
112, 4azuC, 0.7550, 2.41, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
113, 4azuB, 0.7550, 2.45, 0.146, 128, 123, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
114, 2azuB, 0.7550, 2.27, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
115, 1jvoG, 0.7550, 2.24, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
116, 1e5yB, 0.7550, 2.28, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
117, 6iavB, 0.7549, 2.23, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
118, 4ko6A, 0.7549, 2.35, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
119, 3fpyA, 0.7549, 2.36, 0.130, 128, 123, AZURIN C112D/M121L
120, 4ko9A, 0.7548, 2.36, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
121, 4ko7D, 0.7548, 2.36, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
122, 2i7sB, 0.7548, 2.32, 0.146, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
123, 1jvoI, 0.7548, 2.25, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
124, 4mfhC, 0.7547, 2.36, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
125, 1jvoC, 0.7547, 2.25, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
126, 1e67C, 0.7547, 2.40, 0.146, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
127, 1jvoB, 0.7546, 2.25, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
128, 1etjB, 0.7546, 2.24, 0.139, 128, 122, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
129, 1e5zA, 0.7546, 2.26, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
130, 5azuB, 0.7545, 2.28, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
131, 2azuC, 0.7545, 2.27, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
132, 2azuA, 0.7545, 2.26, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
133, 1r1cA, 0.7545, 2.24, 0.164, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
134, 1jvoH, 0.7545, 2.26, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
135, 1iluK, 0.7545, 2.25, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
136, 1jvlB, 0.7544, 2.38, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
137, 1jvlA, 0.7544, 2.38, 0.146, 128, 123, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
138, 4kobC, 0.7543, 2.36, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
139, 1jvoF, 0.7542, 2.25, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
140, 1e5yA, 0.7542, 2.26, 0.148, 128, 122, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
141, 1vlxD, 0.7541, 2.26, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
142, 1ilsB, 0.7541, 2.27, 0.131, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
143, 4qlwA, 0.7540, 2.27, 0.131, 128, 122, AZURIN MUTANT M121E WITH IRON
144, 3jt2B, 0.7540, 2.26, 0.139, 128, 122, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
145, 2xv3A, 0.7540, 2.46, 0.129, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
146, 1xb6A, 0.7540, 2.35, 0.146, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
147, 1e67B, 0.7540, 2.45, 0.146, 128, 123, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
148, 6mjrA, 0.7539, 2.41, 0.146, 128, 123, AZURIN 122W/124F/126RE 
149, 6gyiD, 0.7539, 2.25, 0.148, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
150, 4ko7C, 0.7539, 2.39, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
151, 4jknC, 0.7539, 2.44, 0.146, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
152, 4azuD, 0.7539, 2.26, 0.139, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
153, 2xv3B, 0.7539, 2.44, 0.129, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
154, 2azuD, 0.7539, 2.27, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
155, 1jvoL, 0.7539, 2.26, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
156, 1jvoK, 0.7539, 2.26, 0.148, 128, 122, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
157, 1ilsD, 0.7539, 2.26, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
158, 1azrD, 0.7539, 2.24, 0.139, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
159, 5azuA, 0.7538, 2.27, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
160, 4ko7A, 0.7538, 2.39, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
161, 2tsbB, 0.7538, 2.27, 0.131, 128, 122, AZURIN MUTANT M121A-AZIDE
162, 1nzrC, 0.7538, 2.42, 0.146, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
163, 1iluD, 0.7538, 2.28, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
164, 3azuB, 0.7537, 2.27, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
165, 1jzgA, 0.7537, 2.40, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA REDUCED AZURIN (CU1+) RU(TPY)(PHEN) (HIS83)
166, 4jknB, 0.7535, 2.42, 0.146, 128, 123, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
167, 1azrB, 0.7535, 2.28, 0.148, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
168, 3iboD, 0.7534, 2.36, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
169, 2i7oA, 0.7534, 2.38, 0.138, 128, 123, STRUCTURE OF RE(47-DIMETHYL-PHEN)(THR124HIS)(LYS122TRP)(HIS83GLN) AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
170, 1r1cD, 0.7534, 2.33, 0.154, 128, 123, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
171, 1e65B, 0.7534, 2.45, 0.146, 128, 123, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
172, 3ft0A, 0.7533, 2.43, 0.129, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
173, 1xb8C, 0.7533, 2.17, 0.149, 126, 121, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
174, 1jzfA, 0.7533, 2.41, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA OXIDIZED AZURIN(CU2+) RU(TPY)(PHEN) (HIS83)
175, 2tsaB, 0.7532, 2.27, 0.131, 128, 122, AZURIN MUTANT M121A
176, 4ko7B, 0.7531, 2.37, 0.154, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
177, 4azuA, 0.7531, 2.28, 0.148, 128, 122, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
178, 1nzrB, 0.7531, 2.47, 0.146, 128, 123, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
179, 4k9jA, 0.7529, 2.26, 0.148, 127, 122, STRUCTURE OF RE(CO)3(47-DIMETHYL-PHEN)(THR126HIS)(LYS122TRP) (HIS83GLU)(TRP48PHE)(TYR72PHE)(TYR108PHE)AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
180, 1vlxB, 0.7529, 2.29, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
181, 1gr7A, 0.7529, 2.31, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
182, 3ugeB, 0.7528, 2.28, 0.148, 128, 122, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
183, 1jzjB, 0.7528, 2.44, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
184, 1aznD, 0.7528, 2.28, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
185, 6gyiA, 0.7526, 2.28, 0.139, 127, 122, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
186, 1joiA, 0.7526, 2.45, 0.138, 128, 123, STRUCTURE OF PSEUDOMONAS FLUORESCENS HOLO AZURIN
187, 1aznA, 0.7526, 2.24, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
188, 1vlxA, 0.7525, 2.27, 0.148, 128, 122, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
189, 1e67D, 0.7525, 2.27, 0.139, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
190, 4bwwA, 0.7524, 2.46, 0.130, 127, 123, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
191, 2i7sA, 0.7524, 2.35, 0.138, 128, 123, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
192, 4mfhB, 0.7523, 2.39, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
193, 1gr7D, 0.7523, 2.32, 0.148, 126, 122, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
194, 1ilsA, 0.7522, 2.28, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
195, 1ezlD, 0.7522, 2.30, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
196, 1e67A, 0.7522, 2.28, 0.148, 128, 122, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
197, 1iluF, 0.7521, 2.28, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
198, 6mjtA, 0.7520, 2.27, 0.148, 128, 122, AZURIN 122F/124W/126RE 
199, 6iavD, 0.7520, 2.24, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
200, 4jknA, 0.7520, 2.28, 0.139, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
201, 3jtbD, 0.7520, 2.42, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
202, 3fszA, 0.7520, 2.44, 0.129, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
203, 4qlwC, 0.7518, 2.29, 0.131, 128, 122, AZURIN MUTANT M121E WITH IRON
204, 1iluI, 0.7518, 2.30, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
205, 1aznC, 0.7518, 2.27, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
206, 6mjrC, 0.7517, 2.30, 0.148, 128, 122, AZURIN 122W/124F/126RE 
207, 4kobB, 0.7517, 2.42, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
208, 1nzrD, 0.7517, 2.28, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
209, 1iluA, 0.7517, 2.28, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
210, 1azrA, 0.7516, 2.27, 0.139, 128, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
211, 6iavC, 0.7515, 2.27, 0.148, 127, 122, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
212, 1ezlA, 0.7515, 2.27, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
213, 4ko6D, 0.7514, 2.41, 0.146, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
214, 3ft0B, 0.7514, 2.47, 0.137, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
215, 3fszB, 0.7514, 2.45, 0.129, 129, 124, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
216, 4hz1C, 0.7513, 2.30, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
217, 4bwwB, 0.7513, 2.31, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
218, 1nzrA, 0.7513, 2.29, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
219, 1cc3B, 0.7513, 2.63, 0.120, 130, 125, PURPLE CUA CENTER
220, 4ko9B, 0.7512, 2.42, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
221, 3fq1A, 0.7512, 2.40, 0.130, 128, 123, AZURIN C112D/M121I
222, 1iluB, 0.7512, 2.31, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
223, 5i28P, 0.7511, 2.38, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
224, 1iluM, 0.7511, 2.28, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
225, 4qlwB, 0.7510, 2.43, 0.138, 128, 123, AZURIN MUTANT M121E WITH IRON
226, 4bwwC, 0.7510, 2.48, 0.138, 127, 123, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
227, 1iluL, 0.7510, 2.29, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
228, 1bexB, 0.7509, 2.47, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
229, 4kocA, 0.7508, 2.41, 0.138, 128, 123, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I/Y108F)
230, 4mfhA, 0.7507, 2.39, 0.138, 128, 123, CRYSTAL STRUCTURE OF M121G AZURIN
231, 3fswD, 0.7507, 2.32, 0.131, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
232, 1iluC, 0.7507, 2.31, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
233, 3np3A, 0.7506, 2.41, 0.130, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
234, 3ay2A, 0.7506, 2.33, 0.131, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
235, 1uatA, 0.7506, 2.44, 0.169, 129, 124, THE SIGNIFICANCE OF THE FLEXIBLE LOOP IN THE AZURIN (AZ-ISO2) FROM THE OBLIGATE METHYLOTROPH METHYLOMONAS SP. STRAIN J
236, 4jknD, 0.7504, 2.33, 0.139, 128, 122, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
237, 1bexA, 0.7504, 2.48, 0.146, 128, 123, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
238, 6mjsD, 0.7503, 2.21, 0.149, 126, 121, AZURIN 122W/124W/126RE 
239, 6mjsB, 0.7503, 2.20, 0.149, 126, 121, AZURIN 122W/124W/126RE 
240, 3fqyA, 0.7503, 2.42, 0.130, 128, 123, AZURIN C112D
241, 5i28J, 0.7501, 2.37, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
242, 5i26A, 0.7501, 2.38, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM I
243, 4bwwD, 0.7501, 2.31, 0.139, 127, 122, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
244, 3u25B, 0.7501, 2.30, 0.139, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
245, 1r1cB, 0.7500, 2.34, 0.156, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
246, 6mjsC, 0.7498, 2.15, 0.150, 125, 120, AZURIN 122W/124W/126RE 
247, 5i28H, 0.7498, 2.40, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
248, 1iluE, 0.7498, 2.31, 0.148, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
249, 5i28G, 0.7497, 2.37, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
250, 5i28A, 0.7496, 2.39, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
251, 2gi0A, 0.7495, 2.44, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
252, 1ezlB, 0.7495, 2.33, 0.148, 128, 122, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
253, 3u25A, 0.7494, 2.32, 0.139, 127, 122, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
254, 3jtbA, 0.7494, 2.46, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
255, 2ghzA, 0.7493, 2.43, 0.138, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
256, 2fnwB, 0.7492, 2.13, 0.140, 128, 121, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
257, 3np4A, 0.7491, 2.41, 0.130, 128, 123, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
258, 3jtbC, 0.7489, 2.46, 0.138, 128, 123, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
259, 3iboA, 0.7489, 2.39, 0.138, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
260, 1iluG, 0.7489, 2.31, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
261, 1iluH, 0.7488, 2.33, 0.139, 128, 122, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
262, 5i28K, 0.7487, 2.41, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
263, 3jtbB, 0.7487, 2.28, 0.148, 128, 122, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
264, 1cc3A, 0.7487, 2.71, 0.120, 130, 125, PURPLE CUA CENTER
265, 5i28E, 0.7486, 2.40, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
266, 4hhgA, 0.7486, 2.38, 0.139, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN RUH107NO YOH109
267, 2ghzB, 0.7486, 2.46, 0.138, 128, 123, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
268, 5i28I, 0.7485, 2.42, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
269, 3fq2A, 0.7485, 2.41, 0.130, 128, 123, AZURIN C112D/M121F
270, 2gi0B, 0.7485, 2.46, 0.138, 128, 123, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
271, 3in0B, 0.7484, 2.31, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
272, 3in0C, 0.7483, 2.34, 0.131, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
273, 2fnwA, 0.7479, 2.41, 0.146, 128, 123, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
274, 6mjrD, 0.7477, 2.50, 0.146, 128, 123, AZURIN 122W/124F/126RE 
275, 3ay2B, 0.7477, 2.34, 0.131, 126, 122, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
276, 1xb6B, 0.7474, 2.43, 0.138, 128, 123, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
277, 5i28O, 0.7473, 2.43, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM II
278, 5i28N, 0.7473, 2.42, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
279, 5i26B, 0.7469, 2.40, 0.139, 127, 122, AZURIN T30R1 CRYSTAL FORM I
280, 2hxaB, 0.7469, 2.42, 0.139, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
281, 1azuA, 0.7469, 2.26, 0.149, 126, 121, STRUCTURAL FEATURES OF AZURIN AT 2.7 ANGSTROMS RESOLUTION
282, 5i28D, 0.7468, 2.43, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
283, 5i28C, 0.7467, 2.44, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
284, 4qlwD, 0.7467, 2.38, 0.139, 128, 122, AZURIN MUTANT M121E WITH IRON
285, 3in0D, 0.7467, 2.34, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
286, 5i28M, 0.7466, 2.43, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
287, 5i28F, 0.7465, 2.41, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
288, 4hz1B, 0.7465, 2.38, 0.148, 127, 122, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
289, 6mjrB, 0.7464, 2.42, 0.148, 128, 122, AZURIN 122W/124F/126RE 
290, 3in0A, 0.7460, 2.39, 0.131, 128, 122, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
291, 2iweG, 0.7460, 2.50, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
292, 2n0mA, 0.7457, 2.40, 0.122, 130, 123, THE SOLUTION STRUCTURE OF THE SOLUBLE FORM OF THE LIPID-MODIFIED AZURIN FROM NEISSERIA GONORRHOEAE
293, 5i28B, 0.7456, 2.45, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
294, 3fswA, 0.7455, 2.37, 0.131, 127, 122, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
295, 2iweA, 0.7455, 2.47, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
296, 5i28L, 0.7452, 2.43, 0.148, 127, 122, AZURIN T30R1 CRYSTAL FORM II
297, 1xb3B, 0.7444, 2.47, 0.138, 128, 123, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
298, 3in2A, 0.7443, 2.37, 0.139, 128, 122, CRYSTAL STRUCTURE OF THE N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
299, 2iweJ, 0.7443, 2.51, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
300, 5i26D, 0.7442, 2.50, 0.139, 126, 122, AZURIN T30R1 CRYSTAL FORM I
301, 2iweD, 0.7442, 2.51, 0.138, 128, 123, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
302, 1ezlC, 0.7441, 2.59, 0.138, 128, 123, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
303, 4wkxA, 0.7440, 2.43, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
304, 4wkxB, 0.7436, 2.44, 0.130, 128, 123, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
305, 3n2jK, 0.7434, 2.39, 0.123, 128, 122, AZURIN H117G OXIDIZED FORM
306, 4hhwB, 0.7432, 2.44, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
307, 3n2jL, 0.7432, 2.41, 0.123, 128, 122, AZURIN H117G OXIDIZED FORM
308, 1r1cC, 0.7432, 2.41, 0.148, 128, 122, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
309, 4hipA, 0.7424, 2.40, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
310, 4hipB, 0.7421, 2.46, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
311, 4hhwA, 0.7414, 2.50, 0.148, 127, 122, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
312, 3n2jE, 0.7414, 2.59, 0.130, 128, 123, AZURIN H117G OXIDIZED FORM
313, 4qktB, 0.7404, 2.38, 0.132, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
314, 3n2jF, 0.7400, 2.42, 0.131, 128, 122, AZURIN H117G OXIDIZED FORM
315, 3n2jG, 0.7396, 2.43, 0.123, 128, 122, AZURIN H117G OXIDIZED FORM
316, 2hxaA, 0.7390, 2.29, 0.142, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
317, 3n2jB, 0.7386, 2.58, 0.130, 128, 123, AZURIN H117G OXIDIZED FORM
318, 2hx8B, 0.7385, 2.47, 0.139, 127, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
319, 5i26C, 0.7383, 2.22, 0.151, 124, 119, AZURIN T30R1 CRYSTAL FORM I
320, 3n2jI, 0.7383, 2.55, 0.130, 128, 123, AZURIN H117G OXIDIZED FORM
321, 3n2jA, 0.7383, 2.43, 0.123, 128, 122, AZURIN H117G OXIDIZED FORM
322, 3n2jJ, 0.7381, 2.58, 0.130, 128, 123, AZURIN H117G OXIDIZED FORM
323, 3n2jD, 0.7380, 2.43, 0.131, 128, 122, AZURIN H117G OXIDIZED FORM
324, 3n2jC, 0.7375, 2.59, 0.130, 128, 123, AZURIN H117G OXIDIZED FORM
325, 3n2jH, 0.7370, 2.45, 0.131, 128, 122, AZURIN H117G OXIDIZED FORM
326, 2hx7B, 0.7367, 2.49, 0.139, 127, 122, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
327, 2hx9A, 0.7361, 2.31, 0.142, 124, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
328, 2hx8A, 0.7358, 2.34, 0.142, 125, 120, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
329, 2hx9B, 0.7350, 2.55, 0.131, 125, 122, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
330, 4qktA, 0.7349, 2.42, 0.140, 125, 121, AZURIN MUTANT M121EM44K WITH COPPER
331, 3fswC, 0.7343, 2.33, 0.126, 124, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
332, 2hx7A, 0.7331, 2.37, 0.142, 125, 120, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
333, 2xv0A, 0.7329, 2.51, 0.133, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.8
334, 2ftaC, 0.7323, 2.34, 0.134, 124, 119, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
335, 2ftaA, 0.7280, 2.19, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
336, 2xv2A, 0.7277, 2.57, 0.133, 124, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.2
337, 2ftaD, 0.7275, 2.19, 0.145, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
338, 2ft7A, 0.7263, 2.28, 0.137, 122, 117, STRUCTURE OF CU(I)AZURIN AT PH 6 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
339, 3fs9A, 0.7256, 2.59, 0.125, 125, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM)
340, 2ftaB, 0.7254, 2.31, 0.144, 123, 118, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
341, 2ft8A, 0.7250, 2.24, 0.137, 122, 117, STRUCTURE OF CU(I)AZURIN PH8 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
342, 3oqrA, 0.7249, 2.41, 0.134, 123, 119, C112D/M121E AZURIN PH 10.0
343, 2ft6A, 0.7237, 2.30, 0.137, 122, 117, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
344, 3fsaA, 0.7215, 2.58, 0.126, 122, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM); CHEMICALLY REDUCED.
345, 5yt7C, 0.6666, 2.44, 0.119, 130, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
346, 5yt7B, 0.6641, 2.40, 0.128, 132, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
347, 5yt7D, 0.6603, 2.53, 0.119, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
348, 5yt7A, 0.6600, 2.49, 0.119, 133, 109, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
349, 1a8zA, 0.6504, 2.15, 0.192, 153, 104, STRUCTURE DETERMINATION OF A 16.8KDA COPPER PROTEIN RUSTICYANIN AT 2.1A RESOLUTION USING ANOMALOUS SCATTERING DATA WITH DIRECT METHODS
350, 2cakA, 0.6494, 2.15, 0.183, 154, 104, 1.27ANGSTROM STRUCTURE OF RUSTICYANIN FROM THIOBACILLUS FERROOXIDANS
351, 1e30A, 0.6487, 2.20, 0.173, 153, 104, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
352, 1a3zA, 0.6485, 2.17, 0.183, 150, 104, REDUCED RUSTICYANIN AT 1.9 ANGSTROMS
353, 1gy2B, 0.6479, 2.20, 0.173, 155, 104, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
354, 1gy1B, 0.6475, 2.22, 0.183, 154, 104, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
355, 1gy1A, 0.6474, 2.19, 0.183, 154, 104, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
356, 1e30B, 0.6474, 2.23, 0.173, 153, 104, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
357, 1rcyA, 0.6471, 2.18, 0.183, 151, 104, RUSTICYANIN (RC) FROM THIOBACILLUS FERROOXIDANS
358, 1gy2A, 0.6465, 2.23, 0.173, 155, 104, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
359, 5ue6F, 0.6456, 1.86, 0.228, 307, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
360, 1ntdA, 0.6456, 1.87, 0.238, 336, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE MUTANT M150E THAT CONTAINS ZINC
361, 2calA, 0.6454, 2.21, 0.173, 153, 104, CRYSTAL STRUCTURE OF HIS143MET RUSTICYANIN
362, 5ue6C, 0.6453, 1.87, 0.228, 310, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
363, 1kbvE, 0.6451, 1.86, 0.228, 302, 101, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
364, 2avfC, 0.6450, 2.15, 0.235, 316, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
365, 1ndsA, 0.6450, 2.15, 0.206, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
366, 5tb7A, 0.6449, 1.87, 0.228, 312, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
367, 1ndsC, 0.6449, 2.15, 0.206, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
368, 1j9rB, 0.6449, 1.88, 0.238, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
369, 5ue6I, 0.6448, 1.87, 0.228, 311, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
370, 5ue6H, 0.6448, 1.88, 0.228, 310, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
371, 1kbvB, 0.6448, 1.87, 0.228, 302, 101, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
372, 5ue6E, 0.6447, 1.88, 0.228, 310, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
373, 5tb7B, 0.6447, 1.88, 0.228, 311, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
374, 2ppfB, 0.6447, 2.16, 0.235, 337, 102, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
375, 1kbwB, 0.6447, 1.87, 0.228, 302, 101, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
376, 2ppaB, 0.6446, 2.16, 0.235, 337, 102, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
377, 1kbwC, 0.6446, 1.88, 0.228, 302, 101, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
378, 1kbwA, 0.6446, 1.88, 0.228, 302, 101, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
379, 1kbvA, 0.6446, 1.87, 0.228, 302, 101, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
380, 1et7A, 0.6446, 1.88, 0.248, 339, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASP MUTANT FROM ALCALIGENES FAECALIS S-6
381, 5tb7C, 0.6445, 1.88, 0.228, 311, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
382, 5d4jB, 0.6445, 2.17, 0.235, 336, 102, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
383, 5ue6B, 0.6444, 1.88, 0.228, 310, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
384, 3h56A, 0.6444, 1.88, 0.238, 335, 101, MET150LEU/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
385, 1kbwE, 0.6444, 1.88, 0.228, 302, 101, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
386, 1j9tB, 0.6444, 1.88, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
387, 1kbwF, 0.6443, 1.88, 0.228, 302, 101, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
388, 1kbvD, 0.6443, 1.87, 0.228, 302, 101, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
389, 1j9rC, 0.6443, 1.88, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
390, 2pp9B, 0.6442, 2.16, 0.235, 337, 102, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
391, 1kbwD, 0.6442, 1.88, 0.228, 302, 101, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
392, 1et8A, 0.6442, 1.90, 0.238, 339, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASN MUTANT FROM ALCALIGENES FAECALIS
393, 1snrB, 0.6441, 2.17, 0.235, 337, 102, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
394, 1sjmB, 0.6441, 2.17, 0.235, 336, 102, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
395, 1ndsB, 0.6441, 1.87, 0.218, 330, 101, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
396, 1ndrC, 0.6441, 2.15, 0.206, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
397, 1et5A, 0.6441, 2.17, 0.235, 336, 102, CRYSTAL STRUCTURE OF NITRITE REDUCTASE ASP98ASN MUTANT FROM ALCALIGENES FAECALIS S-6
398, 1as8B, 0.6441, 1.88, 0.248, 336, 101, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
399, 5ue6D, 0.6440, 1.88, 0.228, 309, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
400, 2e86B, 0.6440, 2.17, 0.235, 337, 102, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
401, 2b08B, 0.6440, 1.89, 0.228, 336, 101, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
402, 2afnA, 0.6440, 1.90, 0.238, 331, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
403, 1ndrA, 0.6440, 2.15, 0.206, 330, 102, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
404, 3h4fB, 0.6439, 2.16, 0.235, 336, 102, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
405, 1niaC, 0.6439, 1.90, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
406, 1l9oB, 0.6439, 1.88, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
407, 1kcbA, 0.6439, 1.90, 0.238, 333, 101, CRYSTAL STRUCTURE OF A NO-FORMING NITRITE REDUCTASE MUTANT: AN ANALOG OF A TRANSITION STATE IN ENZYMATIC REACTION
408, 5f7aB, 0.6438, 1.90, 0.238, 337, 101, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
409, 2ppfC, 0.6438, 2.17, 0.235, 336, 102, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
410, 1nibB, 0.6438, 1.91, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
411, 1l9pB, 0.6438, 1.88, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
412, 5ue6G, 0.6437, 1.88, 0.228, 314, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
413, 2ppdB, 0.6437, 1.90, 0.228, 337, 101, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
414, 2ppaC, 0.6437, 2.17, 0.235, 336, 102, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
415, 2afnC, 0.6437, 1.89, 0.248, 331, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
416, 2afnB, 0.6437, 1.90, 0.238, 331, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
417, 5f7bB, 0.6436, 1.90, 0.238, 337, 101, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
418, 3zbmA, 0.6436, 1.91, 0.208, 455, 101, STRUCTURE OF M92A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII
419, 2ppeB, 0.6436, 1.90, 0.228, 337, 101, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
420, 1npjB, 0.6436, 1.90, 0.228, 336, 101, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
421, 1niaB, 0.6436, 1.91, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
422, 1l9rB, 0.6436, 1.90, 0.238, 336, 101, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
423, 1l9qB, 0.6436, 1.89, 0.248, 336, 101, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
424, 1j9qB, 0.6436, 1.89, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
425, 5d4iB, 0.6435, 1.90, 0.238, 341, 101, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
426, 2nrdA, 0.6435, 1.91, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
427, 2avfE, 0.6435, 1.92, 0.238, 315, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
428, 1npnB, 0.6435, 1.90, 0.228, 336, 101, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
429, 1ndtA, 0.6435, 2.18, 0.235, 336, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
430, 1l9tB, 0.6435, 1.89, 0.248, 336, 101, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
431, 5og6A, 0.6434, 1.90, 0.248, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.24MGY 
432, 5d4iA, 0.6434, 1.91, 0.238, 334, 101, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
433, 2xx1A, 0.6434, 1.90, 0.238, 335, 101, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
434, 1nibC, 0.6434, 1.91, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
435, 1ndrB, 0.6434, 1.88, 0.218, 330, 101, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
436, 1j9sB, 0.6434, 1.90, 0.238, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
437, 2jfcA, 0.6433, 2.19, 0.225, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
438, 1nibA, 0.6433, 1.91, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
439, 1l9sB, 0.6433, 1.89, 0.248, 336, 101, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
440, 1gs8A, 0.6433, 2.18, 0.235, 336, 102, CRYSTAL STRUCTURE OF  MUTANT D92N ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
441, 6gcgA, 0.6432, 1.92, 0.238, 333, 101, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE POLYMORPH DATASET 15 
442, 5ue6A, 0.6432, 1.89, 0.228, 314, 101, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
443, 5d4hB, 0.6432, 1.91, 0.238, 341, 101, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
444, 2fjsB, 0.6432, 1.91, 0.238, 337, 101, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
445, 1nicA, 0.6432, 1.92, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
446, 1as6B, 0.6432, 1.89, 0.248, 336, 101, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
447, 5ofgA, 0.6431, 1.92, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.06MGY 
448, 5n8hA, 0.6431, 1.92, 0.238, 333, 101, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 3.
449, 4yseB, 0.6431, 1.90, 0.248, 337, 101, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
450, 2pp8B, 0.6431, 1.91, 0.238, 336, 101, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
451, 2p80B, 0.6431, 1.89, 0.248, 336, 101, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
452, 2fjsC, 0.6431, 2.18, 0.235, 336, 102, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
453, 1sjmC, 0.6431, 2.18, 0.235, 336, 102, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
454, 1nieA, 0.6431, 1.92, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
455, 1niaA, 0.6431, 1.91, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
456, 1j9sC, 0.6431, 1.90, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
457, 6gb8A, 0.6430, 1.92, 0.238, 333, 101, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: SMALL CELL POLYMORPH DATASET 1 
458, 5og5A, 0.6430, 1.91, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.21MGY 
459, 5og4A, 0.6430, 1.92, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.18MGY 
460, 5og3A, 0.6430, 1.91, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
461, 5og2A, 0.6430, 1.92, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.09MGY 
462, 5ofhA, 0.6430, 1.92, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
463, 5d4jA, 0.6430, 1.89, 0.248, 335, 101, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
464, 5d4iC, 0.6430, 1.92, 0.238, 334, 101, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
465, 4cspA, 0.6430, 2.19, 0.235, 335, 102, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
466, 2zooA, 0.6430, 1.93, 0.218, 438, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM PSEUDOALTEROMONAS HALOPLANKTIS TAC125
467, 2ppcB, 0.6430, 1.91, 0.238, 337, 101, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
468, 2pp9C, 0.6430, 2.17, 0.235, 336, 102, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
469, 2pp7B, 0.6430, 1.91, 0.238, 337, 101, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
470, 1snrC, 0.6430, 2.18, 0.235, 336, 102, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
471, 1nidA, 0.6430, 1.92, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
472, 1mzzC, 0.6430, 1.91, 0.218, 334, 101, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
473, 1kbvF, 0.6430, 1.89, 0.228, 302, 101, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
474, 1as7B, 0.6430, 1.89, 0.248, 337, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
475, 6gbyA, 0.6429, 1.91, 0.248, 333, 101, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: NON- POLYMORPH SEPARATED DATASET 1 
476, 5n8gA, 0.6429, 1.92, 0.238, 333, 101, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 2.
477, 5i6pA, 0.6429, 1.92, 0.238, 332, 101, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 27.60 MGY
478, 2xwzF, 0.6429, 2.19, 0.235, 334, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
479, 2jfcF, 0.6429, 2.19, 0.225, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
480, 1npjC, 0.6429, 2.18, 0.225, 336, 102, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
481, 1l9pC, 0.6429, 1.89, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
482, 1l9oC, 0.6429, 1.91, 0.238, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
483, 1j9tC, 0.6429, 1.90, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
484, 6gtjA, 0.6428, 1.92, 0.238, 333, 101, NEUTRON CRYSTAL STRUCTURE FOR COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.8 A RESOLUTION 
485, 6gbbA, 0.6428, 1.92, 0.238, 333, 101, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE CELL POLYMORPH DATASET 1 
486, 5oggA, 0.6428, 1.92, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.30MGY 
487, 5f7bA, 0.6428, 1.92, 0.238, 336, 101, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
488, 4yscB, 0.6428, 1.91, 0.238, 336, 101, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
489, 4yscA, 0.6428, 2.18, 0.235, 336, 102, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
490, 2xwzA, 0.6428, 2.19, 0.235, 335, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
491, 2dv6A, 0.6428, 1.91, 0.228, 422, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
492, 1rzqB, 0.6428, 1.92, 0.238, 328, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
493, 1kbvC, 0.6428, 1.89, 0.228, 302, 101, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
494, 1gs7A, 0.6428, 2.18, 0.235, 336, 102, CRYSTAL STRUCTURE OF H254F MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
495, 1gs6X, 0.6428, 1.91, 0.228, 336, 101, CRYSTAL STRUCTURE OF M144A MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
496, 1aq8B, 0.6428, 1.92, 0.238, 331, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
497, 5n8fA, 0.6427, 1.92, 0.238, 333, 101, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 1.
498, 3h4hB, 0.6427, 1.90, 0.248, 334, 101, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
499, 2xxfB, 0.6427, 2.19, 0.235, 335, 102, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
500, 2xx1F, 0.6427, 1.91, 0.238, 335, 101, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
501, 2p80C, 0.6427, 2.18, 0.235, 336, 102, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
502, 2jfcD, 0.6427, 2.20, 0.225, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
503, 2e86C, 0.6427, 2.19, 0.235, 336, 102, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
504, 2dv6F, 0.6427, 1.92, 0.228, 422, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
505, 1zdsB, 0.6427, 1.90, 0.238, 336, 101, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
506, 1hauA, 0.6427, 1.92, 0.238, 336, 101, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9 A RESOLUTION
507, 1bq5A, 0.6427, 1.90, 0.248, 333, 101, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS GIFU 1051
508, 6fjaA, 0.6426, 1.92, 0.208, 455, 101, CRYSTAL STRUCTURE OF T2D THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
509, 5ogfA, 0.6426, 1.92, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.27MGY 
510, 5i6oA, 0.6426, 1.92, 0.238, 332, 101, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 20.70 MGY
511, 5f7bC, 0.6426, 1.92, 0.238, 336, 101, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
512, 5f7aC, 0.6426, 1.92, 0.238, 336, 101, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
513, 2ppfA, 0.6426, 2.18, 0.235, 336, 102, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
514, 1l9sC, 0.6426, 1.90, 0.248, 336, 101, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
515, 5offA, 0.6425, 1.92, 0.238, 332, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.03MGY 
516, 5f7aA, 0.6425, 1.92, 0.238, 336, 101, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
517, 3ziyA, 0.6425, 1.92, 0.208, 457, 101, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE  FROM RALSTONIA PICKETTII AT 1.01 A RESOLUTION
518, 2yqbA, 0.6425, 1.92, 0.218, 454, 101, STRUCTURE OF P93A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.4 A RESOLUTION
519, 2vw6B, 0.6425, 1.92, 0.238, 334, 101, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
520, 2ppeA, 0.6425, 1.90, 0.238, 336, 101, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
521, 2ppdC, 0.6425, 1.90, 0.238, 336, 101, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
522, 2b08A, 0.6425, 2.18, 0.225, 335, 102, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
523, 1nifA, 0.6425, 1.93, 0.238, 333, 101, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
524, 1as8A, 0.6425, 1.91, 0.248, 336, 101, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
525, 1as6C, 0.6425, 1.90, 0.248, 335, 101, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
526, 5d4hA, 0.6424, 1.91, 0.248, 337, 101, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
527, 2xxfA, 0.6424, 2.19, 0.235, 335, 102, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
528, 2vw4B, 0.6424, 1.92, 0.238, 333, 101, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
529, 2bp0B, 0.6424, 1.91, 0.228, 335, 101, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
530, 1l9tC, 0.6424, 1.92, 0.238, 336, 101, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
531, 1l9rC, 0.6424, 1.92, 0.238, 336, 101, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
532, 1l9qC, 0.6424, 1.92, 0.238, 336, 101, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
533, 1hawA, 0.6424, 1.92, 0.238, 336, 101, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION
534, 2vw7A, 0.6423, 1.93, 0.238, 335, 101, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
535, 2ppaA, 0.6423, 2.18, 0.235, 336, 102, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
536, 2pp8A, 0.6423, 2.18, 0.235, 336, 102, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
537, 2dy2A, 0.6423, 1.92, 0.228, 329, 101, NITRITE REDUCTASE PH 6.0
538, 2dv6D, 0.6423, 1.92, 0.228, 422, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
539, 2dv6B, 0.6423, 1.92, 0.228, 422, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
540, 2bwdA, 0.6423, 1.92, 0.238, 334, 101, ATOMIC RESOLUTION STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH ENDOGENOUSLY BOUND NITRITE AND NO
541, 1rzqA, 0.6423, 1.92, 0.238, 328, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
542, 1mzzB, 0.6423, 1.92, 0.218, 334, 101, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
543, 1j9qC, 0.6423, 1.92, 0.238, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
544, 1as7C, 0.6423, 1.90, 0.248, 337, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
545, 6gtiA, 0.6422, 1.92, 0.238, 333, 101, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.0 
546, 5ocfA, 0.6422, 1.92, 0.208, 455, 101, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND TO THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
547, 2ppcC, 0.6422, 1.92, 0.238, 336, 101, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
548, 2pp7C, 0.6422, 1.92, 0.238, 336, 101, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
549, 1waeA, 0.6422, 1.92, 0.238, 334, 101, CRYSTAL STRUCTURE OF H129V MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
550, 1wa1X, 0.6422, 1.93, 0.238, 335, 101, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
551, 1snrA, 0.6422, 2.19, 0.235, 336, 102, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
552, 1npnC, 0.6422, 1.92, 0.228, 336, 101, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
553, 1as8C, 0.6422, 1.90, 0.248, 336, 101, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
554, 5oboA, 0.6421, 1.93, 0.208, 456, 101, CRYSTAL STRUCTURE OF NITRITE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
555, 5i6nA, 0.6421, 1.93, 0.238, 332, 101, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 11.73 MGY
556, 4yscC, 0.6421, 1.93, 0.238, 335, 101, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
557, 4cszA, 0.6421, 1.93, 0.238, 335, 101, STRUCTURE OF F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS WITH NITRITE BOUND
558, 2y1aA, 0.6421, 1.93, 0.238, 332, 101, CRYSTAL STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH BOUND NO
559, 1sjmA, 0.6421, 2.19, 0.235, 335, 102, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
560, 1n70A, 0.6421, 1.93, 0.218, 334, 101, THE CRYSTAL STRUCTURE OF NITRITE REDUCTASE MUTANT HIS287ALA FROM RHODOBACTER SPHAEROIDES
561, 1mzzA, 0.6421, 1.92, 0.218, 334, 101, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
562, 6gtkA, 0.6420, 1.93, 0.238, 333, 101, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.5 
563, 5onyA, 0.6420, 1.93, 0.238, 335, 101, AS-ISOLATED RESTING STATE COPPER NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
564, 5i6lA, 0.6420, 1.93, 0.238, 332, 101, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 2.76 MGY
565, 2vw6A, 0.6420, 1.93, 0.238, 333, 101, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
566, 2vw4A, 0.6420, 1.93, 0.238, 333, 101, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
567, 2vm3A, 0.6420, 1.94, 0.238, 333, 101, STRUCTURE OF ALCALIGENES XYLOSOXIDANS IN SPACE GROUP R3 - 1 OF 2
568, 2ppeC, 0.6420, 1.92, 0.228, 336, 101, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
569, 1zdqB, 0.6420, 1.91, 0.238, 336, 101, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
570, 1rzpB, 0.6420, 1.92, 0.248, 328, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
571, 1oe2A, 0.6420, 2.20, 0.235, 334, 102, ATOMIC RESOLUTION STRUCTURE OF D92E MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
572, 1oe1A, 0.6420, 2.20, 0.235, 335, 102, ATOMIC RESOLUTION STRUCTURE OF THE WILDTYPE NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
573, 6gtlA, 0.6419, 1.93, 0.238, 333, 101, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.0 
574, 4cspF, 0.6419, 1.93, 0.238, 335, 101, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
575, 4ax3D, 0.6419, 1.93, 0.208, 457, 101, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
576, 3h4fC, 0.6419, 2.18, 0.235, 336, 102, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
577, 2xx0A, 0.6419, 2.19, 0.235, 335, 102, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
578, 2vm4A, 0.6419, 1.94, 0.238, 334, 101, STRUCTURE OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE IN SPACE GROUP R3 - 2 OF 2
579, 2ppdA, 0.6419, 1.92, 0.228, 336, 101, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
580, 2pp9A, 0.6419, 2.18, 0.235, 336, 102, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
581, 2pp8C, 0.6419, 1.92, 0.238, 336, 101, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
582, 2bw5A, 0.6419, 1.93, 0.238, 334, 101, ATOMIC RESOLUTION STRUCTURE OF NO-BOUND ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
583, 1wa0X, 0.6419, 1.93, 0.238, 335, 101, CRYSTAL STRUCTURE OF W138H MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
584, 1rzqC, 0.6419, 1.94, 0.238, 332, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
585, 1oe3A, 0.6419, 2.20, 0.235, 335, 102, ATOMIC RESOLUTION STRUCTURE OF  HALF APO  NIR
586, 1l9rA, 0.6419, 1.91, 0.248, 336, 101, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
587, 1l9pA, 0.6419, 1.91, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
588, 1j9sA, 0.6419, 1.91, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
589, 1as6A, 0.6419, 1.91, 0.248, 335, 101, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
590, 5i6mA, 0.6418, 1.93, 0.238, 332, 101, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 7.59 MGY
591, 5i6kA, 0.6418, 1.93, 0.238, 334, 101, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 0.69 MGY
592, 4yseA, 0.6418, 1.91, 0.248, 337, 101, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
593, 2xx0B, 0.6418, 2.19, 0.235, 336, 102, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
594, 2dv6E, 0.6418, 1.92, 0.228, 422, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
595, 2b08C, 0.6418, 1.93, 0.228, 336, 101, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
596, 2a3tA, 0.6418, 1.94, 0.218, 328, 101, CU-CONTAINING NITRITE REDUCTASE
597, 1mzyA, 0.6418, 1.94, 0.218, 331, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE
598, 6f1qA, 0.6417, 1.93, 0.208, 456, 101, CRYSTAL STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII IN I213 SPACE GROUP 
599, 5ocbA, 0.6417, 1.93, 0.208, 453, 101, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
600, 3h4fA, 0.6417, 2.18, 0.235, 336, 102, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
601, 1rzpC, 0.6417, 1.94, 0.238, 332, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
602, 1rzpA, 0.6417, 1.94, 0.238, 328, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
603, 1l9oA, 0.6417, 1.91, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
604, 5d4hC, 0.6416, 1.92, 0.248, 339, 101, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
605, 4ax3C, 0.6416, 1.93, 0.208, 455, 101, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
606, 2vw7B, 0.6416, 1.93, 0.238, 334, 101, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
607, 2vn3A, 0.6416, 2.21, 0.235, 336, 102, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
608, 1aq8C, 0.6416, 1.91, 0.248, 331, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
609, 6gtnA, 0.6415, 1.94, 0.238, 333, 101, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.5 
610, 5d4jC, 0.6415, 1.93, 0.238, 336, 101, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
611, 2zonB, 0.6415, 1.94, 0.238, 334, 101, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
612, 2ppcA, 0.6415, 1.91, 0.248, 336, 101, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
613, 2dv6C, 0.6415, 1.93, 0.228, 422, 101, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
614, 2bp0A, 0.6415, 1.93, 0.228, 335, 101, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
615, 1zdsC, 0.6415, 1.93, 0.228, 336, 101, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
616, 1wa2X, 0.6415, 1.94, 0.238, 334, 101, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE WITH NITRITE BOUND
617, 1l9tA, 0.6415, 1.91, 0.248, 336, 101, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
618, 1l9sA, 0.6415, 1.91, 0.248, 336, 101, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
619, 1as7A, 0.6415, 1.93, 0.238, 337, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
620, 5ofdA, 0.6414, 1.93, 0.238, 333, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
621, 5ofcA, 0.6414, 1.93, 0.238, 334, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 21.65MGY 
622, 4ax3A, 0.6414, 1.94, 0.208, 456, 101, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
623, 2pp7A, 0.6414, 1.91, 0.248, 336, 101, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
624, 2dwtA, 0.6414, 1.95, 0.218, 329, 101, CU-CONTAINING NITRITE REDUCTASE AT PH 6.0 WITH BOUND NITRITE
625, 2bp8B, 0.6414, 1.93, 0.228, 335, 101, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
626, 2bo0A, 0.6414, 2.20, 0.225, 335, 102, CRYSTAL STRUCTURE OF THE C130A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
627, 5onxA, 0.6413, 1.94, 0.238, 335, 101, RESTING STATE COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY
628, 5b1jA, 0.6413, 1.93, 0.248, 334, 101, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
629, 2zonC, 0.6413, 1.94, 0.238, 334, 101, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
630, 2xx1D, 0.6413, 1.94, 0.248, 335, 101, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
631, 2xwzE, 0.6413, 2.20, 0.235, 335, 102, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
632, 1j9tA, 0.6413, 1.91, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
633, 5of8A, 0.6412, 1.94, 0.238, 333, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
634, 5b1kA, 0.6412, 1.94, 0.238, 334, 101, CRYSTAL STRUCTURE OF THE CHLORIDE-BOUND FORM OF BLUE COPPER NITRITE REDUCTASE
635, 5b1jB, 0.6412, 1.93, 0.238, 334, 101, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
636, 2fjsA, 0.6412, 1.94, 0.238, 336, 101, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
637, 1npjA, 0.6412, 1.93, 0.228, 336, 101, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
638, 1j9rA, 0.6412, 1.92, 0.248, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
639, 1j9qA, 0.6412, 1.93, 0.238, 336, 101, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
640, 6gt2A, 0.6411, 1.93, 0.248, 333, 101, REDUCED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
641, 6gsqA, 0.6411, 1.94, 0.238, 333, 101, OXIDISED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
642, 5ofeA, 0.6411, 1.94, 0.238, 334, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
643, 3h4hC, 0.6411, 1.92, 0.248, 334, 101, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
644, 2xwzD, 0.6411, 1.94, 0.238, 335, 101, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
645, 1aq8A, 0.6411, 1.94, 0.238, 331, 101, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
646, 5of7A, 0.6410, 1.94, 0.238, 334, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
647, 2p80A, 0.6410, 1.92, 0.248, 335, 101, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
648, 2e86A, 0.6410, 1.92, 0.248, 336, 101, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
649, 2bw4A, 0.6410, 1.94, 0.238, 334, 101, ATOMIC RESOLUTION STRUCTURE OF RESTING STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
650, 2bp8A, 0.6410, 1.93, 0.228, 335, 101, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
651, 1zdqC, 0.6410, 1.92, 0.238, 336, 101, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
652, 1npnA, 0.6410, 1.93, 0.228, 336, 101, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
653, 6gt0A, 0.6409, 1.94, 0.238, 333, 101, NITRITE-BOUND COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
654, 5of6A, 0.6409, 1.94, 0.238, 334, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
655, 3h4hA, 0.6409, 1.92, 0.248, 334, 101, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
656, 2jfcB, 0.6409, 2.21, 0.225, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
657, 2dwsA, 0.6409, 1.95, 0.218, 328, 101, CU-CONTAINING NITRITE REDUCTASE AT PH 8.4 WITH BOUND NITRITE
658, 1l9qA, 0.6409, 1.93, 0.238, 336, 101, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
659, 2jfcE, 0.6408, 2.21, 0.225, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
660, 5akrA, 0.6407, 1.95, 0.238, 337, 101, ATOMIC RESOLUTION STRUCTURE OF NITRITE BOUND STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE AT 0.87 A RESOLUTION
661, 2jfcC, 0.6407, 2.22, 0.225, 335, 102, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
662, 1zdsA, 0.6407, 1.92, 0.238, 335, 101, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
663, 5n8iA, 0.6406, 1.95, 0.238, 334, 101, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 100K REFERENCE DATASET.
664, 4ax3B, 0.6406, 1.94, 0.208, 455, 101, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
665, 1zv2A, 0.6406, 1.95, 0.218, 328, 101, CU-CONTAINING NITRITE REDUCTASE
666, 2xxgC, 0.6404, 1.95, 0.238, 335, 101, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
667, 2xxgA, 0.6402, 1.96, 0.238, 334, 101, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
668, 1zdqA, 0.6402, 1.93, 0.238, 335, 101, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
669, 4yseC, 0.6401, 1.93, 0.248, 337, 101, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
670, 2zonA, 0.6400, 1.95, 0.238, 334, 101, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
671, 5zl1C, 0.6399, 1.97, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
672, 5zl1D, 0.6398, 1.97, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
673, 5zl1A, 0.6398, 1.97, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
674, 2bwiA, 0.6398, 1.96, 0.238, 334, 101, ATOMIC RESOLUTION STRUCTURE OF NITRITE -SOAKED ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
675, 5zl1B, 0.6396, 1.97, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
676, 2xwzB, 0.6394, 1.97, 0.238, 335, 101, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
677, 2xwzC, 0.6391, 1.97, 0.238, 335, 101, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
678, 3fsvA, 0.6389, 2.81, 0.093, 118, 108, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAHAAAM)
679, 5of5A, 0.6386, 2.00, 0.238, 333, 101, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 
680, 2avfF, 0.6383, 2.58, 0.233, 323, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
681, 2xx1E, 0.6380, 1.99, 0.238, 335, 101, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
682, 2xx1C, 0.6376, 2.01, 0.238, 334, 101, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
683, 2xx1B, 0.6376, 2.01, 0.238, 335, 101, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
684, 4enzA, 0.6366, 2.77, 0.178, 1029, 107, STRUCTURE OF HUMAN CERULOPLASMIN AT 2.6 A RESOLUTION
685, 4q89A, 0.6360, 2.58, 0.106, 501, 104, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
686, 4q8bA, 0.6357, 2.59, 0.106, 499, 104, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
687, 2bhfA, 0.6353, 2.76, 0.105, 504, 105, 3D STRUCTURE OF THE REDUCED FORM OF COTA
688, 4yvuA, 0.6352, 2.78, 0.105, 506, 105, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME IN THE ACID CONDITION PH5.6
689, 2x87A, 0.6352, 2.77, 0.105, 504, 105, CRYSTAL STRUCTURE OF THE RECONSTITUTED COTA
690, 1gskA, 0.6352, 2.77, 0.105, 502, 105, CRYSTAL STRUCTURE OF COTA AN ENDOSPORE COAT PROTEIN FROM BACILLUS SUBTILIS
691, 4knsB, 0.6351, 2.10, 0.210, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
692, 4yvnA, 0.6350, 2.78, 0.105, 505, 105, CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH ABTS AT A NOVEL BINDING SITE
693, 5zljA, 0.6349, 2.78, 0.105, 503, 105, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME; PH8.0 
694, 4akqA, 0.6349, 2.78, 0.105, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498D MUTANT
695, 4akpA, 0.6348, 2.78, 0.105, 504, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE:E498T MUTANT
696, 4akoA, 0.6348, 2.78, 0.105, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498L MUTANT
697, 5zllA, 0.6347, 2.77, 0.105, 503, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493C MUTANT; PH 8.0 
698, 4knuD, 0.6347, 2.11, 0.210, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
699, 4knsC, 0.6345, 2.10, 0.210, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
700, 4a66A, 0.6345, 2.77, 0.114, 501, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116A MUTANT
701, 2x88A, 0.6345, 2.78, 0.105, 504, 105, CRYSTAL STRUCTURE OF HOLOCOTA
702, 1w6lA, 0.6345, 2.78, 0.105, 503, 105, 3D STRUCTURE OF COTA INCUBATED WITH CUCL2
703, 4knsD, 0.6344, 2.11, 0.210, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
704, 4a67A, 0.6344, 2.77, 0.105, 504, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116E MUTANT
705, 4knuB, 0.6343, 2.11, 0.210, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
706, 4a68A, 0.6343, 2.77, 0.105, 502, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116N MUTANT
707, 2wsdA, 0.6342, 2.79, 0.105, 504, 105, PROXIMAL MUTATIONS AT THE TYPE 1 CU SITE OF COTA-LACCASE: I494A MUTANT
708, 1of0A, 0.6342, 2.59, 0.106, 502, 104, CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH EBS
709, 5zlmA, 0.6339, 2.60, 0.106, 502, 104, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H491C MUTANT; PH 8.0 
710, 5zlkA, 0.6339, 2.78, 0.105, 506, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493A MUTANT; PH 8.0 
711, 1w6wA, 0.6339, 2.60, 0.106, 502, 104, 3D STRUCTURE OF COTA INCUBATED WITH SODIUM AZIDE
712, 4q8bB, 0.6338, 2.60, 0.106, 499, 104, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
713, 4kntC, 0.6338, 2.12, 0.210, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
714, 4kntA, 0.6337, 2.12, 0.210, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
715, 3zdwA, 0.6337, 2.60, 0.106, 502, 104, SUBSTRATE AND DIOXYGEN BINDING TO THE ENDOSPORE COAT LACCASE COTA FROM BACILLUS SUBTILIS
716, 1w8eA, 0.6336, 2.60, 0.106, 505, 104, 3D STRUCTURE OF COTA INCUBATED WITH HYDROGEN PEROXIDE
717, 4kntB, 0.6335, 2.12, 0.210, 285, 100, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
718, 4knsA, 0.6335, 2.11, 0.210, 285, 100, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
719, 4bxsV, 0.6333, 2.46, 0.154, 1262, 104, CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS
720, 1curA, 0.6333, 2.39, 0.181, 155, 105, REDUCED RUSTICYANIN NMR
721, 4q89B, 0.6324, 2.62, 0.106, 499, 104, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
722, 2avfA, 0.6323, 2.29, 0.238, 314, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
723, 2avfB, 0.6307, 2.29, 0.240, 316, 100, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
724, 1qniA, 0.6306, 1.80, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
725, 3gdcC, 0.6305, 1.77, 0.173, 286, 98, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
726, 1qniE, 0.6304, 1.80, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
727, 2avfD, 0.6303, 2.10, 0.242, 320, 99, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
728, 3gdcB, 0.6301, 1.78, 0.173, 285, 98, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
729, 3wiaG, 0.6295, 2.09, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
730, 3wiaD, 0.6295, 2.09, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
731, 3gdcA, 0.6295, 1.80, 0.173, 288, 98, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
732, 1qniF, 0.6295, 1.81, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
733, 1qniC, 0.6295, 1.81, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
734, 3wiaA, 0.6293, 2.09, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
735, 1qniB, 0.6292, 1.81, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
736, 3x1gA, 0.6291, 2.09, 0.212, 296, 99, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS SHOWING TWO COORDINATION GEOMETRIES AT THE T2CU SITE
737, 1qniD, 0.6290, 1.82, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
738, 1sddA, 0.6289, 2.99, 0.139, 268, 108, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
739, 3wiaC, 0.6287, 2.10, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
740, 3wiaB, 0.6286, 2.10, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
741, 6iqzA, 0.6284, 2.51, 0.079, 535, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
742, 5zd6A, 0.6284, 2.51, 0.079, 535, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
743, 3x1fA, 0.6284, 2.10, 0.212, 296, 99, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
744, 3wiaH, 0.6284, 2.11, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
745, 3wiaF, 0.6282, 2.11, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
746, 3wiaE, 0.6279, 2.10, 0.202, 273, 99, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
747, 6iqyB, 0.6278, 2.50, 0.079, 536, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
748, 5zd7B, 0.6278, 2.50, 0.079, 536, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
749, 4ysdA, 0.6277, 1.82, 0.214, 299, 98, ROOM TEMPERATURE STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
750, 2xllA, 0.6277, 2.50, 0.079, 533, 101, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
751, 4ysaA, 0.6276, 1.83, 0.214, 294, 98, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
752, 2xllC, 0.6276, 2.51, 0.079, 533, 101, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
753, 2xllB, 0.6276, 2.51, 0.079, 533, 101, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
754, 2xllD, 0.6275, 2.50, 0.079, 533, 101, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
755, 1fwxA, 0.6273, 1.82, 0.175, 591, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
756, 6iqyA, 0.6272, 2.50, 0.079, 536, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
757, 5zd7A, 0.6272, 2.50, 0.079, 536, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
758, 3x1nA, 0.6272, 1.83, 0.204, 298, 98, NITRITE-BOUND THERMOSTABLE COPPER NITRITE REDUCTASE AT 320 K
759, 6iqxB, 0.6270, 2.51, 0.079, 535, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
760, 1fwxC, 0.6270, 1.82, 0.175, 590, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
761, 5ytlA, 0.6268, 1.84, 0.214, 294, 98, CRYSTAL STRUCTURE OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE DETERMINED WITH AN ANAEROBICALLY MANIPULATED CRYSTAL 
762, 6iqxA, 0.6267, 2.51, 0.079, 535, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
763, 4ystA, 0.6266, 1.84, 0.214, 294, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 24.9 MGY
764, 4ysrA, 0.6266, 1.84, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.6 MGY
765, 4zk8A, 0.6265, 1.85, 0.214, 294, 98, COPPER-CONTAINING NITRITE REDUCTASE FROM THERMOPHILIC BACTERIUM GEOBACILLUS THERMODENITRIFICANS (RE-REFINED)
766, 4yspA, 0.6265, 1.84, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.32 MGY
767, 5ytnA, 0.6264, 1.85, 0.204, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH PEROXIDE 
768, 3wkqA, 0.6264, 1.85, 0.214, 299, 98, COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH FORMATE
769, 4ysuA, 0.6263, 1.85, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 25.0 MGY
770, 4yssA, 0.6263, 1.85, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.7 MGY
771, 5ytmA, 0.6262, 1.85, 0.204, 298, 98, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS DETERMINED BY IN-OUSE SOURCE 
772, 4ysqA, 0.6262, 1.85, 0.214, 295, 98, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.38 MGY
773, 3x1eA, 0.6262, 1.85, 0.214, 295, 98, STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS WITHOUT CHLORIDE
774, 4ysoA, 0.6260, 1.85, 0.214, 295, 98, COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 0.064 MGY
775, 3wniA, 0.6259, 1.85, 0.214, 298, 98, 1.50 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
776, 3wnjA, 0.6258, 1.85, 0.214, 298, 98, 1.20 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
777, 3wkpA, 0.6258, 1.86, 0.204, 295, 98, C135A MUTANT OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE IN COMPLEX WITH NITRITE
778, 5i5mA, 0.6252, 1.83, 0.155, 575, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
779, 5i5mB, 0.6248, 1.84, 0.155, 576, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
780, 6rkzB, 0.6235, 1.92, 0.224, 586, 98, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
781, 3g5wA, 0.6235, 2.18, 0.172, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
782, 2iwfB, 0.6235, 1.80, 0.187, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
783, 6rl0C, 0.6232, 1.87, 0.227, 582, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
784, 3wiaI, 0.6232, 1.82, 0.206, 272, 97, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
785, 6rl0D, 0.6231, 1.87, 0.227, 581, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
786, 5n4lA, 0.6231, 2.79, 0.162, 1034, 105, RAT CERULOPLASMIN TRIGONAL FORM
787, 3kw8A, 0.6229, 2.55, 0.139, 273, 101, TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR AT 2.3 A RESOLUTION
788, 2iwfA, 0.6228, 1.81, 0.187, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
789, 2iwkA, 0.6225, 1.82, 0.187, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
790, 3g5wE, 0.6224, 2.19, 0.172, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
791, 4e9wC, 0.6221, 2.21, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
792, 6rl0A, 0.6220, 1.88, 0.227, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
793, 4e9yC, 0.6220, 2.21, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
794, 3cg8C, 0.6220, 2.36, 0.140, 272, 100, LACCASE FROM STREPTOMYCES COELICOLOR
795, 2iwkB, 0.6220, 1.83, 0.187, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
796, 4e9vC, 0.6219, 2.21, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA1)
797, 3tbbB, 0.6219, 2.53, 0.129, 278, 101, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
798, 6rl0B, 0.6218, 1.88, 0.227, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
799, 4e9xC, 0.6218, 2.22, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA3)
800, 3cg8B, 0.6218, 2.34, 0.130, 272, 100, LACCASE FROM STREPTOMYCES COELICOLOR
801, 3cg8A, 0.6217, 2.35, 0.130, 270, 100, LACCASE FROM STREPTOMYCES COELICOLOR
802, 1fwxB, 0.6217, 1.81, 0.177, 589, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
803, 3g5wC, 0.6216, 2.20, 0.172, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
804, 3g5wF, 0.6215, 2.20, 0.172, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
805, 3g5wD, 0.6215, 2.20, 0.172, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
806, 4nb7A, 0.6214, 2.33, 0.130, 280, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 180 MIN SOAKING
807, 3tasA, 0.6214, 2.33, 0.120, 300, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
808, 2zwnC, 0.6213, 2.22, 0.202, 316, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
809, 5o3kF, 0.6212, 2.37, 0.130, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
810, 3g5wB, 0.6212, 2.20, 0.172, 318, 99, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
811, 5o4iA, 0.6211, 2.35, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
812, 1fwxD, 0.6211, 1.83, 0.177, 588, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
813, 5lhlC, 0.6210, 2.35, 0.130, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
814, 4uanB, 0.6209, 2.55, 0.119, 270, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
815, 4gybA, 0.6209, 2.34, 0.130, 279, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AT 2.4 A RESOLUTION AC1709
816, 5o4qF, 0.6208, 2.56, 0.139, 275, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
817, 4e9vA, 0.6208, 2.23, 0.202, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA1)
818, 6rhqF, 0.6207, 2.35, 0.130, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
819, 3tasC, 0.6207, 2.34, 0.120, 300, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
820, 6s0oB, 0.6206, 2.32, 0.140, 280, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
821, 4gxfC, 0.6206, 2.35, 0.130, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
822, 4e9yA, 0.6206, 2.24, 0.202, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
823, 4e9xA, 0.6206, 2.24, 0.202, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA3)
824, 5o4iL, 0.6205, 2.37, 0.130, 280, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
825, 5k8dA, 0.6205, 3.04, 0.130, 611, 108, CRYSTAL STRUCTURE OF RFVIIIFC
826, 4e9wA, 0.6205, 2.24, 0.202, 317, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
827, 2zwnA, 0.6205, 2.24, 0.202, 317, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
828, 5o4iB, 0.6204, 2.37, 0.130, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
829, 4gxfB, 0.6204, 2.32, 0.140, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
830, 3sbpF, 0.6204, 1.90, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
831, 4wtqB, 0.6203, 2.42, 0.120, 269, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
832, 6rhqA, 0.6202, 2.33, 0.140, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
833, 5o4iK, 0.6202, 2.35, 0.140, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
834, 4wtqC, 0.6202, 2.42, 0.120, 269, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
835, 3tbcB, 0.6201, 2.33, 0.120, 278, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
836, 6fdjF, 0.6200, 2.37, 0.140, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
837, 5o4qJ, 0.6200, 2.36, 0.130, 280, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
838, 5o4qD, 0.6200, 2.37, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
839, 5o4qC, 0.6200, 2.37, 0.130, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
840, 5o4iC, 0.6200, 2.62, 0.139, 277, 101, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
841, 4uahB, 0.6200, 2.35, 0.110, 271, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
842, 4gy4B, 0.6200, 2.34, 0.130, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
843, 2uxtA, 0.6200, 2.53, 0.099, 422, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
844, 3tasB, 0.6199, 2.31, 0.130, 301, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
845, 3sbqA, 0.6199, 1.90, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
846, 6rkzA, 0.6197, 1.89, 0.227, 586, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
847, 5o4qL, 0.6197, 2.37, 0.130, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
848, 5o4qE, 0.6197, 2.36, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
849, 5o4iI, 0.6197, 2.34, 0.140, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
850, 4gy4A, 0.6197, 2.33, 0.140, 276, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
851, 3sbpH, 0.6197, 1.89, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
852, 6s0oC, 0.6196, 2.35, 0.130, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
853, 6rhqB, 0.6196, 2.35, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
854, 6fc7G, 0.6196, 2.38, 0.150, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
855, 4najA, 0.6196, 2.33, 0.140, 279, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 90 MIN SOAKING
856, 3sbrF, 0.6196, 1.92, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
857, 5o4qG, 0.6195, 2.36, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
858, 5o3kG, 0.6195, 2.34, 0.140, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
859, 5mkmC, 0.6195, 2.36, 0.140, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
860, 3sbqB, 0.6195, 1.90, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
861, 5o4qA, 0.6194, 2.34, 0.140, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
862, 5o3kK, 0.6194, 2.36, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
863, 5lhlD, 0.6194, 2.35, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
864, 4gxfA, 0.6194, 2.34, 0.140, 279, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
865, 3sbrE, 0.6194, 1.90, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
866, 4w1tB, 0.6193, 2.35, 0.110, 269, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
867, 5o4iH, 0.6192, 2.37, 0.130, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
868, 4gy4C, 0.6192, 2.34, 0.140, 278, 100, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
869, 4bdvA, 0.6192, 2.95, 0.131, 612, 107, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
870, 3tbbC, 0.6192, 2.36, 0.120, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
871, 6fdjC, 0.6191, 2.33, 0.140, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
872, 5o3kA, 0.6191, 2.41, 0.140, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
873, 5o3kH, 0.6190, 2.33, 0.140, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
874, 3tbcC, 0.6190, 2.36, 0.120, 277, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
875, 3sbpD, 0.6190, 1.91, 0.227, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
876, 5o3kC, 0.6189, 2.38, 0.130, 277, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
877, 5mkmA, 0.6189, 2.37, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
878, 3sbpG, 0.6189, 1.91, 0.227, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
879, 5o4qH, 0.6188, 2.37, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
880, 5mkmD, 0.6188, 2.35, 0.140, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
881, 5lhlF, 0.6188, 2.34, 0.140, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
882, 3sbrD, 0.6188, 1.91, 0.227, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
883, 3sbpE, 0.6188, 1.91, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
884, 6s0oD, 0.6187, 2.37, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
885, 3sbpB, 0.6187, 1.92, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
886, 2zwnB, 0.6187, 2.26, 0.202, 316, 99, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
887, 6rhqD, 0.6186, 2.35, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
888, 6fc7J, 0.6186, 2.36, 0.140, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
889, 4w1tC, 0.6186, 2.56, 0.119, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
890, 4uanC, 0.6186, 2.37, 0.110, 272, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
891, 4uahC, 0.6186, 2.60, 0.119, 276, 101, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
892, 3sbrH, 0.6186, 1.90, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
893, 6fdjG, 0.6185, 2.35, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
894, 5o4qI, 0.6185, 2.36, 0.130, 275, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
895, 3tbbA, 0.6184, 2.35, 0.130, 279, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
896, 3sbrA, 0.6184, 1.93, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
897, 6fdjJ, 0.6183, 2.36, 0.140, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
898, 5lhlE, 0.6183, 2.36, 0.130, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
899, 4uanA, 0.6183, 2.46, 0.110, 276, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
900, 4e9xB, 0.6183, 2.27, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA3)
901, 3sbpC, 0.6183, 1.91, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
902, 5mkmF, 0.6182, 2.36, 0.140, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
903, 3sbpA, 0.6182, 1.92, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
904, 5o4qK, 0.6181, 2.37, 0.130, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
905, 4w1tA, 0.6181, 2.36, 0.110, 272, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
906, 4e9yB, 0.6181, 2.27, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA4)
907, 3sbrB, 0.6181, 1.91, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
908, 4uahA, 0.6180, 2.36, 0.110, 272, 100, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
909, 4e9wB, 0.6180, 2.27, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA2)
910, 6rh9F, 0.6179, 2.37, 0.140, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
911, 6hbeB, 0.6179, 2.32, 0.222, 425, 99, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
912, 4m3hB, 0.6179, 2.37, 0.110, 269, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
913, 6fdjA, 0.6178, 2.39, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
914, 6fc7B, 0.6178, 2.39, 0.130, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
915, 5o3kD, 0.6178, 2.35, 0.140, 281, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
916, 5lhlA, 0.6178, 2.35, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
917, 4e9vB, 0.6178, 2.27, 0.202, 316, 99, MULTICOPPER OXIDASE MGLAC (DATA1)
918, 3sbrG, 0.6178, 1.93, 0.227, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
919, 3sbrC, 0.6178, 1.91, 0.227, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
920, 6hbeC, 0.6177, 2.31, 0.222, 427, 99, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
921, 4n8uC, 0.6177, 2.36, 0.120, 275, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
922, 3tbcA, 0.6177, 2.37, 0.120, 279, 100, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
923, 6hbeA, 0.6176, 2.32, 0.222, 425, 99, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
924, 5o3kE, 0.6176, 2.35, 0.140, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
925, 4m3hC, 0.6176, 2.44, 0.120, 270, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
926, 6rhqC, 0.6175, 2.38, 0.130, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
927, 6fc7K, 0.6175, 2.40, 0.140, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
928, 6fc7I, 0.6175, 2.37, 0.140, 281, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
929, 5o4qB, 0.6175, 2.42, 0.140, 278, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
930, 3gyrA, 0.6175, 2.44, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
931, 1aozB, 0.6175, 2.29, 0.172, 552, 99, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
932, 3gyrB, 0.6174, 2.44, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
933, 1asqB, 0.6174, 2.30, 0.172, 552, 99, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
934, 6s0oA, 0.6173, 2.37, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
935, 4m3hA, 0.6173, 2.38, 0.110, 269, 100, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
936, 6fdjL, 0.6171, 2.34, 0.140, 276, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
937, 5mkmE, 0.6171, 2.38, 0.140, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
938, 5lhlB, 0.6171, 2.35, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
939, 3gyrE, 0.6171, 2.44, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
940, 6rh9J, 0.6170, 2.41, 0.150, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
941, 6fdjE, 0.6170, 2.36, 0.140, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
942, 5o3kL, 0.6170, 2.36, 0.140, 276, 100, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
943, 3gyrL, 0.6170, 2.44, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
944, 2uxtB, 0.6170, 2.67, 0.099, 420, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
945, 1asoB, 0.6169, 2.30, 0.172, 552, 99, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
946, 2fqdA, 0.6168, 2.67, 0.119, 464, 101, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
947, 6rh9C, 0.6167, 2.39, 0.150, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
948, 3pauA, 0.6167, 2.68, 0.129, 464, 101, CUEO IN THE RESTING OXIDIZED STATE
949, 3gyrG, 0.6167, 2.45, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
950, 3gyrI, 0.6166, 2.45, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
951, 6rh9I, 0.6165, 2.38, 0.150, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
952, 5mkmB, 0.6165, 2.39, 0.130, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
953, 4ejxA, 0.6164, 2.74, 0.173, 1034, 104, STRUCTURE OF CERULOPLASMIN-MYELOPEROXIDASE COMPLEX
954, 1asqA, 0.6163, 2.31, 0.172, 552, 99, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
955, 4n8uA, 0.6162, 2.39, 0.130, 275, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
956, 2fqfA, 0.6162, 2.67, 0.119, 465, 101, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
957, 3gyrF, 0.6161, 2.45, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
958, 2fqeA, 0.6161, 2.67, 0.119, 463, 101, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
959, 1aspA, 0.6161, 2.31, 0.172, 552, 99, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
960, 3gyrK, 0.6160, 2.45, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
961, 6s0oE, 0.6159, 2.43, 0.140, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
962, 5b7eA, 0.6159, 2.70, 0.119, 477, 101, STRUCTURE OF PERDEUTERATED CUEO
963, 3gyrH, 0.6159, 2.55, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
964, 1asoA, 0.6159, 2.36, 0.172, 552, 99, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
965, 3gyrD, 0.6158, 2.55, 0.188, 587, 101, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
966, 2fqgA, 0.6157, 2.50, 0.120, 464, 100, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
967, 1n68A, 0.6157, 2.73, 0.129, 464, 101, COPPER BOUND TO THE MULTICOPPER OXIDASE CUEO
968, 6rh9L, 0.6156, 2.36, 0.150, 275, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
969, 6rh9A, 0.6156, 2.47, 0.150, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
970, 1aozA, 0.6155, 2.32, 0.172, 552, 99, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
971, 5b7mB, 0.6154, 2.70, 0.119, 464, 101, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
972, 3ta4D, 0.6154, 2.18, 0.152, 273, 99, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
973, 3t9wA, 0.6153, 2.18, 0.152, 270, 99, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116
974, 2uxvB, 0.6152, 2.58, 0.099, 422, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
975, 3nscA, 0.6151, 2.73, 0.129, 470, 101, C500S MUTANT OF CUEO BOUND TO CU(II)
976, 6rh9B, 0.6150, 2.37, 0.150, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
977, 6rh9E, 0.6147, 2.48, 0.150, 277, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
978, 6rikA, 0.6145, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRTEENTH STRUCTURE OF THE SERIES WITH 5200 KGY DOSE. 
979, 5ys5A, 0.6145, 2.54, 0.120, 457, 100, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT WITH SEVEN COPPER IONS 
980, 5b7mC, 0.6145, 2.54, 0.120, 462, 100, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
981, 4n8uB, 0.6145, 2.41, 0.120, 276, 100, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
982, 3j2qA, 0.6145, 2.98, 0.131, 630, 107, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
983, 3cdzA, 0.6145, 2.98, 0.131, 630, 107, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
984, 6ri2A, 0.6144, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
985, 3od3A, 0.6144, 2.73, 0.129, 488, 101, CUEO AT 1.1 A RESOLUTION INCLUDING RESIDUES IN PREVIOUSLY DISORDERED REGION
986, 3nsyA, 0.6144, 2.72, 0.119, 465, 101, THE MULTI-COPPER OXIDASE CUEO WITH SIX MET TO SER MUTATIONS (M358S M361SM362SM364SM366SM368S)
987, 6rhoA, 0.6143, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
988, 3pavA, 0.6143, 2.73, 0.119, 466, 101, THE REDUCED FORM OF CUEO
989, 1pf3A, 0.6143, 2.74, 0.129, 463, 101, CRYSTAL STRUCTURE OF THE M441L MUTANT OF THE MULTICOPPER OXIDASE CUEO
990, 1kv7A, 0.6143, 2.70, 0.119, 463, 101, CRYSTAL STRUCTURE OF CUEO A MULTI-COPPER OXIDASE FROM E. COLI INVOLVED IN COPPER HOMEOSTASIS
991, 4hakA, 0.6142, 2.71, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT E506A
992, 4e9tA, 0.6142, 2.73, 0.129, 476, 101, MULTICOPPER OXIDASE CUEO (DATA6)
993, 3qqxA, 0.6142, 2.75, 0.129, 474, 101, REDUCED NATIVE INTERMEDIATE OF THE MULTICOPPER OXIDASE CUEO
994, 3nt0A, 0.6142, 2.74, 0.129, 468, 101, C500S (T1D) MUTANT OF CUEO SOAKED IN AND BOUND TO CU(I)
995, 6rilA, 0.6141, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTEENTH STRUCTURE OF THE SERIES WITH 5600 KGY DOSE (DATA WAS COLLECTED AFTER REFREEZING). 
996, 6rhhA, 0.6141, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
997, 5midA, 0.6141, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 14-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 393 MIN.
998, 5micA, 0.6141, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 13-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 363 MIN.
999, 5mhyA, 0.6141, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SEVENTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 183 MIN.
1000, 4e9sA, 0.6141, 2.73, 0.129, 476, 101, MULTICOPPER OXIDASE CUEO (DATA5)
1001, 4e9rA, 0.6141, 2.73, 0.129, 476, 101, MULTICOPPER OXIDASE CUEO (DATA4)
1002, 4e9qA, 0.6141, 2.73, 0.129, 476, 101, MULTICOPPER OXIDASE CUEO (DATA2)
1003, 6ri0A, 0.6140, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
1004, 6rhiA, 0.6140, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
1005, 6rgpA, 0.6140, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
1006, 6rghA, 0.6140, 2.82, 0.137, 499, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
1007, 5migA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 16-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 453 MIN. THE CRYSTAL WAS QUICK REFREEZING BEFORE THIS DATA COLLECTION.
1008, 5mieA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 15-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 423 MIN.
1009, 5mibA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 12-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 333 MIN.
1010, 5miaA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 11-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 303 MIN.
1011, 5mi2A, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 10-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 273 MIN.
1012, 5mi1A, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 9-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 243 MIN.
1013, 5mhzA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 8-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 213 MIN.
1014, 5mhxA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SIXTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 153 MIN.
1015, 5mhwA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FIFTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 123 MIN.
1016, 5mhvA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FOURTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 93 MIN.
1017, 5mhuA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE THIRD STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 63 MIN.
1018, 5mewA, 0.6140, 2.82, 0.137, 499, 102, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. SECOND STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 33 MIN.
1019, 5mejA, 0.6140, 2.82, 0.137, 499, 102, STRUCTURAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. FIRST STRUCTURE OF THE SERIES WITH 3 MIN TOTAL X-RAY EXPOSITION TIME.
1020, 4nerA, 0.6140, 2.74, 0.129, 476, 101, MULTICOPPER OXIDASE CUEO (DATA1)
1021, 3uadA, 0.6140, 2.73, 0.129, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA5)
1022, 3uabA, 0.6140, 2.73, 0.129, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA2)
1023, 3ta4E, 0.6140, 2.23, 0.141, 267, 99, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1024, 3gyrJ, 0.6140, 3.03, 0.143, 587, 105, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1025, 3gyrC, 0.6140, 3.03, 0.143, 587, 105, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1026, 6riiA, 0.6139, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTH STRUCTURE OF THE SERIES WITH 1200 KGY DOSE. 
1027, 6ri6A, 0.6139, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 400 KGY DOSE. 
1028, 6ri4A, 0.6139, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 13 KGY DOSE. 
1029, 6rhxA, 0.6139, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
1030, 6rhuA, 0.6139, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
1031, 6rhrA, 0.6139, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
1032, 6rhpA, 0.6139, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTY FIRST STRUCTURE OF THE SERIES WITH 4415 KGY DOSE (COLLECTED AFTER REFREEZING). 
1033, 5z22A, 0.6139, 2.81, 0.147, 494, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
1034, 5z1xA, 0.6139, 2.80, 0.147, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
1035, 4halA, 0.6139, 2.72, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT E506I
1036, 2yxwA, 0.6139, 2.75, 0.129, 440, 101, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1037, 6ri8A, 0.6138, 2.82, 0.137, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 800 KGY DOSE. 
1038, 5z1xB, 0.6138, 2.81, 0.147, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
1039, 5ys1A, 0.6138, 2.53, 0.120, 461, 100, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT 
1040, 5b7mA, 0.6138, 2.74, 0.119, 463, 101, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
1041, 3uaaA, 0.6138, 2.73, 0.129, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA1)
1042, 3kw7A, 0.6137, 2.87, 0.137, 502, 102, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
1043, 5n0kA, 0.6136, 2.39, 0.192, 1034, 99, RAT CERULOPLASMIN ORTHORHOMBIC FORM
1044, 6rh9H, 0.6134, 2.39, 0.150, 278, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1045, 3nsfA, 0.6134, 2.52, 0.120, 480, 100, APO FORM OF THE MULTICOPPER OXIDASE CUEO
1046, 3nsdA, 0.6134, 2.75, 0.129, 462, 101, SILVER BOUND TO THE MULTICOPPER OXIDASE CUEO (UNTAGGED)
1047, 3t6vA, 0.6132, 2.82, 0.127, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
1048, 3uaeA, 0.6130, 2.54, 0.120, 476, 100, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA6)
1049, 3uacA, 0.6130, 2.54, 0.120, 476, 100, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA4)
1050, 3t6zA, 0.6129, 2.83, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
1051, 3kw7B, 0.6128, 2.81, 0.137, 502, 102, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
1052, 1kyaB, 0.6128, 2.86, 0.127, 499, 102, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1053, 1kyaA, 0.6128, 2.86, 0.127, 499, 102, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1054, 3t6xA, 0.6127, 2.82, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
1055, 2yxwB, 0.6127, 2.53, 0.120, 444, 100, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1056, 5e9nA, 0.6126, 2.83, 0.137, 495, 102, STECCHERINUM MURASHKINSKYI LACCASE AT 0.95 RESOLUTION
1057, 2j5wA, 0.6126, 2.37, 0.172, 1029, 99, CERULOPLASMIN REVISITED: STRUCTURAL AND FUNCTIONAL ROLES OF VARIOUS METAL CATION BINDING SITES
1058, 3t6wA, 0.6125, 2.82, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
1059, 2yxvB, 0.6125, 2.53, 0.120, 440, 100, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1060, 5i5iB, 0.6124, 1.62, 0.172, 537, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
1061, 5ehfA, 0.6124, 2.82, 0.118, 497, 102, LACCASE FROM ANTRODIELLA FAGINEA
1062, 6im8A, 0.6123, 2.56, 0.120, 469, 100, CUEO-PM2 MULTICOPPER OXIDASE 
1063, 3t6zC, 0.6123, 2.83, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
1064, 3t6vB, 0.6123, 2.85, 0.127, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
1065, 2uxvA, 0.6123, 2.69, 0.099, 422, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
1066, 4x4kA, 0.6122, 2.21, 0.155, 525, 97, STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT
1067, 3t71A, 0.6122, 2.83, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1068, 3t6vC, 0.6122, 2.83, 0.127, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
1069, 6im9A, 0.6121, 2.55, 0.120, 490, 100, MDM2 BOUND CUEO-PM2 SENSOR 
1070, 3v9eA, 0.6121, 2.20, 0.155, 539, 97, STRUCTURE OF THE L499M MUTANT OF THE LACCASE FROM B.ACLADA
1071, 3t6wC, 0.6121, 2.84, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
1072, 3t6wB, 0.6121, 2.85, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
1073, 3v9cA, 0.6120, 2.88, 0.108, 499, 102, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION
1074, 3t6xC, 0.6120, 2.84, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
1075, 2yxvA, 0.6120, 2.77, 0.129, 444, 101, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1076, 5gnoA, 0.6119, 2.58, 0.120, 463, 100, STRUCTURE OF MULTICOPPER OXIDASE CUEO - SIGNAL PEPTIDE-FREE
1077, 5b7fA, 0.6119, 2.58, 0.120, 463, 100, STRUCTURE OF CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
1078, 3t6zB, 0.6119, 2.86, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
1079, 3pxlA, 0.6119, 2.88, 0.108, 499, 102, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA
1080, 3t71C, 0.6118, 2.84, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1081, 3divA, 0.6117, 2.89, 0.118, 497, 102, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.76A RESOLUTION
1082, 3t6xB, 0.6116, 2.86, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
1083, 5i5iA, 0.6115, 1.63, 0.172, 539, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
1084, 3t71B, 0.6115, 2.86, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
1085, 3sqrA, 0.6114, 2.21, 0.155, 539, 97, CRYSTAL STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA AT 1.67 A RESOLUTION
1086, 4ef3A, 0.6112, 2.61, 0.120, 466, 100, MULTICOPPER OXIDASE CUEO (CITRATE BUFFER)
1087, 5n4lB, 0.6111, 2.40, 0.192, 1034, 99, RAT CERULOPLASMIN TRIGONAL FORM
1088, 2xybA, 0.6109, 2.90, 0.127, 497, 102, CRYSTAL STRUCTURE OF A FULLY FUNCTIONAL LACCASE FROM THE LIGNINOLYTIC FUNGUS PYCNOPORUS CINNABARINUS
1089, 3zx1A, 0.6105, 2.36, 0.190, 471, 100, MULTICOPPER OXIDASE FROM CAMPYLOBACTER JEJUNI: A METALLO-OXIDASE
1090, 1kcwA, 0.6105, 2.41, 0.172, 1017, 99, X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS
1091, 5nq9A, 0.6094, 2.85, 0.118, 497, 102, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1092, 6evgA, 0.6091, 2.54, 0.090, 444, 100, STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF A BACTERIAL LACCASE-LIKE MULTI-COPPER OXIDASE CUEO FROM LIGNIN-DEGRADING BACTERIUM OCHROBACTRUM SP. WITH OXIDASE ACTIVITY TOWARDS LIGNIN MODEL COMPOUNDS AND LIGNOSULFONATE 
1093, 5k3kA, 0.6085, 2.69, 0.178, 439, 101, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CUSO4 20 MIN)
1094, 5g3dA, 0.6085, 2.69, 0.178, 438, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CCASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1095, 5jrrA, 0.6083, 2.49, 0.180, 439, 100, CRYSTAL STRUCTURE OF NATIVE LACCASE FROM THERMUS THERMOPHILUS HB27
1096, 2ih9A, 0.6083, 2.41, 0.143, 559, 98, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1097, 5afaA, 0.6081, 2.50, 0.180, 439, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH AG CRYSTAL OF THE HOLOENZYME SOAKED FOR 30 M IN 5 MM AGNO3 AT 278 K.
1098, 5k84A, 0.6080, 2.50, 0.180, 439, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 10 MIN)
1099, 5jx9A, 0.6080, 2.50, 0.180, 439, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 5 MIN)
1100, 5k5kA, 0.6079, 2.50, 0.180, 439, 100, CRYSTAL STRUCTURE OF LACCASSE FROM THERMUS THERMOPHILUS HB27 (ASCORBIC ACID 10 MIN)
1101, 2yaoA, 0.6079, 2.50, 0.180, 437, 100, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (50.0-62.5 PERCENT DOSE)
1102, 2yarA, 0.6078, 2.50, 0.180, 436, 100, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (87.5-100.0 PERCENT DOSE)
1103, 2yapA, 0.6078, 2.50, 0.180, 437, 100, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (62.5-75.0 PERCENT DOSE)
1104, 2yaeA, 0.6078, 2.50, 0.180, 438, 100, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27(0.0-12.5 PERCENT DOSE)
1105, 5g3hA, 0.6077, 2.50, 0.180, 438, 100, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1106, 2xu9A, 0.6077, 2.50, 0.180, 439, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27
1107, 5k8dB, 0.6076, 2.57, 0.160, 619, 100, CRYSTAL STRUCTURE OF RFVIIIFC
1108, 5k15A, 0.6076, 2.51, 0.180, 439, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU2PO 8 MIN)
1109, 5k0dA, 0.6076, 2.50, 0.180, 439, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 3 MIN)
1110, 5g3cA, 0.6076, 2.50, 0.180, 435, 100, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS TERMOPHILUS MULTICOPPER OXIDASE
1111, 2yamA, 0.6076, 2.50, 0.180, 436, 100, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (37.5-50.0 PERCENT DOSE)
1112, 2yafA, 0.6076, 2.50, 0.180, 438, 100, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (12.5-25.0 PERCENT DOSE)
1113, 2ih8B, 0.6076, 2.57, 0.141, 559, 99, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1114, 6im7A, 0.6075, 2.33, 0.122, 461, 98, CUEO-12.1 MULTICOPPER OXIDASE 
1115, 5k7aA, 0.6075, 2.50, 0.180, 439, 100, CRYSTAL STRUCTURE OF LACCASE FRON THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 1.5 MIN)
1116, 5g3eA, 0.6075, 2.50, 0.180, 437, 100, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1117, 2yaqA, 0.6074, 2.50, 0.180, 436, 100, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (75.0-87.5 PERCENT DOSE)
1118, 2yahA, 0.6073, 2.50, 0.180, 436, 100, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (25.0-37.5 PERCENT DOSE)
1119, 5nq7A, 0.6070, 2.96, 0.118, 497, 102, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM I
1120, 3fu8A, 0.6068, 2.57, 0.141, 558, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1121, 2xuwA, 0.6067, 2.51, 0.180, 437, 100, CRYSTAL STRUCTURE OF APOLACCASE FROM THERMUS THERMOPHILUS HB27
1122, 3fu9A, 0.6066, 2.42, 0.143, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1123, 3dkhA, 0.6066, 2.56, 0.141, 558, 99, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1124, 3fu9B, 0.6063, 2.58, 0.141, 559, 99, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1125, 3cdzB, 0.6050, 2.16, 0.134, 631, 97, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
1126, 2r7eB, 0.6043, 2.54, 0.160, 644, 100, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1127, 1hfuA, 0.6031, 2.85, 0.119, 500, 101, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION
1128, 2vmjA, 0.6029, 1.97, 0.232, 326, 95, TYPE 1 COPPER-BINDING LOOP OF NITRITE REDUCTASE MUTANT: 130- CAPEGMVPWHVVSGM-144 TO 130-CTPHPFM-136
1129, 5a7eA, 0.6027, 2.87, 0.129, 495, 101, CRYSTALLOGRAPHIC STRUCTURAL DETERMINATION OF A TRIGONAL LACCASE FROM CORIOLOPSIS GALLICA (CGL) TO 1.5 A RESOLUTION
1130, 5g3fA, 0.6019, 2.70, 0.180, 437, 100, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1131, 5g3bA, 0.6018, 2.70, 0.180, 437, 100, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE: THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1132, 1sddB, 0.6012, 1.98, 0.147, 601, 95, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
1133, 5g3gA, 0.6008, 2.51, 0.182, 437, 99, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1134, 4bdvB, 0.6006, 2.08, 0.167, 606, 96, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
1135, 4ai7A, 0.6000, 2.59, 0.180, 437, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 2 H IN 5 MM HGCL2 AT 278 K.
1136, 3ta4F, 0.5998, 2.12, 0.216, 282, 97, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1137, 5o4iG, 0.5995, 2.46, 0.172, 278, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1138, 5o3kB, 0.5993, 2.47, 0.172, 278, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1139, 4knsF, 0.5993, 2.79, 0.121, 285, 99, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
1140, 2xvbA, 0.5988, 2.60, 0.180, 438, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 5 MIN. IN 5 MM HGCL2 AT 278 K.
1141, 3j2sB, 0.5987, 2.29, 0.144, 631, 97, MEMBRANE-BOUND FACTOR VIII LIGHT CHAIN
1142, 6fdjI, 0.5985, 2.47, 0.172, 276, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1143, 4knuA, 0.5985, 2.78, 0.111, 285, 99, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
1144, 5o4iF, 0.5981, 2.48, 0.172, 277, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1145, 5o4iJ, 0.5977, 2.49, 0.172, 279, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1146, 4wtqA, 0.5977, 2.41, 0.162, 270, 99, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
1147, 4knsE, 0.5976, 2.63, 0.112, 285, 98, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
1148, 5o4iE, 0.5975, 2.49, 0.172, 278, 99, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1149, 4knuE, 0.5974, 2.64, 0.112, 285, 98, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
1150, 4knuF, 0.5973, 2.64, 0.112, 285, 98, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
1151, 6fdjH, 0.5972, 2.49, 0.172, 277, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1152, 6fdjK, 0.5970, 2.45, 0.172, 276, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1153, 3abgA, 0.5970, 2.90, 0.118, 508, 102, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1154, 4knuC, 0.5969, 2.66, 0.112, 285, 98, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
1155, 3j2qB, 0.5967, 2.53, 0.173, 631, 98, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
1156, 6rhqE, 0.5966, 2.67, 0.170, 282, 100, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1157, 3wi9A, 0.5966, 2.49, 0.196, 303, 97, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS KAUSTOPHILUS
1158, 6fdjD, 0.5961, 2.50, 0.172, 278, 99, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1159, 6fc7L, 0.5960, 2.25, 0.175, 276, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1160, 5o4iD, 0.5958, 2.29, 0.175, 278, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1161, 6fc7C, 0.5954, 2.27, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1162, 6fc7D, 0.5952, 2.27, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1163, 6s0oF, 0.5950, 2.28, 0.175, 275, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1164, 6fdjB, 0.5949, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1165, 6rh9K, 0.5946, 2.29, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1166, 5o3kI, 0.5946, 2.27, 0.175, 275, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1167, 6fc7H, 0.5945, 2.28, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1168, 5o3kJ, 0.5944, 2.30, 0.175, 281, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1169, 6rh9D, 0.5935, 2.30, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1170, 3aw5A, 0.5932, 2.78, 0.172, 438, 99, STRUCTURE OF A MULTICOPPER OXIDASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROBACULUM AEROPHILUM
1171, 6rh9G, 0.5929, 2.32, 0.175, 279, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1172, 6fc7F, 0.5925, 2.29, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1173, 6fc7E, 0.5923, 2.29, 0.175, 278, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1174, 6fc7A, 0.5923, 2.30, 0.175, 281, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1175, 3abgB, 0.5918, 2.76, 0.077, 518, 104, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1176, 2r7eA, 0.5863, 2.61, 0.101, 693, 99, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1177, 3fpxA, 0.5853, 3.15, 0.117, 499, 103, NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA
1178, 4a2hA, 0.5850, 3.05, 0.127, 495, 102, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLOPSIS GALLICA PH 7.0
1179, 4a2fA, 0.5847, 3.05, 0.127, 495, 102, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 12.65 KEV
1180, 2qt6B, 0.5846, 3.17, 0.126, 498, 103, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
1181, 5anhC, 0.5839, 3.20, 0.126, 496, 103, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1182, 2hzhA, 0.5835, 3.17, 0.126, 499, 103, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLUS ZONATUS AT 2.6 A RESOLUTION
1183, 5lduA, 0.5830, 3.16, 0.117, 499, 103, RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA
1184, 4a2dA, 0.5829, 2.90, 0.119, 495, 101, CORIOLOPSIS GALLICA LACCASE T2 COPPER DEPLETED AT PH  4.5
1185, 2qt6A, 0.5828, 3.06, 0.137, 498, 102, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
1186, 5anhB, 0.5825, 2.92, 0.139, 496, 101, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1187, 5lwxA, 0.5823, 2.47, 0.146, 554, 96, CRYSTAL STRUCTURE OF THE H253D MUTANT OF MCOG FROM ASPERGILLUS NIGER
1188, 5nq8A, 0.5820, 3.17, 0.117, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II
1189, 5anhA, 0.5820, 3.08, 0.127, 496, 102, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1190, 4jhvA, 0.5815, 3.25, 0.117, 496, 103, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA
1191, 3x1bB, 0.5815, 3.04, 0.147, 500, 102, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
1192, 4a2gA, 0.5814, 2.76, 0.130, 495, 100, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 8.98 KEV
1193, 5lm8A, 0.5812, 2.48, 0.146, 549, 96, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER
1194, 4jhuA, 0.5811, 3.10, 0.127, 496, 102, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA SOAKED WITH CUCL
1195, 3x1bA, 0.5807, 3.05, 0.147, 500, 102, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
1196, 5lwwA, 0.5804, 2.49, 0.146, 550, 96, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM ASPERGILLUS NIGER BOUND TO ZINC
1197, 1gycA, 0.5799, 3.05, 0.127, 499, 102, CRYSTAL STRUCTURE DETERMINATION AT ROOM TEMPERATURE OF A LACCASE FROM TRAMETES VERSICOLOR IN ITS OXIDISED FORM CONTAINING A FULL COMPLEMENT OF COPPER IONS
1198, 2hrgA, 0.5794, 3.12, 0.127, 496, 102, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII COMPLEXED WITH P-METHYLBENZOATE
1199, 5nq9C, 0.5791, 3.21, 0.117, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1200, 3pnrB, 0.5775, 3.82, 0.052, 129, 116, STRUCTURE OF PBICP-C IN COMPLEX WITH FALCIPAIN-2
1201, 1a65A, 0.5769, 2.80, 0.182, 504, 99, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS
1202, 1aspB, 0.5768, 2.69, 0.165, 552, 97, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
1203, 2h5uA, 0.5764, 3.23, 0.126, 497, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION
1204, 1ibzA, 0.5746, 1.66, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1205, 1ic0C, 0.5744, 1.67, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1206, 1ibzB, 0.5744, 1.93, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1207, 1ic0E, 0.5738, 1.68, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1208, 1ibyC, 0.5736, 1.90, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1209, 1ibyA, 0.5734, 1.84, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1210, 1ic0D, 0.5733, 1.74, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1211, 1ibyB, 0.5732, 1.89, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1212, 1ic0B, 0.5729, 1.72, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1213, 1ibzC, 0.5712, 1.63, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1214, 1zpuA, 0.5708, 2.55, 0.189, 529, 95, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1215, 1zpuD, 0.5706, 2.55, 0.189, 529, 95, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1216, 1zpuE, 0.5705, 2.55, 0.189, 529, 95, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1217, 1zpuB, 0.5705, 2.55, 0.189, 529, 95, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1218, 1zpuF, 0.5704, 2.55, 0.189, 529, 95, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1219, 1zpuC, 0.5703, 2.55, 0.189, 529, 95, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1220, 5i5jB, 0.5701, 1.30, 0.153, 529, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1221, 5i5jA, 0.5701, 1.31, 0.153, 531, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1222, 1ic0F, 0.5700, 1.64, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1223, 1ibzD, 0.5696, 1.79, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1224, 6f5kA, 0.5695, 2.96, 0.163, 557, 98, CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA 
1225, 1kyaC, 0.5688, 2.76, 0.134, 499, 97, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1226, 1kyaD, 0.5682, 2.78, 0.134, 499, 97, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
1227, 1ibyD, 0.5682, 1.78, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1228, 1gw0B, 0.5679, 2.82, 0.135, 559, 96, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1229, 1v10A, 0.5675, 2.82, 0.144, 487, 97, STRUCTURE OF RIGIDOPORUS LIGNOSUS LACCASE FROM HEMIHEDRALLY TWINNED CRYSTALS
1230, 1gw0A, 0.5668, 2.84, 0.135, 559, 96, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1231, 2ih8A, 0.5663, 2.83, 0.135, 559, 96, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
1232, 1ic0A, 0.5663, 1.73, 0.216, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1233, 3fu7A, 0.5659, 2.84, 0.135, 558, 96, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1234, 3dkhB, 0.5659, 2.85, 0.135, 558, 96, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
1235, 3qpkA, 0.5658, 3.05, 0.134, 559, 97, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1236, 3fu7B, 0.5658, 2.84, 0.135, 559, 96, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1237, 2q9oB, 0.5657, 2.84, 0.135, 558, 96, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1238, 2q9oA, 0.5655, 2.84, 0.135, 558, 96, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1239, 3fu8B, 0.5654, 2.85, 0.135, 558, 96, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1240, 2hrhA, 0.5654, 2.79, 0.165, 496, 97, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII
1241, 2ih9B, 0.5653, 2.85, 0.135, 559, 96, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1242, 3qpkB, 0.5651, 2.89, 0.135, 559, 96, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1243, 3ppsD, 0.5647, 3.11, 0.134, 564, 97, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1244, 3ppsA, 0.5647, 3.11, 0.134, 564, 97, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1245, 3ppsB, 0.5638, 3.09, 0.134, 564, 97, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1246, 3ppsC, 0.5637, 3.08, 0.134, 564, 97, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1247, 4a2eA, 0.5631, 2.86, 0.144, 495, 97, CRYSTAL STRUCTURE OF A CORIOLOPSIS GALLICA LACCASE AT 1.7 A RESOLUTION PH 5.5
1248, 2wo3B, 0.5622, 3.60, 0.071, 142, 113, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINA2 COMPLEX
1249, 4m4rF, 0.5605, 3.42, 0.027, 138, 112, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1250, 4l0pB, 0.5603, 3.27, 0.036, 139, 110, STRUCTURE OF THE HUMAN EPHA3 RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH EPHRIN-A5
1251, 4bkfD, 0.5601, 3.17, 0.084, 141, 107, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1252, 4bkfC, 0.5601, 3.17, 0.084, 141, 107, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRINB3
1253, 3d12B, 0.5601, 3.17, 0.084, 141, 107, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1254, 6ci0D, 0.5597, 2.58, 0.106, 257, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1255, 3om3D, 0.5594, 2.60, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1256, 3omnD, 0.5592, 2.60, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1257, 2gsmB, 0.5592, 2.61, 0.106, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1258, 3fyeD, 0.5590, 2.60, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1259, 2gsmD, 0.5590, 2.60, 0.106, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1260, 1ar1B, 0.5589, 2.58, 0.138, 252, 94, STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1261, 3omaD, 0.5588, 2.61, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1262, 3omaB, 0.5588, 2.62, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1263, 3omiD, 0.5587, 2.60, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1264, 3om3B, 0.5587, 2.61, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1265, 4m4rD, 0.5586, 3.41, 0.036, 140, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1266, 3ehbB, 0.5586, 2.56, 0.149, 252, 94, A D-PATHWAY MUTATION DECOUPLES THE PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE BY ALTERING THE SIDE CHAIN ORIENTATION OF A DISTANT CONSERVED GLUTAMATE
1267, 3omiB, 0.5585, 2.62, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1268, 3fyiD, 0.5585, 2.61, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1269, 6ci0B, 0.5584, 2.61, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1270, 3fyeB, 0.5584, 2.62, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1271, 3omnB, 0.5583, 2.62, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1272, 1qleB, 0.5583, 2.55, 0.149, 252, 94, CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1273, 5wehB, 0.5582, 2.62, 0.106, 254, 94, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1274, 3dtuD, 0.5582, 2.61, 0.106, 258, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1275, 3fyiB, 0.5581, 2.63, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1276, 3hb3B, 0.5580, 2.58, 0.138, 252, 94, HIGH RESOLUTION CRYSTAL STRUCTURE OF PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE
1277, 1m56B, 0.5578, 2.60, 0.106, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1278, 3dtuB, 0.5573, 2.63, 0.106, 259, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1279, 1m56H, 0.5570, 2.62, 0.106, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1280, 5wehH, 0.5567, 2.64, 0.106, 253, 94, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1281, 4m4rB, 0.5567, 3.31, 0.036, 141, 110, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1282, 1m57H, 0.5564, 2.62, 0.106, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1283, 1m57B, 0.5564, 2.62, 0.106, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1284, 4f2fA, 0.5558, 1.88, 0.159, 100, 88, CRYSTAL STRUCTURE OF THE METAL BINDING DOMAIN (MBD) OF THE STREPTOCOCCUS PNEUMONIAE D39 CU(I) EXPORTING P-TYPE ATPASE COPA WITH CU(I)
1285, 1ikoP, 0.5555, 3.07, 0.065, 141, 108, CRYSTAL STRUCTURE OF THE MURINE EPHRIN-B2 ECTODOMAIN
1286, 2ckbC, 0.5534, 3.45, 0.128, 202, 109, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1287, 2ckbA, 0.5534, 3.45, 0.128, 202, 109, STRUCTURE OF THE 2C/KB/DEV8 COMPLEX
1288, 4m4rH, 0.5532, 3.57, 0.027, 138, 112, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1289, 6hu9b, 0.5524, 2.67, 0.149, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1290, 5z62B, 0.5519, 2.59, 0.128, 227, 94, STRUCTURE OF HUMAN CYTOCHROME C OXIDASE 
1291, 3tpuA, 0.5513, 3.48, 0.128, 205, 109, 42F3 P5E8/H2-LD COMPLEX
1292, 3mx0D, 0.5508, 3.43, 0.027, 138, 110, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1293, 2x11B, 0.5508, 3.67, 0.018, 138, 111, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN A5 RECEPTOR BINDING DOMAIN
1294, 3d12E, 0.5507, 3.31, 0.102, 141, 108, CRYSTAL STRUCTURES OF NIPAH VIRUS G ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH ITS RECEPTOR EPHRIN-B3
1295, 6hu9n, 0.5505, 2.68, 0.138, 236, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1296, 2wo2B, 0.5504, 3.16, 0.083, 136, 108, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINB2 COMPLEX
1297, 5x1bO, 0.5502, 2.68, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1298, 4n5eC, 0.5502, 3.53, 0.138, 199, 109, 42F3 TCR PCPA12/H-2LD COMPLEX
1299, 1shwA, 0.5502, 3.68, 0.018, 138, 111, EPHB2 / EPHRINA5 COMPLEX STRUCTURE
1300, 3tpuG, 0.5499, 3.49, 0.128, 202, 109, 42F3 P5E8/H2-LD COMPLEX
1301, 3heiB, 0.5496, 3.47, 0.064, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1302, 1kgyE, 0.5493, 3.18, 0.074, 138, 108, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1303, 3tpuM, 0.5489, 3.48, 0.138, 204, 109, 42F3 P5E8/H2-LD COMPLEX
1304, 3tpuC, 0.5488, 3.46, 0.138, 204, 109, 42F3 P5E8/H2-LD COMPLEX
1305, 5b1bO, 0.5487, 2.68, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1306, 4w9zA, 0.5487, 2.68, 0.128, 138, 94, CRYSTAL STRUCTURE OF THE PERIPLASMIC DOMAIN OF SUBUNIT II OF CYTOCHROME OXIDASE (COXB) OF BRADYRHIZOBIUM JAPONICUM
1307, 3abkO, 0.5487, 2.68, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1308, 1kgyG, 0.5487, 3.14, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1309, 4nhuA, 0.5486, 3.43, 0.139, 197, 108, THE M33 TCR P3M33L/H-2 LD COMPLEX
1310, 3ag2O, 0.5486, 2.69, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1311, 1shxA, 0.5486, 3.74, 0.044, 138, 113, EPHRIN A5 LIGAND STRUCTURE
1312, 6nmfO, 0.5485, 2.72, 0.106, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1313, 3mx0B, 0.5485, 3.53, 0.018, 138, 111, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1314, 2einB, 0.5485, 2.72, 0.106, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1315, 3ag4O, 0.5484, 2.69, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1316, 1shxB, 0.5484, 3.75, 0.044, 138, 113, EPHRIN A5 LIGAND STRUCTURE
1317, 6j8mO, 0.5483, 2.69, 0.106, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1318, 5zcpO, 0.5482, 2.70, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1319, 5x1fO, 0.5482, 2.70, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1320, 5b3sO, 0.5482, 2.70, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1321, 3abmO, 0.5482, 2.69, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1322, 5zcqO, 0.5481, 2.71, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1323, 5x19O, 0.5480, 2.70, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1324, 5b1aO, 0.5480, 2.70, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1325, 4n0cG, 0.5480, 3.57, 0.128, 197, 109, 42F3 TCR PCPE3/H-2LD COMPLEX
1326, 3ag3O, 0.5479, 2.69, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1327, 2einO, 0.5479, 2.73, 0.106, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1328, 5zcoO, 0.5478, 2.71, 0.106, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1329, 5z85O, 0.5478, 2.71, 0.106, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1330, 2y69O, 0.5478, 2.70, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1331, 5z86O, 0.5477, 2.71, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1332, 4mxqC, 0.5477, 3.53, 0.138, 199, 109, 42F3 TCR PCPC5/H-2LD COMPLEX
1333, 3heiJ, 0.5477, 3.49, 0.073, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1334, 1kgyH, 0.5477, 3.15, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1335, 5xdqO, 0.5476, 2.71, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1336, 3ag3B, 0.5476, 2.75, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1337, 1v54O, 0.5476, 2.73, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1338, 5z84O, 0.5475, 2.71, 0.106, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1339, 2zxwO, 0.5475, 2.72, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1340, 3wg7O, 0.5474, 2.70, 0.117, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1341, 3asoO, 0.5474, 2.71, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1342, 3ag1B, 0.5474, 2.76, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1343, 1v55O, 0.5474, 2.72, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1344, 3x2qO, 0.5473, 2.71, 0.117, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1345, 2eikO, 0.5473, 2.72, 0.106, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1346, 6nmpO, 0.5472, 2.73, 0.106, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1347, 5x1bB, 0.5472, 2.73, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1348, 2eikB, 0.5472, 2.73, 0.106, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1349, 2eijO, 0.5472, 2.72, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1350, 1v54B, 0.5472, 2.74, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1351, 1g6rC, 0.5472, 3.51, 0.128, 202, 109, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1352, 5waub, 0.5471, 2.71, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1353, 5w97b, 0.5471, 2.73, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1354, 3asnO, 0.5471, 2.71, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1355, 2eimO, 0.5471, 2.73, 0.106, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1356, 2dyrO, 0.5471, 2.73, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1357, 1mwaC, 0.5471, 3.43, 0.139, 202, 108, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1358, 6nmfB, 0.5470, 2.76, 0.106, 226, 94, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1359, 6nknO, 0.5470, 2.75, 0.106, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1360, 4mvbC, 0.5470, 3.42, 0.130, 199, 108, 42F3 PCPB7/H-2LD COMPLEX
1361, 3heiL, 0.5470, 3.51, 0.064, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1362, 3ablO, 0.5470, 2.71, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1363, 2eimB, 0.5470, 2.73, 0.106, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1364, 1v55B, 0.5470, 2.72, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1365, 1ocrO, 0.5470, 2.74, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1366, 5xdxO, 0.5469, 2.70, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1367, 2dysO, 0.5469, 2.73, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1368, 2dyrB, 0.5469, 2.74, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1369, 5xtiWD, 0.5468, 2.76, 0.106, 227, 94, struct.pdbx_descriptor              
1370, 5xtiUA, 0.5468, 2.76, 0.106, 227, 94, struct.pdbx_descriptor              
1371, 5xthUA, 0.5468, 2.76, 0.106, 227, 94, struct.pdbx_descriptor              
1372, 5wauB, 0.5468, 2.74, 0.117, 226, 94, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1373, 5lufy, 0.5468, 2.76, 0.106, 227, 94, CRYO-EM OF BOVINE RESPIRASOME
1374, 5gupVB, 0.5468, 2.76, 0.106, 227, 94, 
1375, 5gpnIB, 0.5468, 2.76, 0.106, 227, 94, 
1376, 3ag1O, 0.5468, 2.73, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
1377, 3abkB, 0.5468, 2.75, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1378, 2ybbM, 0.5468, 2.76, 0.106, 227, 94, FITTED MODEL FOR BOVINE  MITOCHONDRIAL SUPERCOMPLEX I1III2IV1 BY SINGLE PARTICLE CRYO-EM (EMD-1876)
1379, 2vsmB, 0.5468, 3.22, 0.083, 137, 108, NIPAH VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1380, 2eilO, 0.5468, 2.74, 0.106, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1381, 1occO, 0.5468, 2.76, 0.106, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1382, 1occB, 0.5468, 2.76, 0.106, 227, 94, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1383, 5iy5B, 0.5467, 2.77, 0.106, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1384, 2eijB, 0.5467, 2.73, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1385, 2dysB, 0.5467, 2.74, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
1386, 1ocrB, 0.5467, 2.74, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1387, 5iy5O, 0.5466, 2.73, 0.106, 226, 94, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
1388, 3wg7B, 0.5466, 2.77, 0.106, 226, 94, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1389, 2eilB, 0.5466, 2.74, 0.106, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1390, 6nknB, 0.5463, 2.78, 0.106, 226, 94, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1391, 5b3sB, 0.5463, 2.77, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1392, 3x2qB, 0.5463, 2.76, 0.106, 226, 94, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
1393, 2zxwB, 0.5463, 2.76, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
1394, 5z86B, 0.5462, 2.76, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1395, 5x1fB, 0.5462, 2.75, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1396, 2occO, 0.5462, 2.76, 0.106, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1397, 5zcpB, 0.5461, 2.76, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1398, 3ag2B, 0.5461, 2.75, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1399, 3abmB, 0.5461, 2.76, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1400, 5x19B, 0.5460, 2.75, 0.117, 226, 94, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1401, 2occB, 0.5460, 2.77, 0.106, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1402, 6j8mB, 0.5459, 2.77, 0.117, 226, 94, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1403, 5z85B, 0.5459, 2.76, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1404, 3tfkC, 0.5459, 3.57, 0.147, 201, 109, 42F3-P4B10/H2-LD
1405, 3ag4B, 0.5459, 2.75, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1406, 5z84B, 0.5458, 2.77, 0.117, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1407, 5b1bB, 0.5458, 2.76, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1408, 4ydjH, 0.5458, 3.89, 0.087, 238, 115, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1409, 3heiP, 0.5458, 3.52, 0.073, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1410, 3heiN, 0.5458, 3.53, 0.064, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1411, 5zcqB, 0.5457, 2.77, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1412, 5b1aB, 0.5457, 2.77, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1413, 4uf7C, 0.5457, 3.34, 0.064, 138, 109, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1414, 3asoB, 0.5457, 2.77, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1415, 2y69B, 0.5457, 2.76, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
1416, 5zcoB, 0.5456, 2.77, 0.117, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1417, 5xdqB, 0.5456, 2.77, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1418, 1ocoB, 0.5456, 2.77, 0.106, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1419, 6nmpB, 0.5455, 2.79, 0.106, 226, 94, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
1420, 3asnB, 0.5455, 2.77, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1421, 3ablB, 0.5455, 2.78, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1422, 1ocoO, 0.5455, 2.77, 0.106, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
1423, 5xdxB, 0.5454, 2.75, 0.117, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1424, 3p2dB, 0.5454, 3.66, 0.056, 352, 107, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1425, 1zshA, 0.5453, 3.47, 0.066, 354, 106, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE (IP6)
1426, 1oczO, 0.5451, 2.77, 0.106, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1427, 4ms8C, 0.5450, 3.43, 0.139, 196, 108, 42F3 TCR PCPB9/H-2LD COMPLEX
1428, 4nhuC, 0.5449, 3.44, 0.139, 199, 108, THE M33 TCR P3M33L/H-2 LD COMPLEX
1429, 3ugxA, 0.5449, 3.71, 0.028, 369, 108, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1430, 3czuB, 0.5449, 3.49, 0.064, 130, 109, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2- EPHRIN A1 COMPLEX
1431, 4uf7E, 0.5448, 3.23, 0.065, 139, 108, GHANAIAN HENIPAVIRUS (GH-M74A) ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN EPHRINB2
1432, 3heiH, 0.5448, 3.53, 0.064, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1433, 1oczB, 0.5448, 2.77, 0.117, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
1434, 3p2dA, 0.5447, 3.55, 0.065, 354, 107, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1435, 1i9eA, 0.5447, 3.41, 0.112, 115, 107, TCR DOMAIN
1436, 1mwaA, 0.5446, 3.59, 0.118, 202, 110, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
1437, 5w97B, 0.5442, 2.57, 0.118, 226, 93, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
1438, 4n0cC, 0.5441, 3.58, 0.138, 195, 109, 42F3 TCR PCPE3/H-2LD COMPLEX
1439, 1jsyA, 0.5441, 3.48, 0.066, 358, 106, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
1440, 1g6rA, 0.5441, 3.41, 0.120, 202, 108, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
1441, 1kgyF, 0.5436, 3.18, 0.084, 138, 107, CRYSTAL STRUCTURE OF THE EPHB2-EPHRINB2 COMPLEX
1442, 4ydjA, 0.5434, 3.86, 0.087, 238, 115, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1443, 3gxuB, 0.5431, 3.22, 0.075, 138, 107, CRYSTAL STRUCTURE OF EPH RECEPTOR AND EPHRIN COMPLEX
1444, 3tjhC, 0.5430, 3.62, 0.128, 201, 109, 42F3-P3A1/H2-LD COMPLEX
1445, 3gd1C, 0.5430, 3.61, 0.075, 345, 106, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
1446, 2wtrB, 0.5425, 3.73, 0.075, 367, 107, FULL LENGTH ARRESTIN2
1447, 4z7wE, 0.5421, 3.61, 0.128, 199, 109, T316 COMPLEX
1448, 3vxmD, 0.5420, 3.58, 0.110, 198, 109, THE COMPLEX BETWEEN C1-28 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
1449, 1tcrA, 0.5419, 3.63, 0.128, 202, 109, MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
1450, 6eh9A, 0.5415, 3.58, 0.138, 202, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1451, 6eh8A, 0.5414, 3.62, 0.128, 201, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1452, 4z7wG, 0.5413, 3.62, 0.128, 191, 109, T316 COMPLEX
1453, 4oiiI, 0.5413, 3.72, 0.089, 217, 112, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1454, 4oiiH, 0.5413, 3.72, 0.089, 217, 112, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1455, 4jqiA, 0.5409, 3.61, 0.103, 353, 107, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
1456, 3heiD, 0.5409, 3.58, 0.064, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1457, 3heiF, 0.5408, 3.54, 0.064, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1458, 5whzH, 0.5407, 3.83, 0.052, 341, 115, PGDM1400-10E8V4 CODV FAB
1459, 3m4dC, 0.5406, 3.84, 0.073, 293, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1460, 3m2lA, 0.5404, 3.86, 0.073, 293, 110, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1461, 2e7lA, 0.5404, 3.50, 0.130, 112, 108, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1462, 4f2eA, 0.5402, 2.03, 0.172, 98, 87, CRYSTAL STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE D39 COPPER CHAPERONE CUPA WITH CU(I)
1463, 1sujA, 0.5402, 3.42, 0.048, 363, 104, X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN
1464, 1g4mB, 0.5402, 3.61, 0.066, 357, 106, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1465, 4tw1P, 0.5400, 3.97, 0.089, 286, 112, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
1466, 4tw1F, 0.5400, 3.92, 0.090, 284, 111, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
1467, 4gkzA, 0.5399, 3.58, 0.128, 202, 109, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
1468, 3m4dF, 0.5399, 3.86, 0.073, 293, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1469, 5wkhD, 0.5398, 3.36, 0.143, 198, 105, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
1470, 3m4eB, 0.5398, 3.85, 0.073, 293, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1471, 5wkfI, 0.5395, 3.38, 0.143, 198, 105, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
1472, 3uzqA, 0.5395, 3.72, 0.062, 234, 112, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
1473, 6fr8A, 0.5394, 3.55, 0.147, 202, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1474, 6fr7A, 0.5394, 3.58, 0.138, 203, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1475, 3m3rE, 0.5394, 3.83, 0.082, 293, 110, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1476, 2mryA, 0.5394, 1.99, 0.163, 98, 86, NMR SOLUTION STRUCTURE OF COPPER BINDING PROTEIN IN THE APO FORM
1477, 4a6yH, 0.5393, 3.88, 0.096, 215, 115, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1478, 3m4dG, 0.5393, 3.86, 0.073, 293, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1479, 4txvB, 0.5392, 2.84, 0.128, 142, 94, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1480, 3m3rA, 0.5392, 3.86, 0.073, 293, 110, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1481, 1j8hD, 0.5390, 3.55, 0.147, 198, 109, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
1482, 6fumA, 0.5389, 3.49, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1483, 4zrgA, 0.5389, 3.83, 0.028, 343, 108, VISUAL ARRESTIN MUTANT - R175E
1484, 3m4eC, 0.5389, 3.85, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1485, 6funA, 0.5386, 3.60, 0.156, 202, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1486, 6eh7A, 0.5386, 3.51, 0.157, 202, 108, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1487, 1ngpH, 0.5386, 3.91, 0.096, 215, 114, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
1488, 3m4eG, 0.5385, 3.86, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1489, 5wkhI, 0.5383, 3.44, 0.142, 198, 106, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS3
1490, 4a6yB, 0.5383, 3.84, 0.096, 214, 114, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1491, 3m4eD, 0.5383, 3.87, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1492, 1g4mA, 0.5382, 3.65, 0.065, 356, 107, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1493, 3m4eE, 0.5381, 3.87, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1494, 3m4eA, 0.5381, 3.87, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1495, 3m3rG, 0.5381, 3.87, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1496, 4tw1D, 0.5380, 3.89, 0.099, 289, 111, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
1497, 2qadH, 0.5380, 3.90, 0.079, 229, 114, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1498, 1ngqH, 0.5380, 3.89, 0.096, 215, 115, N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1499, 1fytD, 0.5380, 3.56, 0.147, 198, 109, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR1
1500, 1ayrC, 0.5380, 3.84, 0.037, 368, 109, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1501, 6furA, 0.5379, 3.49, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1502, 3vxsD, 0.5379, 3.59, 0.112, 204, 107, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(6L) PEPTIDE
1503, 3uguA, 0.5379, 3.89, 0.037, 345, 109, CRYSTAL STRUCTURE OF P44 (SPLICE VARIANT OF VISUAL ARRESTIN)
1504, 2qadD, 0.5379, 3.90, 0.079, 229, 114, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1505, 1ayrA, 0.5379, 3.91, 0.036, 368, 110, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1506, 6frbA, 0.5378, 3.51, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1507, 3vxqA, 0.5378, 3.62, 0.110, 204, 109, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1508, 2y07H, 0.5378, 3.93, 0.088, 215, 114, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
1509, 2y06H, 0.5378, 3.92, 0.088, 215, 114, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
1510, 3m2lG, 0.5377, 3.88, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1511, 2vskD, 0.5377, 3.16, 0.095, 131, 105, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1512, 7ahlA, 0.5375, 3.92, 0.072, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1513, 6eh6A, 0.5375, 3.51, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1514, 3mbwB, 0.5375, 3.52, 0.065, 127, 107, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 LBD AND CRD DOMAINS IN COMPLEX WITH EPHRIN A1
1515, 4yhdG, 0.5374, 3.94, 0.072, 281, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1516, 3m4eF, 0.5374, 3.87, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1517, 3m4dE, 0.5374, 3.89, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1518, 3m4dA, 0.5374, 3.88, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1519, 1cf1A, 0.5374, 3.86, 0.028, 373, 108, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1520, 6fuqA, 0.5373, 3.50, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1521, 3ugxC, 0.5373, 3.67, 0.028, 358, 106, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1522, 3m3rB, 0.5373, 3.90, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1523, 1ayrD, 0.5373, 3.87, 0.028, 363, 108, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1524, 4txvD, 0.5372, 2.70, 0.140, 133, 93, CRYSTAL STRUCTURE OF THE MIXED DISULFIDE INTERMEDIATE BETWEEN THIOREDOXIN-LIKE TLPAS(C110S) AND SUBUNIT II OF CYTOCHROME C OXIDASE COXBPD (C233S)
1525, 3m4dB, 0.5372, 3.89, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1526, 3m3rD, 0.5372, 3.89, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1527, 1cf1C, 0.5372, 3.86, 0.028, 380, 108, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1528, 1ayrB, 0.5372, 3.87, 0.028, 363, 108, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1529, 6q3sD, 0.5371, 3.64, 0.110, 203, 109, ENGINEERED HUMAN HLA_A2 MHC CLASS I MOLECULE IN COMPLEX WITH TCR AND SV9 PEPTIDE 
1530, 5eu6D, 0.5371, 3.54, 0.112, 204, 107, HLA CLASS I ANTIGEN
1531, 3m2lE, 0.5371, 3.89, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1532, 3m2lD, 0.5371, 3.90, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1533, 6giqb, 0.5370, 2.81, 0.149, 235, 94, SACCHAROMYCES CEREVISIAE RESPIRATORY SUPERCOMPLEX III2IV 
1534, 6furC, 0.5370, 3.51, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1535, 6fr9A, 0.5370, 3.51, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1536, 3m4dD, 0.5370, 3.89, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
1537, 2y36H, 0.5370, 3.90, 0.096, 215, 114, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
1538, 7ahlF, 0.5369, 3.89, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1539, 7ahlC, 0.5369, 3.87, 0.073, 293, 110, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1540, 6fupA, 0.5369, 3.53, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1541, 6fr6A, 0.5369, 3.60, 0.147, 202, 109, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1542, 4m6nH, 0.5369, 3.87, 0.071, 213, 113, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
1543, 3m3rC, 0.5369, 3.88, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1544, 3m2lC, 0.5368, 3.89, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1545, 3anzG, 0.5367, 3.88, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1546, 2vskB, 0.5367, 3.17, 0.095, 131, 105, HENDRA VIRUS ATTACHMENT GLYCOPROTEIN IN COMPLEX WITH HUMAN CELL SURFACE RECEPTOR EPHRINB2
1547, 5wkfD, 0.5366, 3.39, 0.143, 198, 105, D30 TCR IN COMPLEX WITH HLA-A*11:01-GTS1
1548, 2wtrA, 0.5366, 3.69, 0.065, 356, 107, FULL LENGTH ARRESTIN2
1549, 3m2lB, 0.5365, 3.91, 0.090, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1550, 3anzY, 0.5365, 3.88, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1551, 6fuoA, 0.5364, 3.52, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1552, 6frcA, 0.5363, 3.52, 0.157, 202, 108, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1553, 7ahlB, 0.5362, 3.89, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1554, 3m3rF, 0.5362, 3.90, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1555, 3anzK, 0.5362, 3.88, 0.073, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1556, 1dbaH, 0.5362, 3.85, 0.088, 219, 114, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
1557, 7ahlD, 0.5361, 3.89, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1558, 3ujjH, 0.5361, 3.92, 0.062, 230, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
1559, 3tf7C, 0.5361, 3.49, 0.121, 232, 107, 42F3 QL9/H2-LD COMPLEX
1560, 1oayH, 0.5361, 3.78, 0.088, 121, 113, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1561, 5brzD, 0.5360, 3.73, 0.110, 197, 109, MAGE-A3 REACTIVE TCR IN COMPLEX WITH MAGE-A3 IN HLA-A1
1562, 4yhdA, 0.5360, 3.91, 0.090, 281, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1563, 4p24F, 0.5360, 3.90, 0.090, 290, 111, PORE FORMING TOXIN
1564, 4m6mH, 0.5360, 3.89, 0.071, 215, 113, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
1565, 4bkaC, 0.5360, 3.99, 0.044, 136, 114, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5
1566, 3revA, 0.5360, 3.62, 0.101, 201, 109, CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
1567, 3anzO, 0.5360, 3.89, 0.073, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1568, 3vxqD, 0.5359, 3.64, 0.110, 204, 109, H27-14 TCR SPECIFIC FOR HLA-A24-NEF134-10
1569, 3m2lF, 0.5359, 3.90, 0.081, 293, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1570, 1oayJ, 0.5359, 3.79, 0.097, 121, 113, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1571, 2hleB, 0.5358, 3.09, 0.087, 133, 104, STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE EPHB4-EPHRINB2 PROTEIN PROTEIN INTERACTION AND RECEPTOR SPECIFICITY.
1572, 5w0pA, 0.5357, 3.97, 0.027, 847, 110, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1573, 4p24C, 0.5355, 3.89, 0.090, 291, 111, PORE FORMING TOXIN
1574, 4bk5C, 0.5355, 3.99, 0.044, 136, 114, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)
1575, 3qpqJ, 0.5355, 3.87, 0.088, 216, 113, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1576, 4tw1B, 0.5354, 3.86, 0.117, 282, 111, CRYSTAL STRUCTURE OF THE OCTAMERIC PORE COMPLEX OF THE STAPHYLOCOCCUS AUREUS BI-COMPONENT TOXIN LUKGH
1577, 2xzqH, 0.5354, 3.83, 0.088, 215, 113, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF
1578, 3jabQ, 0.5353, 3.86, 0.088, 221, 114, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1579, 3jabH, 0.5353, 3.86, 0.088, 221, 114, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1580, 3anzM, 0.5353, 3.89, 0.073, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1581, 3anzL, 0.5353, 3.89, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1582, 3anzB, 0.5353, 3.89, 0.073, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1583, 3anzA, 0.5353, 3.89, 0.073, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1584, 12e8H, 0.5353, 3.86, 0.088, 221, 114, 2E8 FAB FRAGMENT
1585, 7ahlE, 0.5352, 3.90, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1586, 5vkhA, 0.5352, 3.83, 0.080, 219, 113, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
1587, 2oslH, 0.5352, 3.82, 0.115, 224, 113, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1588, 3anzI, 0.5351, 3.89, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1589, 2op4H, 0.5351, 3.89, 0.071, 217, 113, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
1590, 1s5hB, 0.5351, 3.83, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
1591, 7ahlG, 0.5350, 3.90, 0.090, 293, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1592, 5t5fH, 0.5350, 3.79, 0.107, 212, 112, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
1593, 3anzZ, 0.5350, 3.89, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1594, 3anzX, 0.5350, 3.90, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1595, 3anzS, 0.5350, 3.89, 0.073, 295, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1596, 3anzJ, 0.5350, 3.89, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1597, 5xcqA, 0.5349, 3.86, 0.070, 166, 114, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
1598, 4yhdD, 0.5349, 3.90, 0.073, 282, 110, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1599, 3anzT, 0.5349, 3.89, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1600, 2f53D, 0.5349, 3.66, 0.110, 193, 109, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
1601, 1gafH, 0.5349, 3.98, 0.113, 217, 115, 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1602, 1dbbH, 0.5349, 3.84, 0.088, 219, 114, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
1603, 6cqrD, 0.5348, 3.59, 0.102, 200, 108, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1604, 5yslA, 0.5348, 3.77, 0.080, 211, 112, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1605, 5eblA, 0.5348, 3.84, 0.080, 219, 113, KCSA T75G IN THE CONDUCTIVE STATE
1606, 4idjA, 0.5348, 3.80, 0.082, 276, 110, S.AUREUS A-HEMOLYSIN MONOMER IN COMPLEX WITH FAB
1607, 3anzP, 0.5348, 3.89, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1608, 6aniI, 0.5347, 3.86, 0.088, 214, 113, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1609, 5fhxH, 0.5347, 3.83, 0.080, 340, 113, CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.
1610, 4jzjA, 0.5347, 3.90, 0.080, 214, 113, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
1611, 3ulvF, 0.5347, 3.89, 0.097, 217, 113, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
1612, 2uweE, 0.5347, 3.58, 0.120, 194, 108, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
1613, 6mi2A, 0.5346, 3.84, 0.071, 209, 112, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1614, 5ec2A, 0.5346, 3.85, 0.080, 219, 113, KCSA WITH V76ESTER+G77DA MUTATIONS
1615, 3anzC, 0.5346, 3.89, 0.073, 294, 110, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1616, 3fb8A, 0.5345, 3.83, 0.080, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
1617, 3fb6A, 0.5345, 3.83, 0.080, 219, 113, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
1618, 3f7yA, 0.5345, 3.83, 0.080, 219, 113, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
1619, 3f5wA, 0.5345, 3.83, 0.080, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
1620, 1k4cA, 0.5345, 3.83, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
1621, 5yslC, 0.5344, 3.78, 0.081, 210, 111, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1622, 3or7A, 0.5344, 3.84, 0.080, 219, 113, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
1623, 1dbjH, 0.5344, 3.84, 0.088, 219, 114, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1624, 5tkjJ, 0.5343, 3.87, 0.096, 211, 114, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1625, 3stlA, 0.5343, 3.85, 0.080, 219, 113, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
1626, 6fraA, 0.5342, 3.65, 0.156, 201, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
1627, 5tv1A, 0.5342, 3.76, 0.056, 337, 107, ACTIVE ARRESTIN-3 WITH INOSITOL HEXAKISPHOSPHATE
1628, 1r3jB, 0.5342, 3.84, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
1629, 1oazH, 0.5342, 3.88, 0.088, 122, 114, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
1630, 6by3A, 0.5341, 3.85, 0.080, 219, 113, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
1631, 4yhkH, 0.5341, 3.82, 0.088, 222, 113, REVERSAL AGENT FOR DABIGATRAN
1632, 3qpqH, 0.5341, 3.90, 0.088, 215, 113, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1633, 2itcA, 0.5341, 3.84, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
1634, 1a4kB, 0.5341, 3.84, 0.097, 219, 113, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1635, 5bs0D, 0.5340, 3.74, 0.110, 197, 109, MAGE-A3 REACTIVE TCR IN COMPLEX WITH TITIN EPITOPE IN HLA-A1
1636, 1cf1D, 0.5340, 3.88, 0.028, 368, 108, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1637, 6fr5A, 0.5339, 3.69, 0.111, 202, 108, HA1.7 TCR STUDY OF CDR LOOP FLEXIBILITY 
1638, 4mswA, 0.5339, 3.85, 0.080, 219, 113, Y78 ESTER MUTANT OF KCSA IN HIGH K+
1639, 3rgvA, 0.5339, 3.72, 0.083, 200, 109, A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
1640, 3hg1E, 0.5339, 3.74, 0.118, 244, 110, GERMLINE-GOVERNED RECOGNITION OF A CANCER EPITOPE BY AN IMMUNODOMINANT HUMAN T CELL RECEPTOR
1641, 1cf1B, 0.5339, 3.71, 0.028, 360, 106, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1642, 5tkjD, 0.5338, 3.87, 0.096, 211, 114, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1643, 1oazJ, 0.5338, 3.88, 0.088, 122, 114, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
1644, 3c60A, 0.5337, 3.63, 0.084, 199, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
1645, 3c5zE, 0.5337, 3.63, 0.111, 201, 108, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
1646, 2p7tA, 0.5337, 3.85, 0.080, 219, 113, CRYSTAL STRUCTURE OF KCSA MUTANT
1647, 1r3iH, 0.5337, 3.85, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
1648, 1oarJ, 0.5337, 3.88, 0.088, 122, 114, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1649, 1oarH, 0.5337, 3.88, 0.088, 122, 114, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1650, 1k4dA, 0.5337, 3.85, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
1651, 5tkjA, 0.5336, 3.86, 0.096, 211, 114, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1652, 4m43H, 0.5336, 3.93, 0.088, 219, 114, CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
1653, 3vxrD, 0.5336, 3.60, 0.111, 194, 108, THE COMPLEX BETWEEN H27-14 TCR AND HLA-A24 BOUND TO HIV-1 NEF134- 10(WT) PEPTIDE
1654, 3c5zA, 0.5336, 3.63, 0.111, 202, 108, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
1655, 3anzF, 0.5336, 3.91, 0.090, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1656, 2dweA, 0.5336, 3.84, 0.080, 219, 113, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
1657, 1g4rA, 0.5336, 3.84, 0.056, 353, 108, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1658, 1a6wH, 0.5336, 3.81, 0.080, 120, 112, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3- NITROPHENYL) ACETATE COMPOUND
1659, 3anzD, 0.5335, 3.92, 0.090, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1660, 2oslA, 0.5335, 3.84, 0.106, 221, 113, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1661, 2hvkA, 0.5335, 3.85, 0.080, 219, 113, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
1662, 2hfeA, 0.5335, 3.86, 0.080, 219, 113, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1663, 5ec1A, 0.5334, 3.85, 0.080, 219, 113, KCSA WITH V76ESTER MUTATION
1664, 3anzb, 0.5334, 3.91, 0.090, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1665, 3anzW, 0.5334, 3.91, 0.090, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1666, 2xwtA, 0.5334, 3.96, 0.053, 215, 113, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A BLOCKING TYPE TSHR AUTOANTIBODY
1667, 2ntfB, 0.5334, 3.96, 0.088, 222, 114, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1668, 2ih3A, 0.5334, 3.85, 0.080, 219, 113, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
1669, 1oaxJ, 0.5334, 3.88, 0.088, 122, 114, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1670, 1n7mL, 0.5334, 3.94, 0.088, 216, 114, GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1671, 6fr3A, 0.5333, 3.68, 0.111, 202, 108, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
1672, 5iblH, 0.5333, 3.81, 0.081, 216, 111, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
1673, 3anzU, 0.5333, 3.92, 0.090, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1674, 1oaxH, 0.5333, 3.88, 0.088, 122, 114, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1675, 6eh5A, 0.5332, 3.69, 0.111, 202, 108, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
1676, 5vk6A, 0.5332, 3.86, 0.080, 219, 113, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
1677, 4etqA, 0.5332, 3.76, 0.080, 217, 112, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
1678, 2ih1A, 0.5332, 3.86, 0.080, 219, 113, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
1679, 1oauJ, 0.5332, 3.88, 0.088, 122, 114, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1680, 1oauH, 0.5332, 3.88, 0.088, 122, 114, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1681, 5wk3Q, 0.5331, 3.99, 0.062, 221, 113, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1682, 4yhdB, 0.5331, 3.92, 0.090, 283, 111, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1683, 3stzA, 0.5331, 3.83, 0.088, 219, 113, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
1684, 5w0pC, 0.5330, 4.03, 0.036, 849, 110, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1685, 4jzjH, 0.5330, 3.92, 0.070, 215, 114, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
1686, 3c60E, 0.5330, 3.63, 0.084, 199, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
1687, 2ntfH, 0.5330, 3.96, 0.088, 222, 114, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1688, 2hjfA, 0.5330, 3.86, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
1689, 2h8pA, 0.5330, 3.86, 0.080, 219, 113, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1690, 6mi2D, 0.5329, 3.97, 0.062, 210, 113, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1691, 3anzV, 0.5329, 3.91, 0.081, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1692, 3anzR, 0.5329, 3.91, 0.081, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1693, 3anzN, 0.5329, 3.91, 0.081, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1694, 2bnrD, 0.5329, 3.69, 0.110, 203, 109, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
1695, 5wk3U, 0.5328, 3.86, 0.062, 221, 112, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1696, 5w0pD, 0.5328, 3.90, 0.028, 773, 109, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1697, 5ebmA, 0.5328, 3.94, 0.079, 218, 114, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
1698, 4rirA, 0.5328, 3.96, 0.062, 219, 113, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1699, 3i9gH, 0.5328, 3.86, 0.054, 222, 112, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
1700, 3anza, 0.5328, 3.92, 0.090, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1701, 1a6uH, 0.5328, 3.80, 0.080, 120, 112, B1-8 FV FRAGMENT
1702, 12e8P, 0.5328, 3.92, 0.088, 221, 114, 2E8 FAB FRAGMENT
1703, 5tkjG, 0.5327, 3.88, 0.096, 208, 114, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1704, 5mhrI, 0.5327, 3.87, 0.062, 213, 113, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1705, 3anzQ, 0.5327, 3.92, 0.081, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1706, 2pyeD, 0.5327, 3.66, 0.111, 195, 108, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
1707, 6c68D, 0.5326, 3.62, 0.075, 238, 107, MHC-INDEPENDENT T CELL RECEPTOR A11 
1708, 3ugxD, 0.5326, 3.89, 0.028, 348, 108, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1709, 3anzH, 0.5326, 3.92, 0.081, 294, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1710, 3anzE, 0.5326, 3.92, 0.081, 295, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1711, 1ymhB, 0.5326, 3.81, 0.080, 218, 113, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
1712, 6cqrI, 0.5325, 3.64, 0.101, 201, 109, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1713, 4zsoB, 0.5325, 3.98, 0.114, 218, 114, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1714, 2hg5A, 0.5325, 3.86, 0.080, 219, 113, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1715, 2d7tL, 0.5325, 3.70, 0.103, 110, 107, CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
1716, 1r3lB, 0.5325, 3.86, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
1717, 1aj7H, 0.5325, 3.92, 0.096, 217, 114, IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
1718, 6dcvB, 0.5324, 4.05, 0.079, 226, 114, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
1719, 5yslG, 0.5324, 3.86, 0.080, 210, 112, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1720, 5w1vN, 0.5324, 3.63, 0.142, 202, 106, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
1721, 5npjA, 0.5324, 3.93, 0.070, 232, 114, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1722, 5npiA, 0.5324, 3.94, 0.070, 232, 114, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1723, 3ugxB, 0.5324, 3.77, 0.028, 352, 107, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1724, 3hplA, 0.5324, 3.87, 0.080, 219, 113, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
1725, 2nljB, 0.5324, 3.87, 0.080, 218, 113, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
1726, 2jk5A, 0.5324, 3.87, 0.080, 219, 113, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
1727, 6dcvH, 0.5323, 4.05, 0.079, 226, 114, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
1728, 6cuhA, 0.5323, 3.65, 0.083, 187, 108, CRYSTAL STRUCTURE OF THE UNLIGANDED BC8B TCR 
1729, 5j9pA, 0.5323, 3.88, 0.080, 219, 113, KCSA IN VITRO
1730, 4yxlH, 0.5323, 3.98, 0.088, 218, 114, CRYSTAL STRUCTURE OF SYRIAN HAMSTER PRION PROTEIN COMPLEXED WITH POM1 FAB
1731, 3mlwH, 0.5323, 3.88, 0.071, 228, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
1732, 2cdeB, 0.5323, 3.78, 0.073, 244, 110, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
1733, 2bnuA, 0.5323, 3.72, 0.110, 203, 109, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
1734, 1yuhH, 0.5323, 3.93, 0.105, 218, 114, FAB FRAGMENT
1735, 1lp9E, 0.5323, 3.61, 0.111, 194, 108, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
1736, 1jerA, 0.5323, 3.13, 0.122, 110, 98, CUCUMBER STELLACYANIN CU2+ PH 7.0
1737, 6qexC, 0.5322, 3.93, 0.096, 225, 114, NANODISC RECONSTITUTED HUMAN ABCB1 IN COMPLEX WITH UIC2 FAB AND TAXOL 
1738, 5npjB, 0.5322, 3.94, 0.070, 232, 114, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1739, 3gi9H, 0.5322, 3.89, 0.088, 217, 113, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
1740, 2h32H, 0.5322, 3.96, 0.053, 211, 113, CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
1741, 2e7lB, 0.5322, 3.47, 0.123, 110, 106, STRUCTURE OF A HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
1742, 2dblH, 0.5322, 3.86, 0.088, 219, 114, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1743, 1rjlB, 0.5322, 3.87, 0.097, 221, 113, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
1744, 6dg2A, 0.5321, 3.99, 0.096, 217, 114, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
1745, 6azzF, 0.5321, 3.92, 0.079, 220, 114, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
1746, 5yslE, 0.5321, 3.87, 0.080, 210, 112, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1747, 5w0pB, 0.5321, 3.91, 0.028, 802, 109, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1748, 5npiB, 0.5321, 3.94, 0.070, 233, 114, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1749, 3uluF, 0.5321, 3.92, 0.097, 217, 113, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
1750, 2vljD, 0.5321, 3.61, 0.123, 199, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
1751, 2f54D, 0.5321, 3.68, 0.119, 205, 109, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
1752, 1zwiA, 0.5321, 3.87, 0.080, 219, 113, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
1753, 1r3kB, 0.5321, 3.86, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
1754, 6cugD, 0.5320, 3.63, 0.083, 186, 108, CRYSTAL STRUCTURE OF BC8B TCR-CD1B-PC COMPLEX 
1755, 6azzC, 0.5320, 3.92, 0.079, 217, 114, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
1756, 5vkeA, 0.5320, 3.86, 0.080, 219, 113, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
1757, 5mhrR, 0.5320, 3.82, 0.062, 213, 112, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1758, 4wuuE, 0.5320, 3.83, 0.071, 223, 112, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
1759, 3or6A, 0.5320, 3.87, 0.080, 219, 113, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
1760, 3fb5A, 0.5320, 3.84, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
1761, 3f7vA, 0.5320, 3.84, 0.088, 219, 113, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
1762, 2bnqD, 0.5320, 3.70, 0.110, 203, 109, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
1763, 6fr4A, 0.5319, 3.71, 0.111, 202, 108, 003 TCR STUDY OF CDR LOOP FLEXIBILITY 
1764, 6aniH, 0.5319, 3.92, 0.088, 216, 113, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1765, 5wk2H, 0.5319, 4.02, 0.062, 217, 113, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
1766, 5tjeE, 0.5319, 3.88, 0.100, 116, 110, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
1767, 4mnqE, 0.5319, 3.72, 0.065, 240, 108, TCR-PEPTIDE SPECIFICITY OVERRIDES AFFINITY ENHANCING TCR-MHC INTERACTIONS
1768, 3qpqD, 0.5319, 3.93, 0.097, 218, 113, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1769, 3naaH, 0.5319, 3.90, 0.080, 225, 112, CRYSTAL STRUCTURE OF FAB15 MUT5
1770, 3fb7A, 0.5319, 3.84, 0.088, 219, 113, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
1771, 2dwdA, 0.5319, 3.87, 0.080, 219, 113, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
1772, 1lp9L, 0.5319, 3.57, 0.120, 194, 108, XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND TO P1049/HLA-A2.1
1773, 6c68C, 0.5318, 3.70, 0.119, 205, 109, MHC-INDEPENDENT T CELL RECEPTOR A11 
1774, 4zsoD, 0.5318, 4.00, 0.105, 219, 114, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1775, 4uujA, 0.5318, 3.88, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
1776, 3ncjH, 0.5318, 3.97, 0.088, 225, 113, CRYSTAL STRUCTURE OF FAB15 MUT8
1777, 3bikB, 0.5318, 3.78, 0.093, 116, 107, CRYSTAL STRUCTURE OF THE PD-1/PD-L1 COMPLEX
1778, 1a4jH, 0.5318, 3.92, 0.096, 217, 114, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1779, 6eh4D, 0.5317, 3.74, 0.111, 204, 108, 003 HUMAN T-CELL RECEPTOR SPECIFIC FOR HIV GAG EPITOPE SLYNTVATL CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-A*0201 
1780, 6by2A, 0.5317, 3.87, 0.080, 219, 113, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
1781, 5iblC, 0.5317, 3.74, 0.082, 216, 110, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
1782, 4u6vB, 0.5317, 3.82, 0.082, 272, 110, MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY
1783, 4rqqB, 0.5317, 3.82, 0.053, 239, 113, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1784, 4j2qB, 0.5317, 3.83, 0.037, 346, 107, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1785, 4al8H, 0.5317, 3.78, 0.098, 212, 112, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
1786, 2vlkD, 0.5317, 3.61, 0.113, 199, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
1787, 1mhhD, 0.5317, 3.95, 0.079, 214, 114, ANTIBODY-ANTIGEN COMPLEX
1788, 1fgnH, 0.5317, 3.90, 0.097, 214, 113, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
1789, 1ahwE, 0.5317, 3.80, 0.080, 214, 112, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1790, 6d6tK, 0.5316, 3.66, 0.082, 116, 110, HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL; CONFORMATION B 
1791, 6c74A, 0.5316, 3.65, 0.055, 111, 109, CRYSTAL STRUCTURE OF MURINE CD300LF IN COMPLEX WITH PHOSPHOCHOLINE 
1792, 3gb7A, 0.5316, 3.85, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
1793, 3b9kF, 0.5316, 3.81, 0.099, 117, 111, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
1794, 3b9kB, 0.5316, 3.81, 0.090, 117, 111, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
1795, 2f54K, 0.5316, 3.70, 0.110, 206, 109, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
1796, 2cdeD, 0.5316, 3.75, 0.073, 244, 110, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
1797, 1tetH, 0.5316, 3.94, 0.088, 209, 114, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
1798, 5zv3H, 0.5315, 3.87, 0.062, 219, 112, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
1799, 5tilK, 0.5315, 3.84, 0.110, 118, 109, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1800, 5hcgH, 0.5315, 3.90, 0.096, 332, 114, CRYSTAL STRUCTURE OF FREE-CODV.
1801, 1qblH, 0.5315, 3.92, 0.080, 219, 113, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
1802, 4rirH, 0.5314, 3.96, 0.062, 219, 113, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1803, 3uluH, 0.5314, 3.92, 0.071, 225, 112, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
1804, 3ogcA, 0.5314, 3.91, 0.080, 219, 113, KCSA E71A VARIANT IN PRESENCE OF NA+
1805, 3gi8H, 0.5314, 3.89, 0.088, 220, 113, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
1806, 2j8uE, 0.5314, 3.60, 0.120, 194, 108, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
1807, 2g60H, 0.5314, 3.81, 0.098, 208, 112, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
1808, 1zeaH, 0.5314, 3.90, 0.105, 209, 114, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
1809, 1nezG, 0.5314, 4.05, 0.070, 122, 114, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
1810, 1afvH, 0.5314, 3.90, 0.097, 220, 113, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1811, 5vnwD, 0.5313, 3.71, 0.072, 120, 111, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
1812, 5ebwA, 0.5313, 3.87, 0.088, 218, 113, KCSA WITH G77ESTER MUTATION
1813, 4lcuA, 0.5313, 3.89, 0.080, 219, 113, STRUCTURE OF KCSA WITH E118A MUTATION
1814, 3v4pM, 0.5313, 3.96, 0.088, 211, 114, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
1815, 3ulvH, 0.5313, 4.09, 0.088, 225, 114, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
1816, 3na9H, 0.5313, 3.94, 0.080, 225, 113, CRYSTAL STRUCTURE OF FAB15
1817, 2bocA, 0.5313, 3.87, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
1818, 2atkA, 0.5313, 3.89, 0.080, 219, 113, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
1819, 1iqwH, 0.5313, 3.87, 0.097, 221, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
1820, 1dbkH, 0.5313, 3.88, 0.088, 219, 114, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1821, 6c68A, 0.5312, 3.70, 0.119, 205, 109, MHC-INDEPENDENT T CELL RECEPTOR A11 
1822, 5yxnA, 0.5312, 3.76, 0.126, 192, 111, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
1823, 5wk3S, 0.5312, 3.83, 0.063, 221, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1824, 5ibuG, 0.5312, 3.99, 0.071, 225, 113, FAB (UNBOUND)
1825, 5epmA, 0.5312, 3.84, 0.098, 218, 112, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
1826, 4p4kC, 0.5312, 3.69, 0.083, 204, 108, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
1827, 3mlwI, 0.5312, 3.90, 0.089, 228, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
1828, 2jelH, 0.5312, 3.84, 0.088, 218, 113, JEL42 FAB/HPR COMPLEX
1829, 2itdA, 0.5312, 3.85, 0.088, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
1830, 5bq7A, 0.5311, 4.03, 0.087, 220, 115, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT
1831, 4zd3H, 0.5311, 4.00, 0.062, 199, 113, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY FAB FRAGMENT
1832, 3sdcD, 0.5311, 3.78, 0.083, 239, 109, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
1833, 3igaA, 0.5311, 3.86, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
1834, 1zglU, 0.5311, 3.62, 0.093, 195, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1835, 1h5bA, 0.5311, 3.60, 0.124, 113, 105, T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN
1836, 1afvK, 0.5311, 3.91, 0.097, 220, 113, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1837, 5mhrN, 0.5310, 3.80, 0.062, 214, 112, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1838, 4bz2H, 0.5310, 3.95, 0.088, 213, 114, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 2D73
1839, 4alaH, 0.5310, 3.81, 0.098, 208, 112, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
1840, 3scmD, 0.5310, 3.79, 0.083, 239, 109, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
1841, 3mltH, 0.5310, 3.95, 0.044, 215, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
1842, 1yuhB, 0.5310, 3.95, 0.123, 218, 114, FAB FRAGMENT
1843, 6ey0F, 0.5309, 3.77, 0.062, 131, 112, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
1844, 6a3wA, 0.5309, 3.72, 0.055, 116, 109, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
1845, 5wk3W, 0.5309, 3.98, 0.062, 221, 112, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1846, 5o14H, 0.5309, 3.80, 0.063, 221, 111, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
1847, 4p4kG, 0.5309, 3.61, 0.084, 203, 107, STRUCTURAL BASIS OF CHRONIC BERYLLIUM DISEASE: BRIDGING THE GAP BETWEEN ALLERGIC HYPERSENSITIVITY AND AUTO IMMUNITY
1848, 3tzvA, 0.5309, 3.67, 0.110, 196, 109, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
1849, 2bobA, 0.5309, 3.89, 0.080, 219, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
1850, 4qokE, 0.5308, 3.75, 0.118, 244, 110, STRUCTURAL BASIS FOR INEFFECTIVE T-CELL RESPONSES TO MHC ANCHOR RESIDUE IMPROVED HETEROCLITIC PEPTIDES
1851, 4ma8H, 0.5308, 4.00, 0.079, 218, 114, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
1852, 2z4qB, 0.5308, 3.98, 0.079, 218, 114, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
1853, 2uylW, 0.5308, 3.92, 0.097, 213, 113, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
1854, 2eysA, 0.5308, 3.58, 0.102, 202, 108, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
1855, 1zglM, 0.5308, 3.66, 0.083, 178, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
1856, 6c08D, 0.5307, 3.77, 0.071, 214, 112, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
1857, 5lxaH, 0.5307, 3.82, 0.080, 238, 113, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 3.0 ANGSTROM RESOLUTION
1858, 5d8jH, 0.5307, 4.03, 0.114, 216, 114, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
1859, 3dggD, 0.5307, 3.93, 0.088, 215, 114, CRYSTAL STRUCTURE OF FABOX108
1860, 2w0fA, 0.5307, 3.88, 0.080, 218, 113, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
1861, 5swzT, 0.5306, 3.69, 0.131, 239, 107, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1862, 5lxgH, 0.5306, 3.74, 0.082, 119, 110, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 IN AN OPEN CONFORMATION
1863, 4aehH, 0.5306, 4.02, 0.114, 219, 114, CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
1864, 3tzvG, 0.5306, 3.65, 0.101, 201, 109, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
1865, 3f83A, 0.5306, 3.92, 0.053, 508, 114, STRUCTURE OF FUSION COMPLEX OF THE MINOR PILIN CFAE AND MAJOR PILIN CFAB OF CFA/I PILI FROM ETEC E. COLI
1866, 2bdnH, 0.5306, 3.88, 0.097, 217, 113, CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY 11K2
1867, 1hklH, 0.5306, 3.79, 0.098, 217, 112, FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
1868, 6fy1H, 0.5305, 3.83, 0.071, 226, 112, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
1869, 5t5nG, 0.5305, 3.89, 0.088, 211, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
1870, 5mhrK, 0.5305, 3.73, 0.063, 122, 111, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
1871, 4yhdC, 0.5305, 3.82, 0.092, 279, 109, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1872, 4lbeA, 0.5305, 3.90, 0.080, 219, 113, STRUCTURE OF KCSA WITH R122A MUTATION
1873, 3nacH, 0.5305, 3.93, 0.088, 225, 113, CRYSTAL STRUCTURE OF FAB15 MUT7
1874, 2j8uL, 0.5305, 3.59, 0.120, 194, 108, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION.
1875, 4j2qA, 0.5304, 3.82, 0.028, 340, 107, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1876, 2cdfB, 0.5304, 3.68, 0.092, 244, 109, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5E)
1877, 6c61A, 0.5303, 3.69, 0.110, 206, 109, MHC-INDEPENDENT T-CELL RECEPTOR B12A 
1878, 6a3wG, 0.5303, 3.71, 0.055, 116, 109, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
1879, 5xj4L, 0.5303, 3.75, 0.084, 113, 107, COMPLEX STRUCTURE OF DURVALUMAB-SCFV/PD-L1 
1880, 4hjjH, 0.5303, 4.18, 0.070, 341, 115, STRUCTURE REVEALS FUNCTION OF THE DUAL VARIABLE DOMAIN IMMUNOGLOBULIN (DVD-IG) MOLECULE
1881, 4grmD, 0.5303, 3.71, 0.083, 243, 109, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
1882, 3v4vM, 0.5303, 3.95, 0.096, 213, 114, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
1883, 3qdmE, 0.5303, 3.69, 0.083, 242, 108, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
1884, 1ob1E, 0.5303, 3.86, 0.088, 219, 113, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
1885, 6cqqI, 0.5302, 3.66, 0.101, 200, 109, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1886, 6b5rH, 0.5302, 3.81, 0.097, 211, 113, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
1887, 5i1lH, 0.5302, 4.01, 0.062, 225, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
1888, 4y1aE, 0.5302, 3.66, 0.093, 240, 108, IMMUNE COMPLEX
1889, 4ww2A, 0.5302, 3.72, 0.110, 203, 109, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 BETA CHAIN- TRBV7-8 ANTIGEN-PRESENTING GLYCOPROTEIN CD1D AND BETA-2- MICROGLOBULIN
1890, 3v4vH, 0.5302, 3.96, 0.096, 211, 114, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
1891, 3uzeA, 0.5302, 3.78, 0.063, 229, 111, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
1892, 3cviH, 0.5302, 3.82, 0.080, 213, 112, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
1893, 1xcqB, 0.5302, 3.91, 0.080, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
1894, 1hxmF, 0.5302, 3.81, 0.117, 230, 111, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1895, 5t5nO, 0.5301, 3.90, 0.088, 211, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
1896, 5t5nI, 0.5301, 3.90, 0.088, 211, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
1897, 4xzuE, 0.5301, 3.90, 0.088, 208, 113, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
1898, 3sdxG, 0.5301, 3.65, 0.101, 196, 109, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1899, 3qpqF, 0.5301, 3.86, 0.089, 220, 112, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1900, 3hmxH, 0.5301, 4.00, 0.053, 217, 114, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
1901, 2po6G, 0.5301, 3.66, 0.101, 204, 109, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1902, 2hvjA, 0.5301, 3.81, 0.080, 218, 112, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
1903, 1t4wA, 0.5301, 3.69, 0.046, 196, 109, STRUCTURAL DIFFERENCES IN THE DNA BINDING DOMAINS OF HUMAN P53 AND ITS C. ELEGANS ORTHOLOG CEP-1: STRUCTURE OF C. ELEGANS CEP-1
1904, 6jmqC, 0.5300, 3.80, 0.062, 214, 112, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
1905, 6e0cM, 0.5300, 3.72, 0.108, 229, 111, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
1906, 6cqqD, 0.5300, 3.66, 0.101, 200, 109, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
1907, 6cdoA, 0.5300, 3.83, 0.098, 230, 112, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
1908, 6amuE, 0.5300, 3.67, 0.083, 241, 108, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE MMWDRGLGMM 
1909, 5xovH, 0.5300, 3.67, 0.120, 245, 108, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
1910, 5epmE, 0.5300, 3.85, 0.098, 218, 112, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
1911, 4qrpK, 0.5300, 3.59, 0.084, 202, 107, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
1912, 3vacA, 0.5300, 4.12, 0.043, 356, 116, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1913, 3sdxE, 0.5300, 3.65, 0.101, 196, 109, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
1914, 3qeqD, 0.5300, 3.44, 0.135, 194, 104, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
1915, 2vl5C, 0.5300, 3.96, 0.114, 218, 114, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
1916, 1hxmB, 0.5300, 3.91, 0.125, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1917, 1ahwB, 0.5300, 3.83, 0.080, 214, 112, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1918, 6cdmD, 0.5299, 3.85, 0.088, 218, 113, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
1919, 5swzE, 0.5299, 3.72, 0.131, 240, 107, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
1920, 5ks9G, 0.5299, 3.62, 0.085, 192, 106, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
1921, 4ma7H, 0.5299, 4.02, 0.088, 218, 114, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
1922, 4bz1H, 0.5299, 3.92, 0.080, 212, 113, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
1923, 3hujH, 0.5299, 3.72, 0.093, 245, 108, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1924, 2r6pF, 0.5299, 3.88, 0.071, 216, 113, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
1925, 2r6pD, 0.5299, 3.88, 0.071, 216, 113, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
1926, 2r29H, 0.5299, 3.88, 0.071, 216, 113, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
1927, 6fr6B, 0.5298, 3.71, 0.102, 241, 108, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
1928, 6a3wD, 0.5298, 3.73, 0.055, 116, 109, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
1929, 4h88H, 0.5298, 4.01, 0.079, 218, 114, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
1930, 3v4pH, 0.5298, 3.87, 0.088, 211, 113, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
1931, 3uzeB, 0.5298, 3.78, 0.063, 226, 111, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
1932, 3qi9D, 0.5298, 3.81, 0.092, 239, 109, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
1933, 2pyfA, 0.5298, 3.69, 0.110, 205, 109, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
1934, 1dbmH, 0.5298, 3.90, 0.088, 219, 114, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1935, 6fn4C, 0.5297, 3.96, 0.096, 225, 115, APO FORM OF UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
1936, 6e0pM, 0.5297, 3.72, 0.108, 229, 111, CRYO-EM STRUCTURE OF THE CENTROMERIC NUCLEOSOME (NATIVE ALPHA SATELLITE DNA) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
1937, 5kqvP, 0.5297, 3.95, 0.088, 220, 113, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
1938, 5kqvC, 0.5297, 3.90, 0.089, 211, 112, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
1939, 4yxhH, 0.5297, 4.01, 0.079, 218, 114, CRYSTAL STRUCTURE OF DEER PRION PROTEIN COMPLEXED WITH POM1 FAB
1940, 4yhoH, 0.5297, 3.84, 0.088, 222, 113, REVERSAL AGENT FOR DABIGATRAN
1941, 4tnwW, 0.5297, 3.85, 0.081, 224, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1942, 4qrpJ, 0.5297, 3.60, 0.084, 203, 107, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
1943, 2po6D, 0.5297, 3.75, 0.092, 244, 109, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1944, 2po6C, 0.5297, 3.61, 0.102, 203, 108, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
1945, 2cdeF, 0.5297, 3.77, 0.082, 244, 110, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
1946, 1xcqD, 0.5297, 3.87, 0.071, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
1947, 5lx9H, 0.5296, 3.83, 0.080, 228, 113, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 2.4 ANGSTROM RESOLUTION
1948, 5e1aA, 0.5296, 3.94, 0.080, 219, 113, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
1949, 4rdqO, 0.5296, 3.91, 0.088, 211, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
1950, 4rdqI, 0.5296, 3.91, 0.088, 211, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
1951, 4qrpD, 0.5296, 3.59, 0.084, 203, 107, CRYSTAL STRUCTURE OF HLA B*0801 IN COMPLEX WITH HSKKKCDEL AND DD31 TCR
1952, 4apqD, 0.5296, 3.72, 0.083, 240, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
1953, 3nabH, 0.5296, 4.00, 0.080, 217, 113, CRYSTAL STRUCTURE OF FAB15 MUT6
1954, 2eyrA, 0.5296, 3.59, 0.102, 202, 108, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
1955, 5yxuF, 0.5295, 3.73, 0.126, 190, 111, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
1956, 5tilG, 0.5295, 3.66, 0.112, 114, 107, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2 DB IN COMPLEX WITH LCMV-DERIVED GP33 ALTERED PEPTIDE V3P AND T-CELL RECEPTOR P14
1957, 5t5nK, 0.5295, 3.91, 0.088, 211, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
1958, 3hujG, 0.5295, 3.67, 0.101, 202, 109, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1959, 2r69L, 0.5295, 3.94, 0.119, 204, 109, CRYSTAL STRUCTURE OF FAB 1A1D-2 COMPLEXED WITH E-DIII OF DENGUE VIRUS AT 3.8 ANGSTROM RESOLUTION
1960, 2ap2B, 0.5295, 3.80, 0.071, 122, 112, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
1961, 1ncbH, 0.5295, 3.79, 0.090, 221, 111, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
1962, 1hxmH, 0.5295, 3.85, 0.116, 230, 112, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1963, 6mtoH, 0.5294, 3.93, 0.071, 219, 113, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
1964, 6gk8H, 0.5294, 3.97, 0.080, 222, 113, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-28.1; DOUBLE MUTANT (S32R; E35K) OF CBTAU-28.1; IN COMPLEX WITH TAU PEPTIDE A7731 (RESIDUES 52-71) 
1965, 6ey0G, 0.5294, 3.79, 0.054, 129, 112, N-TERMINAL PART (RESIDUES 30-212) OF PORM WITH THE LLAMA NANOBODY NB01
1966, 5vqmD, 0.5294, 3.97, 0.088, 216, 114, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
1967, 4h1lG, 0.5294, 3.53, 0.113, 113, 106, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
1968, 3sddD, 0.5294, 3.80, 0.083, 238, 109, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
1969, 3r8bD, 0.5294, 3.78, 0.101, 114, 109, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
1970, 3macH, 0.5294, 3.82, 0.081, 218, 111, CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062
1971, 2vlrI, 0.5294, 3.60, 0.123, 199, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
1972, 1a4jB, 0.5294, 3.87, 0.097, 217, 113, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
1973, 6fy2X, 0.5293, 3.98, 0.088, 219, 113, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
1974, 5w1vI, 0.5293, 3.67, 0.142, 202, 106, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
1975, 5u72E, 0.5293, 3.68, 0.083, 243, 108, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
1976, 4risH, 0.5293, 3.97, 0.080, 228, 113, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1977, 4np4H, 0.5293, 3.95, 0.071, 215, 112, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
1978, 3qdgE, 0.5293, 3.68, 0.083, 242, 108, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
1979, 3hmwH, 0.5293, 3.97, 0.062, 218, 113, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
1980, 3fctD, 0.5293, 3.91, 0.088, 216, 113, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
1981, 1ob1B, 0.5293, 3.90, 0.088, 219, 113, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
1982, 1mhhB, 0.5293, 3.83, 0.080, 215, 112, ANTIBODY-ANTIGEN COMPLEX
1983, 6fn1C, 0.5292, 3.95, 0.104, 225, 115, ZOSUQUIDAR AND UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
1984, 5ikcH, 0.5292, 3.89, 0.088, 214, 113, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
1985, 5ibuH, 0.5292, 3.97, 0.071, 219, 113, FAB (UNBOUND)
1986, 4rgnD, 0.5292, 3.83, 0.089, 210, 112, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
1987, 3vacB, 0.5292, 4.14, 0.052, 356, 116, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
1988, 3sjvI, 0.5292, 3.56, 0.094, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1989, 3r8bH, 0.5292, 3.78, 0.101, 113, 109, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
1990, 3qeuB, 0.5292, 3.69, 0.083, 238, 108, THE CRYSTAL STRUCTURE OF TCR DMF5
1991, 3hujF, 0.5292, 3.71, 0.093, 242, 108, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
1992, 2uylN, 0.5292, 3.92, 0.106, 213, 113, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
1993, 5i1jH, 0.5291, 4.02, 0.062, 213, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11
1994, 4yhiA, 0.5291, 3.84, 0.088, 222, 113, REVERSAL AGENT FOR DABIGATRAN
1995, 4rqqH, 0.5291, 3.87, 0.062, 240, 113, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
1996, 4rgnF, 0.5291, 3.83, 0.089, 210, 112, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
1997, 4rdqG, 0.5291, 3.91, 0.088, 211, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
1998, 3sjvS, 0.5291, 3.57, 0.104, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
1999, 3o6fH, 0.5291, 3.82, 0.092, 243, 109, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
2000, 3fctB, 0.5291, 3.82, 0.080, 216, 112, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
2001, 1e4wH, 0.5291, 3.90, 0.106, 213, 113, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2002, 5fflA, 0.5290, 3.75, 0.055, 113, 110, CRYSTAL STRUCTURE OF MOUSE CD300LF AT 1.6 ANGSTROMS RESOLUTION.
2003, 5e6iL, 0.5290, 3.81, 0.091, 242, 110, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
2004, 5dgyD, 0.5290, 3.85, 0.028, 833, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
2005, 4zwjD, 0.5290, 3.85, 0.028, 833, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
2006, 4etqH, 0.5290, 3.87, 0.080, 215, 113, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
2007, 1rzgC, 0.5290, 3.88, 0.071, 213, 112, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
2008, 1ngwB, 0.5290, 3.82, 0.080, 216, 112, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2009, 1cicB, 0.5290, 3.90, 0.124, 217, 113, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
2010, 6dg2C, 0.5289, 3.91, 0.106, 211, 113, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
2011, 5w23J, 0.5289, 3.88, 0.080, 219, 112, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2012, 5swzO, 0.5289, 3.71, 0.131, 241, 107, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2013, 4yxkH, 0.5289, 4.01, 0.079, 218, 114, CRYSTAL STRUCTURE OF ELK PRION PROTEIN COMPLEXED WITH POM1 FAB
2014, 4np4I, 0.5289, 3.98, 0.071, 221, 112, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
2015, 4hqqH, 0.5289, 3.98, 0.080, 215, 113, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
2016, 3mlvN, 0.5289, 4.01, 0.044, 221, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
2017, 2uylY, 0.5289, 3.92, 0.106, 213, 113, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2018, 2ok0H, 0.5289, 3.85, 0.098, 216, 112, FAB ED10-DNA COMPLEX
2019, 2icwI, 0.5289, 3.53, 0.113, 110, 106, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
2020, 2eytA, 0.5289, 3.69, 0.110, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2021, 1nmaH, 0.5289, 3.75, 0.090, 122, 111, N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
2022, 1nlbH, 0.5289, 3.99, 0.088, 218, 114, CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
2023, 6fy2H, 0.5288, 4.01, 0.088, 219, 113, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
2024, 5hhmD, 0.5288, 3.62, 0.142, 194, 106, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
2025, 4y1aD, 0.5288, 3.58, 0.075, 205, 107, IMMUNE COMPLEX
2026, 4xnyH, 0.5288, 3.97, 0.070, 234, 114, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
2027, 4wo4D, 0.5288, 3.93, 0.099, 242, 111, THE MOLECULAR BASES OF DELTA/ALPHA BETA T CELL-MEDIATED ANTIGEN RECOGNITION.
2028, 4h1lI, 0.5288, 3.52, 0.113, 113, 106, TCR INTERACTION WITH PEPTIDE MIMICS OF NICKEL OFFERS STRUCTURAL INSIGHTS IN NICKEL CONTACT ALLERGY
2029, 4dgiH, 0.5288, 4.03, 0.088, 218, 114, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230
2030, 3gnmH, 0.5288, 3.86, 0.080, 218, 112, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
2031, 2vlrD, 0.5288, 3.62, 0.123, 199, 106, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
2032, 1xcqF, 0.5288, 3.92, 0.080, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2033, 1ngwH, 0.5288, 3.82, 0.080, 216, 112, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2034, 1k6qH, 0.5288, 3.92, 0.088, 213, 113, CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
2035, 6b5pH, 0.5287, 3.84, 0.088, 212, 113, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN ANTIBODY CIS42
2036, 5w23H, 0.5287, 3.86, 0.089, 219, 112, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2037, 4rdqK, 0.5287, 3.91, 0.088, 211, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
2038, 4n8cI, 0.5287, 3.95, 0.088, 221, 113, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
2039, 4ffvH, 0.5287, 3.92, 0.071, 209, 113, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
2040, 3vwkD, 0.5287, 3.66, 0.084, 242, 107, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
2041, 3tyfC, 0.5287, 3.68, 0.110, 197, 109, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
2042, 3hujE, 0.5287, 3.65, 0.101, 199, 109, CRYSTAL STRUCTURE OF HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE IN COMPLEX WITH SEMI-INVARIANT NKT CELL RECEPTOR
2043, 2uylB, 0.5287, 3.93, 0.106, 213, 113, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2044, 2nx5U, 0.5287, 3.85, 0.083, 243, 109, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2045, 5w06H, 0.5286, 3.92, 0.080, 216, 112, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
2046, 5u72G, 0.5286, 3.69, 0.083, 243, 108, STRUCTURE OF HUMAN MR1-5OH-DCF IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2047, 5u17E, 0.5286, 3.68, 0.083, 244, 108, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2048, 5tq2H, 0.5286, 3.88, 0.106, 205, 113, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT GLUN1 AND GLUN2A
2049, 5h2bA, 0.5286, 3.93, 0.080, 216, 113, STRUCTURE OF A NOVEL ANTIBODY G196
2050, 4tnwF, 0.5286, 3.85, 0.081, 221, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2051, 4nqcH, 0.5286, 3.68, 0.083, 243, 108, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2052, 4n8cH, 0.5286, 3.93, 0.088, 220, 113, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
2053, 3uypA, 0.5286, 3.79, 0.063, 226, 111, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 4 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2054, 3sknF, 0.5286, 3.77, 0.092, 241, 109, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
2055, 3r8bB, 0.5286, 3.85, 0.091, 114, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
2056, 2po6H, 0.5286, 3.76, 0.092, 244, 109, CRYSTAL STRUCTURE OF CD1D-LIPID-ANTIGEN COMPLEXED WITH BETA-2- MICROGLOBULIN NKT15 ALPHA-CHAIN AND NKT15 BETA-CHAIN
2057, 1lmkG, 0.5286, 3.88, 0.062, 238, 113, THE STRUCTURE OF A BIVALENT DIABODY
2058, 1ae6H, 0.5286, 3.96, 0.096, 218, 114, IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01
2059, 6qeeC, 0.5285, 3.93, 0.096, 225, 115, NANODISC RECONSTITUTED HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)-EQ MUTANT IN COMPLEX WITH UIC2 FAB AND ZOSUQUIDAR. 
2060, 6eqaE, 0.5285, 3.76, 0.127, 244, 110, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
2061, 6b08C, 0.5285, 4.05, 0.078, 221, 115, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1276
2062, 5w23I, 0.5285, 3.87, 0.080, 219, 112, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2063, 5u6qE, 0.5285, 3.68, 0.083, 244, 108, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2064, 5ksaC, 0.5285, 3.72, 0.103, 195, 107, BEL602-DQ8.5-GLIA-GAMMA1 COMPLEX
2065, 4gq9H, 0.5285, 3.81, 0.098, 218, 112, CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
2066, 3r8bL, 0.5285, 3.84, 0.100, 114, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
2067, 3qh3B, 0.5285, 3.76, 0.083, 245, 109, THE CRYSTAL STRUCTURE OF TCR A6
2068, 3kj6H, 0.5285, 3.83, 0.090, 217, 111, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
2069, 1ymhD, 0.5285, 4.01, 0.070, 218, 114, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
2070, 1a4kH, 0.5285, 3.86, 0.089, 217, 112, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
2071, 6fy0I, 0.5284, 3.89, 0.080, 216, 112, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2072, 6c6qF, 0.5284, 3.75, 0.055, 113, 110, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR 
2073, 6am5E, 0.5284, 3.72, 0.083, 242, 108, CRYSTAL STRUCTURE OF DMF5 TCR BOUND TO HLA-A2 PRESENTING SYNTHETIC PEPTIDE SMLGIGIVPV 
2074, 5yxuA, 0.5284, 3.77, 0.126, 191, 111, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2075, 5tjeG, 0.5284, 3.68, 0.112, 112, 107, MURINE CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX H-2DB IN COMPLEX WITH LCMV-DERIVED GP33 AND T CELL RECEPTOR P14
2076, 4yhiH, 0.5284, 3.86, 0.088, 222, 113, REVERSAL AGENT FOR DABIGATRAN
2077, 4hwbH, 0.5284, 3.89, 0.062, 216, 112, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA 1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
2078, 3wxwH, 0.5284, 3.80, 0.080, 119, 112, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2
2079, 3uzvB, 0.5284, 3.85, 0.071, 229, 112, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
2080, 5yfiH, 0.5283, 3.92, 0.080, 221, 113, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
2081, 5y11A, 0.5283, 4.03, 0.062, 219, 113, SFTSV GN WITH NEUTRALIZING ANTIBODY MAB4-5
2082, 5xovJ, 0.5283, 3.72, 0.119, 245, 109, CRYSTAL STRUCTURE OF PEPTIDE-HLA-A24 BOUND TO S19-2 V-DELTA/V-BETA TCR
2083, 5u16H, 0.5283, 3.68, 0.083, 243, 108, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2084, 5a3iC, 0.5283, 4.05, 0.070, 226, 114, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
2085, 3tyfA, 0.5283, 3.68, 0.110, 199, 109, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
2086, 3r8bF, 0.5283, 3.85, 0.091, 113, 110, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B IN COMPLEX WITH AN AFFINITY MATURED MOUSE TCR VBETA8.2 PROTEIN G5-8
2087, 3o6fD, 0.5283, 3.87, 0.091, 245, 110, CRYSTAL STRUCTURE OF A HUMAN AUTOIMMUNE TCR MS2-3C8 BOUND TO MHC CLASS II SELF-LIGAND MBP/HLA-DR4
2088, 3j2zH, 0.5283, 3.81, 0.098, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2089, 3j2zF, 0.5283, 3.81, 0.098, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2090, 3j2zD, 0.5283, 3.81, 0.098, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2091, 3j2zB, 0.5283, 3.81, 0.098, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
2092, 3j2yH, 0.5283, 3.81, 0.098, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2093, 3j2yF, 0.5283, 3.81, 0.098, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2094, 3j2yD, 0.5283, 3.81, 0.098, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2095, 3j2yB, 0.5283, 3.81, 0.098, 218, 112, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
2096, 2uweL, 0.5283, 3.65, 0.130, 194, 108, LARGE CDR3A LOOP ALTERATION AS A FUNCTION OF MHC MUTATION
2097, 1rziL, 0.5283, 3.94, 0.071, 215, 113, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
2098, 1nqbC, 0.5283, 3.87, 0.080, 232, 113, TRIVALENT ANTIBODY FRAGMENT
2099, 5yxuB, 0.5282, 3.74, 0.074, 242, 108, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
2100, 5d7iF, 0.5282, 3.68, 0.093, 243, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
2101, 4y19E, 0.5282, 3.70, 0.083, 241, 108, IMMUNE COMPLEX
2102, 4amkH, 0.5282, 3.67, 0.091, 215, 110, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
2103, 3wihH, 0.5282, 3.79, 0.099, 219, 111, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2104, 3vwjD, 0.5282, 3.65, 0.093, 241, 107, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
2105, 3pqyJ, 0.5282, 3.76, 0.111, 240, 108, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2106, 3i75B, 0.5282, 3.90, 0.088, 223, 113, ANTIBODY STRUCTURE
2107, 1nfdA, 0.5282, 3.77, 0.110, 203, 109, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2108, 1fskL, 0.5282, 3.96, 0.124, 220, 113, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2109, 1fskI, 0.5282, 3.96, 0.124, 220, 113, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2110, 1fskF, 0.5282, 3.96, 0.124, 220, 113, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2111, 1fskC, 0.5282, 3.96, 0.124, 220, 113, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2112, 5u6qG, 0.5281, 3.71, 0.083, 239, 108, STRUCTURE OF HUMAN MR1-3-F-SA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2113, 5t5nM, 0.5281, 3.85, 0.089, 211, 112, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
2114, 4zezI, 0.5281, 3.69, 0.127, 207, 110, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
2115, 4ww1A, 0.5281, 3.55, 0.123, 197, 106, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV21-TRAJ8 AND BETA CHAIN-TRBV7-8
2116, 4nqeE, 0.5281, 3.68, 0.083, 243, 108, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2117, 3wxvH, 0.5281, 3.89, 0.088, 119, 113, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1
2118, 2vl5A, 0.5281, 3.96, 0.106, 218, 113, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2119, 1rmfH, 0.5281, 3.96, 0.088, 216, 114, STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
2120, 1hxmD, 0.5281, 3.83, 0.117, 230, 111, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
2121, 5x2nH, 0.5280, 3.94, 0.071, 223, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2122, 5uelH, 0.5280, 3.94, 0.079, 232, 114, CRYSTAL STRUCTURE OF 354NC102 FAB
2123, 5k59B, 0.5280, 3.98, 0.080, 293, 112, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2124, 5jo4C, 0.5280, 3.85, 0.098, 221, 112, ANTIBODY FAB FRAGMENT COMPLEX
2125, 4ki5C, 0.5280, 3.85, 0.089, 218, 112, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
2126, 4jr9H, 0.5280, 3.95, 0.088, 213, 114, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
2127, 4hweH, 0.5280, 4.05, 0.062, 213, 113, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
2128, 4am0H, 0.5280, 3.84, 0.089, 214, 112, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2129, 4am0C, 0.5280, 3.84, 0.089, 211, 112, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2130, 3vwjC, 0.5280, 3.71, 0.101, 193, 109, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-C20:2 COMPLEX
2131, 3sdaD, 0.5280, 3.82, 0.083, 239, 109, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2132, 3mltB, 0.5280, 3.98, 0.044, 219, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
2133, 3etbH, 0.5280, 3.75, 0.064, 228, 109, CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18 COMPLEXED WITH ANTHRAX PROTECTIVE ANTIGEN DOMAIN 4
2134, 3cleH, 0.5280, 3.87, 0.088, 218, 113, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
2135, 2vxvH, 0.5280, 4.04, 0.080, 222, 113, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
2136, 2eytC, 0.5280, 3.67, 0.101, 202, 109, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2137, 1xf5B, 0.5280, 3.90, 0.080, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
2138, 6fy3X, 0.5279, 4.05, 0.062, 178, 113, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2139, 5w1wS, 0.5279, 3.63, 0.151, 202, 106, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
2140, 5w0kH, 0.5279, 3.96, 0.088, 213, 113, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2141, 5muqH, 0.5279, 3.92, 0.088, 219, 113, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
2142, 5jziI, 0.5279, 3.75, 0.108, 207, 111, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
2143, 5i8oL, 0.5279, 3.90, 0.111, 217, 108, HMM5 FAB IN COMPLEX WITH DISACCHARIDE
2144, 5hhmI, 0.5279, 3.62, 0.123, 196, 106, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
2145, 5dr5L, 0.5279, 3.83, 0.102, 215, 108, CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097
2146, 4pj5E, 0.5279, 3.68, 0.083, 243, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
2147, 4l4vE, 0.5279, 3.69, 0.083, 243, 108, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
2148, 3tt1H, 0.5279, 3.81, 0.071, 212, 112, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
2149, 3qeqE, 0.5279, 3.75, 0.074, 243, 108, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2150, 2w60A, 0.5279, 3.99, 0.088, 217, 114, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
2151, 5swzJ, 0.5278, 3.78, 0.130, 240, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2152, 5nphH, 0.5278, 4.01, 0.079, 214, 114, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2153, 5mvzA, 0.5278, 4.05, 0.062, 221, 113, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
2154, 5i1kH, 0.5278, 4.04, 0.062, 211, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20
2155, 5dgyC, 0.5278, 3.89, 0.028, 789, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
2156, 4zwjC, 0.5278, 3.89, 0.028, 789, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
2157, 4s1rH, 0.5278, 3.89, 0.071, 235, 113, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H08.F-117225 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
2158, 4llyB, 0.5278, 3.78, 0.093, 209, 107, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A
2159, 3wihI, 0.5278, 3.79, 0.099, 219, 111, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
2160, 3cvhH, 0.5278, 3.84, 0.089, 213, 112, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
2161, 2jccE, 0.5278, 3.76, 0.111, 194, 108, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2162, 1qfuH, 0.5278, 3.93, 0.106, 223, 113, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
2163, 6jmrC, 0.5277, 3.91, 0.071, 214, 113, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
2164, 6ev2C, 0.5277, 3.91, 0.088, 222, 113, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
2165, 6e47G, 0.5277, 3.66, 0.055, 112, 109, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND GLYCOCHENODEOXYCHOLIC ACID 
2166, 6cdpA, 0.5277, 3.87, 0.097, 221, 113, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2167, 6a3wJ, 0.5277, 3.82, 0.055, 116, 110, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
2168, 5muqA, 0.5277, 3.92, 0.097, 219, 113, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
2169, 5ks9E, 0.5277, 3.61, 0.085, 193, 106, BEL502-DQ8-GLIA-ALPHA1 COMPLEX
2170, 5k59A, 0.5277, 3.99, 0.080, 292, 112, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
2171, 4z7qH, 0.5277, 3.99, 0.088, 216, 114, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
2172, 4i9wE, 0.5277, 4.01, 0.088, 211, 114, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
2173, 1ngzB, 0.5277, 3.96, 0.080, 220, 113, CHIMERIC GERMLINE FAB 7G12-APO
2174, 6fy0H, 0.5276, 3.94, 0.080, 226, 112, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2175, 6cdmA, 0.5276, 3.87, 0.088, 218, 113, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2176, 5w0kE, 0.5276, 3.93, 0.097, 214, 113, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2177, 5mx3H, 0.5276, 3.75, 0.081, 219, 111, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
2178, 5ibtH, 0.5276, 4.02, 0.080, 218, 113, UCA FAB (UNBOUND) FROM 6515 LINEAGE
2179, 4x6cH, 0.5276, 3.76, 0.083, 243, 109, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2180, 4am0E, 0.5276, 3.84, 0.098, 212, 112, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2181, 3tf7K, 0.5276, 3.47, 0.152, 220, 105, 42F3 QL9/H2-LD COMPLEX
2182, 3mlrH, 0.5276, 4.00, 0.044, 226, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A NY5 V3 PEPTIDE
2183, 3lh9A, 0.5276, 3.56, 0.078, 286, 103, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
2184, 3h9sE, 0.5276, 3.73, 0.083, 245, 109, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TEL1P PEPTIDE
2185, 3e2hB, 0.5276, 3.44, 0.115, 109, 104, STRUCTURE OF THE M67 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
2186, 3bj91, 0.5276, 4.02, 0.161, 116, 112, CRYSTAL STRUCTURE OF THE SURROGATE LIGHT CHAIN VARIABLE DOMAIN VPREBJ
2187, 2p5wD, 0.5276, 3.70, 0.112, 192, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2188, 1e4xH, 0.5276, 4.01, 0.105, 216, 114, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2189, 6cugE, 0.5275, 3.70, 0.074, 244, 108, CRYSTAL STRUCTURE OF BC8B TCR-CD1B-PC COMPLEX 
2190, 5w5xH, 0.5275, 3.92, 0.115, 211, 113, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY 
2191, 5u1rG, 0.5275, 3.71, 0.083, 241, 108, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2192, 5kzpG, 0.5275, 3.89, 0.089, 226, 112, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
2193, 4yx2H, 0.5275, 3.99, 0.079, 214, 114, CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB
2194, 4y19D, 0.5275, 3.64, 0.083, 205, 108, IMMUNE COMPLEX
2195, 4wfhE, 0.5275, 4.01, 0.088, 211, 114, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
2196, 4iiqB, 0.5275, 3.72, 0.083, 243, 108, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH BOVINE MR1
2197, 4g9fE, 0.5275, 3.75, 0.083, 250, 109, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
2198, 4d3cL, 0.5275, 3.80, 0.093, 209, 107, CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68.
2199, 3tt1I, 0.5275, 3.82, 0.071, 212, 112, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
2200, 3qh3D, 0.5275, 3.74, 0.083, 241, 109, THE CRYSTAL STRUCTURE OF TCR A6
2201, 3lh9B, 0.5275, 3.80, 0.075, 288, 106, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
2202, 3g04B, 0.5275, 3.98, 0.080, 215, 113, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY
2203, 2w65A, 0.5275, 3.98, 0.088, 212, 114, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
2204, 2rcsH, 0.5275, 3.95, 0.097, 217, 113, IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
2205, 1za6F, 0.5275, 3.84, 0.089, 324, 112, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2206, 1n64H, 0.5275, 3.90, 0.080, 218, 113, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
2207, 6faxH, 0.5274, 3.89, 0.080, 216, 113, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
2208, 6b5tH, 0.5274, 3.85, 0.088, 211, 113, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
2209, 5iszD, 0.5274, 3.68, 0.110, 200, 109, CRYSTAL STRUCTURE OF LS01-TCR/M1-HLA-A*02 COMPLEX
2210, 4tnvJ, 0.5274, 3.91, 0.071, 223, 113, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2211, 4r96B, 0.5274, 3.93, 0.070, 213, 114, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
2212, 4plkK, 0.5274, 3.69, 0.123, 208, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2213, 4nqdE, 0.5274, 3.68, 0.083, 243, 108, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2214, 4llyD, 0.5274, 3.78, 0.093, 209, 107, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A
2215, 4lcwE, 0.5274, 3.69, 0.083, 243, 108, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
2216, 4l4tE, 0.5274, 3.68, 0.083, 243, 108, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
2217, 4ebqH, 0.5274, 3.91, 0.080, 218, 113, FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
2218, 3ujtH, 0.5274, 3.93, 0.098, 207, 112, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
2219, 3ubxH, 0.5274, 4.00, 0.079, 221, 114, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
2220, 3ubxG, 0.5274, 4.00, 0.079, 221, 114, CRYSTAL STRUCTURE OF THE MOUSE CD1D-C20:2-AGALCER-L363 MAB FAB COMPLEX
2221, 3nifE, 0.5274, 4.01, 0.088, 216, 114, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2222, 3etbG, 0.5274, 3.76, 0.064, 228, 109, CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18 COMPLEXED WITH ANTHRAX PROTECTIVE ANTIGEN DOMAIN 4
2223, 3d3vE, 0.5274, 3.73, 0.083, 245, 109, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(34-DIFLUOROPHENYLALANINE)) PEPTIDE
2224, 2nr6F, 0.5274, 3.91, 0.088, 213, 113, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2225, 6njmI, 0.5273, 3.82, 0.000, 218, 112, STRUCTURE OF A COMPLEX 
2226, 6furB, 0.5273, 3.72, 0.101, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2227, 6d6uK, 0.5273, 3.73, 0.091, 116, 110, HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL; CONFORMATION A 
2228, 6awnB, 0.5273, 3.91, 0.106, 218, 113, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2229, 4xzuA, 0.5273, 3.81, 0.071, 213, 112, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2230, 4wfeE, 0.5273, 4.01, 0.088, 211, 114, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
2231, 4oz4H, 0.5273, 3.75, 0.081, 219, 111, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
2232, 3uttI, 0.5273, 3.56, 0.086, 199, 105, 1E6-A*0201-ALWGPDPAAA COMPLEX TRICLINIC
2233, 3qdjE, 0.5273, 3.71, 0.083, 242, 108, THE COMPLEX BETWEEN TCR DMF5 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35) NONAMERIC PEPTIDE
2234, 3j7eH, 0.5273, 3.83, 0.099, 121, 111, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2235, 3j7eF, 0.5273, 3.83, 0.099, 121, 111, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2236, 3j7eD, 0.5273, 3.83, 0.099, 121, 111, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2237, 3j7eB, 0.5273, 3.83, 0.099, 121, 111, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2238, 3clfH, 0.5273, 3.95, 0.114, 220, 114, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
2239, 1xctB, 0.5273, 3.92, 0.080, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
2240, 6cqlD, 0.5272, 3.68, 0.101, 200, 109, CRYSTAL STRUCTURE OF A TCR 
2241, 5swzS, 0.5272, 3.68, 0.084, 203, 107, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2242, 5i74B, 0.5272, 4.04, 0.096, 218, 114, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE
2243, 4rqqD, 0.5272, 3.90, 0.062, 237, 113, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2244, 4rdqM, 0.5272, 3.85, 0.089, 211, 112, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
2245, 4jj5B, 0.5272, 3.99, 0.096, 217, 114, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2 A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
2246, 3qa3H, 0.5272, 4.01, 0.096, 224, 114, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2247, 3qa3B, 0.5272, 3.99, 0.096, 224, 114, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2248, 3mlsI, 0.5272, 4.01, 0.044, 226, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
2249, 3gsnA, 0.5272, 3.72, 0.111, 199, 108, CRYSTAL STRUCTURE OF THE PUBLIC RA14 TCR IN COMPLEX WITH THE HCMV DOMINANT NLV/HLA-A2 EPITOPE
2250, 2r4sH, 0.5272, 3.93, 0.098, 217, 112, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2251, 2gkiA, 0.5272, 3.88, 0.071, 235, 113, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
2252, 1za3A, 0.5272, 3.77, 0.103, 213, 107, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
2253, 6e48F, 0.5271, 3.71, 0.055, 113, 110, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
2254, 6dcwH, 0.5271, 3.88, 0.080, 223, 113, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
2255, 5w1wI, 0.5271, 3.66, 0.151, 202, 106, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
2256, 5lwyH, 0.5271, 3.83, 0.080, 119, 112, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID
2257, 4z7oH, 0.5271, 4.00, 0.088, 216, 114, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2258, 4oziH, 0.5271, 4.02, 0.107, 243, 112, S2 PROTEIN COMPLEX
2259, 3v7aF, 0.5271, 3.83, 0.089, 220, 112, STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE
2260, 3v7aE, 0.5271, 3.83, 0.089, 220, 112, STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE
2261, 3t0eD, 0.5271, 3.87, 0.090, 245, 111, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
2262, 3sjvT, 0.5271, 3.77, 0.092, 241, 109, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
2263, 3rifH, 0.5271, 4.01, 0.088, 221, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2264, 3pqyE, 0.5271, 3.80, 0.102, 240, 108, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2265, 3ojdB, 0.5271, 3.91, 0.080, 224, 113, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
2266, 3g6jE, 0.5271, 3.80, 0.112, 214, 107, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
2267, 1xf5D, 0.5271, 3.93, 0.080, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
2268, 1oaqH, 0.5271, 3.84, 0.080, 120, 112, FREE CONFORMATION AB1 OF THE IGE SPE-7
2269, 5sydB, 0.5270, 2.62, 0.180, 131, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
2270, 4wffE, 0.5270, 4.02, 0.088, 211, 114, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
2271, 4pj8D, 0.5270, 3.82, 0.109, 243, 110, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV20 TCR
2272, 4oziF, 0.5270, 4.02, 0.116, 243, 112, S2 PROTEIN COMPLEX
2273, 4jryD, 0.5270, 3.71, 0.111, 201, 108, CRYSTAL STRUCTURE OF SB47 TCR-HLA B*3505-LPEP COMPLEX
2274, 4hfuH, 0.5270, 3.82, 0.062, 224, 113, CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
2275, 3mnvB, 0.5270, 3.95, 0.115, 208, 113, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
2276, 3mlvH, 0.5270, 4.01, 0.044, 221, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH AN NOF V3 PEPTIDE
2277, 3l5wA, 0.5270, 3.79, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
2278, 2nz9E, 0.5270, 3.81, 0.093, 216, 108, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2279, 6mjzL, 0.5269, 3.69, 0.113, 108, 106, CRYO-EM STRUCTURE OF HUMAN PARAINFLUENZA VIRUS TYPE 3 (HPIV3) IN COMPLEX WITH ANTIBODY PIA174 
2280, 5ywyH, 0.5269, 3.90, 0.080, 223, 113, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
2281, 5u1rE, 0.5269, 3.73, 0.083, 243, 108, STRUCTURE OF HUMAN MR1-DICLOFENAC IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2282, 5tz2H, 0.5269, 4.02, 0.079, 213, 114, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
2283, 5tq0H, 0.5269, 3.97, 0.096, 212, 114, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN THE PRESENCE OF EDTA
2284, 5nhrB, 0.5269, 3.74, 0.103, 114, 107, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV CUBIC CRYSTAL FORM
2285, 4tnvV, 0.5269, 3.99, 0.088, 224, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2286, 4tnvF, 0.5269, 3.99, 0.088, 222, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2287, 4buhB, 0.5269, 3.82, 0.064, 231, 110, HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV
2288, 3tf7G, 0.5269, 3.54, 0.112, 224, 107, 42F3 QL9/H2-LD COMPLEX
2289, 3rifJ, 0.5269, 4.00, 0.088, 200, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2290, 3qeuE, 0.5269, 3.71, 0.083, 243, 108, THE CRYSTAL STRUCTURE OF TCR DMF5
2291, 2icwK, 0.5269, 3.49, 0.124, 109, 105, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
2292, 1pg7Z, 0.5269, 4.02, 0.079, 220, 114, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
2293, 1e6jH, 0.5269, 3.85, 0.080, 219, 112, CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
2294, 1ahwD, 0.5269, 3.82, 0.112, 214, 107, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2295, 6b5sH, 0.5268, 3.85, 0.088, 215, 113, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
2296, 5yxnB, 0.5268, 3.80, 0.083, 241, 109, A T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HEPATITIS C VIRUS NS3 PEPTIDE (KLVALGINAV) 
2297, 5ur8A, 0.5268, 3.91, 0.071, 229, 112, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
2298, 5guxH, 0.5268, 3.95, 0.080, 225, 113, CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH XENON
2299, 4zezG, 0.5268, 3.78, 0.108, 207, 111, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
2300, 4x8jB, 0.5268, 3.82, 0.121, 214, 107, CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
2301, 4wfgE, 0.5268, 4.01, 0.088, 211, 114, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
2302, 4tnvW, 0.5268, 4.00, 0.088, 224, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2303, 4tnvU, 0.5268, 3.99, 0.088, 221, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2304, 4tnvI, 0.5268, 3.99, 0.088, 222, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2305, 4tnvG, 0.5268, 4.00, 0.088, 224, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2306, 3zdxH, 0.5268, 4.00, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2307, 3s62H, 0.5268, 3.86, 0.089, 215, 112, STRUCTURE OF FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 AGAINST P. VIVAX P25 PROTEIN
2308, 3rifG, 0.5268, 4.00, 0.088, 214, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2309, 3d39E, 0.5268, 3.72, 0.083, 245, 109, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5(4-FLUOROPHENYLALANINE)) PEPTIDE
2310, 2qscL, 0.5268, 3.83, 0.084, 215, 107, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE
2311, 1za6B, 0.5268, 3.86, 0.089, 324, 112, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2312, 1j8hE, 0.5268, 3.78, 0.102, 241, 108, CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR INFLUENZA HA ANTIGEN PEPTIDE AND MHC CLASS II MOLECULE HLA-DR4
2313, 1i7zA, 0.5268, 3.80, 0.111, 219, 108, ANTIBODY GNC92H2 BOUND TO LIGAND
2314, 1d9kB, 0.5268, 3.63, 0.104, 112, 106, CRYSTAL STRUCTURE OF COMPLEX BETWEEN D10 TCR AND PMHC I-AK/CA
2315, 6mwxO, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2316, 6mwxK, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2317, 6mwxG, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2318, 6mwxC, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2319, 6mwvO, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2320, 6mwvK, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2321, 6mwvG, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2322, 6mwvC, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2323, 6mwcO, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2324, 6mwcK, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2325, 6mwcG, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2326, 6mwcC, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2327, 6mw9O, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2328, 6mw9K, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2329, 6mw9G, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2330, 6mw9C, 0.5267, 3.91, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2331, 6muiO, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2332, 6muiK, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2333, 6muiG, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2334, 6muiC, 0.5267, 3.90, 0.097, 218, 113, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2335, 6dkpE, 0.5267, 3.71, 0.083, 242, 108, THE COMPLEX AMONG DMF5(ALPHA-D26Y; ALPHA-Y50A;BETA-L98W) TCR; HUMAN CLASS I MHC HLA-A2 AND MART-1(26-35)(A27L) PEPTIDE 
2336, 6cqnD, 0.5267, 3.70, 0.101, 200, 109, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
2337, 5x2qH, 0.5267, 3.96, 0.071, 219, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2338, 5mvzH, 0.5267, 4.06, 0.061, 221, 114, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
2339, 5anyL, 0.5267, 3.91, 0.097, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
2340, 5anyJ, 0.5267, 3.91, 0.097, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
2341, 5anyI, 0.5267, 3.91, 0.097, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
2342, 4y4fH, 0.5267, 3.82, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
2343, 4tnvX, 0.5267, 4.00, 0.088, 224, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2344, 4tnvH, 0.5267, 3.99, 0.088, 223, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2345, 4hkbA, 0.5267, 3.90, 0.054, 220, 112, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
2346, 3sdxF, 0.5267, 3.77, 0.101, 242, 109, CRYSTAL STRUCTURE OF HUMAN AUTOREACTIVE-VALPHA24 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2347, 3nigH, 0.5267, 4.00, 0.088, 216, 114, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2348, 3dggB, 0.5267, 3.85, 0.089, 212, 112, CRYSTAL STRUCTURE OF FABOX108
2349, 2zpkI, 0.5267, 3.83, 0.080, 207, 113, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
2350, 2ypvH, 0.5267, 3.96, 0.079, 215, 114, CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
2351, 2p1yC, 0.5267, 3.65, 0.075, 231, 107, 1.B2.D9 A BISPECIFIC ALPHA/BETA TCR
2352, 1rzgA, 0.5267, 3.96, 0.071, 223, 113, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
2353, 1pg7X, 0.5267, 4.01, 0.079, 220, 114, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
2354, 1eapB, 0.5267, 3.97, 0.106, 216, 113, CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
2355, 6rcuB, 0.5266, 3.88, 0.062, 222, 113, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
2356, 6j11F, 0.5266, 3.77, 0.083, 120, 109, MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX 
2357, 6bb4H, 0.5266, 3.91, 0.097, 216, 113, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
2358, 5yhlH, 0.5266, 3.88, 0.080, 223, 113, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
2359, 5x2pH, 0.5266, 3.94, 0.071, 219, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2360, 5x2oH, 0.5266, 3.95, 0.071, 219, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2361, 5hdbH, 0.5266, 3.99, 0.088, 216, 114, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
2362, 5hdbE, 0.5266, 4.00, 0.088, 214, 114, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
2363, 5gisH, 0.5266, 3.92, 0.116, 210, 112, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
2364, 5e8eB, 0.5266, 3.85, 0.071, 228, 112, CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB
2365, 5anyK, 0.5266, 3.91, 0.097, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
2366, 5a3iG, 0.5266, 3.90, 0.071, 226, 113, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
2367, 4wfhG, 0.5266, 3.95, 0.088, 210, 113, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
2368, 4lccB, 0.5266, 3.73, 0.083, 238, 109, CRYSTAL STRUCTURE OF A HUMAN MAIT TCR IN COMPLEX WITH A BACTERIAL ANTIGEN BOUND TO HUMANIZED BOVINE MR1
2369, 4grmB, 0.5266, 3.71, 0.083, 240, 108, THE CRYSTAL STRUCTURE OF THE HIGH AFFINITY TCR A6
2370, 3ze1H, 0.5266, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2371, 3tvmH, 0.5266, 3.81, 0.093, 240, 108, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
2372, 3t3mH, 0.5266, 3.98, 0.088, 216, 114, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2373, 3qfjE, 0.5266, 3.73, 0.083, 245, 109, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED TAX (Y5F) PEPTIDE
2374, 3mltI, 0.5266, 4.02, 0.044, 219, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
2375, 2gcyA, 0.5266, 3.93, 0.101, 216, 109, HUMANIZED ANTIBODY C25 FAB FRAGMENT
2376, 1z3gH, 0.5266, 3.80, 0.099, 214, 111, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
2377, 1xcqH, 0.5266, 3.96, 0.071, 218, 113, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2378, 1uwxH, 0.5266, 3.87, 0.089, 218, 112, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
2379, 6njmM, 0.5265, 3.82, 0.000, 218, 112, STRUCTURE OF A COMPLEX 
2380, 6igtC, 0.5265, 3.70, 0.108, 116, 111, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
2381, 5vqmH, 0.5265, 4.00, 0.088, 216, 114, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
2382, 5mx3A, 0.5265, 3.75, 0.081, 219, 111, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
2383, 5mthA, 0.5265, 3.82, 0.089, 220, 112, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
2384, 5lghH, 0.5265, 3.96, 0.080, 205, 113, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM II SAME AS 5L7X BUT ISOMORPHOUS SETTING INDEXED SAME AS 5L88 5L9D
2385, 5l7xH, 0.5265, 3.96, 0.080, 205, 113, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM II
2386, 4tnvY, 0.5265, 4.00, 0.088, 221, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
2387, 4h0iA, 0.5265, 3.92, 0.106, 238, 113, CRYSTAL STRUCTURE OF SCFV-2D10 IN COMPLEX WITH METHYL ALPHA-D- MANNOPYRANOSIDE
2388, 4ffvD, 0.5265, 3.95, 0.071, 209, 113, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
2389, 4am0A, 0.5265, 3.86, 0.098, 211, 112, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2390, 3zdzE, 0.5265, 3.99, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2391, 3tjhD, 0.5265, 3.74, 0.083, 239, 108, 42F3-P3A1/H2-LD COMPLEX
2392, 3t3pH, 0.5265, 3.99, 0.088, 216, 114, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2393, 3sddC, 0.5265, 3.68, 0.148, 189, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
2394, 3rifI, 0.5265, 4.01, 0.088, 192, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2395, 3pqyT, 0.5265, 3.78, 0.120, 240, 108, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2396, 2r4rH, 0.5265, 3.84, 0.090, 217, 111, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2397, 1lmkE, 0.5265, 3.83, 0.071, 238, 112, THE STRUCTURE OF A BIVALENT DIABODY
2398, 1lk3H, 0.5265, 3.95, 0.080, 219, 113, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
2399, 6bb4I, 0.5264, 3.92, 0.097, 216, 113, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
2400, 5w05H, 0.5264, 3.98, 0.062, 220, 112, ANTI-TISSUE FACTOR ANTIBODY M59 A HUMANIZED VERSION OF 10H10
2401, 4z7qE, 0.5264, 4.00, 0.088, 214, 114, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
2402, 4ygvA, 0.5264, 3.89, 0.088, 220, 113, REVERSAL AGENT FOR DABIGATRAN
2403, 4nryH, 0.5264, 3.92, 0.089, 214, 112, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
2404, 4l8sB, 0.5264, 3.74, 0.101, 242, 109, CRYSTAL STRUCTURE OF A HUMAN VALPHA7.2/VBETA13.3 MAIT TCR IN COMPLEX WITH BOVINE MR1
2405, 4k2uI, 0.5264, 4.02, 0.096, 214, 114, CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT
2406, 4jreH, 0.5264, 3.98, 0.088, 213, 114, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
2407, 4jffE, 0.5264, 3.84, 0.119, 245, 109, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2408, 4h0hB, 0.5264, 3.92, 0.106, 241, 113, CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING 2D10 SCFV WITH PEPTIDE
2409, 3ze1E, 0.5264, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2410, 3ze0E, 0.5264, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2411, 3vg9C, 0.5264, 4.00, 0.096, 224, 114, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
2412, 3nidE, 0.5264, 4.00, 0.088, 214, 114, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2413, 3bkyH, 0.5264, 3.80, 0.090, 226, 111, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
2414, 2p5eD, 0.5264, 3.71, 0.112, 194, 107, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2415, 2b1hH, 0.5264, 3.95, 0.088, 226, 113, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
2416, 1iaiH, 0.5264, 3.91, 0.088, 219, 113, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
2417, 6ddvB, 0.5263, 3.84, 0.089, 222, 112, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2418, 5w24H, 0.5263, 3.85, 0.080, 216, 112, CRYSTAL STRUCTURE OF 5C4 FAB
2419, 5u17G, 0.5263, 3.67, 0.084, 241, 107, STRUCTURE OF HUMAN MR1-DA-6-FP IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2420, 5u16F, 0.5263, 3.68, 0.084, 240, 107, STRUCTURE OF HUMAN MR1-2-OH-1-NA IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2421, 5i1lB, 0.5263, 4.04, 0.080, 213, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1
2422, 4x6dF, 0.5263, 3.73, 0.083, 241, 108, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
2423, 4q0xH, 0.5263, 3.89, 0.088, 216, 113, CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2
2424, 3ri5J, 0.5263, 4.01, 0.088, 215, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2425, 3ri5H, 0.5263, 4.01, 0.079, 221, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2426, 3ri5G, 0.5263, 4.01, 0.088, 200, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2427, 3lhpL, 0.5263, 3.89, 0.074, 111, 108, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
2428, 3lh8B, 0.5263, 3.73, 0.087, 282, 103, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
2429, 2hb0A, 0.5263, 4.04, 0.035, 356, 115, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
2430, 1s3kL, 0.5263, 3.92, 0.138, 216, 109, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
2431, 6fr9B, 0.5262, 3.73, 0.110, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2432, 6ev2A, 0.5262, 3.94, 0.088, 220, 113, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
2433, 6cx7D, 0.5262, 3.81, 0.093, 239, 108, STRUCTURE OF ALPHA-GSA[12;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2434, 5u2vH, 0.5262, 3.68, 0.084, 242, 107, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2435, 5mthH, 0.5262, 3.77, 0.081, 220, 111, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
2436, 5mhrP, 0.5262, 3.92, 0.061, 213, 114, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2437, 5ikcB, 0.5262, 3.90, 0.097, 210, 113, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2438, 5i75B, 0.5262, 4.05, 0.096, 218, 114, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE
2439, 5i4fA, 0.5262, 3.95, 0.106, 237, 113, SCFV 2D10 COMPLEXED WITH ALPHA 16 MANNOBIOSE
2440, 5d2lK, 0.5262, 3.66, 0.110, 192, 109, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2441, 5c7kE, 0.5262, 3.87, 0.062, 224, 113, CRYSTAL STRUCTURE BG505 SOSIP GP140 HIV-1 ENV TRIMER BOUND TO BROADLY NEUTRALIZING ANTIBODIES PGT128 AND 8ANC195
2442, 4tnwY, 0.5262, 4.01, 0.088, 221, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2443, 4o4yL, 0.5262, 3.78, 0.103, 218, 107, CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
2444, 3ze0H, 0.5262, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2445, 3qumC, 0.5262, 3.83, 0.130, 218, 108, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
2446, 3pwpE, 0.5262, 3.74, 0.083, 245, 109, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND HUD PEPTIDE
2447, 3phqA, 0.5262, 3.91, 0.119, 216, 109, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
2448, 2b1aH, 0.5262, 3.95, 0.088, 226, 113, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
2449, 1rziB, 0.5262, 3.97, 0.071, 216, 113, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
2450, 1ogaD, 0.5262, 3.67, 0.132, 199, 106, A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN T-CELL RECEPTOR RECOGNITION.
2451, 1a6tB, 0.5262, 3.93, 0.088, 217, 113, FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
2452, 6erxD, 0.5261, 3.99, 0.071, 215, 113, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2453, 6eh7B, 0.5261, 3.77, 0.101, 240, 109, F11 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS HAAEMAGGLUTININ EPITOPE PKYVKQNTLKLAT CARRIED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2454, 5hhoD, 0.5261, 3.63, 0.123, 195, 106, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E
2455, 5ggtH, 0.5261, 3.90, 0.071, 216, 112, PD-L1 IN COMPLEX WITH BMS-936559 FAB
2456, 5e6iA, 0.5261, 3.51, 0.105, 196, 105, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
2457, 4z7nE, 0.5261, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2458, 4wffG, 0.5261, 3.95, 0.088, 210, 113, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
2459, 4webH, 0.5261, 4.07, 0.088, 216, 114, STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2
2460, 4tnwI, 0.5261, 3.99, 0.079, 222, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2461, 4od2B, 0.5261, 3.87, 0.117, 214, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-DR5 ANTIBODY BOUND TO DR5
2462, 4h0gA, 0.5261, 3.81, 0.089, 242, 112, CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING NATIVE 2D10 SCFV
2463, 4evnI, 0.5261, 3.90, 0.088, 221, 113, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2464, 3wiiH, 0.5261, 3.99, 0.088, 220, 114, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
2465, 3t3pE, 0.5261, 4.01, 0.088, 214, 114, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2466, 3argD, 0.5261, 3.67, 0.093, 236, 107, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)
2467, 2eytD, 0.5261, 3.69, 0.084, 243, 107, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
2468, 1i7zC, 0.5261, 3.78, 0.111, 219, 108, ANTIBODY GNC92H2 BOUND TO LIGAND
2469, 6igtD, 0.5260, 3.73, 0.108, 116, 111, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
2470, 5gzoL, 0.5260, 3.81, 0.093, 213, 107, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2471, 4z7nH, 0.5260, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2472, 4xhjG, 0.5260, 3.80, 0.103, 196, 107, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
2473, 4wfgG, 0.5260, 3.95, 0.088, 210, 113, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
2474, 4s1sH, 0.5260, 3.90, 0.097, 228, 113, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H5.F-185917 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
2475, 4oz4A, 0.5260, 3.75, 0.090, 219, 111, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
2476, 4jfdE, 0.5260, 3.85, 0.119, 245, 109, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2477, 4ffwD, 0.5260, 3.94, 0.071, 209, 113, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
2478, 4evnM, 0.5260, 3.91, 0.080, 221, 113, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2479, 4cadB, 0.5260, 3.90, 0.088, 221, 113, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
2480, 3vfgL, 0.5260, 3.74, 0.113, 211, 106, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
2481, 3ri5I, 0.5260, 4.01, 0.079, 199, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2482, 3nigE, 0.5260, 4.00, 0.088, 214, 114, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2483, 3nifH, 0.5260, 4.01, 0.088, 219, 114, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2484, 6d78E, 0.5259, 3.66, 0.084, 240, 107, THE COMPLEX BETWEEN HIGH-AFFINITY TCR DMF5(ALPHA-D26Y;BETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(27-35)PEPTIDE 
2485, 5xajF, 0.5259, 3.97, 0.071, 213, 113, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
2486, 5u8qH, 0.5259, 3.76, 0.072, 118, 111, STRUCTURE OF THE ECTODOMAIN OF THE HUMAN TYPE 1 INSULIN-LIKE GROWTH FACTOR RECEPTOR IN COMPLEX WITH IGF-I
2487, 4x6cF, 0.5259, 3.76, 0.083, 243, 109, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2488, 4tnwG, 0.5259, 3.92, 0.071, 222, 113, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2489, 4r7nB, 0.5259, 3.82, 0.093, 211, 107, FAB C2E3
2490, 4pljC, 0.5259, 3.84, 0.131, 201, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2491, 4lu5L, 0.5259, 3.94, 0.138, 219, 109, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
2492, 4l4tH, 0.5259, 3.68, 0.084, 242, 107, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-6-FP
2493, 4jamH, 0.5259, 3.82, 0.071, 223, 112, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
2494, 4i9wG, 0.5259, 3.96, 0.088, 210, 113, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
2495, 4ffwH, 0.5259, 3.94, 0.071, 208, 113, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
2496, 4dgvH, 0.5259, 3.92, 0.070, 226, 114, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 P2(1) FORM
2497, 4cadE, 0.5259, 3.90, 0.088, 220, 113, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
2498, 3zdyH, 0.5259, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2499, 3riaH, 0.5259, 4.02, 0.088, 221, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2500, 3rhwH, 0.5259, 4.02, 0.088, 221, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2501, 3rhwG, 0.5259, 4.01, 0.088, 200, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2502, 3ngbH, 0.5259, 3.89, 0.080, 224, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
2503, 3mlsH, 0.5259, 4.02, 0.053, 226, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
2504, 2p1yA, 0.5259, 3.66, 0.084, 231, 107, 1.B2.D9 A BISPECIFIC ALPHA/BETA TCR
2505, 2brrY, 0.5259, 3.92, 0.080, 225, 113, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
2506, 1uwxM, 0.5259, 3.94, 0.088, 218, 113, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
2507, 1fbiH, 0.5259, 4.08, 0.087, 221, 115, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
2508, 6igtB, 0.5258, 3.72, 0.108, 117, 111, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
2509, 6fuoB, 0.5258, 3.76, 0.110, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2510, 6frbB, 0.5258, 3.75, 0.110, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2511, 6bnkH, 0.5258, 3.83, 0.093, 239, 108, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
2512, 6bj2E, 0.5258, 3.89, 0.119, 241, 109, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
2513, 5x2pJ, 0.5258, 3.96, 0.071, 218, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2514, 5e6iB, 0.5258, 3.74, 0.083, 241, 109, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
2515, 5d93F, 0.5258, 3.83, 0.062, 216, 112, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY
2516, 5d7lE, 0.5258, 3.75, 0.110, 241, 109, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAV36 TCR
2517, 4wfeG, 0.5258, 3.95, 0.088, 210, 113, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
2518, 4uifG, 0.5258, 3.80, 0.092, 120, 109, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
2519, 4tnwH, 0.5258, 3.99, 0.079, 223, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2520, 4r7nD, 0.5258, 3.82, 0.093, 211, 107, FAB C2E3
2521, 4nrzH, 0.5258, 4.02, 0.088, 226, 114, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
2522, 4nrzA, 0.5258, 3.98, 0.097, 225, 113, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
2523, 4evnG, 0.5258, 3.90, 0.088, 221, 113, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2524, 3tt3H, 0.5258, 3.88, 0.071, 218, 112, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
2525, 3riaJ, 0.5258, 4.01, 0.088, 215, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2526, 3riaG, 0.5258, 4.01, 0.088, 200, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2527, 3rhwJ, 0.5258, 4.01, 0.088, 215, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2528, 3pqyO, 0.5258, 3.80, 0.102, 240, 108, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
2529, 2vweE, 0.5258, 4.06, 0.078, 219, 115, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
2530, 2jccL, 0.5258, 3.70, 0.120, 194, 108, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2531, 2fatH, 0.5258, 4.02, 0.105, 214, 114, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
2532, 2cdgB, 0.5258, 3.71, 0.092, 244, 109, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE-SPECIFIC T CELL RECEPTORS (TCR 5B)
2533, 1jv5B, 0.5258, 3.84, 0.117, 117, 111, ANTI-BLOOD GROUP A FV
2534, 6fumB, 0.5257, 3.78, 0.092, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2535, 6fraB, 0.5257, 3.78, 0.092, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2536, 6cwbD, 0.5257, 3.83, 0.093, 239, 108, STRUCTURE OF ALPHA-GSA[8;4P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2537, 6awpB, 0.5257, 3.93, 0.106, 218, 113, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH FLUVOXAMINE AT THE CENTRAL SITE
2538, 5ywoR, 0.5257, 3.94, 0.088, 218, 113, STRUCTURE OF JEV-2F2 FAB COMPLEX
2539, 5ywoN, 0.5257, 3.94, 0.088, 218, 113, STRUCTURE OF JEV-2F2 FAB COMPLEX
2540, 5x2mH, 0.5257, 3.96, 0.071, 219, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2541, 5v7rL, 0.5257, 3.92, 0.102, 215, 108, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-7.1 FAB
2542, 5uddK, 0.5257, 3.77, 0.063, 220, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2543, 5lqbH, 0.5257, 3.90, 0.106, 219, 113, COMPLEX STRUCTURE OF HUMAN IL2 MUTANT PROLEUKIN WITH FAB FRAGMENT OF NARA1 ANTIBODY
2544, 5i66A, 0.5257, 3.93, 0.106, 218, 113, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
2545, 4ygvF, 0.5257, 3.97, 0.080, 220, 113, REVERSAL AGENT FOR DABIGATRAN
2546, 4y4hD, 0.5257, 3.84, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
2547, 4qxtA, 0.5257, 3.85, 0.080, 114, 112, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH FC27-MSP2 14-30
2548, 4kmtH, 0.5257, 4.03, 0.080, 218, 113, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
2549, 3zdzH, 0.5257, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2550, 3t3mE, 0.5257, 4.00, 0.088, 214, 114, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2551, 3riaI, 0.5257, 4.02, 0.088, 199, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2552, 3rhwI, 0.5257, 4.02, 0.088, 199, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2553, 3g6jG, 0.5257, 3.80, 0.112, 214, 107, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
2554, 3bn9E, 0.5257, 3.79, 0.093, 211, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
2555, 2oz4H, 0.5257, 3.92, 0.071, 208, 113, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
2556, 2cdeC, 0.5257, 3.69, 0.121, 192, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2557, 2b0sH, 0.5257, 3.95, 0.088, 226, 113, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
2558, 1mh5B, 0.5257, 3.85, 0.099, 172, 111, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
2559, 6fuqB, 0.5256, 3.74, 0.110, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2560, 6cuhB, 0.5256, 3.78, 0.074, 240, 108, CRYSTAL STRUCTURE OF THE UNLIGANDED BC8B TCR 
2561, 5ywfD, 0.5256, 3.96, 0.079, 218, 114, CRYSTAL STRUCTURE OF 2H4 FAB
2562, 5xqwH, 0.5256, 3.88, 0.088, 210, 113, CATALYTIC ANTIBODY 7B9 
2563, 5jueH, 0.5256, 3.96, 0.096, 225, 114, CRYSTAL STRUCTURE OF UIC2 FAB
2564, 5d2lI, 0.5256, 3.76, 0.111, 185, 108, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
2565, 4yhnA, 0.5256, 3.92, 0.088, 220, 113, DABIGATRAN REVERSAL AGENT
2566, 4rgmH, 0.5256, 3.88, 0.088, 216, 113, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
2567, 4rgmC, 0.5256, 3.88, 0.088, 217, 113, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
2568, 4isvB, 0.5256, 3.93, 0.088, 212, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2 A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
2569, 4ffyH, 0.5256, 3.97, 0.080, 119, 113, CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TO DENV-1 DIII STRAIN 16007.
2570, 4f3fB, 0.5256, 3.76, 0.072, 219, 111, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
2571, 4evnK, 0.5256, 3.92, 0.080, 221, 113, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2572, 3sknB, 0.5256, 3.75, 0.083, 241, 109, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
2573, 3phoA, 0.5256, 3.78, 0.111, 216, 108, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
2574, 2q8bH, 0.5256, 3.77, 0.083, 199, 109, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2575, 1rziD, 0.5256, 3.98, 0.071, 216, 113, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
2576, 1nmbH, 0.5256, 3.85, 0.116, 122, 112, THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
2577, 1nfdC, 0.5256, 3.83, 0.110, 203, 109, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
2578, 1fj1D, 0.5256, 4.00, 0.080, 213, 113, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2579, 1ahwA, 0.5256, 3.84, 0.112, 214, 107, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2580, 6awqB, 0.5255, 3.92, 0.106, 218, 113, ANOMALOUS CHLORIDE SIGNAL REVEALS THE POSITION OF SERTRALINE COMPLEXED WITH THE SEROTONIN TRANSPORTER AT THE CENTRAL SITE
2581, 6awoB, 0.5255, 3.92, 0.106, 218, 113, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH SERTRALINE AT THE CENTRAL SITE
2582, 6avfA, 0.5255, 3.66, 0.128, 202, 109, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
2583, 5xctA, 0.5255, 3.93, 0.070, 167, 114, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
2584, 5x2nJ, 0.5255, 3.97, 0.071, 219, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2585, 5jhdI, 0.5255, 3.80, 0.117, 203, 111, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
2586, 4y4hH, 0.5255, 3.84, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/GCK152/INKTCR TERNARY COMPLEX
2587, 4r97C, 0.5255, 3.84, 0.089, 218, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
2588, 4r96F, 0.5255, 3.94, 0.088, 213, 113, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
2589, 4nqdH, 0.5255, 3.68, 0.084, 242, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND NON-COVALENTLY BOUND 5-(2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2590, 4m62M, 0.5255, 3.69, 0.093, 113, 107, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
2591, 4ky1H, 0.5255, 3.91, 0.071, 220, 113, HUMANIZED HP1/2 FAB
2592, 4k3jL, 0.5255, 3.90, 0.102, 217, 108, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
2593, 4j1uC, 0.5255, 3.80, 0.102, 213, 108, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2594, 3sqoL, 0.5255, 3.81, 0.103, 213, 107, PCSK9 J16 FAB COMPLEX
2595, 3q3gH, 0.5255, 4.01, 0.096, 224, 114, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2596, 3p11L, 0.5255, 3.82, 0.093, 211, 107, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION
2597, 3mlsJ, 0.5255, 4.02, 0.044, 226, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
2598, 2w65C, 0.5255, 4.07, 0.088, 211, 114, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4 IN COMPLEX WITH A CITRULLINATED PEPTIDE
2599, 1c1eH, 0.5255, 3.94, 0.088, 219, 113, CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN
2600, 6mjqH, 0.5254, 3.82, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX 
2601, 6mjaD, 0.5254, 3.82, 0.093, 240, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXO (JJ294) /INKTCR TERNARY COMPLEX 
2602, 6igtA, 0.5254, 3.73, 0.108, 117, 111, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
2603, 6hf1F, 0.5254, 3.84, 0.062, 210, 112, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
2604, 6bnkD, 0.5254, 3.83, 0.111, 239, 108, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
2605, 5xajE, 0.5254, 3.95, 0.071, 215, 113, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
2606, 5uddM, 0.5254, 3.88, 0.062, 221, 112, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2607, 5mvjH, 0.5254, 3.77, 0.081, 218, 111, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2608, 5az2L, 0.5254, 3.79, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN
2609, 4y2dD, 0.5254, 3.85, 0.102, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
2610, 4tnwU, 0.5254, 4.02, 0.088, 221, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2611, 4r7dB, 0.5254, 3.82, 0.093, 211, 107, FAB HU 15C1
2612, 4qyoA, 0.5254, 3.85, 0.080, 114, 112, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 14-22
2613, 4okvA, 0.5254, 3.96, 0.107, 214, 112, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
2614, 4nqeH, 0.5254, 3.68, 0.084, 231, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX BOUND TO 5-(2- OXOETHYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2615, 4l3eE, 0.5254, 3.73, 0.083, 242, 108, THE COMPLEX BETWEEN HIGH AFFINITY TCR DMF5(ALPHA-D26YBETA-L98W) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) PEPTIDE
2616, 4kaqH, 0.5254, 3.81, 0.116, 220, 112, STRUCTURE OF RITUXIMAB FAB
2617, 4d9rD, 0.5254, 3.81, 0.093, 213, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2618, 3q3gK, 0.5254, 4.02, 0.096, 224, 114, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2619, 3mltE, 0.5254, 3.93, 0.045, 219, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
2620, 3cmoH, 0.5254, 3.97, 0.080, 222, 113, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
2621, 2nr6D, 0.5254, 3.96, 0.097, 213, 113, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2622, 1lmkA, 0.5254, 3.95, 0.062, 238, 113, THE STRUCTURE OF A BIVALENT DIABODY
2623, 6mjqD, 0.5253, 3.82, 0.093, 240, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXP (JJ295) /INKTCR TERNARY COMPLEX 
2624, 6a0zH, 0.5253, 3.95, 0.080, 223, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 BOUND TO H5N1 INFLUENZA HEMAGGLUTININ; HA HEAD REGION 
2625, 5vnwC, 0.5253, 3.74, 0.082, 120, 110, CRYSTAL STRUCTURE OF NB.B201 BOUND TO HUMAN SERUM ALBUMIN
2626, 5u2vF, 0.5253, 3.67, 0.084, 242, 107, STRUCTURE OF HUMAN MR1-HMB IN COMPLEX WITH HUMAN MAIT A-F7 TCR
2627, 5tihH, 0.5253, 4.01, 0.105, 212, 114, STRUCTURAL BASIS FOR INHIBITION OF ERYTHROCYTE INVASION BY ANTIBODIES TO PLASMODIUM FALCIPARUM PROTEIN CYRPA
2628, 5i6zB, 0.5253, 4.06, 0.096, 218, 114, X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER
2629, 5d5mH, 0.5253, 3.67, 0.093, 241, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
2630, 4x6cG, 0.5253, 3.69, 0.102, 201, 108, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2631, 4pj5H, 0.5253, 3.68, 0.084, 242, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT TRBV6-1 TCR
2632, 4ftvE, 0.5253, 3.83, 0.082, 245, 110, THE COMPLEX BETWEEN THE HIGH AFFINITY VERSION OF A6 TCR (A6C134) AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND TAX NONAMERIC PEPTIDE
2633, 4dzbB, 0.5253, 4.00, 0.098, 244, 112, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
2634, 4cadK, 0.5253, 4.01, 0.088, 221, 114, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
2635, 3u9pL, 0.5253, 3.80, 0.112, 212, 107, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
2636, 3nidH, 0.5253, 4.01, 0.088, 216, 114, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2637, 3nfsH, 0.5253, 3.92, 0.080, 209, 113, CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB
2638, 3mffD, 0.5253, 3.72, 0.111, 242, 108, 1F1E8HU TCR
2639, 1mvuB, 0.5253, 3.76, 0.073, 121, 109, SINGLE CHAIN FV OF C219 HEAVY CHAIN V101L MUTANT IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
2640, 6frcB, 0.5252, 3.78, 0.101, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2641, 6eh6B, 0.5252, 3.77, 0.092, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2642, 6ea5Q, 0.5252, 3.91, 0.097, 222, 113, STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
2643, 5swzN, 0.5252, 3.75, 0.101, 201, 109, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2644, 5menE, 0.5252, 3.75, 0.065, 240, 108, HUMAN LEUKOCYTE ANTIGEN A02 PRESENTING ILAKFLHWL IN COMPLEX WITH COGNATE T-CELL RECEPTOR
2645, 5lspH, 0.5252, 4.06, 0.070, 216, 114, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
2646, 5it2H, 0.5252, 4.07, 0.070, 218, 114, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY 693-10-B06 FAB FRAGMENT
2647, 5i71B, 0.5252, 3.86, 0.089, 218, 112, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
2648, 5d7jH, 0.5252, 3.69, 0.093, 242, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
2649, 5d7iH, 0.5252, 3.69, 0.093, 241, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT M33.64 TCR
2650, 4nqcE, 0.5252, 3.68, 0.084, 240, 107, CRYSTAL STRUCTURE OF TCR-MR1 TERNARY COMPLEX AND COVALENTLY BOUND 5- (2-OXOPROPYLIDENEAMINO)-6-D-RIBITYLAMINOURACIL
2651, 4l4vH, 0.5252, 3.69, 0.084, 240, 107, STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH HUMAN MR1-RL-6-ME-7-OH
2652, 4jfeE, 0.5252, 3.85, 0.119, 245, 109, PRESERVATION OF PEPTIDE SPECIFICITY DURING TCR-MHC CONTACT DOMINATED AFFINITY ENHANCEMENT OF A MELANOMA-SPECIFIC TCR
2653, 4ffzL, 0.5252, 3.96, 0.119, 216, 109, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2654, 4cadH, 0.5252, 4.01, 0.088, 221, 114, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
2655, 3zdyE, 0.5252, 4.01, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2656, 3qa3K, 0.5252, 4.01, 0.096, 224, 114, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2657, 3nfpH, 0.5252, 3.94, 0.088, 214, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
2658, 3j8dD, 0.5252, 3.82, 0.112, 425, 107, CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5
2659, 3j8dA, 0.5252, 3.82, 0.112, 425, 107, CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5
2660, 3bn9C, 0.5252, 3.79, 0.093, 210, 107, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
2661, 3ardD, 0.5252, 3.68, 0.093, 238, 107, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3 DEOXY-ALPHA- GALACTOSYLCERAMIDE
2662, 2xqyJ, 0.5252, 3.97, 0.088, 216, 113, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
2663, 1ncaH, 0.5252, 3.83, 0.071, 221, 112, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2664, 6fupB, 0.5251, 3.77, 0.110, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2665, 6erxO, 0.5251, 3.92, 0.062, 215, 113, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2666, 6ea7Q, 0.5251, 3.92, 0.097, 222, 113, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
2667, 6bpaE, 0.5251, 3.95, 0.071, 215, 113, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
2668, 6bb4J, 0.5251, 3.92, 0.088, 216, 113, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
2669, 5jziD, 0.5251, 3.72, 0.127, 207, 110, CRYSTAL STRUCTURE OF 1406 TCR BOUND TO HLA-A2 WITH HCV 1406-1415 ANTIGEN PEPTIDE
2670, 5jhdD, 0.5251, 3.74, 0.118, 201, 110, CRYSTAL STRUCTURE OF LS10-TCR/M1-HLA-A*02 COMPLEX
2671, 5e6iQ, 0.5251, 3.73, 0.073, 238, 109, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
2672, 5dgyB, 0.5251, 3.85, 0.019, 673, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
2673, 4zwjB, 0.5251, 3.85, 0.019, 673, 108, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
2674, 4zfgL, 0.5251, 3.93, 0.093, 213, 108, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
2675, 4yhnF, 0.5251, 3.95, 0.088, 220, 113, DABIGATRAN REVERSAL AGENT
2676, 4r7nH, 0.5251, 3.83, 0.093, 211, 107, FAB C2E3
2677, 4okvC, 0.5251, 3.96, 0.107, 215, 112, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
2678, 4lluB, 0.5251, 3.78, 0.103, 210, 107, STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A
2679, 4ffzY, 0.5251, 3.95, 0.119, 216, 109, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2680, 3ze2E, 0.5251, 4.02, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2681, 3to4C, 0.5251, 3.66, 0.157, 190, 108, STRUCTURE OF MOUSE VALPHA14VBETA2-MOUSECD1D-ALPHA-GALACTOSYLCERAMIDE
2682, 3sdaC, 0.5251, 3.66, 0.157, 196, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-GALACTOSYLCERAMIDE
2683, 3ri5F, 0.5251, 4.04, 0.079, 188, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
2684, 3p0vM, 0.5251, 3.80, 0.093, 212, 107, ANTI-EGFR/HER3 FAB DL11 ALONE
2685, 3p0vL, 0.5251, 3.81, 0.093, 212, 107, ANTI-EGFR/HER3 FAB DL11 ALONE
2686, 3jbf7, 0.5251, 3.75, 0.082, 123, 110, COMPLEX OF POLIOVIRUS WITH VHH PVSP19B
2687, 2ojzI, 0.5251, 3.99, 0.097, 216, 113, ANTI-DNA ANTIBODY ED10
2688, 2nx5J, 0.5251, 3.84, 0.073, 243, 109, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2689, 1zglS, 0.5251, 3.76, 0.093, 176, 108, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2690, 1nqbA, 0.5251, 3.78, 0.071, 232, 112, TRIVALENT ANTIBODY FRAGMENT
2691, 1ncdH, 0.5251, 3.84, 0.089, 221, 112, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2692, 6meeC, 0.5250, 4.17, 0.078, 229, 115, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2693, 6funB, 0.5250, 3.77, 0.110, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
2694, 6cx5D, 0.5250, 3.84, 0.093, 239, 108, STRUCTURE OF ALPHA-GSA[8;8P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2695, 5zmjH, 0.5250, 3.91, 0.062, 227, 112, CRYSTAL STRUCTURE OF THE FAB REGION OF A NEUTRALIZING FULLY HUMAN ANTIBODY AGAINST GM-CSF 
2696, 5vkkH, 0.5250, 3.95, 0.080, 218, 113, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
2697, 5vf2A, 0.5250, 3.94, 0.106, 237, 113, SCFV 2D10 COMPLEXED WITH ALPHA 16 MANNOBIOSE RE-REFINEMENT
2698, 5uddN, 0.5250, 3.78, 0.072, 221, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2699, 5tudF, 0.5250, 3.89, 0.089, 233, 112, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
2700, 5m00G, 0.5250, 3.72, 0.110, 187, 109, CRYSTAL STRUCTURE OF MURINE P14 TCR COMPLEX WITH H-2DB AND Y4A MODIFIED GP33 PEPTIDE FROM LCMV
2701, 4tnwX, 0.5250, 3.93, 0.071, 224, 113, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2702, 4m7lH, 0.5250, 3.93, 0.080, 222, 112, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
2703, 4jreB, 0.5250, 3.99, 0.088, 213, 114, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
2704, 4gayB, 0.5250, 3.98, 0.119, 216, 109, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
2705, 3ze2H, 0.5250, 3.93, 0.088, 216, 113, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2706, 3wfbH, 0.5250, 3.96, 0.080, 225, 113, REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2707, 3rifF, 0.5250, 4.04, 0.088, 171, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
2708, 3o4lE, 0.5250, 4.01, 0.099, 245, 111, GENETIC AND STRUCTURAL BASIS FOR SELECTION OF A UBIQUITOUS T CELL RECEPTOR DEPLOYED IN EPSTEIN-BARR VIRUS
2709, 3ngbE, 0.5250, 3.92, 0.071, 224, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
2710, 3gbmI, 0.5250, 3.89, 0.071, 213, 113, CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
2711, 3fo1A, 0.5250, 3.98, 0.138, 216, 109, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
2712, 3e8uL, 0.5250, 3.79, 0.120, 216, 108, CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
2713, 1uweU, 0.5250, 3.81, 0.131, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2714, 1q0xH, 0.5250, 4.02, 0.096, 215, 114, ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
2715, 6qkdT, 0.5249, 3.95, 0.083, 213, 108, CRYSTAL STRUCTURE OF VHH-BASED FAB-FRAGMENT OF ANTIBODY BCD-085 
2716, 6ogeE, 0.5249, 3.98, 0.089, 220, 112, CRYO-EM STRUCTURE OF HER2 EXTRACELLULAR DOMAIN-TRASTUZUMAB FAB- PERTUZUMAB FAB COMPLEX 
2717, 6mkrA, 0.5249, 3.81, 0.119, 195, 109, 5287 TCR BOUND TO IAB PADI4 
2718, 6hf1C, 0.5249, 3.85, 0.062, 209, 112, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
2719, 6fxnO, 0.5249, 3.92, 0.071, 215, 113, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
2720, 6bnlD, 0.5249, 3.86, 0.093, 240, 108, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
2721, 5x2oJ, 0.5249, 3.96, 0.071, 220, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2722, 5x2mJ, 0.5249, 3.97, 0.071, 217, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2723, 5o14C, 0.5249, 3.93, 0.062, 223, 113, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2724, 5i8kL, 0.5249, 3.92, 0.093, 216, 108, HHH1 FAB FRAGMENT
2725, 4xhjC, 0.5249, 3.73, 0.093, 207, 107, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
2726, 4x7tB, 0.5249, 3.82, 0.111, 218, 108, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2727, 4r7nN, 0.5249, 3.83, 0.093, 211, 107, FAB C2E3
2728, 4p3dL, 0.5249, 3.94, 0.147, 218, 109, MT1-MMP:FAB COMPLEX (FORM II)
2729, 4nm8J, 0.5249, 3.97, 0.062, 213, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2730, 4nm8H, 0.5249, 3.97, 0.062, 215, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
2731, 4j8rB, 0.5249, 3.76, 0.090, 220, 111, STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT
2732, 4irjD, 0.5249, 3.82, 0.093, 239, 108, STRUCTURE OF THE MOUSE CD1D-4CLPHC-ALPHA-GALCER-INKT TCR COMPLEX
2733, 4hkbC, 0.5249, 3.91, 0.062, 218, 113, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
2734, 4d9rL, 0.5249, 3.82, 0.093, 214, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2735, 3zdxE, 0.5249, 4.02, 0.088, 216, 114, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2736, 3sdcC, 0.5249, 3.69, 0.157, 191, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
2737, 3rtqD, 0.5249, 3.82, 0.093, 239, 108, STRUCTURE OF THE MOUSE CD1D-HS44-INKT TCR COMPLEX
2738, 3fo2A, 0.5249, 3.98, 0.138, 216, 109, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
2739, 3fo1L, 0.5249, 3.99, 0.138, 216, 109, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
2740, 3fo0L, 0.5249, 4.00, 0.138, 216, 109, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
2741, 3c5zB, 0.5249, 3.70, 0.084, 240, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
2742, 2pcxA, 0.5249, 3.72, 0.038, 205, 106, CRYSTAL STRUCTURE OF P53DBD(R282Q) AT 1.54-ANGSTROM RESOLUTION
2743, 2ojzH, 0.5249, 4.00, 0.097, 216, 113, ANTI-DNA ANTIBODY ED10
2744, 1jnlH, 0.5249, 3.93, 0.080, 216, 113, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
2745, 1fbiQ, 0.5249, 4.06, 0.079, 221, 114, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
2746, 6higH, 0.5248, 3.99, 0.079, 209, 114, HPD-1/NBO1A FAB COMPLEX 
2747, 6ev1K, 0.5248, 3.87, 0.080, 218, 112, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
2748, 6c09C, 0.5248, 3.74, 0.092, 192, 109, TERNARY CRYSTAL STRUCTURE OF THE 3C8 TCR-CD1C-MONOACYLGLYCEROL COMPLEX
2749, 6bfsH, 0.5248, 3.92, 0.080, 211, 112, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2750, 5vcjD, 0.5248, 3.82, 0.093, 239, 108, STRUCTURE OF ALPHA-GALACTOSYLPHYTOSPHINGOSINE BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR
2751, 5mo3H, 0.5248, 3.89, 0.089, 219, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
2752, 5jsaE, 0.5248, 3.81, 0.062, 224, 112, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 10- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
2753, 5ggsA, 0.5248, 3.98, 0.071, 219, 112, PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB
2754, 5eocL, 0.5248, 3.85, 0.120, 216, 108, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
2755, 4ye4H, 0.5248, 3.90, 0.071, 227, 112, CRYSTAL STRUCTURE OF NEUTRALIZING ANTIBODY HJ16 IN COMPLEX WITH HIV-1 GP120
2756, 4jhwH, 0.5248, 3.80, 0.063, 226, 111, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
2757, 4gajL, 0.5248, 3.98, 0.119, 215, 109, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 411-424)
2758, 4dgyH, 0.5248, 3.92, 0.080, 226, 113, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 C2 FORM
2759, 3vwkC, 0.5248, 3.61, 0.102, 194, 108, TERNARY CRYSTAL STRUCTURE OF THE HUMAN NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE COMPLEX
2760, 3vgaC, 0.5248, 4.01, 0.096, 220, 114, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
2761, 3qq9L, 0.5248, 3.93, 0.102, 217, 108, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
2762, 3qdmD, 0.5248, 3.54, 0.114, 195, 105, THE COMPLEX BETWEEN TCR DMF4 AND HUMAN CLASS I MHC HLA-A2 WITH THE BOUND MART-1(26-35)(A27L) DECAMERIC PEPTIDE
2763, 3c5zF, 0.5248, 3.70, 0.084, 240, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR B3K506
2764, 3bgfB, 0.5248, 3.97, 0.106, 216, 113, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
2765, 1a6vI, 0.5248, 3.75, 0.073, 119, 110, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
2766, 6miyH, 0.5247, 3.83, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX 
2767, 6gk7H, 0.5247, 3.99, 0.070, 223, 115, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
2768, 6ddrB, 0.5247, 3.93, 0.124, 221, 113, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
2769, 6cxfD, 0.5247, 3.83, 0.093, 239, 108, STRUCTURE OF ALPHA-GSA[26;P5P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2770, 6cxeD, 0.5247, 3.84, 0.093, 239, 108, STRUCTURE OF ALPHA-GSA[26;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2771, 5tpwH, 0.5247, 3.91, 0.106, 211, 113, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT THE GLUN2A
2772, 5mg7B, 0.5247, 3.72, 0.038, 199, 106, P53-DNA COMPLEX 7 
2773, 5l0qF, 0.5247, 4.00, 0.080, 214, 113, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
2774, 5i73B, 0.5247, 3.93, 0.106, 218, 113, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES
2775, 5i0zA, 0.5247, 3.79, 0.072, 120, 111, CRYSTAL STRUCTURE OF THE SINGLE DOMAIN CATALYTIC ANTIBODY 3D8-VH
2776, 5e6iP, 0.5247, 3.52, 0.114, 191, 105, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
2777, 4y2dH, 0.5247, 3.83, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/7DW8-5/INKTCR TERNARY COMPLEX
2778, 4x7sL, 0.5247, 3.81, 0.111, 218, 108, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
2779, 4x6dH, 0.5247, 3.74, 0.083, 242, 108, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
2780, 4pjeH, 0.5247, 3.69, 0.093, 240, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
2781, 4lcwH, 0.5247, 3.68, 0.084, 240, 107, THE STRUCTURE OF HUMAN MAIT TCR IN COMPLEX WITH MR1-K43A-RL-6-ME-7OH
2782, 4l5fL, 0.5247, 3.81, 0.112, 213, 107, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
2783, 4i2xC, 0.5247, 3.86, 0.150, 214, 107, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
2784, 4bklA, 0.5247, 4.02, 0.088, 216, 114, CRYSTAL STRUCTURE OF THE ARTHRITOGENIC ANTIBODY M2139 (FAB FRAGMENT) IN COMPLEX WITH THE TRIPLE-HELICAL J1 PEPTIDE
2785, 3u9pM, 0.5247, 3.83, 0.103, 211, 107, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
2786, 3qa3D, 0.5247, 4.02, 0.096, 224, 114, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2787, 3o8xD, 0.5247, 3.84, 0.093, 239, 108, RECOGNITION OF GLYCOLIPID ANTIGEN BY INKT CELL TCR
2788, 3mluH, 0.5247, 4.00, 0.053, 220, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A ZAM18 V3 PEPTIDE
2789, 3mlsK, 0.5247, 4.05, 0.044, 224, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
2790, 3j3oH, 0.5247, 3.89, 0.107, 220, 112, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
2791, 3bszH, 0.5247, 3.81, 0.090, 215, 111, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
2792, 3bgfH, 0.5247, 3.89, 0.107, 216, 112, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
2793, 3aazL, 0.5247, 3.98, 0.156, 228, 109, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
2794, 1rihH, 0.5247, 4.04, 0.079, 221, 114, CRYSTAL STRUCTURE OF FAB 14F7 A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3
2795, 1mjuL, 0.5247, 3.89, 0.120, 219, 108, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
2796, 6j11H, 0.5246, 3.85, 0.107, 128, 112, MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX 
2797, 6eh8B, 0.5246, 3.78, 0.102, 241, 108, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
2798, 5swsE, 0.5246, 3.79, 0.121, 239, 107, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
2799, 5mcvA, 0.5246, 3.73, 0.038, 200, 106, P53-DNA COMPLEX 3 
2800, 5eocH, 0.5246, 3.93, 0.089, 212, 112, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
2801, 5d2nC, 0.5246, 3.61, 0.120, 198, 108, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
2802, 4yhmH, 0.5246, 3.91, 0.088, 222, 113, REVERSAL AGENT FOR DABIGATRAN
2803, 4y16D, 0.5246, 3.83, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/NC-AGC/INKTCR TERNARY COMPLEX
2804, 4tnwJ, 0.5246, 3.92, 0.071, 222, 113, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2805, 4pjeF, 0.5246, 3.69, 0.093, 240, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-B10 TCR
2806, 4p3cL, 0.5246, 3.95, 0.147, 218, 109, MT1-MMP:FAB COMPLEX (FORM I)
2807, 4mxvE, 0.5246, 3.79, 0.121, 211, 107, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2808, 3wfcH, 0.5246, 3.96, 0.080, 225, 113, REDUCED AND CARBONMONOXIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2809, 3vi3F, 0.5246, 4.06, 0.079, 218, 114, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
2810, 3tf7I, 0.5246, 3.72, 0.074, 228, 108, 42F3 QL9/H2-LD COMPLEX
2811, 3qynC, 0.5246, 3.67, 0.066, 196, 106, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
2812, 3q3gB, 0.5246, 4.03, 0.096, 224, 114, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
2813, 3okmA, 0.5246, 3.94, 0.120, 215, 108, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
2814, 3bszN, 0.5246, 3.81, 0.090, 215, 111, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
2815, 2wbjD, 0.5246, 3.97, 0.090, 270, 111, TCR COMPLEX
2816, 2nx5P, 0.5246, 3.87, 0.100, 243, 110, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2817, 2nx5E, 0.5246, 3.86, 0.083, 243, 109, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
2818, 1mjjH, 0.5246, 3.91, 0.116, 209, 112, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2819, 6mjiD, 0.5245, 3.83, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXS (JJ304) /INKTCR TERNARY COMPLEX 
2820, 6mj6D, 0.5245, 3.83, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXX (JJ166) /INKTCR TERNARY COMPLEX 
2821, 6bnlH, 0.5245, 3.86, 0.093, 240, 108, CRYSTAL STRUCTURE OF TCR-MHC-LIKE MOLECULE
2822, 5wuxA, 0.5245, 3.92, 0.054, 210, 112, TNFALPHA-CERTOLIZUMAB FAB
2823, 5udcH, 0.5245, 3.86, 0.071, 217, 112, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
2824, 5mg7A, 0.5245, 3.73, 0.038, 199, 106, P53-DNA COMPLEX 7 
2825, 5m01G, 0.5245, 3.72, 0.110, 188, 109, CRYSTAL STRUCTURE OF MURINE P14 TCR/ H-2DB COMPLEX WITH PA MODIFIED GP33 PEPTIDE FROM LCMV
2826, 5kvgH, 0.5245, 3.87, 0.080, 218, 112, ZIKA SPECIFIC ANTIBODY ZV-67 BOUND TO ZIKA ENVELOPE DIII
2827, 5fc9A, 0.5245, 2.12, 0.170, 95, 88, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
2828, 5d7kE, 0.5245, 3.80, 0.128, 241, 109, STRUCTURE OF MR1-REACTIVE MAV36 TCR
2829, 5buaA, 0.5245, 3.74, 0.038, 199, 106, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH DNA.
2830, 4xvsH, 0.5245, 3.99, 0.062, 228, 113, CRYSTAL STRUCTURE OF HIV-1 DONOR 45 D45-01DG5 COREE GP120 WITH ANTIBODY 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
2831, 4uihF, 0.5245, 3.78, 0.091, 120, 110, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.
2832, 4uifI, 0.5245, 3.78, 0.091, 120, 110, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
2833, 4g8gE, 0.5245, 3.75, 0.083, 248, 108, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
2834, 4buhA, 0.5245, 3.90, 0.063, 236, 111, HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV
2835, 3riaF, 0.5245, 4.05, 0.088, 191, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
2836, 3rhwF, 0.5245, 4.05, 0.088, 191, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
2837, 3p0yL, 0.5245, 3.80, 0.093, 213, 107, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
2838, 3mxwH, 0.5245, 3.85, 0.080, 220, 112, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
2839, 2zjsH, 0.5245, 4.02, 0.088, 220, 114, CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT
2840, 2yplE, 0.5245, 3.69, 0.093, 238, 107, STRUCTURAL FEATURES UNDERLYING T-CELL RECEPTOR SENSITIVITY TO CONCEALED MHC CLASS I MICROPOLYMORPHISMS
2841, 2vl5B, 0.5245, 3.80, 0.120, 217, 108, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
2842, 2vc2H, 0.5245, 4.02, 0.088, 219, 114, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
2843, 1jpsL, 0.5245, 3.84, 0.093, 213, 107, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
2844, 6miyD, 0.5244, 3.83, 0.093, 240, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXA (JJ239)/INKTCR TERNARY COMPLEX 
2845, 6igwA, 0.5244, 3.81, 0.098, 119, 112, MPZL1 MUTANT - S86G; V145G; Q146K;P147T;G148S 
2846, 6h3hA, 0.5244, 3.97, 0.088, 222, 114, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
2847, 6cx9D, 0.5244, 3.83, 0.093, 239, 108, STRUCTURE OF ALPHA-GSA[16;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2848, 5viyJ, 0.5244, 3.93, 0.123, 223, 114, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2849, 5viyH, 0.5244, 3.93, 0.123, 223, 114, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
2850, 5uddJ, 0.5244, 3.79, 0.063, 224, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2851, 5t0yI, 0.5244, 3.94, 0.088, 217, 113, 2A10 ANTIBODY FAB FRAGMENT
2852, 5mv3B, 0.5244, 3.96, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
2853, 5lmjD, 0.5244, 3.78, 0.083, 123, 109, LLAMA NANOBODY PORM_19
2854, 5anmH, 0.5244, 4.03, 0.070, 208, 114, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2855, 4tnwV, 0.5244, 4.02, 0.088, 224, 114, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
2856, 4r7dN, 0.5244, 3.85, 0.093, 211, 107, FAB HU 15C1
2857, 4mxvL, 0.5244, 3.80, 0.112, 211, 107, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2858, 4hkbE, 0.5244, 4.04, 0.070, 220, 114, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
2859, 4evnE, 0.5244, 3.92, 0.080, 221, 113, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2860, 4bh8B, 0.5244, 3.84, 0.071, 218, 112, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE GDPRPSYISHLL
2861, 3wiiI, 0.5244, 3.93, 0.088, 220, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
2862, 3wfeH, 0.5244, 3.97, 0.080, 225, 113, REDUCED AND CYANIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2863, 3o41L, 0.5244, 3.94, 0.111, 218, 108, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
2864, 3fo2L, 0.5244, 3.99, 0.138, 216, 109, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
2865, 3esvF, 0.5244, 3.73, 0.073, 228, 110, CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY M18
2866, 2p5wE, 0.5244, 3.77, 0.083, 242, 109, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
2867, 2nyyC, 0.5244, 3.82, 0.093, 216, 108, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2868, 2cdeE, 0.5244, 3.71, 0.121, 192, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
2869, 1riuL, 0.5244, 3.85, 0.120, 218, 108, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
2870, 1p7kH, 0.5244, 3.95, 0.080, 220, 113, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
2871, 1iaiL, 0.5244, 3.87, 0.140, 214, 107, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
2872, 1fl6L, 0.5244, 3.87, 0.139, 217, 108, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2873, 1fl6A, 0.5244, 3.86, 0.139, 217, 108, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2874, 6cweD, 0.5243, 3.84, 0.093, 239, 108, STRUCTURE OF ALPHA-GSA[8;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2875, 6cw9D, 0.5243, 3.84, 0.093, 239, 108, STRUCTURE OF ALPHA-GC[8;16P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2876, 5xcrA, 0.5243, 3.92, 0.070, 166, 114, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
2877, 5xbmB, 0.5243, 3.83, 0.080, 221, 112, STRUCTURE OF SCARB2-JL2 COMPLEX 
2878, 5vshF, 0.5243, 3.81, 0.112, 211, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2879, 5mv4J, 0.5243, 3.83, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2880, 5mf7A, 0.5243, 3.73, 0.038, 188, 106, P53-DNA COMPLEX 6 
2881, 5mcvB, 0.5243, 3.73, 0.038, 200, 106, P53-DNA COMPLEX 3 
2882, 5kzcH, 0.5243, 3.83, 0.080, 214, 112, CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01
2883, 5hdqH, 0.5243, 3.85, 0.071, 213, 112, MNTC CO-STRUCTURE WITH MAB 305-78-7
2884, 4zakD, 0.5243, 3.83, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/DB06-1/INKTCR TERNARY COMPLEX
2885, 4z8fL, 0.5243, 3.85, 0.093, 214, 107, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
2886, 4y4fD, 0.5243, 3.83, 0.102, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/GCK127/INKTCR TERNARY COMPLEX
2887, 4nrxD, 0.5243, 3.94, 0.080, 228, 113, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2888, 4nhuB, 0.5243, 3.79, 0.093, 238, 108, THE M33 TCR P3M33L/H-2 LD COMPLEX
2889, 4guoB, 0.5243, 3.70, 0.066, 198, 106, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
2890, 4evnA, 0.5243, 3.93, 0.071, 221, 113, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
2891, 3wfdH, 0.5243, 3.97, 0.080, 225, 113, REDUCED AND ACETALDOXIME-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2892, 3sobL, 0.5243, 3.81, 0.112, 213, 107, THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
2893, 3rzcD, 0.5243, 3.82, 0.093, 239, 108, STRUCTURE OF THE SELF-ANTIGEN IGB3 BOUND TO MOUSE CD1D AND IN COMPLEX WITH THE INKT TCR
2894, 3quyD, 0.5243, 3.84, 0.093, 239, 108, STRUCTURE OF THE MOUSE CD1D-BNNH-GSL-1 -INKT TCR COMPLEX
2895, 3mffB, 0.5243, 3.74, 0.111, 242, 108, 1F1E8HU TCR
2896, 3gkwL, 0.5243, 3.96, 0.138, 199, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
2897, 3difA, 0.5243, 3.86, 0.150, 213, 107, CRYSTAL STRUCTURE OF FABOX117
2898, 2rmnA, 0.5243, 3.63, 0.067, 233, 105, THE SOLUTION STRUCTURE OF THE P63 DNA-BINDING DOMAIN
2899, 2jccM, 0.5243, 3.83, 0.092, 237, 109, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
2900, 1mwaB, 0.5243, 3.84, 0.093, 237, 108, 2C/H-2KBM3/DEV8 ALLOGENEIC COMPLEX
2901, 1e4xI, 0.5243, 4.02, 0.105, 217, 114, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
2902, 1ap2D, 0.5243, 3.96, 0.080, 123, 113, SINGLE CHAIN FV OF C219
2903, 6r7tA, 0.5242, 3.97, 0.096, 123, 114, CRYSTAL STRUCTURE OF HUMAN MELANOMA-ASSOCIATED ANTIGEN B1 (MAGEB1) IN COMPLEX WITH NANOBODY 
2904, 6mj4D, 0.5242, 3.84, 0.093, 239, 108, CRYSTAL STRUCTURE OF MCD1D/INKTCR TERNARY COMPLEX BOUND TO GLYCOLIPID (XXW) 
2905, 6m87B, 0.5242, 3.80, 0.072, 215, 111, FAB 10A6 IN COMPLEX WITH MPTS 
2906, 6fy3H, 0.5242, 4.06, 0.062, 226, 113, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2907, 6d9wH, 0.5242, 3.97, 0.080, 211, 113, CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MNTH; AN NRAMP-FAMILY TRANSITION METAL TRANSPORTER; IN THE INWARD-OPEN APO STATE 
2908, 6avuL, 0.5242, 3.89, 0.112, 211, 107, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
2909, 6avrL, 0.5242, 3.89, 0.112, 211, 107, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
2910, 6avqL, 0.5242, 3.89, 0.112, 211, 107, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
2911, 5vj6Q, 0.5242, 3.90, 0.062, 224, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
2912, 5vj6O, 0.5242, 3.90, 0.062, 224, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
2913, 5vj6M, 0.5242, 3.90, 0.062, 224, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PG9 AND 8ANC195
2914, 5uddL, 0.5242, 3.78, 0.063, 221, 111, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2915, 5tudC, 0.5242, 3.90, 0.089, 229, 112, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
2916, 5mp1C, 0.5242, 3.85, 0.098, 214, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2917, 5mctA, 0.5242, 3.73, 0.038, 200, 106, P53-DNA COMPLEX 1 
2918, 5girH, 0.5242, 3.84, 0.117, 208, 111, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
2919, 5d2nD, 0.5242, 3.61, 0.120, 198, 108, CRYSTAL STRUCTURE OF C25-NLV-HLA-A2 COMPLEX
2920, 5cjxD, 0.5242, 3.90, 0.062, 224, 112, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
2921, 4xr8D, 0.5242, 3.71, 0.038, 199, 106, CRYSTAL STRUCTURE OF THE HPV16 E6/E6AP/P53 TERNARY COMPLEX AT 2.25 A RESOLUTION
2922, 4x6cE, 0.5242, 3.63, 0.085, 198, 106, CD1A TERNARY COMPLEX WITH LYSOPHOSPHATIDYLCHOLINE AND BK6 TCR
2923, 4wnqD, 0.5242, 3.99, 0.099, 242, 111, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
2924, 4pj9D, 0.5242, 3.77, 0.092, 230, 109, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRAJ20 TCR
2925, 4p3dB, 0.5242, 3.94, 0.147, 218, 109, MT1-MMP:FAB COMPLEX (FORM II)
2926, 4lkcA, 0.5242, 3.84, 0.112, 213, 107, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
2927, 4guqB, 0.5242, 3.70, 0.075, 198, 106, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
2928, 3o0rH, 0.5242, 3.97, 0.080, 225, 113, CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2929, 3hr5L, 0.5242, 3.84, 0.120, 219, 108, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
2930, 3dggA, 0.5242, 3.86, 0.102, 217, 108, CRYSTAL STRUCTURE OF FABOX108
2931, 3areD, 0.5242, 3.75, 0.102, 238, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE
2932, 2r0kL, 0.5242, 3.85, 0.112, 214, 107, PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
2933, 2j1wA, 0.5242, 3.70, 0.028, 195, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V143A-V203A-N239Y-N268D
2934, 2ialB, 0.5242, 3.79, 0.073, 239, 109, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
2935, 1uweL, 0.5242, 3.83, 0.131, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
2936, 1moeA, 0.5242, 3.92, 0.110, 240, 109, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
2937, 1lk3I, 0.5242, 3.96, 0.080, 219, 113, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
2938, 1fptL, 0.5242, 4.02, 0.138, 219, 109, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
2939, 1a5fH, 0.5242, 3.88, 0.080, 212, 113, FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
2940, 6mkdA, 0.5241, 3.78, 0.110, 193, 109, 4699 TCR BOUND TO I-AB PADI4 
2941, 6j11D, 0.5241, 3.82, 0.108, 120, 111, MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX 
2942, 6d9gC, 0.5241, 3.87, 0.071, 221, 112, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
2943, 6cw6D, 0.5241, 3.84, 0.093, 239, 108, STRUCTURE OF ALPHA-GC[8;18] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2944, 6a0xC, 0.5241, 3.85, 0.080, 223, 112, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
2945, 5x2qJ, 0.5241, 3.97, 0.071, 218, 113, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2946, 5w1vD, 0.5241, 3.61, 0.152, 201, 105, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
2947, 5trpL, 0.5241, 3.94, 0.128, 217, 109, CRYSTAL STRUCTURE OF THE UNLIGANDED DH270 COOPERATING LINEAGE MEMBER DH272
2948, 5tezJ, 0.5241, 3.70, 0.074, 240, 108, TCR F50 RECGONIZING M1-HLA-A2
2949, 5swzI, 0.5241, 3.73, 0.102, 186, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
2950, 5mv4D, 0.5241, 3.83, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2951, 5mv4B, 0.5241, 3.82, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2952, 5mf7B, 0.5241, 3.73, 0.038, 188, 106, P53-DNA COMPLEX 6 
2953, 5mctB, 0.5241, 3.73, 0.038, 200, 106, P53-DNA COMPLEX 1 
2954, 5i6xB, 0.5241, 3.99, 0.097, 218, 113, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2955, 5girA, 0.5241, 3.95, 0.116, 206, 112, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
2956, 5ezoL, 0.5241, 3.82, 0.112, 213, 107, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
2957, 5c0sH, 0.5241, 3.84, 0.080, 221, 112, CRYSTAL STRUCTURE OF A GENERATION 4 INFLUENZA HEMAGGLUTININ STABILIZED STEM IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODY CR6261
2958, 4uimH, 0.5241, 4.03, 0.096, 222, 114, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
2959, 4qexH, 0.5241, 3.85, 0.080, 206, 112, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
2960, 4nobA, 0.5241, 3.63, 0.075, 112, 106, CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220]
2961, 4jreL, 0.5241, 3.84, 0.121, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
2962, 4grlD, 0.5241, 3.87, 0.138, 257, 109, CRYSTAL STRUCTURE OF A AUTOIMMUNE TCR-MHC COMPLEX
2963, 4f33B, 0.5241, 3.89, 0.080, 219, 112, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
2964, 3qumK, 0.5241, 4.02, 0.096, 219, 114, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
2965, 3o2wH, 0.5241, 4.01, 0.079, 214, 114, CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
2966, 3ngbJ, 0.5241, 3.87, 0.071, 224, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
2967, 3ngbB, 0.5241, 3.93, 0.071, 224, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
2968, 35c8H, 0.5241, 4.04, 0.096, 217, 114, CATALYTIC ANTIBODY 5C8 FAB-INHIBITOR COMPLEX
2969, 2pcpB, 0.5241, 3.82, 0.081, 215, 111, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
2970, 2icwJ, 0.5241, 3.83, 0.092, 113, 109, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
2971, 2hb0B, 0.5241, 3.98, 0.053, 355, 114, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
2972, 2brrH, 0.5241, 3.98, 0.080, 224, 113, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
2973, 2bimA, 0.5241, 3.71, 0.028, 195, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273H
2974, 1seqL, 0.5241, 3.83, 0.132, 208, 106, FAB MNAC13
2975, 1p7kB, 0.5241, 3.94, 0.080, 217, 113, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
2976, 1nj9H, 0.5241, 3.89, 0.062, 215, 113, COCAINE HYDROLYTIC ANTIBODY 15A10
2977, 1mfdH, 0.5241, 3.93, 0.097, 211, 113, THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
2978, 1mfbH, 0.5241, 3.93, 0.097, 211, 113, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
2979, 1kcsL, 0.5241, 3.86, 0.121, 214, 107, CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
2980, 1h5bC, 0.5241, 3.65, 0.144, 113, 104, T CELL RECEPTOR VALPHA11 (AV11S5) DOMAIN
2981, 1bd2E, 0.5241, 3.67, 0.075, 242, 107, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7 VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
2982, 6mjjD, 0.5240, 3.84, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXM (JJ290) /INKTCR TERNARY COMPLEX 
2983, 6mivD, 0.5240, 3.84, 0.093, 239, 108, CRYSTAL STRUCTURE OF THE MCD1D/XXQ (JJ300)/INKTCR TERNARY COMPLEX 
2984, 6ea5H, 0.5240, 3.86, 0.098, 213, 112, STRUCTURE OF BDBV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
2985, 6dcqM, 0.5240, 3.85, 0.090, 135, 111, ECTODOMAIN OF FULL LENGTH; WILD TYPE HIV-1 GLYCOPROTEIN CLONE PC64M18C043 IN COMPLEX WITH PGT151 FAB 
2986, 6cxaD, 0.5240, 3.84, 0.093, 239, 108, STRUCTURE OF ALPHA-GSA[20;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
2987, 6crqD, 0.5240, 3.80, 0.071, 125, 112, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
2988, 6c9uH, 0.5240, 3.96, 0.116, 205, 112, CRYSTAL STRUCTURE OF [KS3][AT3] DIDOMAIN FROM MODULE 3 OF 6- DEOXYERTHRONOLIDE B SYNTHASE IN COMPLEX WITH ANTIBODY FRAGMENT (FAB) 
2989, 5vshD, 0.5240, 3.82, 0.112, 211, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2990, 5vl3C, 0.5240, 3.94, 0.071, 212, 113, CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB
2991, 5uemH, 0.5240, 4.14, 0.096, 230, 115, CRYSTAL STRUCTURE OF 354NC37 FAB IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
2992, 5or7C, 0.5240, 3.75, 0.055, 111, 109, ATOMIC STRUCTURE OF THE MURINE NOROVIRUS PROTRUDING DOMAIN AND SCD300LF RECEPTOR COMPLEX
2993, 5mv4V, 0.5240, 3.83, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
2994, 5i18H, 0.5240, 3.79, 0.062, 211, 112, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1
2995, 5i15H, 0.5240, 3.81, 0.062, 213, 112, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
2996, 5gzoD, 0.5240, 3.82, 0.093, 213, 107, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2997, 5bzdA, 0.5240, 3.87, 0.111, 213, 108, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2998, 4qexI, 0.5240, 3.85, 0.080, 210, 112, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
2999, 4jhaH, 0.5240, 3.81, 0.063, 226, 111, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
3000, 4irsD, 0.5240, 3.83, 0.093, 239, 108, STRUCTURE OF THE MOUSE CD1D-PYRC-ALPHA-GALCER-INKT TCR COMPLEX
3001, 3t2nH, 0.5240, 3.93, 0.080, 203, 113, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3002, 3qynD, 0.5240, 3.68, 0.066, 190, 106, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3003, 3qumH, 0.5240, 4.03, 0.105, 217, 114, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
3004, 3q3gD, 0.5240, 4.03, 0.096, 224, 114, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3005, 3difC, 0.5240, 3.86, 0.150, 214, 107, CRYSTAL STRUCTURE OF FABOX117
3006, 3b2vL, 0.5240, 3.83, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3007, 3aazB, 0.5240, 4.00, 0.156, 229, 109, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3008, 2y5tA, 0.5240, 4.08, 0.105, 222, 114, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
3009, 2vweL, 0.5240, 4.07, 0.078, 219, 115, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
3010, 2vdqH, 0.5240, 4.02, 0.088, 219, 114, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
3011, 2vdlH, 0.5240, 4.03, 0.088, 219, 114, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3012, 2ialD, 0.5240, 3.79, 0.073, 239, 109, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3013, 2geqA, 0.5240, 3.72, 0.019, 188, 106, CRYSTAL STRUCTURE OF A P53 CORE DIMER BOUND TO DNA
3014, 2adfH, 0.5240, 4.00, 0.088, 218, 114, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
3015, 1xgyH, 0.5240, 3.96, 0.080, 216, 113, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
3016, 1rhhA, 0.5240, 3.92, 0.102, 215, 108, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
3017, 1i9rK, 0.5240, 4.01, 0.088, 219, 114, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
3018, 15c8H, 0.5240, 4.08, 0.096, 217, 114, CATALYTIC ANTIBODY 5C8 FREE FAB
3019, 6furD, 0.5239, 3.79, 0.101, 240, 109, F11 T-CELL RECEPTOR RECOGNISING PKYVKQNTLKLAT PEPTIDE PRESENTED BY HLA-DR*0101 
3020, 6fr7B, 0.5239, 3.81, 0.102, 241, 108, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3021, 6ev2G, 0.5239, 4.03, 0.096, 215, 114, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
3022, 6eh9B, 0.5239, 3.80, 0.074, 241, 108, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
3023, 6a0xA, 0.5239, 3.85, 0.080, 223, 112, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3024, 5ywfB, 0.5239, 4.00, 0.079, 218, 114, CRYSTAL STRUCTURE OF 2H4 FAB
3025, 5w1wN, 0.5239, 3.53, 0.154, 199, 104, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
3026, 5vgaB, 0.5239, 4.04, 0.088, 224, 114, ALTERNATIVE MODEL FOR FAB 36-65
3027, 5swzD, 0.5239, 3.69, 0.102, 198, 108, CRYSTAL STRUCTURE OF NP1-B17 TCR-H2DB-NP COMPLEX
3028, 5mv4G, 0.5239, 3.83, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3029, 5js9E, 0.5239, 3.82, 0.062, 224, 112, UNCLEAVED PREFUSION OPTIMIZED GP140 TRIMER WITH AN ENGINEERED 8- RESIDUE HR1 TURN BOUND TO BROADLY NEUTRALIZING ANTIBODIES 8ANC195 AND PGT128
3030, 5jo4A, 0.5239, 4.03, 0.088, 221, 114, ANTIBODY FAB FRAGMENT COMPLEX
3031, 5anmD, 0.5239, 4.01, 0.079, 219, 114, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3032, 4z95L, 0.5239, 3.85, 0.093, 214, 107, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
3033, 4pjiH, 0.5239, 3.69, 0.093, 238, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
3034, 4pjbH, 0.5239, 3.72, 0.083, 238, 108, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
3035, 4mvbD, 0.5239, 3.66, 0.084, 239, 107, 42F3 PCPB7/H-2LD COMPLEX
3036, 4mauL, 0.5239, 3.96, 0.119, 216, 109, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
3037, 4g6aD, 0.5239, 3.89, 0.120, 218, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
3038, 4evnO, 0.5239, 3.92, 0.080, 221, 113, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3039, 4apqC, 0.5239, 3.69, 0.157, 196, 108, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-SULFATIDE
3040, 3tvmD, 0.5239, 3.83, 0.083, 239, 108, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
3041, 3ts8B, 0.5239, 3.66, 0.048, 234, 105, CRYSTAL STRUCTURE OF A MULTIDOMAIN HUMAN P53 TETRAMER BOUND TO THE NATURAL CDKN1A(P21) P53-RESPONSE ELEMENT
3042, 3iy0H, 0.5239, 3.86, 0.107, 120, 112, VARIABLE DOMAINS OF THE X-RAY STRUCTURE OF FAB 14 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 14 COMPLEX
3043, 3idxL, 0.5239, 3.89, 0.083, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C222
3044, 2vdrH, 0.5239, 4.02, 0.088, 219, 114, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
3045, 2vdoH, 0.5239, 4.02, 0.088, 219, 114, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
3046, 2vdmH, 0.5239, 4.02, 0.088, 219, 114, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
3047, 2vdkH, 0.5239, 4.03, 0.088, 219, 114, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3048, 2ap2D, 0.5239, 3.95, 0.080, 122, 113, SINGLE CHAIN FV OF C219 IN COMPLEX WITH SYNTHETIC EPITOPE PEPTIDE
3049, 1xgyI, 0.5239, 4.02, 0.096, 215, 114, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
3050, 1xctD, 0.5239, 3.89, 0.080, 218, 112, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
3051, 1q0yH, 0.5239, 4.03, 0.096, 215, 114, ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
3052, 1p2cD, 0.5239, 3.84, 0.121, 211, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
3053, 1fj1B, 0.5239, 3.93, 0.080, 213, 112, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3054, 1fj1A, 0.5239, 3.81, 0.103, 213, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3055, 1ai1L, 0.5239, 3.86, 0.111, 215, 108, HIV-1 V3 LOOP MIMIC
3056, 6fbjH, 0.5238, 3.96, 0.080, 214, 113, MONOCLONAL ANTIBODY TARGETING MATRIX METALLOPROTEINASE 7 
3057, 6crqJ, 0.5238, 3.83, 0.071, 125, 112, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
3058, 5ksbG, 0.5238, 3.74, 0.093, 200, 107, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
3059, 5d93C, 0.5238, 3.86, 0.062, 207, 112, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY
3060, 5d5mF, 0.5238, 3.67, 0.084, 240, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64 TCR
3061, 4zdhB, 0.5238, 3.73, 0.084, 241, 107, CRYSTAL STRUCTURE OF JKA6 TCR
3062, 4wwkB, 0.5238, 3.68, 0.103, 240, 107, CRYSTAL STRUCTURE OF HUMAN TCR ALPHA CHAIN-TRAV12-3 BETA CHAIN-TRBV6- 5 ANTIGEN-PRESENTING MOLECULE CD1D AND BETA-2-MICROGLOBULIN
3063, 4qxgH, 0.5238, 3.93, 0.071, 218, 113, ANTIGEN BINDING FRAGMENT OF AN ANTI IFNAR1 ANTIBODY
3064, 4pjaF, 0.5238, 3.69, 0.093, 235, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
3065, 4lu5M, 0.5238, 3.83, 0.139, 219, 108, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
3066, 4fzeH, 0.5238, 3.87, 0.054, 221, 111, CRYSTAL STRUCTURE OF N26_I1 FAB AN ADCC MEDIATING ANTI-HIV-1 ANTIBODY.
3067, 4evnC, 0.5238, 3.92, 0.080, 221, 113, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3068, 3pl6D, 0.5238, 3.85, 0.147, 257, 109, STRUCTURE OF AUTOIMMUNE TCR HY.1B11 IN COMPLEX WITH HLA-DQ1 AND MBP 85-99
3069, 3nfpA, 0.5238, 3.99, 0.088, 213, 114, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
3070, 3gi9L, 0.5238, 3.92, 0.139, 219, 108, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3071, 3e3qI, 0.5238, 3.50, 0.114, 109, 105, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3072, 3e3qD, 0.5238, 3.50, 0.114, 109, 105, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3073, 2xqyG, 0.5238, 4.00, 0.097, 216, 113, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3074, 2arjL, 0.5238, 3.82, 0.103, 211, 107, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
3075, 1yntD, 0.5238, 3.94, 0.080, 218, 113, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
3076, 1uweX, 0.5238, 3.83, 0.131, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
3077, 1rfdL, 0.5238, 3.85, 0.139, 218, 108, ANTI-COCAINE ANTIBODY M82G2
3078, 1q72L, 0.5238, 3.84, 0.139, 218, 108, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
3079, 1mlbB, 0.5238, 3.89, 0.080, 218, 112, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
3080, 1j05H, 0.5238, 3.95, 0.062, 121, 112, THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT
3081, 1i9rX, 0.5238, 4.02, 0.088, 219, 114, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
3082, 1fj1C, 0.5238, 3.80, 0.103, 213, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3083, 1ct8B, 0.5238, 3.99, 0.096, 220, 114, CATALYTIC ANTIBODY 7C8 COMPLEX
3084, 1clzL, 0.5238, 3.99, 0.138, 219, 109, IGG FAB (IGG3 KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
3085, 6m87F, 0.5237, 3.79, 0.072, 215, 111, FAB 10A6 IN COMPLEX WITH MPTS 
3086, 6ea7H, 0.5237, 3.91, 0.088, 213, 113, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
3087, 6e48G, 0.5237, 3.73, 0.055, 111, 109, CRYSTAL STRUCTURE OF THE MURINE NOROVIRUS VP1 P DOMAIN IN COMPLEX WITH THE CD300LF RECEPTOR AND LITHOCHOLIC ACID 
3088, 5viyO, 0.5237, 3.90, 0.062, 227, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3089, 5tljF, 0.5237, 3.84, 0.090, 219, 111, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
3090, 5swsD, 0.5237, 3.75, 0.101, 198, 109, CRYSTAL STRUCTURE OF NP2-B17 TCR-H2DB-NP COMPLEX
3091, 5mo9H, 0.5237, 3.90, 0.088, 212, 113, STRUCTURE OF HUMAN TRKB RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE FAB FRGMENT OF ANTIBODY AB20
3092, 5g64M, 0.5237, 3.82, 0.111, 214, 108, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
3093, 5epmF, 0.5237, 3.97, 0.147, 218, 109, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
3094, 5cbaC, 0.5237, 3.83, 0.063, 127, 111, 3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13
3095, 5anmB, 0.5237, 4.01, 0.079, 220, 114, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3096, 4r7dJ, 0.5237, 3.86, 0.093, 212, 107, FAB HU 15C1
3097, 4qy8A, 0.5237, 3.77, 0.081, 114, 111, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8) IN COMPLEX WITH 3D7-MSP2 14-30
3098, 4pljL, 0.5237, 3.87, 0.121, 212, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3099, 4pjiF, 0.5237, 3.69, 0.093, 240, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-C10 TCR
3100, 4g6aL, 0.5237, 3.99, 0.119, 218, 109, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
3101, 4f33D, 0.5237, 3.89, 0.071, 219, 112, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
3102, 4dcqB, 0.5237, 3.92, 0.097, 218, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10 AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM)
3103, 3t2nI, 0.5237, 3.93, 0.080, 205, 113, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
3104, 3se9H, 0.5237, 4.02, 0.070, 225, 114, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG04 IN COMPLEX WITH HIV-1 GP120
3105, 3of6B, 0.5237, 3.98, 0.109, 242, 110, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3106, 3fzuL, 0.5237, 3.82, 0.093, 213, 107, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3107, 3fzuD, 0.5237, 3.83, 0.103, 213, 107, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
3108, 2vdpH, 0.5237, 4.02, 0.088, 219, 114, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
3109, 2nw2B, 0.5237, 3.76, 0.083, 243, 108, CRYSTAL STRUCTURE OF ELS4 TCR AT 1.4A
3110, 1t3fB, 0.5237, 4.00, 0.071, 219, 113, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
3111, 1nj9B, 0.5237, 3.91, 0.062, 215, 113, COCAINE HYDROLYTIC ANTIBODY 15A10
3112, 1i9rH, 0.5237, 4.02, 0.088, 219, 114, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
3113, 1egjL, 0.5237, 3.85, 0.102, 215, 108, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
3114, 6mehH, 0.5236, 4.25, 0.070, 225, 115, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3115, 5ywpN, 0.5236, 4.04, 0.071, 218, 113, JEV-2H4 FAB COMPLEX 
3116, 5y9cL, 0.5236, 3.83, 0.103, 203, 107, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
3117, 5viyM, 0.5236, 3.90, 0.062, 227, 112, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3118, 5mv4S, 0.5236, 3.83, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3119, 5mu2N, 0.5236, 3.98, 0.138, 218, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3120, 5mp1J, 0.5236, 3.85, 0.098, 214, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3121, 5dgyA, 0.5236, 3.84, 0.028, 833, 107, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
3122, 5dfvF, 0.5236, 3.86, 0.120, 217, 108, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
3123, 5cjxH, 0.5236, 3.90, 0.062, 227, 112, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
3124, 5bzwA, 0.5236, 3.87, 0.120, 213, 108, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
3125, 4zwjA, 0.5236, 3.84, 0.028, 833, 107, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
3126, 4xr8C, 0.5236, 3.74, 0.038, 199, 106, CRYSTAL STRUCTURE OF THE HPV16 E6/E6AP/P53 TERNARY COMPLEX AT 2.25 A RESOLUTION
3127, 4xakD, 0.5236, 3.91, 0.071, 218, 113, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD
3128, 4nrxA, 0.5236, 3.92, 0.080, 229, 113, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3129, 4nc1E, 0.5236, 3.86, 0.082, 124, 110, CRYSTAL STRUCTURE OF TCDA-A2 BOUND TO A20.1 VHH AND A26.8 VHH
3130, 4k7pH, 0.5236, 3.91, 0.088, 213, 113, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
3131, 4g6mL, 0.5236, 3.85, 0.084, 213, 107, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
3132, 3quzD, 0.5236, 3.83, 0.093, 239, 108, STRUCTURE OF THE MOUSE CD1D-NU-ALPHA-GALCER-INKT TCR COMPLEX
3133, 3e3qM, 0.5236, 3.50, 0.114, 109, 105, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3134, 3areC, 0.5236, 3.65, 0.148, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-4 DEOXY-ALPHA- GALACTOSYLCERAMIDE
3135, 2nz9C, 0.5236, 3.84, 0.093, 216, 108, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
3136, 2b4cL, 0.5236, 3.93, 0.111, 215, 108, CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
3137, 1uywH, 0.5236, 3.78, 0.072, 218, 111, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3138, 1t04D, 0.5236, 3.91, 0.071, 218, 112, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
3139, 1rivL, 0.5236, 3.85, 0.120, 218, 108, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
3140, 1q9wD, 0.5236, 4.00, 0.079, 226, 114, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
3141, 1kegH, 0.5236, 3.96, 0.080, 216, 113, ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT
3142, 1b6dA, 0.5236, 3.82, 0.084, 212, 107, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
3143, 6ogeC, 0.5235, 4.07, 0.061, 222, 114, CRYO-EM STRUCTURE OF HER2 EXTRACELLULAR DOMAIN-TRASTUZUMAB FAB- PERTUZUMAB FAB COMPLEX 
3144, 6m87L, 0.5235, 3.88, 0.080, 215, 112, FAB 10A6 IN COMPLEX WITH MPTS 
3145, 5yd5C, 0.5235, 3.87, 0.071, 240, 112, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH EPITOPE PEPTIDE (MUTATION N3A) 
3146, 5vshB, 0.5235, 3.82, 0.112, 213, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
3147, 5mv4M, 0.5235, 3.83, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3148, 5mu2B, 0.5235, 3.99, 0.138, 218, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3149, 5l0qC, 0.5235, 4.01, 0.080, 213, 113, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
3150, 5e9dE, 0.5235, 3.60, 0.075, 115, 106, RD-1 MART-1 HIGH BOUND TO MART-1 DECAMERIC PEPTIDE (ELA) IN COMPLEX WITH HLA-A2
3151, 4plkI, 0.5235, 3.84, 0.099, 218, 111, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3152, 4pjaH, 0.5235, 3.70, 0.093, 238, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-B10 TCR
3153, 4odtL, 0.5235, 3.86, 0.093, 214, 107, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3154, 4nylB, 0.5235, 3.80, 0.103, 117, 107, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3155, 4nm8I, 0.5235, 3.97, 0.062, 211, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3156, 4nm4H, 0.5235, 4.04, 0.079, 219, 114, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
3157, 4lmqL, 0.5235, 3.82, 0.103, 214, 107, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
3158, 4ki5D, 0.5235, 3.82, 0.123, 211, 106, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
3159, 4f33F, 0.5235, 3.89, 0.071, 219, 112, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
3160, 4d9qL, 0.5235, 3.83, 0.093, 213, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
3161, 3vi4H, 0.5235, 3.97, 0.080, 218, 113, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
3162, 3ta3D, 0.5235, 3.84, 0.093, 239, 108, STRUCTURE OF THE MOUSE CD1D-GLC-DAG-S2-INKT TCR COMPLEX
3163, 3ijhB, 0.5235, 3.92, 0.071, 221, 113, STRUCTURE OF S67-27 IN COMPLEX WITH KO
3164, 3e3qd, 0.5235, 3.50, 0.124, 109, 105, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3165, 3e3qZ, 0.5235, 3.50, 0.124, 109, 105, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3166, 3e3qR, 0.5235, 3.50, 0.114, 109, 105, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3167, 3e3qC, 0.5235, 3.50, 0.124, 109, 105, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3168, 2zpkH, 0.5235, 3.88, 0.080, 207, 113, CRYSTAL STRUCTURE OF P20.1 FAB FRAGMENT IN COMPLEX WITH ITS ANTIGEN PEPTIDE
3169, 2y5tB, 0.5235, 3.96, 0.128, 218, 109, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
3170, 2pcpD, 0.5235, 4.00, 0.080, 215, 113, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3171, 1xiwH, 0.5235, 3.85, 0.062, 122, 112, CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT
3172, 1wejH, 0.5235, 4.01, 0.080, 223, 113, IGG1 FAB FRAGMENT (OF E8 ANTIBODY) COMPLEXED WITH HORSE CYTOCHROME C AT 1.8 A RESOLUTION
3173, 1mjjA, 0.5235, 3.87, 0.093, 218, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
3174, 1jnnH, 0.5235, 3.94, 0.088, 214, 113, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3175, 1it9H, 0.5235, 3.94, 0.106, 219, 113, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A
3176, 6i8sH, 0.5234, 3.88, 0.071, 214, 112, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
3177, 6crqI, 0.5234, 3.82, 0.071, 125, 112, GLUTARALDEHYDE-TREATED BG505 SOSIP.664 ENV IN COMPLEX WITH PGV04 FAB 
3178, 5ywpR, 0.5234, 4.02, 0.071, 218, 113, JEV-2H4 FAB COMPLEX 
3179, 5vshL, 0.5234, 3.82, 0.112, 213, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
3180, 5vlpH, 0.5234, 3.87, 0.071, 220, 112, PCSK9 COMPLEX WITH LDLR ANTAGONIST PEPTIDE AND FAB7G7
3181, 5mu2D, 0.5234, 4.00, 0.138, 218, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3182, 5mu0J, 0.5234, 3.83, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3183, 5i0zB, 0.5234, 3.80, 0.072, 120, 111, CRYSTAL STRUCTURE OF THE SINGLE DOMAIN CATALYTIC ANTIBODY 3D8-VH
3184, 5d7jB, 0.5234, 3.71, 0.083, 240, 108, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT M33.64(Y95ALPHAF) TCR
3185, 5d6cA, 0.5234, 3.94, 0.119, 219, 109, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
3186, 4x6dG, 0.5234, 3.60, 0.086, 200, 105, CD1A TERNARY COMPLEX WITH ENDOGENOUS LIPIDS AND BK6 TCR
3187, 4pjxF, 0.5234, 3.69, 0.093, 237, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
3188, 4m7kH, 0.5234, 3.87, 0.089, 228, 112, CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
3189, 4lciH, 0.5234, 3.87, 0.080, 120, 112, ANTI CANINE CD28 ANTIBODY 1C6
3190, 4f33H, 0.5234, 3.90, 0.071, 219, 112, CRYSTAL STRUCTURE OF THERAPEUTIC ANTIBODY MORAB-009
3191, 4en3B, 0.5234, 3.76, 0.093, 240, 108, CRYSTAL STRUCTURE OF A HUMAN VALPHA24(-) NKT TCR IN COMPLEX WITH CD1D/ALPHA-GALACTOSYLCERAMIDE
3192, 4d9qD, 0.5234, 3.83, 0.093, 213, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
3193, 3vxtB, 0.5234, 3.78, 0.083, 241, 109, T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3194, 3o9wD, 0.5234, 3.86, 0.093, 239, 108, RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
3195, 3idyL, 0.5234, 3.82, 0.083, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
3196, 3idyC, 0.5234, 3.82, 0.083, 214, 108, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
3197, 3e3qV, 0.5234, 3.50, 0.114, 109, 105, STRUCTURE OF THE 3ALPHAM13 HIGH-AFFINITY MUTANT OF THE 2C TCR IN COMPLEX WITH LD/QL9
3198, 3d85B, 0.5234, 4.00, 0.088, 216, 113, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
3199, 2xa8L, 0.5234, 3.83, 0.111, 218, 108, CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
3200, 2i5yR, 0.5234, 4.05, 0.088, 223, 114, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3201, 2eyrB, 0.5234, 3.75, 0.093, 241, 108, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
3202, 2arjA, 0.5234, 3.83, 0.103, 211, 107, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
3203, 1z3gI, 0.5234, 3.84, 0.090, 214, 111, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
3204, 1yntB, 0.5234, 3.95, 0.080, 218, 113, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
3205, 1tcrB, 0.5234, 3.81, 0.093, 237, 108, MURINE T-CELL ANTIGEN RECEPTOR 2C CLONE
3206, 1qygL, 0.5234, 3.85, 0.139, 218, 108, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
3207, 6njnL, 0.5233, 3.89, 0.000, 218, 112, STRUCTURE OF A COMPLEX 
3208, 6m87D, 0.5233, 3.89, 0.080, 215, 112, FAB 10A6 IN COMPLEX WITH MPTS 
3209, 6jmrE, 0.5233, 3.87, 0.080, 215, 112, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
3210, 6fxnD, 0.5233, 4.01, 0.070, 215, 114, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
3211, 6ffjA, 0.5233, 3.79, 0.054, 232, 111, ANTI-TUMOR ANTIBODY 14F7-DERIVED SINGLE CHAIN FRAGMENT VARIABLE (SCFV) 
3212, 6dc7H, 0.5233, 4.00, 0.115, 210, 113, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
3213, 6db6H, 0.5233, 3.95, 0.062, 226, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 311-11D IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
3214, 5xhvQ, 0.5233, 3.81, 0.093, 214, 107, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
3215, 5mv4P, 0.5233, 3.84, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
3216, 5mu2J, 0.5233, 3.98, 0.138, 218, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3217, 5iw1D, 0.5233, 3.67, 0.123, 233, 106, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
3218, 5fc9B, 0.5233, 2.16, 0.159, 95, 88, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
3219, 5bzdC, 0.5233, 3.86, 0.111, 214, 108, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
3220, 4xccH, 0.5233, 3.96, 0.080, 226, 113, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP
3221, 4r7dD, 0.5233, 3.86, 0.093, 211, 107, FAB HU 15C1
3222, 4jreC, 0.5233, 3.86, 0.121, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
3223, 4jfhE, 0.5233, 3.75, 0.130, 244, 108, HIGH AFFINITY ALPHA24-BETA17 T CELL RECEPTOR FOR A2 HLA-MELANOMA PEPTIDE COMPLEX
3224, 4i2xB, 0.5233, 3.97, 0.106, 229, 113, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3225, 4hs6L, 0.5233, 3.86, 0.102, 218, 108, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
3226, 4g8eB, 0.5233, 3.76, 0.083, 241, 108, CRYSTAL STRUCTURE OF CLONE18 TCR
3227, 4dkfM, 0.5233, 3.83, 0.093, 207, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
3228, 4alaL, 0.5233, 3.90, 0.121, 212, 107, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
3229, 3vw3L, 0.5233, 4.00, 0.138, 215, 109, ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT
3230, 3vi4F, 0.5233, 4.06, 0.079, 218, 114, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
3231, 3scmC, 0.5233, 3.75, 0.156, 191, 109, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-ISOGLOBOTRIHEXOSYLCERAMIDE
3232, 3ojdA, 0.5233, 3.86, 0.159, 214, 107, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
3233, 3hr5P, 0.5233, 3.84, 0.120, 219, 108, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3234, 2wgxA, 0.5233, 3.72, 0.038, 195, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I- N268D
3235, 2nmsA, 0.5233, 3.77, 0.092, 112, 109, THE CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE INHIBITOR RECEPTOR EXPRESSED ON MYELOID CELLS IREM-1
3236, 2ac0A, 0.5233, 3.72, 0.038, 198, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
3237, 1kzyA, 0.5233, 3.74, 0.038, 195, 106, CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53
3238, 1j05B, 0.5233, 3.95, 0.062, 121, 112, THE CRYSTAL STRUCTURE OF ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY T84.66 FV FRAGMENT
3239, 1i8mB, 0.5233, 3.96, 0.097, 213, 113, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
3240, 1eajA, 0.5233, 3.97, 0.089, 124, 112, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
3241, 6rcqA, 0.5232, 4.00, 0.088, 222, 114, PFRH5-BINDING MONOCLONAL ANTIBODY R5.011 
3242, 6gc2L, 0.5232, 3.86, 0.112, 214, 107, ABLIFT: ANTIBODY STABILITY AND AFFINITY OPTIMIZATION BY COMPUTATIONAL DESIGN OF THE VARIABLE LIGHT-HEAVY CHAIN INTERFACE 
3243, 6dznH, 0.5232, 3.94, 0.097, 226, 113, PAN-EBOLAVIRUS HUMAN ANTIBODY ADI-15878 FAB 
3244, 6bckH, 0.5232, 3.92, 0.115, 222, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY N49P7 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE. 
3245, 6al5H, 0.5232, 3.90, 0.080, 221, 112, COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
3246, 5w0kL, 0.5232, 3.88, 0.121, 210, 107, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
3247, 5o4gA, 0.5232, 3.81, 0.103, 214, 107, HER2 IN COMPLEX WITH FAB MF3958 
3248, 5mp1F, 0.5232, 3.86, 0.089, 215, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3249, 5lz0B, 0.5232, 3.73, 0.055, 124, 109, LLAMA NANOBODY PORM_01
3250, 5ksbE, 0.5232, 3.77, 0.093, 200, 107, T15-DQ8.5-GLIA-GAMMA1 COMPLEX
3251, 5kanL, 0.5232, 3.86, 0.084, 214, 107, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
3252, 5iwlA, 0.5232, 3.93, 0.071, 232, 113, CD47-DIABODY COMPLEX
3253, 4y4kD, 0.5232, 3.86, 0.083, 239, 109, CRYSTAL STRUCTURE OF THE MCD1D/EF77/INKTCR TERNARY COMPLEX
3254, 4uimA, 0.5232, 4.02, 0.096, 224, 114, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
3255, 4uikH, 0.5232, 3.99, 0.080, 218, 113, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1
3256, 4u6hC, 0.5232, 3.90, 0.088, 217, 113, VACCINIA L1/M12B9-FAB COMPLEX
3257, 4r7nF, 0.5232, 3.79, 0.112, 211, 107, FAB C2E3
3258, 4pjdF, 0.5232, 3.69, 0.093, 233, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
3259, 4oqtL, 0.5232, 3.87, 0.084, 214, 107, LINGO-1/LI81 FAB COMPLEX
3260, 4nryL, 0.5232, 3.83, 0.121, 207, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
3261, 4nm4I, 0.5232, 4.01, 0.062, 223, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
3262, 4dkfL, 0.5232, 3.84, 0.093, 212, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
3263, 3v6oE, 0.5232, 3.92, 0.131, 213, 107, LEPTIN RECEPTOR-ANTIBODY COMPLEX
3264, 3s96C, 0.5232, 3.92, 0.097, 218, 113, CRYSTAL STRUCTURE OF 3B5H10
3265, 3quxD, 0.5232, 3.89, 0.092, 239, 109, STRUCTURE OF THE MOUSE CD1D-ALPHA-C-GALCER-INKT TCR COMPLEX
3266, 3arbD, 0.5232, 3.72, 0.084, 236, 107, TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
3267, 2vl5D, 0.5232, 3.83, 0.120, 216, 108, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
3268, 2vdnH, 0.5232, 4.03, 0.088, 219, 114, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
3269, 2pyfB, 0.5232, 3.74, 0.083, 241, 108, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY UNBOUND TCR CLONE 5-1
3270, 2jixL, 0.5232, 3.75, 0.093, 214, 107, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
3271, 2ij0C, 0.5232, 3.82, 0.102, 118, 108, STRUCTURAL BASIS OF T CELL SPECIFICITY AND ACTIVATION BY THE BACTERIAL SUPERANTIGEN TOXIC SHOCK SYNDROME TOXIN-1
3272, 2gsiC, 0.5232, 3.85, 0.120, 215, 108, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
3273, 2f54L, 0.5232, 3.73, 0.083, 241, 108, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
3274, 1za6H, 0.5232, 3.92, 0.089, 324, 112, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3275, 1tetL, 0.5232, 4.00, 0.147, 216, 109, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
3276, 1t04B, 0.5232, 3.90, 0.071, 218, 112, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
3277, 6at6B, 0.5231, 3.73, 0.093, 240, 108, CRYSTAL STRUCTURE OF THE KFJ5 TCR
3278, 5mvjC, 0.5231, 3.86, 0.098, 213, 112, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3279, 5l21B, 0.5231, 3.93, 0.064, 119, 110, CRYSTAL STRUCTURE OF BONT/A RECEPTOR BINDING DOMAIN IN COMPLEX WITH VHH C2
3280, 5gz0D, 0.5231, 3.87, 0.089, 221, 112, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
3281, 4ygaB, 0.5231, 3.79, 0.093, 124, 108, CDPK1 FROM TOXOPLASMA GONDII BOUND TO INHIBITORY VHH-1B7
3282, 4u6hA, 0.5231, 3.92, 0.088, 217, 113, VACCINIA L1/M12B9-FAB COMPLEX
3283, 4r7nJ, 0.5231, 3.87, 0.084, 211, 107, FAB C2E3
3284, 4pjbF, 0.5231, 3.74, 0.083, 230, 108, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
3285, 4gagL, 0.5231, 4.01, 0.119, 215, 109, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)
3286, 3vi3H, 0.5231, 3.97, 0.080, 218, 113, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
3287, 3s35H, 0.5231, 4.01, 0.088, 211, 113, STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
3288, 3l7eA, 0.5231, 3.84, 0.103, 213, 107, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
3289, 3arfC, 0.5231, 3.66, 0.157, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
3290, 2eysB, 0.5231, 3.75, 0.093, 243, 108, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
3291, 25c8H, 0.5231, 4.05, 0.105, 217, 114, CATALYTIC ANTIBODY 5C8 FAB-HAPTEN COMPLEX
3292, 1za6D, 0.5231, 3.93, 0.089, 324, 112, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3293, 1mlcD, 0.5231, 4.08, 0.088, 218, 114, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
3294, 1bj1J, 0.5231, 3.82, 0.103, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3295, 6j5gH, 0.5230, 3.77, 0.064, 120, 110, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH TICK-BORNE ENCEPHALITIS VIRUS ENVELOPE PROTEIN 
3296, 6cphD, 0.5230, 3.72, 0.101, 200, 109, CRYSTAL STRUCTURE OF A TCR 
3297, 6azkB, 0.5230, 3.82, 0.081, 219, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
3298, 6avfB, 0.5230, 3.81, 0.119, 242, 109, CRYSTAL STRUCTURE OF THE KFJ5 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
3299, 5opyL, 0.5230, 3.90, 0.112, 212, 107, CRYSTAL STRUCTURE OF ANTI-ALPHAVBETA3 INTEGRIN FAB LM609
3300, 5mu2L, 0.5230, 3.99, 0.138, 218, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3301, 5mu0N, 0.5230, 3.84, 0.120, 215, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3302, 5mu0F, 0.5230, 3.84, 0.120, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3303, 5mcwB, 0.5230, 3.74, 0.038, 199, 106, P53-DNA COMPLEX 4 
3304, 5kzcB, 0.5230, 3.99, 0.080, 214, 113, CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01
3305, 4yqxN, 0.5230, 3.86, 0.099, 121, 111, MOUSE IL-2 BOUND TO JES6-1 SCFV FRAGMENT
3306, 4priD, 0.5230, 3.74, 0.093, 202, 107, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG COMPLEX
3307, 4pj7H, 0.5230, 3.69, 0.093, 238, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
3308, 4pj7F, 0.5230, 3.67, 0.093, 238, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT TRBV6-4 TCR
3309, 4i3rH, 0.5230, 4.01, 0.079, 228, 114, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P3221
3310, 4gayL, 0.5230, 3.98, 0.119, 213, 109, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
3311, 4f2mA, 0.5230, 4.03, 0.096, 214, 114, CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
3312, 4bh7B, 0.5230, 3.96, 0.088, 218, 113, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE PPYPAWHAPGNI
3313, 3us0C, 0.5230, 3.78, 0.065, 196, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3314, 3sjvJ, 0.5230, 3.75, 0.093, 240, 108, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
3315, 3opzI, 0.5230, 3.89, 0.081, 220, 111, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
3316, 3mxvH, 0.5230, 3.81, 0.090, 220, 111, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
3317, 3juyB, 0.5230, 3.83, 0.064, 240, 110, CRYSTAL STRUCTURE OF A 3B3 VARIANT A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY
3318, 3gbnH, 0.5230, 3.92, 0.080, 160, 113, CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH THE 1918 H1N1 INFLUENZA VIRUS HEMAGGLUTININ
3319, 3cmoY, 0.5230, 4.00, 0.080, 222, 113, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3320, 2z4qA, 0.5230, 3.98, 0.147, 219, 109, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
3321, 2o5yL, 0.5230, 3.98, 0.138, 218, 109, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
3322, 2iomA, 0.5230, 3.72, 0.019, 187, 106, MOUSE P53 CORE DOMAIN SOAKED WITH 2-PROPANOL
3323, 2fjfE, 0.5230, 3.82, 0.112, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3324, 2ddqH, 0.5230, 4.05, 0.106, 211, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT
3325, 2bnrE, 0.5230, 3.73, 0.083, 241, 108, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
3326, 1ztxH, 0.5230, 3.94, 0.088, 219, 113, WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
3327, 1uywM, 0.5230, 3.86, 0.080, 218, 112, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3328, 1uwgL, 0.5230, 3.84, 0.121, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
3329, 1mimH, 0.5230, 3.76, 0.091, 215, 110, IGG FAB FRAGMENT (CD25-BINDING)
3330, 1gpoM, 0.5230, 3.85, 0.120, 218, 108, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
3331, 1g6rB, 0.5230, 3.80, 0.102, 237, 108, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
3332, 1ct8D, 0.5230, 3.94, 0.097, 220, 113, CATALYTIC ANTIBODY 7C8 COMPLEX
3333, 1ct8A, 0.5230, 3.85, 0.112, 214, 107, CATALYTIC ANTIBODY 7C8 COMPLEX
3334, 6qnoH, 0.5229, 3.88, 0.098, 221, 112, RHODOPSIN-GI PROTEIN COMPLEX 
3335, 6mnnA, 0.5229, 3.79, 0.119, 196, 109, 6236 TCR BOUND TO I-AB PADI4 
3336, 6m87J, 0.5229, 3.88, 0.080, 215, 112, FAB 10A6 IN COMPLEX WITH MPTS 
3337, 6bjzH, 0.5229, 3.99, 0.080, 225, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY CONTAINING THE FLUORESCENT NON-CANONICAL AMINO ACID L-(7- HYDROXYCOUMARIN-4-YL)ETHYLGLYCINE AT PH 5.5 
3338, 6a0xE, 0.5229, 3.89, 0.080, 223, 112, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3339, 5y9kH, 0.5229, 4.00, 0.063, 216, 111, STRUCTURE OF THE BELIMUMAB FAB FRAGMENT
3340, 5x2nL, 0.5229, 3.96, 0.119, 216, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
3341, 5wlgE, 0.5229, 3.83, 0.083, 243, 108, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
3342, 5njdO, 0.5229, 3.67, 0.094, 213, 106, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
3343, 5mu0P, 0.5229, 3.85, 0.120, 216, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3344, 5mp1H, 0.5229, 3.78, 0.081, 215, 111, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3345, 5mcwA, 0.5229, 3.74, 0.038, 199, 106, P53-DNA COMPLEX 4 
3346, 5mcuB, 0.5229, 3.71, 0.038, 195, 106, P53-DNA COMPLEX 2 
3347, 5mcuA, 0.5229, 3.71, 0.038, 195, 106, P53-DNA COMPLEX 2 
3348, 5i1dL, 0.5229, 3.95, 0.111, 220, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
3349, 5e6iG, 0.5229, 3.64, 0.132, 201, 106, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
3350, 5bo1L, 0.5229, 3.83, 0.112, 214, 107, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
3351, 4xmpH, 0.5229, 3.92, 0.097, 231, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08 IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
3352, 4rbpM, 0.5229, 3.87, 0.089, 224, 112, CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE
3353, 4r7dH, 0.5229, 3.87, 0.093, 212, 107, FAB HU 15C1
3354, 4pjxH, 0.5229, 3.69, 0.093, 241, 107, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT C-A11 TCR
3355, 4m1dH, 0.5229, 3.91, 0.106, 231, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
3356, 4kuzH, 0.5229, 3.93, 0.088, 220, 113, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
3357, 4j8rD, 0.5229, 3.94, 0.106, 220, 113, STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT
3358, 3us2H, 0.5229, 3.58, 0.067, 182, 105, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
3359, 3u79B, 0.5229, 3.71, 0.105, 111, 105, AL-103 Y32F Y96F
3360, 3tpuH, 0.5229, 3.75, 0.083, 240, 108, 42F3 P5E8/H2-LD COMPLEX
3361, 3sknD, 0.5229, 3.77, 0.110, 241, 109, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3362, 3qynB, 0.5229, 3.77, 0.065, 193, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3363, 3qi9C, 0.5229, 3.76, 0.156, 196, 109, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-PHOSPHOTIDYLINOSITOL WITH MOUSE VALPHA14-VBETA6 2A3-D NKT TCR
3364, 3ikcB, 0.5229, 3.92, 0.080, 221, 113, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3365, 3cvhQ, 0.5229, 3.91, 0.080, 210, 113, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
3366, 2p52A, 0.5229, 3.77, 0.019, 196, 106, MOUSE P53 DNA-BINDING DOMAIN IN ZINC-FREE OXIDIZED STATE
3367, 7pcyA, 0.5228, 2.38, 0.169, 98, 89, THE CRYSTAL STRUCTURE OF PLASTOCYANIN FROM A GREEN ALGA ENTEROMORPHA PROLIFERA
3368, 6ev2E, 0.5228, 3.95, 0.088, 214, 113, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
3369, 6ehgC, 0.5228, 3.89, 0.099, 124, 111, COMPLEMENT COMPONENT C3B IN COMPLEX WITH A NANOBODY
3370, 6a0xG, 0.5228, 3.89, 0.080, 223, 112, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
3371, 5xbmE, 0.5228, 3.94, 0.088, 221, 113, STRUCTURE OF SCARB2-JL2 COMPLEX 
3372, 5t0yH, 0.5228, 3.92, 0.080, 217, 113, 2A10 ANTIBODY FAB FRAGMENT
3373, 5mv3D, 0.5228, 3.84, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3374, 5mp3H, 0.5228, 3.87, 0.089, 219, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
3375, 5m02G, 0.5228, 3.68, 0.111, 187, 108, CRYSTAL STRUCTURE OF MURINE P14 TCR / H-2DB WITH PF MODIFIED GP33 PEPTIDE FROM LCMV
3376, 5dqdL, 0.5228, 3.87, 0.130, 217, 108, STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3377, 4xzuB, 0.5228, 3.82, 0.123, 213, 106, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
3378, 4nj9H, 0.5228, 3.91, 0.071, 217, 112, CRYSTAL STRUCTURE OF FAB 8B10 IN COMPLEX WITH MPTS
3379, 4ma3L, 0.5228, 3.82, 0.103, 218, 107, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
3380, 4jlrL, 0.5228, 3.81, 0.113, 210, 106, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3381, 4i2xD, 0.5228, 3.98, 0.106, 219, 113, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3382, 4i2xA, 0.5228, 3.85, 0.150, 214, 107, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3383, 3us2J, 0.5228, 3.58, 0.067, 182, 105, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
3384, 3us2B, 0.5228, 3.58, 0.067, 182, 105, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
3385, 3s96A, 0.5228, 3.93, 0.097, 218, 113, CRYSTAL STRUCTURE OF 3B5H10
3386, 3hr5Q, 0.5228, 3.84, 0.120, 219, 108, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3387, 3eyvA, 0.5228, 3.87, 0.139, 219, 108, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
3388, 3dmmD, 0.5228, 4.00, 0.080, 123, 113, CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX
3389, 2r51A, 0.5228, 3.68, 0.049, 283, 103, CRYSTAL STRUCTURE OF MOUSE VPS26B
3390, 2g60L, 0.5228, 4.00, 0.147, 213, 109, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
3391, 2eytB, 0.5228, 3.71, 0.084, 243, 107, A STRUCTURAL BASIS FOR SELECTION AND CROSS-SPECIES REACTIVITY OF THE SEMI-INVARIANT NKT CELL RECEPTOR IN CD1D/GLYCOLIPID RECOGNITION
3392, 2a6kH, 0.5228, 3.97, 0.071, 216, 113, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
3393, 1qbmH, 0.5228, 4.08, 0.088, 219, 114, FAB E8B ANTIBODY X-RAY STRUCTURE AT 2.37 ANGSTROMS RESOLUTION
3394, 1p2cA, 0.5228, 3.85, 0.121, 212, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
3395, 1op5M, 0.5228, 3.89, 0.098, 225, 112, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN9GLCNAC2
3396, 6azlB, 0.5227, 3.83, 0.081, 220, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3397, 5xzcE, 0.5227, 3.74, 0.038, 232, 106, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3398, 5xzcC, 0.5227, 3.74, 0.038, 232, 106, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3399, 5wlgJ, 0.5227, 3.76, 0.083, 241, 108, CRYSTAL STRUCTURE OF H-2DB WITH THE GAP501 PEPTIDE (SQL)
3400, 5w1vS, 0.5227, 3.61, 0.152, 201, 105, STRUCTURE OF THE HLA-E-VMAPRTLIL/GF4 TCR COMPLEX
3401, 5w08K, 0.5227, 4.01, 0.070, 235, 114, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
3402, 5mu0L, 0.5227, 3.85, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3403, 5lgyA, 0.5227, 3.74, 0.038, 196, 106, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
3404, 5jhlL, 0.5227, 3.89, 0.121, 211, 107, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
3405, 5i1aA, 0.5227, 3.86, 0.084, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
3406, 5ezjB, 0.5227, 3.85, 0.121, 213, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM
3407, 5cgyH, 0.5227, 3.94, 0.080, 222, 113, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
3408, 5cbaA, 0.5227, 3.83, 0.063, 127, 111, 3B4 IN COMPLEX WITH CXCL13 - 3B4-CXCL13
3409, 4ygaH, 0.5227, 3.79, 0.083, 123, 108, CDPK1 FROM TOXOPLASMA GONDII BOUND TO INHIBITORY VHH-1B7
3410, 4ygaF, 0.5227, 3.82, 0.093, 123, 108, CDPK1 FROM TOXOPLASMA GONDII BOUND TO INHIBITORY VHH-1B7
3411, 4x7tL, 0.5227, 3.82, 0.111, 218, 108, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
3412, 4pjgH, 0.5227, 3.74, 0.083, 240, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
3413, 4p2cJ, 0.5227, 3.81, 0.073, 127, 109, COMPLEX OF SHIGA TOXIN 2E WITH A NEUTRALIZING SINGLE-DOMAIN ANTIBODY
3414, 4nrxB, 0.5227, 3.83, 0.121, 207, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3415, 4nhuD, 0.5227, 3.79, 0.093, 238, 108, THE M33 TCR P3M33L/H-2 LD COMPLEX
3416, 4mxwV, 0.5227, 3.83, 0.121, 211, 107, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
3417, 4lsvH, 0.5227, 4.03, 0.070, 221, 114, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 CLADE C C1086 GP120
3418, 4lssH, 0.5227, 4.01, 0.070, 224, 114, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE A STRAIN KER_2018_11 GP120
3419, 4c2iH, 0.5227, 3.98, 0.088, 228, 113, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH FAB FRAGMENTS OF HUMAN ANTIBODY 1F4
3420, 3vw3H, 0.5227, 4.04, 0.105, 216, 114, ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT
3421, 3us2D, 0.5227, 3.58, 0.067, 182, 105, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 19 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING TWO HALF SITES WITH A SINGLE BASE PAIR OVERLAP
3422, 3ujiH, 0.5227, 4.08, 0.071, 218, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE
3423, 3ldbB, 0.5227, 3.82, 0.120, 217, 108, STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.
3424, 3ld8B, 0.5227, 3.96, 0.165, 217, 109, STRUCTURE OF JMJD6 AND FAB FRAGMENTS
3425, 3kmdC, 0.5227, 3.74, 0.038, 200, 106, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
3426, 3hi6Y, 0.5227, 3.83, 0.093, 209, 107, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
3427, 2xqyK, 0.5227, 3.99, 0.119, 218, 109, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3428, 2i9lF, 0.5227, 3.96, 0.106, 219, 113, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3429, 2i9lB, 0.5227, 3.96, 0.106, 219, 113, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3430, 2fd6H, 0.5227, 3.96, 0.097, 212, 113, STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
3431, 1xiwD, 0.5227, 3.82, 0.072, 122, 111, CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT
3432, 1sy6H, 0.5227, 4.04, 0.088, 219, 114, CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
3433, 1nc4D, 0.5227, 3.85, 0.071, 215, 112, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
3434, 1mh5H, 0.5227, 3.80, 0.108, 190, 111, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
3435, 1cl7H, 0.5227, 4.05, 0.070, 135, 114, ANTI HIV1 PROTEASE FAB
3436, 6marM, 0.5226, 3.80, 0.090, 135, 111, HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151 
3437, 6h3hC, 0.5226, 3.90, 0.080, 214, 113, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
3438, 6eyoI, 0.5226, 3.84, 0.088, 208, 113, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
3439, 6bitI, 0.5226, 3.84, 0.072, 213, 111, SIRPALPHA ANTIBODY COMPLEX
3440, 5tlkB, 0.5226, 3.92, 0.107, 212, 112, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
3441, 5t0yA, 0.5226, 4.01, 0.079, 217, 114, 2A10 ANTIBODY FAB FRAGMENT
3442, 5mu0D, 0.5226, 3.84, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3443, 5f88D, 0.5226, 3.81, 0.081, 214, 111, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
3444, 5eziL, 0.5226, 3.82, 0.112, 214, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM
3445, 5c0nD, 0.5226, 3.89, 0.093, 216, 107, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
3446, 5aumH, 0.5226, 4.06, 0.071, 208, 113, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
3447, 5aumA, 0.5226, 4.07, 0.079, 209, 114, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
3448, 4ubdD, 0.5226, 4.00, 0.083, 213, 108, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
3449, 4r7nT, 0.5226, 3.86, 0.093, 211, 107, FAB C2E3
3450, 4pjdH, 0.5226, 3.69, 0.093, 239, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-C10 TCR
3451, 4p5tA, 0.5226, 3.70, 0.102, 197, 108, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
3452, 4onhB, 0.5226, 3.76, 0.083, 233, 109, CRYSTAL STRUCTURE OF DN6 TCR
3453, 4nylD, 0.5226, 3.87, 0.103, 211, 107, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3454, 4eupH, 0.5226, 3.70, 0.103, 241, 107, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
3455, 4dn3L, 0.5226, 3.92, 0.093, 214, 108, CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
3456, 3us1D, 0.5226, 3.58, 0.067, 182, 105, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR RESPONSE ELEMENT CONTAINING A TWO BASE PAIR GC SPACER BETWEEN HALF SITES
3457, 3ulvE, 0.5226, 3.84, 0.121, 215, 107, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
3458, 3sjvO, 0.5226, 3.80, 0.092, 241, 109, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
3459, 3mmeC, 0.5226, 4.03, 0.079, 222, 114, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
3460, 3fkuZ, 0.5226, 3.83, 0.072, 236, 111, CRYSTAL STRUCTURE OF INFLUENZA HEMAGGLUTININ (H5) IN COMPLEX WITH A BROADLY NEUTRALIZING ANTIBODY F10
3461, 2zclH, 0.5226, 3.99, 0.080, 230, 113, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
3462, 2xraL, 0.5226, 3.79, 0.103, 215, 107, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
3463, 2q8bL, 0.5226, 3.86, 0.121, 213, 107, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3464, 2pcpA, 0.5226, 4.00, 0.138, 216, 109, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3465, 2oslB, 0.5226, 3.79, 0.123, 213, 106, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
3466, 2oqjE, 0.5226, 3.97, 0.088, 224, 113, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
3467, 2jccF, 0.5226, 3.85, 0.092, 237, 109, AH3 RECOGNITION OF MUTANT HLA-A2 W167A
3468, 2ioiA, 0.5226, 3.74, 0.019, 187, 106, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DOMAIN AT 1.55 A
3469, 2i9lH, 0.5226, 3.96, 0.106, 219, 113, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3470, 2i9lD, 0.5226, 3.96, 0.106, 219, 113, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3471, 2i60R, 0.5226, 4.03, 0.079, 222, 114, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3472, 2fjfC, 0.5226, 3.83, 0.112, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3473, 2axjA, 0.5226, 3.64, 0.084, 242, 107, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
3474, 2ataA, 0.5226, 3.72, 0.038, 197, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
3475, 1yylR, 0.5226, 4.03, 0.088, 229, 114, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3476, 1ynkH, 0.5226, 4.05, 0.079, 219, 114, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
3477, 1nccH, 0.5226, 3.94, 0.062, 221, 113, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
3478, 1mj8H, 0.5226, 3.94, 0.116, 216, 112, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
3479, 1igfL, 0.5226, 4.02, 0.128, 219, 109, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
3480, 1f5wA, 0.5226, 3.98, 0.089, 124, 112, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
3481, 1e6oH, 0.5226, 3.96, 0.088, 219, 113, CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24
3482, 1bj1L, 0.5226, 3.84, 0.103, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3483, 6i8sF, 0.5225, 3.78, 0.072, 214, 111, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
3484, 6ev1E, 0.5225, 3.89, 0.080, 211, 112, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
3485, 6ev1A, 0.5225, 3.96, 0.088, 211, 113, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
3486, 5usiH, 0.5225, 4.01, 0.070, 212, 114, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
3487, 5sx4I, 0.5225, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
3488, 5mx3L, 0.5225, 3.94, 0.157, 218, 108, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3489, 5mv3G, 0.5225, 3.85, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3490, 5mp3A, 0.5225, 3.88, 0.089, 219, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
3491, 5k59F, 0.5225, 3.83, 0.103, 212, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
3492, 5ivxE, 0.5225, 3.74, 0.101, 194, 109, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
3493, 5gjtL, 0.5225, 3.84, 0.093, 211, 107, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/WASHINGTON/05/2011 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
3494, 5g4mA, 0.5225, 3.72, 0.028, 195, 106, CRYSTAL STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH A MONOFLUORINATED DERIVATIVE OF THE SMALL MOLECULE STABILIZER PHIKAN083
3495, 5fb8A, 0.5225, 3.88, 0.111, 218, 108, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
3496, 5bo1M, 0.5225, 3.80, 0.112, 214, 107, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
3497, 5aumB, 0.5225, 3.98, 0.128, 216, 109, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
3498, 4yhiL, 0.5225, 4.00, 0.138, 219, 109, REVERSAL AGENT FOR DABIGATRAN
3499, 4ubdX, 0.5225, 4.00, 0.083, 213, 108, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
3500, 4qthA, 0.5225, 4.04, 0.096, 215, 114, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
3501, 4prhD, 0.5225, 3.78, 0.093, 202, 107, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:08-HPVG-D5 COMPLEX
3502, 4pljD, 0.5225, 3.84, 0.099, 216, 111, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3503, 4pjgF, 0.5225, 3.73, 0.083, 241, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-F3-C1 TCR
3504, 4ms8D, 0.5225, 3.70, 0.084, 239, 107, 42F3 TCR PCPB9/H-2LD COMPLEX
3505, 4m6oL, 0.5225, 3.85, 0.103, 214, 107, CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
3506, 4khxH, 0.5225, 3.79, 0.073, 208, 110, CRYSTAL STRUCTURE OF GP41 HELIX COMPLEXED WITH ANTIBODY 8062
3507, 4hk3J, 0.5225, 3.93, 0.071, 218, 113, I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE
3508, 4hk0C, 0.5225, 4.03, 0.070, 222, 114, UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
3509, 3us0B, 0.5225, 3.77, 0.065, 193, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3510, 3revB, 0.5225, 3.75, 0.093, 240, 108, CRYSTAL STRUCTURE OF HUMAN ALLOREACTIVE TCR NB20
3511, 3mbeG, 0.5225, 3.61, 0.142, 192, 106, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
3512, 3mbeC, 0.5225, 3.61, 0.142, 192, 106, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
3513, 3l1oH, 0.5225, 4.00, 0.088, 224, 113, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
3514, 3ixyI, 0.5225, 4.13, 0.070, 221, 115, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
3515, 3ixxI, 0.5225, 4.10, 0.070, 221, 115, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
3516, 3iu4L, 0.5225, 3.85, 0.121, 213, 107, ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
3517, 3eoaL, 0.5225, 3.84, 0.103, 214, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
3518, 2fjhL, 0.5225, 3.83, 0.093, 214, 107, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3519, 2fjfW, 0.5225, 3.83, 0.112, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3520, 2f19H, 0.5225, 3.94, 0.071, 221, 113, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
3521, 2bnqE, 0.5225, 3.74, 0.083, 241, 108, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
3522, 1kemH, 0.5225, 3.99, 0.079, 218, 114, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT
3523, 1kelH, 0.5225, 3.96, 0.097, 218, 113, CATALYTIC ANTIBODY 28B4 FAB FRAGMENT COMPLEXED WITH HAPTEN (1-[N-4 -NITROBENZYL-N-4 -CARBOXYBUTYLAMINO] METHYLPHOSPHONIC ACID)
3524, 1f11C, 0.5225, 3.85, 0.120, 216, 108, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
3525, 1cz8X, 0.5225, 3.83, 0.103, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
3526, 1b4jH, 0.5225, 3.98, 0.088, 219, 113, COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
3527, 6ggeA, 0.5224, 3.72, 0.028, 197, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9327 
3528, 6csfL, 0.5224, 3.85, 0.150, 213, 107, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH D-ALANINE BOUND 
3529, 5xzcB, 0.5224, 3.74, 0.038, 232, 106, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3530, 5x2nK, 0.5224, 3.87, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
3531, 5vr9L, 0.5224, 3.81, 0.094, 212, 106, CH1/CKAPPA FAB BASED ON MATUZUMAB
3532, 5otjH, 0.5224, 3.92, 0.088, 222, 113, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
3533, 5itfB, 0.5224, 3.83, 0.081, 217, 111, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
3534, 5e6iH, 0.5224, 3.71, 0.083, 239, 108, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
3535, 5dmiL, 0.5224, 3.85, 0.103, 213, 107, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB
3536, 5cmaA, 0.5224, 3.86, 0.093, 213, 107, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
3537, 5cckH, 0.5224, 3.98, 0.105, 224, 114, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC315 FAB
3538, 4plkJ, 0.5224, 3.85, 0.108, 216, 111, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3539, 4pjfH, 0.5224, 3.75, 0.083, 240, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR
3540, 4pjfF, 0.5224, 3.74, 0.083, 240, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-C10 TCR
3541, 4ojfL, 0.5224, 3.87, 0.120, 219, 108, HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8
3542, 4mzrC, 0.5224, 3.73, 0.057, 234, 106, CRYSTAL STRUCTURE OF A POLYPEPTIDE P53 MUTANT BOUND TO DNA
3543, 4irzH, 0.5224, 3.91, 0.080, 217, 113, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
3544, 4hxbH, 0.5224, 3.87, 0.089, 212, 112, CRYSTAL STRUCTURE OF 6B9 FAB
3545, 4dn4H, 0.5224, 3.80, 0.072, 214, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A
3546, 4am0B, 0.5224, 3.89, 0.121, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3547, 4ag4H, 0.5224, 3.97, 0.124, 209, 113, CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
3548, 3tpuB, 0.5224, 3.76, 0.083, 240, 108, 42F3 P5E8/H2-LD COMPLEX
3549, 3l7fL, 0.5224, 3.89, 0.103, 213, 107, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
3550, 3l7eL, 0.5224, 3.83, 0.093, 213, 107, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
3551, 3kmdB, 0.5224, 3.74, 0.038, 200, 106, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
3552, 3j30H, 0.5224, 3.96, 0.106, 217, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3553, 3j30F, 0.5224, 3.96, 0.106, 217, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3554, 3j30D, 0.5224, 3.96, 0.106, 217, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3555, 3j30B, 0.5224, 3.96, 0.106, 217, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
3556, 3j2xH, 0.5224, 3.96, 0.106, 217, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
3557, 3j2xF, 0.5224, 3.96, 0.106, 217, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
3558, 3j2xD, 0.5224, 3.96, 0.106, 217, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
3559, 3j2xB, 0.5224, 3.96, 0.106, 217, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
3560, 3eyvL, 0.5224, 3.85, 0.130, 216, 108, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
3561, 2uylA, 0.5224, 3.99, 0.147, 218, 109, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3562, 2j5lB, 0.5224, 3.88, 0.113, 212, 106, STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
3563, 2i5yH, 0.5224, 4.04, 0.079, 224, 114, CRYSTAL STRUCTURE OF CD4M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3564, 2atpB, 0.5224, 3.85, 0.092, 115, 109, CRYSTAL STRUCTURE OF A CD8AB HETERODIMER
3565, 2ahiA, 0.5224, 3.74, 0.038, 198, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
3566, 1uwgX, 0.5224, 3.85, 0.131, 213, 107, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
3567, 1uj3B, 0.5224, 3.99, 0.062, 217, 113, CRYSTAL STRUCTURE OF A HUMANIZED FAB FRAGMENT OF ANTI- TISSUE-FACTOR ANTIBODY IN COMPLEX WITH TISSUE FACTOR
3568, 1pskH, 0.5224, 3.93, 0.088, 198, 113, THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE
3569, 1jptL, 0.5224, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF FAB D3H44
3570, 6mefL, 0.5223, 3.87, 0.093, 212, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3571, 6igoC, 0.5223, 4.03, 0.106, 122, 113, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
3572, 6fj5A, 0.5223, 3.74, 0.038, 199, 106, P53-DNA COMPLEX 5 
3573, 6b9jH, 0.5223, 4.02, 0.079, 212, 114, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
3574, 6azkD, 0.5223, 3.81, 0.081, 220, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
3575, 5vzxL, 0.5223, 3.87, 0.130, 218, 108, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3576, 5sx4L, 0.5223, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
3577, 5mvjA, 0.5223, 3.87, 0.089, 218, 112, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3578, 5mu2H, 0.5223, 3.99, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3579, 5mu2F, 0.5223, 3.99, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3580, 5i1eL, 0.5223, 3.84, 0.103, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39
3581, 5ggqL, 0.5223, 3.84, 0.084, 211, 107, CRYSTAL STRUCTURE OF NIVOLUMAB FAB FRAGMENT
3582, 5c0nL, 0.5223, 3.90, 0.093, 216, 107, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
3583, 5az2H, 0.5223, 3.78, 0.081, 220, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN
3584, 4uinH, 0.5223, 4.05, 0.105, 221, 114, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3 WITH QUININE
3585, 4p46A, 0.5223, 3.64, 0.121, 199, 107, J809.B5 Y31A TCR BOUND TO IAB3K
3586, 4oz4L, 0.5223, 3.94, 0.157, 218, 108, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3587, 4nrxH, 0.5223, 3.96, 0.080, 231, 113, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3588, 4kroC, 0.5223, 3.83, 0.093, 211, 107, NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
3589, 3iu3A, 0.5223, 3.77, 0.100, 215, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
3590, 3gbmH, 0.5223, 3.93, 0.080, 214, 113, CRYSTAL STRUCTURE OF FAB CR6261 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ.
3591, 3ardC, 0.5223, 3.67, 0.157, 202, 108, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-3 DEOXY-ALPHA- GALACTOSYLCERAMIDE
3592, 2x0uA, 0.5223, 3.72, 0.028, 195, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO A 2- AMINO SUBSTITUTED BENZOTHIAZOLE SCAFFOLD
3593, 1za6G, 0.5223, 3.96, 0.111, 220, 108, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3594, 1xcqA, 0.5223, 3.81, 0.111, 220, 108, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3595, 1uwgH, 0.5223, 3.77, 0.073, 208, 110, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
3596, 1tpxB, 0.5223, 3.99, 0.088, 212, 113, OVINE RECOMBINANT PRP(114-234) ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
3597, 1lmkC, 0.5223, 3.79, 0.072, 238, 111, THE STRUCTURE OF A BIVALENT DIABODY
3598, 1fptH, 0.5223, 3.91, 0.088, 220, 113, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
3599, 1egjH, 0.5223, 3.95, 0.080, 220, 113, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
3600, 1cz8L, 0.5223, 3.82, 0.103, 213, 107, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
3601, 1a6tD, 0.5223, 3.99, 0.097, 217, 113, FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
3602, 6jbtH, 0.5222, 3.81, 0.063, 217, 111, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
3603, 6iuvC, 0.5222, 3.73, 0.063, 224, 111, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
3604, 6hkgB, 0.5222, 3.83, 0.093, 214, 107, STRUCTURE OF FISW84 FAB FRAGMENT 
3605, 6fg2I, 0.5222, 3.89, 0.071, 218, 112, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3606, 6fg2H, 0.5222, 3.90, 0.071, 212, 112, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3607, 5vigB, 0.5222, 3.84, 0.103, 212, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
3608, 5mu2P, 0.5222, 4.00, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3609, 5hpmD, 0.5222, 3.81, 0.081, 214, 111, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
3610, 5g4nA, 0.5222, 3.72, 0.028, 196, 106, CRYSTAL STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH A DIFLUORINATED DERIVATIVE OF THE SMALL MOLECULE STABILIZER PHIKAN083
3611, 5eocM, 0.5222, 3.93, 0.112, 215, 107, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
3612, 4yhmL, 0.5222, 4.00, 0.138, 219, 109, REVERSAL AGENT FOR DABIGATRAN
3613, 4ubdH, 0.5222, 3.99, 0.083, 213, 108, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
3614, 4plkL, 0.5222, 3.71, 0.104, 208, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3615, 4nrxL, 0.5222, 3.85, 0.121, 213, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3616, 4mziA, 0.5222, 3.75, 0.057, 193, 106, CRYSTAL STRUCTURE OF A HUMAN MUTANT P53
3617, 4kxzL, 0.5222, 4.01, 0.083, 213, 108, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3618, 4g6kL, 0.5222, 3.87, 0.093, 212, 107, CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE
3619, 3wkmL, 0.5222, 3.90, 0.120, 215, 108, THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
3620, 3vxuJ, 0.5222, 3.76, 0.083, 241, 109, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
3621, 3vxuE, 0.5222, 3.76, 0.083, 241, 109, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE
3622, 3tt1M, 0.5222, 3.84, 0.120, 215, 108, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3623, 3opzH, 0.5222, 3.93, 0.071, 220, 112, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
3624, 3mv8D, 0.5222, 3.70, 0.075, 200, 106, CRYSTAL STRUCTURE OF THE TK3-GLN55HIS TCR IN COMPLEX WITH HLA- B*3501/HPVG
3625, 3ijyB, 0.5222, 3.94, 0.071, 221, 113, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3626, 3hnsH, 0.5222, 3.88, 0.080, 220, 112, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
3627, 3f8uB, 0.5222, 4.45, 0.078, 361, 116, TAPASIN/ERP57 HETERODIMER
3628, 2xqyL, 0.5222, 4.00, 0.119, 218, 109, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3629, 2vxqL, 0.5222, 3.80, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
3630, 2uylM, 0.5222, 4.00, 0.147, 216, 109, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3631, 2j21A, 0.5222, 3.73, 0.028, 188, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R282W
3632, 1zlvH, 0.5222, 3.97, 0.097, 213, 113, FAB 2G12 + MAN7
3633, 1uywN, 0.5222, 3.87, 0.121, 211, 107, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3634, 1nc2D, 0.5222, 3.87, 0.071, 215, 112, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH Y- DOTA
3635, 1n64L, 0.5222, 3.83, 0.111, 220, 108, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
3636, 1kzyB, 0.5222, 3.75, 0.038, 195, 106, CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53
3637, 1f3dK, 0.5222, 4.03, 0.088, 215, 113, CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.
3638, 1f11A, 0.5222, 3.85, 0.120, 216, 108, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
3639, 6ol5A, 0.5221, 3.77, 0.081, 209, 111, STRUCTURE OF IGLB12 FAB IN COMPLEX WITH ANTI-IDIOTYPE IB3 FAB 
3640, 6ggfA, 0.5221, 3.72, 0.028, 196, 106, STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL- MOLECULE STABILIZER PK9328 
3641, 6ev1G, 0.5221, 3.96, 0.088, 211, 113, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
3642, 6azlD, 0.5221, 3.82, 0.081, 215, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3643, 6aynB, 0.5221, 3.83, 0.081, 220, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
3644, 5y9cH, 0.5221, 4.08, 0.079, 210, 114, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
3645, 5w1wD, 0.5221, 3.69, 0.142, 201, 106, STRUCTURE OF THE HLA-E-VMAPRTLVL/GF4 TCR COMPLEX
3646, 5mv3V, 0.5221, 3.88, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3647, 5mp5H, 0.5221, 3.88, 0.098, 218, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3648, 5mp5C, 0.5221, 3.88, 0.089, 219, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3649, 5mhsG, 0.5221, 3.97, 0.101, 205, 109, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
3650, 5kzpE, 0.5221, 3.96, 0.088, 226, 113, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
3651, 5kvlL, 0.5221, 3.84, 0.112, 214, 107, HUMANIZED 10G4 ANTI-LEUKOTRIENE C4 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LEUKOTRIENE C4
3652, 5kmvL, 0.5221, 3.87, 0.130, 218, 108, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3653, 5k9kL, 0.5221, 3.98, 0.093, 215, 108, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
3654, 5i30H, 0.5221, 3.79, 0.072, 212, 111, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
3655, 5i1dA, 0.5221, 3.82, 0.111, 218, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
3656, 5ezlL, 0.5221, 3.84, 0.112, 213, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
3657, 5b3jF, 0.5221, 3.85, 0.103, 211, 107, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
3658, 4z7wF, 0.5221, 3.71, 0.093, 241, 108, T316 COMPLEX
3659, 4ygaD, 0.5221, 3.81, 0.092, 123, 109, CDPK1 FROM TOXOPLASMA GONDII BOUND TO INHIBITORY VHH-1B7
3660, 4ubdT, 0.5221, 4.00, 0.083, 213, 108, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
3661, 4ubdP, 0.5221, 3.99, 0.083, 213, 108, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
3662, 4otxL, 0.5221, 3.94, 0.120, 211, 108, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
3663, 4oluH, 0.5221, 3.95, 0.080, 228, 113, CRYSTAL STRUCTURE OF ANTIBODY VRC07 IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
3664, 4k7pL, 0.5221, 3.89, 0.131, 214, 107, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
3665, 4jlrB, 0.5221, 3.81, 0.113, 210, 106, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3666, 3tt1L, 0.5221, 3.84, 0.120, 215, 108, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3667, 3tpuN, 0.5221, 3.77, 0.083, 240, 108, 42F3 P5E8/H2-LD COMPLEX
3668, 3sknH, 0.5221, 3.78, 0.110, 241, 109, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3669, 2iamD, 0.5221, 3.83, 0.073, 239, 109, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
3670, 1zlsH, 0.5221, 3.99, 0.088, 213, 113, FAB 2G12 + MAN4
3671, 1tqbB, 0.5221, 3.99, 0.088, 212, 113, OVINE RECOMBINANT PRP(114-234) VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
3672, 1svzB, 0.5221, 3.93, 0.062, 232, 112, CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-2 PROTEASE
3673, 1rhhC, 0.5221, 3.85, 0.102, 215, 108, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
3674, 1qseE, 0.5221, 3.69, 0.075, 243, 107, STRUCTURE OF HUMAN A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE V7R
3675, 1q9wA, 0.5221, 3.81, 0.157, 219, 108, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
3676, 1ejoL, 0.5221, 3.99, 0.110, 216, 109, FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
3677, 6m87H, 0.5220, 3.90, 0.080, 215, 112, FAB 10A6 IN COMPLEX WITH MPTS 
3678, 6ffjG, 0.5220, 3.78, 0.063, 226, 111, ANTI-TUMOR ANTIBODY 14F7-DERIVED SINGLE CHAIN FRAGMENT VARIABLE (SCFV) 
3679, 6cseL, 0.5220, 3.85, 0.150, 213, 107, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH L-ALANINE BOUND 
3680, 6bitJ, 0.5220, 3.88, 0.081, 207, 111, SIRPALPHA ANTIBODY COMPLEX
3681, 5yd5A, 0.5220, 3.89, 0.062, 251, 112, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH EPITOPE PEPTIDE (MUTATION N3A) 
3682, 5tljG, 0.5220, 4.01, 0.093, 215, 108, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
3683, 5mu0H, 0.5220, 3.85, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3684, 5lmjA, 0.5220, 3.80, 0.083, 123, 109, LLAMA NANOBODY PORM_19
3685, 5k59L, 0.5220, 3.83, 0.103, 212, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
3686, 5d2lE, 0.5220, 3.66, 0.111, 187, 108, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
3687, 4yhlH, 0.5220, 3.93, 0.098, 220, 112, REVERSAL AGENT FOR DABIGATRAN
3688, 4pjhH, 0.5220, 3.74, 0.083, 239, 108, STRUCTURE OF HUMAN MR1-AC-6-FP IN COMPLEX WITH HUMAN MAIT B-G8 TCR
3689, 4p9hH, 0.5220, 3.91, 0.062, 215, 113, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV- 1 AND SOLUBLE CD4 D1D2
3690, 4oduB, 0.5220, 3.86, 0.093, 212, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
3691, 4m62H, 0.5220, 3.78, 0.064, 127, 110, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
3692, 4i3sH, 0.5220, 4.03, 0.079, 222, 114, CRYSTAL STRUCTURE OF THE OUTER DOMAIN OF HIV-1 GP120 IN COMPLEX WITH VRC-PG04 SPACE GROUP P21
3693, 4h20H, 0.5220, 4.04, 0.079, 220, 114, CRYSTAL STRUCTURE AND COMPUTATIONAL MODELING OF THE FAB FRAGMENT FROM THE PROTECTIVE ANTI-RICIN MONOCLONAL ANTIBODY RAC18
3694, 4gmsJ, 0.5220, 3.88, 0.071, 211, 112, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
3695, 3vxtD, 0.5220, 3.79, 0.083, 241, 109, T36-5 TCR SPECIFIC FOR HLA-A24-NEF134-10
3696, 3rgvB, 0.5220, 3.76, 0.093, 236, 107, A SINGLE TCR BOUND TO MHCI AND MHC II REVEALS SWITCHABLE TCR CONFORMERS
3697, 3of6A, 0.5220, 4.00, 0.127, 240, 110, HUMAN PRE-T CELL RECEPTOR CRYSTAL STRUCTURE
3698, 3o41B, 0.5220, 3.86, 0.120, 217, 108, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
3699, 3nz8H, 0.5220, 3.97, 0.080, 217, 113, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3700, 3mv7D, 0.5220, 3.69, 0.094, 200, 106, CRYSTAL STRUCTURE OF THE TK3 TCR IN COMPLEX WITH HLA-B*3501/HPVG
3701, 3hntH, 0.5220, 3.90, 0.080, 220, 112, CS-35 FAB COMPLEX WITH A LINEAR TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
3702, 3bt2H, 0.5220, 3.95, 0.097, 212, 113, STRUCTURE OF UROKINASE RECEPTOR UROKINASE AND VITRONECTIN COMPLEX
3703, 2pyeE, 0.5220, 3.84, 0.083, 242, 109, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEALNATIVE DIAGONAL BINDING GEOMETRY TCR CLONE C5C1 COMPLEXED WITH MHC
3704, 2jixA, 0.5220, 3.82, 0.093, 214, 107, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
3705, 2f53E, 0.5220, 3.79, 0.083, 243, 109, DIRECTED EVOLUTION OF HUMAN T-CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT APPARENT CROSS-REACTIVITY
3706, 1zlwM, 0.5220, 3.99, 0.088, 209, 113, FAB 2G12 + MAN8
3707, 1ynlH, 0.5220, 4.07, 0.079, 219, 114, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO- CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
3708, 1xf4H, 0.5220, 3.96, 0.097, 213, 113, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
3709, 1xf3B, 0.5220, 4.02, 0.088, 218, 114, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
3710, 1rziH, 0.5220, 4.03, 0.079, 216, 114, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3711, 1q1jH, 0.5220, 3.93, 0.107, 231, 112, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
3712, 1mj8L, 0.5220, 4.00, 0.093, 214, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
3713, 1g6rD, 0.5220, 3.83, 0.092, 237, 109, A FUNCTIONAL HOT SPOT FOR ANTIGEN RECOGNITION IN A SUPERAGONIST TCR/MHC COMPLEX
3714, 6iekE, 0.5219, 4.04, 0.071, 223, 113, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
3715, 6e0pN, 0.5219, 3.76, 0.109, 229, 110, CRYO-EM STRUCTURE OF THE CENTROMERIC NUCLEOSOME (NATIVE ALPHA SATELLITE DNA) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
3716, 6dc5E, 0.5219, 4.08, 0.079, 221, 114, RSV PREFUSION F IN COMPLEX WITH AM22 FAB 
3717, 6b9jA, 0.5219, 4.02, 0.070, 212, 114, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
3718, 5x2qK, 0.5219, 3.87, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
3719, 5x2pK, 0.5219, 3.87, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
3720, 5x2mK, 0.5219, 3.97, 0.119, 216, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
3721, 5wuxD, 0.5219, 3.83, 0.084, 201, 107, TNFALPHA-CERTOLIZUMAB FAB
3722, 5nb5M, 0.5219, 3.85, 0.130, 218, 108, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
3723, 5iwlB, 0.5219, 3.89, 0.045, 232, 112, CD47-DIABODY COMPLEX
3724, 5fuzL, 0.5219, 3.88, 0.102, 216, 108, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
3725, 5e2tL, 0.5219, 3.96, 0.083, 216, 108, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB
3726, 5b3jL, 0.5219, 3.86, 0.103, 212, 107, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
3727, 4zs6D, 0.5219, 3.85, 0.103, 210, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
3728, 4z7uE, 0.5219, 3.74, 0.119, 198, 109, S13 COMPLEX
3729, 4ywgM, 0.5219, 3.88, 0.093, 215, 107, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
3730, 4ydlH, 0.5219, 4.00, 0.079, 223, 114, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
3731, 4uimE, 0.5219, 4.07, 0.105, 224, 114, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
3732, 4qo1B, 0.5219, 3.77, 0.038, 199, 106, P53 DNA BINDING DOMAIN IN COMPLEX WITH NB139
3733, 4pozC, 0.5219, 3.87, 0.093, 211, 107, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
3734, 4pljH, 0.5219, 3.85, 0.099, 218, 111, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3735, 4nrxE, 0.5219, 3.84, 0.121, 211, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3736, 4nbzB, 0.5219, 3.94, 0.081, 132, 111, CRYSTAL STRUCTURE OF TCDA-A1 BOUND TO A26.8 VHH
3737, 4n0cD, 0.5219, 3.73, 0.083, 239, 108, 42F3 TCR PCPE3/H-2LD COMPLEX
3738, 4mxqD, 0.5219, 3.72, 0.075, 239, 107, 42F3 TCR PCPC5/H-2LD COMPLEX
3739, 4lexL, 0.5219, 3.87, 0.120, 217, 108, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
3740, 4hk0A, 0.5219, 3.97, 0.071, 215, 113, UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
3741, 4gw1B, 0.5219, 3.82, 0.081, 221, 111, CQFD MEDITOPE
3742, 4f24A, 0.5219, 3.92, 0.046, 334, 109, CRYSTAL STRUCTURES REVEAL THE MULTI-LIGAND BINDING MECHANISM OF THE STAPHYLOCOCCUS AUREUS CLFB
3743, 4am0F, 0.5219, 3.89, 0.121, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3744, 3ujtI, 0.5219, 3.95, 0.098, 207, 112, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
3745, 3tpuD, 0.5219, 3.77, 0.083, 240, 108, 42F3 P5E8/H2-LD COMPLEX
3746, 3ixtB, 0.5219, 3.81, 0.104, 210, 106, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
3747, 3gi8L, 0.5219, 3.84, 0.139, 220, 108, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3748, 3cm9O, 0.5219, 3.87, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
3749, 3cm9N, 0.5219, 3.87, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
3750, 2q86B, 0.5219, 3.81, 0.083, 233, 108, STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14
3751, 2o5zL, 0.5219, 3.90, 0.139, 218, 108, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-317-DIONE COMPLEX
3752, 2nr6E, 0.5219, 3.86, 0.140, 211, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
3753, 2iooA, 0.5219, 3.74, 0.019, 187, 106, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DOMAIN
3754, 2axjB, 0.5219, 3.65, 0.084, 242, 107, CRYSTAL STRUCTURES OF T CELL RECEPTOR BETA CHAINS RELATED TO RHEUMATOID ARTHRITIS
3755, 6dl8H, 0.5218, 3.84, 0.072, 216, 111, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB VARIANT CH67:1203D4 CHIMERA 
3756, 6dc8H, 0.5218, 3.92, 0.107, 217, 112, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3757, 6cphE, 0.5218, 3.91, 0.128, 244, 109, CRYSTAL STRUCTURE OF A TCR 
3758, 6cnjG, 0.5218, 4.11, 0.088, 218, 114, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
3759, 6c68B, 0.5218, 3.82, 0.065, 238, 108, MHC-INDEPENDENT T CELL RECEPTOR A11 
3760, 6aynD, 0.5218, 3.82, 0.081, 220, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
3761, 5w08M, 0.5218, 4.01, 0.070, 235, 114, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
3762, 5uz7N, 0.5218, 3.70, 0.083, 128, 109, VOLTA PHASE PLATE CRYO-ELECTRON MICROSCOPY STRUCTURE OF A CALCITONIN RECEPTOR-HETEROTRIMERIC GS PROTEIN COMPLEX
3763, 5tudE, 0.5218, 3.88, 0.104, 211, 106, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
3764, 5szfH, 0.5218, 3.93, 0.080, 217, 113, 2A10 FAB FRAGMENT 2.54 ANGSTOMS
3765, 5o1iA, 0.5218, 3.72, 0.028, 196, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB710 
3766, 5iw1C, 0.5218, 3.75, 0.101, 189, 109, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
3767, 5hysL, 0.5218, 3.95, 0.093, 217, 108, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
3768, 5en2A, 0.5218, 4.04, 0.105, 219, 114, MOLECULAR BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF NEW WORLD HEMORRHAGIC FEVER MAMMARENAVIRUSES
3769, 5drzA, 0.5218, 3.86, 0.102, 218, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
3770, 4yk4B, 0.5218, 3.85, 0.103, 211, 107, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
3771, 4xcyH, 0.5218, 3.89, 0.080, 224, 112, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3772, 4r7nL, 0.5218, 3.87, 0.093, 211, 107, FAB C2E3
3773, 4plkH, 0.5218, 3.86, 0.099, 216, 111, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3774, 4nylL, 0.5218, 3.86, 0.103, 211, 107, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3775, 4nryA, 0.5218, 3.95, 0.080, 218, 113, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
3776, 4l5fH, 0.5218, 3.98, 0.088, 218, 113, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
3777, 4jhaL, 0.5218, 3.83, 0.093, 211, 107, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
3778, 3j93H, 0.5218, 3.94, 0.080, 220, 112, FITTING OF FAB INTO THE CRYOEM DENSITY MAP OF EV71 PROCAPSID IN COMPLEX WITH FAB22A12
3779, 3j3zH, 0.5218, 3.94, 0.080, 220, 112, STRUCTURE OF MA28-7 NEUTRALIZING ANTIBODY FAB FRAGMENT FROM ELECTRON CRYO-MICROSCOPY OF ENTEROVIRUS 71 COMPLEXED WITH A FAB FRAGMENT
3780, 3ixtL, 0.5218, 3.81, 0.104, 211, 106, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
3781, 3gk8H, 0.5218, 3.94, 0.080, 220, 112, X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14 MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS
3782, 3d85A, 0.5218, 3.87, 0.103, 213, 107, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
3783, 3cm9M, 0.5218, 3.87, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
3784, 3cm9L, 0.5218, 3.87, 0.084, 214, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
3785, 2vukA, 0.5218, 3.73, 0.028, 195, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL-MOLECULE DRUG PHIKAN083
3786, 1zlwH, 0.5218, 3.90, 0.089, 224, 112, FAB 2G12 + MAN8
3787, 1yylH, 0.5218, 3.91, 0.071, 229, 112, CRYSTAL STRUCTURE OF CD4M33 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
3788, 1xf2B, 0.5218, 3.97, 0.097, 213, 113, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
3789, 1qnzH, 0.5218, 3.96, 0.098, 119, 112, NMR STRUCTURE OF THE 0.5B ANTI-HIV ANTIBODY COMPLEX WITH THE GP120 V3 PEPTIDE
3790, 1mh5A, 0.5218, 3.99, 0.093, 197, 108, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
3791, 1iqwL, 0.5218, 4.00, 0.128, 215, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
3792, 1fl5L, 0.5218, 3.92, 0.139, 217, 108, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
3793, 1faiH, 0.5218, 3.93, 0.080, 221, 113, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
3794, 1f3dH, 0.5218, 4.00, 0.088, 217, 113, CATALYTIC ANTIBODY 4B2 IN COMPLEX WITH ITS AMIDINIUM HAPTEN.
3795, 1ehlH, 0.5218, 4.08, 0.096, 217, 114, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
3796, 1bqhI, 0.5218, 4.19, 0.062, 122, 113, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
3797, 6ellB, 0.5217, 3.85, 0.103, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3798, 6axpB, 0.5217, 3.83, 0.081, 220, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
3799, 6au5B, 0.5217, 3.83, 0.081, 220, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
3800, 6apdH, 0.5217, 3.98, 0.080, 221, 113, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
3801, 5x2oK, 0.5217, 3.87, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
3802, 5vigL, 0.5217, 3.85, 0.103, 212, 107, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
3803, 5uddT, 0.5217, 3.84, 0.093, 211, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3804, 5sx5L, 0.5217, 3.87, 0.093, 212, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
3805, 5njdU, 0.5217, 3.69, 0.094, 215, 106, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
3806, 5k9kB, 0.5217, 4.03, 0.093, 215, 108, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
3807, 5eocJ, 0.5217, 3.84, 0.098, 214, 112, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
3808, 5cjxA, 0.5217, 3.89, 0.062, 224, 113, CRYSTAL STRUCTURE OF 8ANC195 FAB IN COMPLEX WITH BG505 SOSIP.664 HIV-1 ENV TRIMER
3809, 5bmfL, 0.5217, 3.85, 0.120, 216, 108, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
3810, 4yo0A, 0.5217, 3.97, 0.088, 209, 113, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
3811, 4xcyA, 0.5217, 3.90, 0.098, 228, 112, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3812, 4r96D, 0.5217, 4.01, 0.070, 213, 114, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
3813, 4qthH, 0.5217, 4.06, 0.096, 224, 114, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
3814, 4qexL, 0.5217, 3.88, 0.111, 212, 108, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
3815, 4p5tF, 0.5217, 3.77, 0.093, 229, 107, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
3816, 4nztH, 0.5217, 3.86, 0.081, 222, 111, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
3817, 4hixL, 0.5217, 3.88, 0.120, 219, 108, CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE
3818, 4gw1D, 0.5217, 3.83, 0.081, 220, 111, CQFD MEDITOPE
3819, 4g7vL, 0.5217, 3.85, 0.103, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.5 A)
3820, 4f2mC, 0.5217, 4.01, 0.080, 220, 113, CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10
3821, 4eowH, 0.5217, 4.04, 0.080, 228, 113, CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
3822, 4am0D, 0.5217, 3.89, 0.121, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3823, 3wkmM, 0.5217, 3.90, 0.120, 214, 108, THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
3824, 3sjvE, 0.5217, 3.82, 0.092, 241, 109, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
3825, 3mnvD, 0.5217, 3.94, 0.107, 208, 112, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
3826, 3ijsB, 0.5217, 3.94, 0.071, 221, 113, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3827, 3he6C, 0.5217, 3.72, 0.156, 203, 109, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
3828, 3arbC, 0.5217, 3.68, 0.157, 203, 108, TERNARY CRYSTAL STRUCTURE OF THE NKT TCR-CD1D-ALPHA-GALACTOSYLCERAMIDE ANALOGUE-OCH
3829, 2e27L, 0.5217, 3.54, 0.097, 107, 103, CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN
3830, 1zluH, 0.5217, 3.95, 0.080, 221, 113, FAB 2G12 + MAN5
3831, 1yy8D, 0.5217, 3.90, 0.080, 221, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
3832, 1xf5C, 0.5217, 3.85, 0.111, 220, 108, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
3833, 1rzfH, 0.5217, 3.97, 0.080, 218, 112, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY E51
3834, 1l7iL, 0.5217, 3.76, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
3835, 1emtH, 0.5217, 3.93, 0.107, 208, 112, FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
3836, 1acyL, 0.5217, 3.88, 0.111, 215, 108, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
3837, 6iekB, 0.5216, 4.04, 0.071, 223, 113, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
3838, 6d6tJ, 0.5216, 3.77, 0.091, 116, 110, HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL; CONFORMATION B 
3839, 5w0kF, 0.5216, 3.90, 0.121, 212, 107, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
3840, 5nuzH, 0.5216, 3.93, 0.089, 215, 112, JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT
3841, 5mv3P, 0.5216, 3.89, 0.120, 215, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3842, 5mubM, 0.5216, 4.00, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3843, 5mu0B, 0.5216, 3.85, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
3844, 5mhsF, 0.5216, 3.95, 0.083, 212, 108, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
3845, 5lspT, 0.5216, 3.88, 0.103, 212, 107, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
3846, 5kteH, 0.5216, 3.96, 0.080, 211, 112, CRYSTAL STRUCTURE OF DEINOCOCCUS RADIODURANS MNTH AN NRAMP-FAMILY TRANSITION METAL TRANSPORTER
3847, 5ivzD, 0.5216, 3.84, 0.081, 213, 111, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
3848, 5i9qH, 0.5216, 3.98, 0.062, 213, 113, CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120
3849, 5ewiL, 0.5216, 3.84, 0.130, 217, 108, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90
3850, 4z7oE, 0.5216, 4.00, 0.087, 216, 115, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
3851, 4ydlB, 0.5216, 4.00, 0.079, 223, 114, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
3852, 4uihD, 0.5216, 3.87, 0.082, 120, 110, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.
3853, 4uifK, 0.5216, 3.87, 0.082, 120, 110, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
3854, 4r97B, 0.5216, 3.89, 0.121, 214, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
3855, 4qexM, 0.5216, 3.88, 0.111, 213, 108, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
3856, 4pjcF, 0.5216, 3.73, 0.093, 239, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
3857, 4m61C, 0.5216, 3.85, 0.120, 219, 108, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3858, 4kq4L, 0.5216, 3.88, 0.140, 214, 107, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
3859, 4j1uA, 0.5216, 3.86, 0.120, 210, 108, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
3860, 4ibuA, 0.5216, 3.74, 0.038, 197, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3861, 4hs8L, 0.5216, 3.97, 0.110, 218, 109, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3
3862, 4guoD, 0.5216, 3.72, 0.066, 198, 106, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
3863, 3tfkD, 0.5216, 3.70, 0.084, 239, 107, 42F3-P4B10/H2-LD
3864, 3sknC, 0.5216, 3.72, 0.093, 197, 107, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
3865, 3ra7M, 0.5216, 3.91, 0.103, 211, 107, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
3866, 3oz9H, 0.5216, 3.92, 0.062, 219, 112, CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
3867, 3npsB, 0.5216, 3.90, 0.071, 226, 112, CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3868, 2uylX, 0.5216, 3.99, 0.147, 216, 109, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3869, 2q8aH, 0.5216, 3.89, 0.090, 199, 111, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
3870, 2q86D, 0.5216, 3.77, 0.093, 233, 107, STRUCTURE OF THE MOUSE INVARIANT NKT CELL RECEPTOR VALPHA14
3871, 2oz4L, 0.5216, 3.83, 0.121, 214, 107, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
3872, 2oslL, 0.5216, 3.81, 0.123, 213, 106, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
3873, 2g5bE, 0.5216, 3.96, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3874, 2cdeA, 0.5216, 3.74, 0.121, 192, 107, STRUCTURE AND BINDING KINETICS OF THREE DIFFERENT HUMAN CD1D-ALPHA-GALACTOSYLCERAMIDE SPECIFIC T CELL RECEPTORS - INKT-TCR
3875, 1tqcB, 0.5216, 4.00, 0.088, 212, 113, OVINE RECOMBINANT PRP(114-234) ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)
3876, 1rziP, 0.5216, 3.96, 0.080, 216, 113, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3877, 1r70A, 0.5216, 3.87, 0.084, 214, 107, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
3878, 1mlcB, 0.5216, 4.07, 0.096, 218, 114, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
3879, 1gc1H, 0.5216, 3.92, 0.071, 229, 112, HIV-1 GP120 CORE COMPLEXED WITH CD4 AND A NEUTRALIZING HUMAN ANTIBODY
3880, 1ct8C, 0.5216, 3.81, 0.121, 214, 107, CATALYTIC ANTIBODY 7C8 COMPLEX
3881, 1bqhH, 0.5216, 4.25, 0.061, 125, 115, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
3882, 1bd2D, 0.5216, 3.73, 0.093, 190, 108, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7 VIRAL PEPTIDE (TAX) AND MHC CLASS I MOLECULE HLA-A 0201
3883, 6mnoA, 0.5215, 3.80, 0.119, 196, 109, 6235 TCR BOUND TO I-AB PADI4 
3884, 6j5fH, 0.5215, 3.84, 0.063, 120, 111, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH TICK-BORNE ENCEPHALITIS VIRUS ENVELOPE PROTEIN DOMAIN III 
3885, 6fy1Y, 0.5215, 3.88, 0.073, 192, 110, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A SCAFFOLDED AUTOLOGOUS V1V2 
3886, 6erxH, 0.5215, 3.97, 0.062, 216, 113, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
3887, 6cqrJ, 0.5215, 3.81, 0.111, 245, 108, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
3888, 5xzcD, 0.5215, 3.75, 0.038, 232, 106, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3889, 5x2qL, 0.5215, 3.89, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
3890, 5vk2D, 0.5215, 4.09, 0.088, 218, 114, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
3891, 5tlkF, 0.5215, 3.80, 0.081, 211, 111, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
3892, 5tbdE, 0.5215, 3.85, 0.072, 113, 111, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB4D11) IN COMPLEX WITH 3D7-MSP2 215-222
3893, 5myxA, 0.5215, 3.86, 0.139, 219, 108, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
3894, 5myoB, 0.5215, 3.94, 0.062, 221, 112, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
3895, 5mubV, 0.5215, 4.00, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3896, 5mubD, 0.5215, 4.01, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3897, 5lgyC, 0.5215, 3.75, 0.038, 196, 106, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
3898, 5kzpF, 0.5215, 3.96, 0.088, 226, 113, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
3899, 5fcsL, 0.5215, 4.02, 0.079, 240, 114, DIABODY
3900, 5do2L, 0.5215, 3.90, 0.093, 214, 107, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
3901, 4z7wH, 0.5215, 3.70, 0.093, 239, 108, T316 COMPLEX
3902, 4z7uG, 0.5215, 3.56, 0.121, 198, 107, S13 COMPLEX
3903, 4yhiB, 0.5215, 4.00, 0.138, 219, 109, REVERSAL AGENT FOR DABIGATRAN
3904, 4xbgA, 0.5215, 4.01, 0.080, 227, 113, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3905, 4uimC, 0.5215, 4.05, 0.105, 221, 114, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
3906, 4rbpH, 0.5215, 3.99, 0.088, 220, 113, CRYSTAL STRUCTURE OF HIV NEUTRALIZING ANTIBODY 2G12 IN COMPLEX WITH A BACTERIAL OLIGOSACCHARIDE ANALOG OF MAMMALIAN OLIGOMANOSE
3907, 4r7dF, 0.5215, 3.89, 0.093, 211, 107, FAB HU 15C1
3908, 4m61A, 0.5215, 3.83, 0.120, 219, 108, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3909, 4hkbI, 0.5215, 4.03, 0.096, 220, 114, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
3910, 4am0L, 0.5215, 3.91, 0.121, 212, 107, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
3911, 4aglA, 0.5215, 3.73, 0.028, 195, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN784
3912, 3w0wE, 0.5215, 3.73, 0.083, 241, 108, THE COMPLEX BETWEEN T36-5 TCR AND HLA-A24 BOUND TO HIV-1 NEF134-10(2F) PEPTIDE IN SPACE GROUP P212121
3913, 3qumD, 0.5215, 4.03, 0.080, 219, 113, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
3914, 3mv9D, 0.5215, 3.65, 0.094, 200, 106, CRYSTAL STRUCTURE OF THE TK3-GLN55ALA TCR IN COMPLEX WITH HLA- B*3501/HPVG
3915, 3l7fD, 0.5215, 3.91, 0.103, 213, 107, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
3916, 3j5mL, 0.5215, 4.02, 0.070, 225, 114, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3917, 3j5mH, 0.5215, 4.02, 0.070, 225, 114, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3918, 3j5mD, 0.5215, 4.02, 0.070, 225, 114, CRYO-EM STRUCTURE OF THE BG505 SOSIP.664 HIV-1 ENV TRIMER WITH 3 PGV04 FABS
3919, 3eobL, 0.5215, 3.85, 0.103, 214, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
3920, 3dxaO, 0.5215, 3.78, 0.103, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
3921, 3difB, 0.5215, 3.93, 0.080, 211, 112, CRYSTAL STRUCTURE OF FABOX117
3922, 2nxzD, 0.5215, 4.00, 0.088, 222, 113, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (T257S S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
3923, 1igjD, 0.5215, 3.89, 0.071, 217, 112, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
3924, 1figL, 0.5215, 3.89, 0.111, 215, 108, ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
3925, 1cgsH, 0.5215, 3.96, 0.062, 214, 113, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
3926, 6ggaA, 0.5214, 3.73, 0.028, 196, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9284 
3927, 6cnkG, 0.5214, 3.98, 0.088, 218, 113, STRUCTURE OF THE 3ALPHA2BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
3928, 5yxuG, 0.5214, 3.84, 0.074, 239, 108, AN AFFINITY ENHANCED T CELL RECEPTOR IN COMPLEX WITH HLA-A0201 RESTRICTED HCV NS3 PEPTIDE KLVALGINAV 
3929, 5vzxI, 0.5214, 3.87, 0.130, 219, 108, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
3930, 5vtaF, 0.5214, 3.89, 0.071, 217, 112, CO-CRYSTAL STRUCTURE OF DPPIV WITH A CHEMIBODY INHIBITOR 
3931, 5vl3H, 0.5214, 4.03, 0.079, 214, 114, CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB
3932, 5viyK, 0.5214, 3.89, 0.062, 227, 113, BG505 SOSIP.664 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES BG1 AND 8ANC195
3933, 5tbdA, 0.5214, 3.78, 0.081, 114, 111, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB4D11) IN COMPLEX WITH 3D7-MSP2 215-222
3934, 5l88H, 0.5214, 3.92, 0.080, 217, 112, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM I NON-PARSIMONIOUS MODEL
3935, 5l0qE, 0.5214, 3.87, 0.121, 212, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
3936, 5k8aM, 0.5214, 3.81, 0.113, 213, 106, NIST FAB
3937, 5iw1F, 0.5214, 3.69, 0.104, 233, 106, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
3938, 5drzL, 0.5214, 3.98, 0.101, 216, 109, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
3939, 4ygvB, 0.5214, 4.00, 0.138, 218, 109, REVERSAL AGENT FOR DABIGATRAN
3940, 4ydiH, 0.5214, 4.04, 0.062, 209, 113, CRYSTAL STRUCTURE OF BROAD AND POTENTLY NEUTRALIZING VRC01-CLASS ANTIBODY Z258-VRC27.01 ISOLATED FROM HUMAN DONOR Z258 IN COMPLEX WITH HIV-1 GP120 FROM CLADE A STRAIN Q23.17
3941, 4s11A, 0.5214, 3.88, 0.071, 129, 112, GELSOLIN NANOBODY SHIELDING MUTANT PLASMA GELSOLIN FROM FURIN PROTEOLYSIS
3942, 4qlrA, 0.5214, 3.91, 0.090, 130, 111, LLAMA NANOBODY N02 RAISED AGAINST EAEC T6SS TSSM
3943, 4pjcH, 0.5214, 3.71, 0.093, 240, 107, STRUCTURE OF HUMAN MR1-5-OP-RU IN COMPLEX WITH HUMAN MAIT C-A11 TCR
3944, 4mhhL, 0.5214, 3.98, 0.128, 217, 109, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
3945, 4kxzJ, 0.5214, 3.96, 0.071, 217, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3946, 4jr9L, 0.5214, 3.85, 0.121, 211, 107, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
3947, 4imlA, 0.5214, 3.98, 0.062, 234, 113, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
3948, 4ijtA, 0.5214, 3.75, 0.038, 198, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H (FORM II)
3949, 4g8gD, 0.5214, 3.75, 0.110, 204, 109, CRYSTAL STRUCTURE OF C12C TCR-HA B2705-KK10
3950, 4elmH, 0.5214, 3.71, 0.123, 211, 106, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
3951, 3us0D, 0.5214, 3.78, 0.065, 192, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3952, 3umtA, 0.5214, 3.89, 0.071, 227, 112, SCFV12 ANTI-BCLA ANTIBODY SINGLE CHAIN VARIABLE FRAGMENT
3953, 3tzvH, 0.5214, 3.79, 0.093, 244, 108, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
3954, 3tyfD, 0.5214, 3.67, 0.093, 242, 107, CRYSTAL STRUCTURE OF A CD1D-LYSOPHOSPHATIDYLCHOLINE REACTIVE INKT TCR
3955, 3o2dL, 0.5214, 3.99, 0.138, 216, 109, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
3956, 3nz8A, 0.5214, 3.90, 0.071, 217, 112, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3957, 3mbeD, 0.5214, 3.81, 0.074, 236, 108, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
3958, 3ijyC, 0.5214, 3.84, 0.120, 217, 108, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3959, 2vq1A, 0.5214, 3.99, 0.128, 216, 109, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3960, 2orbL, 0.5214, 3.90, 0.121, 212, 107, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT
3961, 2o5xL, 0.5214, 3.91, 0.139, 218, 108, CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY
3962, 2adyA, 0.5214, 3.76, 0.038, 197, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX IV)
3963, 1yy8B, 0.5214, 3.91, 0.080, 221, 112, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
3964, 1yjdH, 0.5214, 3.81, 0.081, 217, 111, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
3965, 1uywL, 0.5214, 3.88, 0.131, 212, 107, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3966, 1uolB, 0.5214, 3.77, 0.028, 195, 106, CRYSTAL STRUCTURE OF THE HUMAN P53 CORE DOMAIN MUTANT M133L/V203A/N239Y/N268D AT 1.9 A RESOLUTION.
3967, 1nsnL, 0.5214, 3.85, 0.130, 217, 108, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
3968, 1hxmG, 0.5214, 3.64, 0.075, 206, 106, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
3969, 1g9mH, 0.5214, 3.95, 0.088, 229, 113, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
3970, 1a3rH, 0.5214, 3.90, 0.098, 212, 112, FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170)
3971, 1a0qL, 0.5214, 3.77, 0.104, 211, 106, 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
3972, 6mtpH, 0.5213, 3.99, 0.062, 218, 113, CRYSTAL STRUCTURE OF VRC42.04 FAB IN COMPLEX WITH GP41 PEPTIDE 
3973, 6fxnH, 0.5213, 3.97, 0.062, 216, 113, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
3974, 6ev1C, 0.5213, 3.96, 0.097, 214, 113, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
3975, 6dc7I, 0.5213, 4.01, 0.115, 211, 113, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
3976, 5udcB, 0.5213, 3.88, 0.071, 218, 112, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3977, 5tlkA, 0.5213, 3.98, 0.119, 215, 109, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
3978, 5tl5L, 0.5213, 3.84, 0.111, 217, 108, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
3979, 5tezI, 0.5213, 3.67, 0.112, 202, 107, TCR F50 RECGONIZING M1-HLA-A2
3980, 5sydA, 0.5213, 2.78, 0.180, 130, 89, CIRCULARLY PERMUTATED AZURIN (CPAZ) BASED ON P. AERUGINOSA AZURIN SEQUENCE
3981, 5nuzA, 0.5213, 3.93, 0.089, 215, 112, JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT
3982, 5mv3M, 0.5213, 3.86, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3983, 5mubJ, 0.5213, 4.01, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
3984, 5mp5E, 0.5213, 3.88, 0.089, 217, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3985, 5l9dH, 0.5213, 3.92, 0.080, 215, 112, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM I PARSIMONIOUS MODEL
3986, 5l2kE, 0.5213, 3.83, 0.092, 242, 109, CRYSTAL STRUCTURE OF GEM42 TCR-CD1B-GMM COMPLEX
3987, 5abaA, 0.5213, 3.74, 0.028, 195, 106, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL- MOLECULE STABILIZER PHIKAN5149
3988, 4yhkL, 0.5213, 3.98, 0.138, 218, 109, REVERSAL AGENT FOR DABIGATRAN
3989, 4p5tB, 0.5213, 3.77, 0.093, 238, 107, 14.C6 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
3990, 4p2aA, 0.5213, 4.04, 0.075, 287, 107, STRUCTURE OF MOUSE VPS26A BOUND TO RAT SNX27 PDZ DOMAIN
3991, 4nryB, 0.5213, 3.82, 0.112, 205, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
3992, 4hs6A, 0.5213, 3.87, 0.102, 218, 108, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
3993, 4hkbJ, 0.5213, 3.98, 0.062, 218, 113, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
3994, 4gw5B, 0.5213, 3.85, 0.081, 216, 111, CQYN MEDITOPE - CETUXIMAB FAB
3995, 4gmsH, 0.5213, 4.02, 0.071, 217, 113, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
3996, 4g8eA, 0.5213, 3.63, 0.103, 201, 107, CRYSTAL STRUCTURE OF CLONE18 TCR
3997, 4g6jL, 0.5213, 3.90, 0.103, 212, 107, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
3998, 4elmF, 0.5213, 3.78, 0.140, 224, 107, CRYSTAL STRUCTURE OF THE MOUSE CD1D-LYSOSULFATIDE-HY19.3 TCR COMPLEX
3999, 3tvmC, 0.5213, 3.82, 0.130, 200, 108, STRUCTURE OF THE MOUSE CD1D-SMC124-INKT TCR COMPLEX
4000, 3o45L, 0.5213, 3.85, 0.120, 218, 108, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
4001, 3nzhL, 0.5213, 3.88, 0.103, 214, 107, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
4002, 3hr5A, 0.5213, 3.89, 0.120, 219, 108, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4003, 3arfD, 0.5213, 3.70, 0.085, 235, 106, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-C20:2
4004, 2xn9A, 0.5213, 3.70, 0.133, 199, 105, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX BETWEEN HUMAN T CELL RECEPTOR STAPHYLOCOCCAL ENTEROTOXIN H AND HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
4005, 2j1zB, 0.5213, 3.77, 0.028, 195, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-F270L
4006, 2gkiB, 0.5213, 3.85, 0.072, 238, 111, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
4007, 2cgrH, 0.5213, 4.06, 0.079, 214, 114, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
4008, 1mpaL, 0.5213, 3.87, 0.120, 219, 108, BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
4009, 1moeB, 0.5213, 3.96, 0.111, 240, 108, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
4010, 1hxmE, 0.5213, 3.69, 0.093, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
4011, 6marH, 0.5212, 3.85, 0.072, 135, 111, HIV-1 ENVELOPE GLYCOPROTEIN CLONE BG505 DELCT N332T IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY FAB PGT151 
4012, 6iuvH, 0.5212, 3.88, 0.062, 228, 112, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
4013, 6i8sG, 0.5212, 3.89, 0.080, 214, 112, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
4014, 6gc2H, 0.5212, 4.10, 0.088, 213, 114, ABLIFT: ANTIBODY STABILITY AND AFFINITY OPTIMIZATION BY COMPUTATIONAL DESIGN OF THE VARIABLE LIGHT-HEAVY CHAIN INTERFACE 
4015, 6eqbE, 0.5212, 3.87, 0.128, 244, 109, HLA CLASS I HISTOCOMPATIBILITY ANTIGEN 
4016, 6ea7M, 0.5212, 3.93, 0.088, 217, 113, STRUCTURE OF EBOV GPCL IN COMPLEX WITH THE PAN-EBOLAVIRUS MAB ADI- 15878 
4017, 6cmiD, 0.5212, 4.00, 0.061, 228, 114, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
4018, 6arpD, 0.5212, 3.91, 0.080, 217, 112, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
4019, 5w5zH, 0.5212, 4.01, 0.115, 209, 113, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY AT HIGH RESOLUTION 
4020, 5usiA, 0.5212, 3.94, 0.080, 211, 113, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV138
4021, 5uddO, 0.5212, 3.75, 0.055, 216, 110, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4022, 5udcE, 0.5212, 3.97, 0.062, 220, 113, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4023, 5tztL, 0.5212, 4.02, 0.128, 219, 109, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4024, 5te4H, 0.5212, 4.06, 0.096, 224, 114, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE G STRAIN X2088 GP120 CORE
4025, 5sx5K, 0.5212, 3.87, 0.093, 213, 107, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
4026, 5otjB, 0.5212, 4.01, 0.088, 222, 114, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
4027, 5mvjE, 0.5212, 3.87, 0.089, 215, 112, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
4028, 5mv3J, 0.5212, 4.02, 0.138, 218, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4029, 5kmvI, 0.5212, 3.88, 0.130, 219, 108, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
4030, 5ir1B, 0.5212, 3.83, 0.081, 220, 111, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4031, 5iczD, 0.5212, 3.82, 0.081, 213, 111, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
4032, 5fb8B, 0.5212, 3.96, 0.080, 223, 113, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
4033, 5esqB, 0.5212, 3.84, 0.081, 215, 111, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
4034, 5dqjL, 0.5212, 3.88, 0.120, 217, 108, STRUCTURE OF UNLIGANDED S55-5 FAB
4035, 5dq9D, 0.5212, 3.86, 0.102, 211, 108, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
4036, 5d1zC, 0.5212, 3.83, 0.093, 208, 107, ISDB NEAT1 BOUND BY CLONE D4-10
4037, 4zs6L, 0.5212, 3.87, 0.103, 210, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
4038, 4xvtH, 0.5212, 4.06, 0.053, 228, 114, CRYSTAL STRUCTURE OF HIV-1 93TH057 COREE GP120 WITH ANTIBODY 45- VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
4039, 4x6bA, 0.5212, 3.63, 0.086, 196, 105, BK6 TCR APO STRUCTURE
4040, 4wnqB, 0.5212, 3.98, 0.099, 241, 111, THE MOLECULAR BASES OF DELTA/ALPHA-BETA T-CELL MEDIATED ANTIGEN RECOGNITION
4041, 4rgoL, 0.5212, 3.81, 0.112, 212, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8
4042, 4khtH, 0.5212, 3.79, 0.073, 214, 110, TRIPLE HELIX BUNDLE OF GP41 COMPLEXED WITH FAB 8066
4043, 4hkbG, 0.5212, 4.02, 0.096, 218, 114, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4044, 3vd0K, 0.5212, 3.71, 0.066, 206, 106, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4045, 3k2uL, 0.5212, 3.85, 0.103, 208, 107, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
4046, 3j7eL, 0.5212, 3.89, 0.140, 115, 107, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
4047, 3j7eE, 0.5212, 3.89, 0.140, 115, 107, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
4048, 3j7eC, 0.5212, 3.89, 0.140, 115, 107, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
4049, 3j7eA, 0.5212, 3.89, 0.140, 115, 107, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
4050, 3hnvH, 0.5212, 3.91, 0.071, 220, 112, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)
4051, 3he7C, 0.5212, 3.77, 0.156, 197, 109, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
4052, 3difD, 0.5212, 3.93, 0.089, 213, 112, CRYSTAL STRUCTURE OF FABOX117
4053, 2r0lL, 0.5212, 3.85, 0.112, 214, 107, SHORT FORM HGFA WITH INHIBITORY FAB75
4054, 2ianJ, 0.5212, 3.83, 0.073, 239, 109, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4055, 2fjhA, 0.5212, 3.85, 0.093, 211, 107, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4056, 2aepL, 0.5212, 3.94, 0.112, 129, 107, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
4057, 1wcbH, 0.5212, 4.05, 0.070, 222, 114, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
4058, 1q1jI, 0.5212, 3.92, 0.107, 231, 112, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
4059, 1om3K, 0.5212, 3.95, 0.097, 225, 113, FAB 2G12 UNLIGANDED
4060, 1mieL, 0.5212, 3.96, 0.093, 218, 108, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
4061, 1c5dA, 0.5212, 3.85, 0.103, 213, 107, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
4062, 1ad9H, 0.5212, 3.97, 0.097, 219, 113, IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
4063, 6rcvC, 0.5211, 4.02, 0.105, 224, 114, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.011 AND R5.016 
4064, 6ogxH, 0.5211, 3.93, 0.080, 206, 112, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
4065, 6ffjC, 0.5211, 3.91, 0.062, 233, 112, ANTI-TUMOR ANTIBODY 14F7-DERIVED SINGLE CHAIN FRAGMENT VARIABLE (SCFV) 
4066, 6eyoH, 0.5211, 3.87, 0.089, 204, 112, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
4067, 6apdF, 0.5211, 3.98, 0.088, 222, 113, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4068, 5xotE, 0.5211, 3.78, 0.083, 242, 108, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
4069, 5x2pL, 0.5211, 3.98, 0.119, 217, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
4070, 5wuvL, 0.5211, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF CERTOLIZUMAB FAB
4071, 5tlkE, 0.5211, 3.85, 0.111, 215, 108, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4072, 5t1lD, 0.5211, 3.83, 0.081, 216, 111, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
4073, 5n7wL, 0.5211, 3.83, 0.093, 211, 107, COMPUTATIONALLY DESIGNED FUNCTIONAL ANTIBODY 
4074, 5j3dL, 0.5211, 3.85, 0.093, 215, 107, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
4075, 5iv2D, 0.5211, 3.82, 0.081, 214, 111, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4076, 5iczB, 0.5211, 3.84, 0.081, 216, 111, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
4077, 5grvL, 0.5211, 3.92, 0.099, 123, 111, CRYSTAL STRUCTURE OF HOMO-SPECIFIC DIABODY
4078, 5ezlB, 0.5211, 3.86, 0.112, 213, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
4079, 5dq9B, 0.5211, 3.86, 0.102, 212, 108, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
4080, 5cjsF, 0.5211, 3.99, 0.061, 217, 114, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4081, 4rgnE, 0.5211, 3.86, 0.130, 220, 108, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
4082, 4r7nR, 0.5211, 3.88, 0.084, 213, 107, FAB C2E3
4083, 4njaL, 0.5211, 3.87, 0.120, 217, 108, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
4084, 4kxzN, 0.5211, 3.89, 0.072, 223, 111, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4085, 4d9rE, 0.5211, 3.99, 0.080, 216, 113, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4086, 3vd1B, 0.5211, 3.74, 0.066, 199, 106, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4087, 3r1gL, 0.5211, 3.84, 0.093, 214, 107, STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY
4088, 3qpqE, 0.5211, 3.85, 0.121, 215, 107, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
4089, 3opzL, 0.5211, 3.83, 0.132, 212, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4090, 3mxwL, 0.5211, 3.87, 0.093, 212, 107, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
4091, 3mxvL, 0.5211, 3.88, 0.093, 212, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
4092, 3j3pH, 0.5211, 3.92, 0.088, 220, 113, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 135S POLIOVIRUS AND C3-FAB COMPLEX
4093, 3ixxG, 0.5211, 4.12, 0.070, 221, 115, THE PSEUDO-ATOMIC STRUCTURE OF WEST NILE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4094, 3ivkA, 0.5211, 4.03, 0.088, 224, 113, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
4095, 3iu3C, 0.5211, 3.78, 0.091, 215, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4096, 3d08A, 0.5211, 3.75, 0.038, 182, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND-SITE SUPPRESSOR MUTATION H168R
4097, 2zchH, 0.5211, 3.98, 0.080, 229, 113, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
4098, 2i60H, 0.5211, 3.96, 0.080, 221, 113, CRYSTAL STRUCTURE OF [PHE23]M47 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4099, 2bioA, 0.5211, 3.73, 0.028, 186, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-R249S-N268D
4100, 2a6jH, 0.5211, 3.99, 0.097, 222, 113, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65
4101, 1rziN, 0.5211, 3.83, 0.081, 216, 111, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
4102, 1rziJ, 0.5211, 4.05, 0.079, 216, 114, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
4103, 1fgnL, 0.5211, 3.88, 0.103, 214, 107, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
4104, 6axpD, 0.5210, 3.83, 0.081, 214, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
4105, 6at6A, 0.5210, 3.59, 0.130, 190, 108, CRYSTAL STRUCTURE OF THE KFJ5 TCR
4106, 5zs0A, 0.5210, 3.97, 0.121, 211, 107, STRUCTURE OF GLYCOPROTEIN B DOMAIN IV OF PSEUDORABIES VIRUS WITH 7B11 ANTIBODY 
4107, 5x2oL, 0.5210, 3.89, 0.120, 216, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
4108, 5w08Q, 0.5210, 4.04, 0.079, 235, 114, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4109, 5vl3A, 0.5210, 3.97, 0.071, 214, 113, CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB
4110, 5o6vH, 0.5210, 4.01, 0.080, 212, 113, THE CRYO-EM STRUCTURE OF TICK-BORNE ENCEPHALITIS VIRUS COMPLEXED WITH FAB FRAGMENT OF NEUTRALIZING ANTIBODY 19/1786
4111, 5njdS, 0.5210, 3.70, 0.094, 214, 106, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
4112, 5mubP, 0.5210, 4.01, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4113, 5mubB, 0.5210, 4.01, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4114, 5i1hL, 0.5210, 3.92, 0.102, 214, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20
4115, 5gjsL, 0.5210, 3.86, 0.093, 207, 107, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/CALIFORNIA/04/2009 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
4116, 5cmaB, 0.5210, 3.89, 0.089, 213, 112, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
4117, 5a1zG, 0.5210, 3.80, 0.082, 120, 110, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
4118, 4yhoL, 0.5210, 4.00, 0.138, 219, 109, REVERSAL AGENT FOR DABIGATRAN
4119, 4xxdA, 0.5210, 3.95, 0.111, 218, 108, CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB
4120, 4xmlL, 0.5210, 3.85, 0.130, 215, 108, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424
4121, 4ubdL, 0.5210, 3.93, 0.083, 213, 108, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
4122, 4rgnG, 0.5210, 3.86, 0.130, 220, 108, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
4123, 4prpD, 0.5210, 3.68, 0.094, 200, 106, CRYSTAL STRUCTURE OF TK3 TCR-HLA-B*35:01-HPVG-Q5 COMPLEX
4124, 4oduL, 0.5210, 3.87, 0.093, 212, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
4125, 4mhhI, 0.5210, 3.89, 0.130, 217, 108, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4126, 4kuzL, 0.5210, 3.97, 0.120, 216, 108, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
4127, 4jm2D, 0.5210, 3.95, 0.088, 220, 113, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4128, 4g7yL, 0.5210, 3.84, 0.103, 211, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
4129, 4fomA, 0.5210, 3.76, 0.102, 302, 108, CRYSTAL STRUCTURE OF HUMAN NECTIN-3 FULL ECTODOMAIN (D1-D3)
4130, 3u7yH, 0.5210, 4.04, 0.080, 221, 113, STRUCTURE OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV
4131, 3rdtA, 0.5210, 3.67, 0.112, 199, 107, CRYSTAL STRUCTURE OF 809.B5 TCR COMPLEXED WITH MHC CLASS II I-AB/3K PEPTIDE
4132, 3o45B, 0.5210, 3.87, 0.120, 217, 108, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
4133, 3ivkH, 0.5210, 4.03, 0.088, 224, 113, CRYSTAL STRUCTURE OF THE CATALYTIC CORE OF AN RNA POLYMERASE RIBOZYME COMPLEXED WITH AN ANTIGEN BINDING ANTIBODY FRAGMENT
4134, 3argC, 0.5210, 3.77, 0.156, 202, 109, TERNARY CRYSTAL STRUCTURE OF THE MOUSE NKT TCR-CD1D-ALPHA- GLUCOSYLCERAMIDE(C20:2)
4135, 2uylV, 0.5210, 3.99, 0.147, 216, 109, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
4136, 2oqjH, 0.5210, 3.88, 0.080, 224, 112, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
4137, 2oi9B, 0.5210, 3.52, 0.104, 110, 106, STRUCTURE OF THE 2C/LD/QL9 ALLOGENEIC COMPLEX
4138, 2o5zH, 0.5210, 3.94, 0.080, 219, 113, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-317-DIONE COMPLEX
4139, 2ny1D, 0.5210, 4.01, 0.088, 223, 113, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (I109C T257S S334A S375W Q428C) COMPLEXED WITH CD4 AND ANTIBODY 17B
4140, 2j1wB, 0.5210, 3.77, 0.028, 195, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V143A-V203A-N239Y-N268D
4141, 2a6dB, 0.5210, 4.08, 0.088, 219, 114, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
4142, 1zoxA, 0.5210, 3.72, 0.056, 110, 108, CLM-1 MOUSE MYELOID RECEPTOR EXTRACELLULAR DOMAIN
4143, 1zeaL, 0.5210, 4.02, 0.147, 216, 109, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
4144, 1p2cB, 0.5210, 4.10, 0.088, 210, 114, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
4145, 1cu4L, 0.5210, 3.88, 0.139, 219, 108, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE
4146, 6j5dH, 0.5209, 3.84, 0.063, 120, 111, COMPLEX STRUCTURE OF MAB 4.2-SCFV WITH LOUPING ILL VIRUS ENVELOPE PROTEIN DOMAIN III 
4147, 6ggdA, 0.5209, 3.75, 0.028, 196, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9324 
4148, 6dztN, 0.5209, 3.85, 0.117, 226, 111, CRYO-EM STRUCTURE OF NUCLEOSOME IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4149, 6dc5B, 0.5209, 4.10, 0.088, 221, 114, RSV PREFUSION F IN COMPLEX WITH AM22 FAB 
4150, 6cseB, 0.5209, 3.82, 0.121, 213, 107, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH L-ALANINE BOUND 
4151, 6avnH, 0.5209, 3.98, 0.088, 221, 113, CRYSTAL STRUCTURE OF UNBOUND ANTI-HIV ANTIBODY FAB PGV19 AT 2.5 A 
4152, 6au5D, 0.5209, 3.83, 0.081, 220, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
4153, 5uxqB, 0.5209, 4.02, 0.110, 217, 109, STRUCTURE OF ANTI-HIV TRIMER APEX ANTIBODY PGT143
4154, 5tljE, 0.5209, 3.97, 0.102, 215, 108, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
4155, 5t1mA, 0.5209, 3.89, 0.093, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
4156, 5t1lB, 0.5209, 3.75, 0.082, 215, 110, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
4157, 5o1gA, 0.5209, 3.73, 0.028, 196, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB487 
4158, 5i76D, 0.5209, 3.91, 0.080, 217, 112, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
4159, 5i2iD, 0.5209, 3.82, 0.081, 216, 111, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4160, 5g4oA, 0.5209, 3.74, 0.028, 196, 106, CRYSTAL STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH A TRIFLUORINATED DERIVATIVE OF THE SMALL MOLECULE STABILIZER PHIKAN083
4161, 5cp7G, 0.5209, 4.03, 0.147, 218, 109, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
4162, 5cjqH, 0.5209, 4.00, 0.070, 217, 114, CRYSTAL STRUCTURE OF A TRIMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4163, 4x7tH, 0.5209, 3.99, 0.071, 222, 113, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
4164, 4o02H, 0.5209, 4.02, 0.096, 218, 114, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
4165, 4m1dI, 0.5209, 3.96, 0.106, 231, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
4166, 4jrxE, 0.5209, 3.75, 0.074, 238, 108, CRYSTAL STRUCTURE OF CA5 TCR-HLA B*3505-LPEP COMPLEX
4167, 3qwoL, 0.5209, 3.83, 0.113, 210, 106, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
4168, 3opzM, 0.5209, 3.84, 0.132, 212, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4169, 3ncyQ, 0.5209, 3.98, 0.080, 218, 112, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
4170, 3ma9H, 0.5209, 3.89, 0.072, 214, 111, CRYSTAL STRUCTURE OF GP41 DERIVED PROTEIN COMPLEXED WITH FAB 8066
4171, 3l7fA, 0.5209, 3.90, 0.103, 213, 107, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
4172, 3hfmL, 0.5209, 3.89, 0.112, 214, 107, STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
4173, 3fo9A, 0.5209, 4.03, 0.138, 219, 109, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
4174, 3dxaE, 0.5209, 3.81, 0.103, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
4175, 2ny3D, 0.5209, 3.91, 0.080, 223, 112, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E267C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
4176, 2a6kB, 0.5209, 3.99, 0.071, 218, 113, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
4177, 1xf4B, 0.5209, 3.93, 0.089, 213, 112, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4178, 1tziA, 0.5209, 3.80, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
4179, 1qsfE, 0.5209, 3.75, 0.083, 243, 108, STRUCTURE OF A6-TCR BOUND TO HLA-A2 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE Y8A
4180, 1q9lC, 0.5209, 3.98, 0.130, 219, 108, S25-2 FAB UNLIGANDED 2
4181, 1jnlL, 0.5209, 3.87, 0.140, 211, 107, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4182, 1i9jL, 0.5209, 4.02, 0.147, 219, 109, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
4183, 1dzbB, 0.5209, 3.92, 0.071, 222, 112, CRYSTAL STRUCTURE OF PHAGE LIBRARY-DERIVED SINGLE-CHAIN FV FRAGMENT 1F9 IN COMPLEX WITH TURKEY EGG-WHITE LYSOZYME
4184, 6q3sE, 0.5208, 3.76, 0.074, 241, 108, ENGINEERED HUMAN HLA_A2 MHC CLASS I MOLECULE IN COMPLEX WITH TCR AND SV9 PEPTIDE 
4185, 6hjqK, 0.5208, 3.97, 0.080, 216, 113, STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
4186, 6hjqI, 0.5208, 3.97, 0.080, 216, 113, STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
4187, 6hjqG, 0.5208, 3.97, 0.080, 216, 113, STRUCTURE OF FULL-LENGTH INFLUENZA HEMAGGLUTININ (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
4188, 6flaH, 0.5208, 3.98, 0.097, 217, 113, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
4189, 6flaA, 0.5208, 3.99, 0.097, 212, 113, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
4190, 6dc5H, 0.5208, 4.09, 0.079, 223, 114, RSV PREFUSION F IN COMPLEX WITH AM22 FAB 
4191, 6d6uJ, 0.5208, 3.85, 0.091, 116, 110, HUMAN GABA-A RECEPTOR ALPHA1-BETA2-GAMMA2 SUBTYPE IN COMPLEX WITH GABA AND FLUMAZENIL; CONFORMATION A 
4192, 5wuxC, 0.5208, 4.07, 0.070, 202, 114, TNFALPHA-CERTOLIZUMAB FAB
4193, 5th2D, 0.5208, 3.83, 0.081, 220, 111, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
4194, 5t1mB, 0.5208, 3.75, 0.082, 218, 110, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
4195, 5o6vI, 0.5208, 3.96, 0.090, 212, 111, THE CRYO-EM STRUCTURE OF TICK-BORNE ENCEPHALITIS VIRUS COMPLEXED WITH FAB FRAGMENT OF NEUTRALIZING ANTIBODY 19/1786
4196, 5mubG, 0.5208, 4.01, 0.138, 217, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4197, 5k8aL, 0.5208, 3.84, 0.113, 213, 106, NIST FAB
4198, 5ihzF, 0.5208, 3.98, 0.135, 213, 111, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
4199, 5icxD, 0.5208, 3.82, 0.081, 212, 111, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
4200, 5i15L, 0.5208, 3.87, 0.103, 214, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
4201, 5dqjB, 0.5208, 3.89, 0.120, 217, 108, STRUCTURE OF UNLIGANDED S55-5 FAB
4202, 5dq9L, 0.5208, 3.86, 0.102, 212, 108, STRUCTURE OF S55-3 FAB IN COMPLEX WITH LIPID A
4203, 5d96B, 0.5208, 3.91, 0.121, 214, 107, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
4204, 5a1zI, 0.5208, 3.77, 0.082, 120, 110, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
4205, 4x6bC, 0.5208, 3.62, 0.086, 186, 105, BK6 TCR APO STRUCTURE
4206, 4x6bB, 0.5208, 3.82, 0.083, 244, 109, BK6 TCR APO STRUCTURE
4207, 4wcyL, 0.5208, 3.99, 0.110, 217, 109, FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY
4208, 4r7dL, 0.5208, 3.89, 0.103, 211, 107, FAB HU 15C1
4209, 4otxM, 0.5208, 3.84, 0.120, 213, 108, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
4210, 4kxzH, 0.5208, 3.79, 0.064, 223, 110, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4211, 4ki5E, 0.5208, 4.00, 0.088, 224, 113, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
4212, 4gw5D, 0.5208, 3.84, 0.081, 215, 111, CQYN MEDITOPE - CETUXIMAB FAB
4213, 4cmhB, 0.5208, 4.06, 0.114, 216, 114, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
4214, 3wd5L, 0.5208, 3.84, 0.103, 213, 107, CRYSTAL STRUCTURE OF TNFALPHA IN COMPLEX WITH ADALIMUMAB FAB FRAGMENT
4215, 3v0wL, 0.5208, 3.89, 0.112, 211, 107, CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
4216, 3t77A, 0.5208, 3.85, 0.120, 219, 108, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
4217, 3opzN, 0.5208, 3.83, 0.132, 212, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4218, 3opzJ, 0.5208, 3.91, 0.080, 221, 112, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4219, 3oayM, 0.5208, 3.99, 0.097, 218, 113, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4220, 3mmeA, 0.5208, 4.07, 0.079, 235, 114, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4221, 3j3oL, 0.5208, 3.98, 0.139, 219, 108, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
4222, 2zchL, 0.5208, 3.94, 0.139, 215, 108, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
4223, 2mpaL, 0.5208, 3.88, 0.120, 219, 108, BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
4224, 2g2rB, 0.5208, 3.90, 0.072, 219, 111, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
4225, 2f54E, 0.5208, 3.78, 0.074, 241, 108, DIRECTED EVOLUTION OF HUMAN T CELL RECEPTOR CDR2 RESIDUES BY PHAGE DISPLAY DRAMATICALLY ENHANCES AFFINITY FOR COGNATE PEPTIDE-MHC WITHOUT INCREASING APPARENT CROSS-REACTIVITY
4226, 1ymhA, 0.5208, 3.84, 0.111, 220, 108, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
4227, 1igyA, 0.5208, 3.85, 0.113, 213, 106, STRUCTURE OF IMMUNOGLOBULIN
4228, 1gpoL, 0.5208, 3.89, 0.130, 216, 108, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
4229, 6rcvH, 0.5207, 4.02, 0.105, 223, 114, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.011 AND R5.016 
4230, 6h3uL, 0.5207, 3.89, 0.093, 113, 107, SCHMALLENBERG VIRUS GLYCOPROTEIN GC HEAD DOMAIN IN COMPLEX WITH SCFV 4B6 
4231, 6flcB, 0.5207, 4.00, 0.097, 216, 113, 2C8 FAB BOUND TO EDIII OF DENV 2 
4232, 6flbH, 0.5207, 3.99, 0.097, 213, 113, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
4233, 6c5jL, 0.5207, 4.03, 0.138, 217, 109, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 1) 
4234, 6arpB, 0.5207, 3.91, 0.080, 214, 112, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
4235, 5x2mL, 0.5207, 3.85, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
4236, 5wuxH, 0.5207, 4.10, 0.053, 212, 114, TNFALPHA-CERTOLIZUMAB FAB
4237, 5w08I, 0.5207, 4.05, 0.070, 238, 114, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4238, 5vk2F, 0.5207, 4.08, 0.088, 217, 114, STRUCTURAL BASIS FOR ANTIBODY-MEDIATED NEUTRALIZATION OF LASSA VIRUS
4239, 5th9L, 0.5207, 3.87, 0.103, 214, 107, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
4240, 5o1eA, 0.5207, 3.73, 0.028, 197, 106, P53 CANCER MUTANT Y220C IM COMPLEX WITH COMPOUND MB577 
4241, 5iw1B, 0.5207, 3.71, 0.104, 233, 106, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
4242, 5iv2B, 0.5207, 3.83, 0.081, 216, 111, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4243, 5itfD, 0.5207, 3.84, 0.081, 215, 111, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
4244, 5id1B, 0.5207, 3.85, 0.081, 214, 111, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
4245, 5hyqD, 0.5207, 3.83, 0.081, 213, 111, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4246, 5hpmB, 0.5207, 3.83, 0.081, 216, 111, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
4247, 5hj3F, 0.5207, 3.88, 0.111, 189, 108, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
4248, 5fc9D, 0.5207, 2.20, 0.159, 95, 88, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
4249, 5f88B, 0.5207, 3.84, 0.081, 216, 111, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
4250, 5d96I, 0.5207, 3.92, 0.121, 214, 107, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
4251, 5c08D, 0.5207, 3.67, 0.084, 189, 107, 1E6 TCR IN COMPLEX WITH HLA-A0E CARRYING RQWGPDPAAV
4252, 5aumL, 0.5207, 3.88, 0.130, 216, 108, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
4253, 4zykB, 0.5207, 3.84, 0.093, 214, 107, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
4254, 4rqsD, 0.5207, 3.91, 0.089, 223, 112, CRYSTAL STRUCTURE OF FULLY GLYCOSYLATED HIV-1 GP120 CORE BOUND TO CD4 AND 17B FAB
4255, 4nkoA, 0.5207, 4.00, 0.128, 115, 109, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4256, 4g9fD, 0.5207, 3.77, 0.110, 204, 109, CRYSTAL STRUCTURE OF C12C TCR-HLAB2705-KK10-L6M
4257, 3he7D, 0.5207, 3.85, 0.110, 240, 109, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA7 NKT TCR
4258, 3dxaJ, 0.5207, 3.82, 0.103, 244, 107, CRYSTAL STRUCTURE OF THE DM1 TCR IN COMPLEX WITH HLA-B*4405 AND DECAMER EBV ANTIGEN
4259, 2o5yH, 0.5207, 3.94, 0.080, 219, 113, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
4260, 2j20B, 0.5207, 3.78, 0.028, 194, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273C
4261, 2j1xB, 0.5207, 3.78, 0.028, 195, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y220C-N239Y-N268D
4262, 2fjgL, 0.5207, 3.90, 0.103, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4263, 2ataC, 0.5207, 3.76, 0.038, 195, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
4264, 1nd0C, 0.5207, 3.88, 0.111, 219, 108, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4265, 1mjjL, 0.5207, 4.03, 0.101, 216, 109, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
4266, 1hu8B, 0.5207, 3.62, 0.019, 186, 105, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DNA-BINDING DOMAIN AT 2.7A RESOLUTION
4267, 1cr9L, 0.5207, 3.99, 0.138, 219, 109, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4
4268, 1beyL, 0.5207, 3.81, 0.093, 214, 107, ANTIBODY TO CAMPATH-1H HUMANIZED FAB
4269, 1ac6B, 0.5207, 3.59, 0.114, 110, 105, CRYSTAL STRUCTURE OF A VARIABLE DOMAIN MUTANT OF A T-CELL RECEPTOR ALPHA CHAIN
4270, 1a6vH, 0.5207, 3.82, 0.091, 118, 110, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
4271, 6qkdJ, 0.5206, 3.86, 0.090, 223, 111, CRYSTAL STRUCTURE OF VHH-BASED FAB-FRAGMENT OF ANTIBODY BCD-085 
4272, 6oz6H, 0.5206, 3.69, 0.084, 124, 107, CRYSTAL STRUCTURE OF MRAY BOUND TO 3 -HYDROXYMUREIDOMYCIN A 
4273, 6igoF, 0.5206, 3.90, 0.108, 119, 111, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
4274, 6ellL, 0.5206, 3.88, 0.103, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4275, 6eleL, 0.5206, 3.86, 0.103, 211, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4276, 6cw2B, 0.5206, 3.87, 0.093, 199, 107, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 1 
4277, 5yy4A, 0.5206, 3.86, 0.063, 236, 111, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH SULFATED EPITOPE PEPTIDE 
4278, 5wuxB, 0.5206, 3.84, 0.093, 212, 107, TNFALPHA-CERTOLIZUMAB FAB
4279, 5vtaH, 0.5206, 3.97, 0.080, 217, 113, CO-CRYSTAL STRUCTURE OF DPPIV WITH A CHEMIBODY INHIBITOR 
4280, 5th9M, 0.5206, 3.85, 0.103, 214, 107, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
4281, 5o1fA, 0.5206, 3.73, 0.028, 196, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB582 
4282, 5kzpH, 0.5206, 3.96, 0.088, 226, 113, STRUCTURE OF THE HCV1-C1 ANTIBODY-ANTIGEN COMPLEX
4283, 5iopB, 0.5206, 3.86, 0.081, 215, 111, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4284, 5hyjD, 0.5206, 3.78, 0.103, 193, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
4285, 5hj3N, 0.5206, 3.86, 0.102, 203, 108, CRYSTAL STRUCTURE OF HOST-PRIMED EBOLA VIRUS GP GPCL.
4286, 5f3bF, 0.5206, 3.84, 0.123, 213, 106, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
4287, 4ygvL, 0.5206, 4.01, 0.138, 218, 109, REVERSAL AGENT FOR DABIGATRAN
4288, 4rgnC, 0.5206, 3.81, 0.121, 213, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
4289, 4r90H, 0.5206, 4.10, 0.097, 224, 113, ANTI CD70 LLAMA GLAMA FAB 27B3
4290, 4olyH, 0.5206, 3.97, 0.080, 228, 113, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54R IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
4291, 4janH, 0.5206, 3.96, 0.080, 218, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
4292, 4irzL, 0.5206, 3.78, 0.085, 208, 106, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
4293, 4gkzB, 0.5206, 3.86, 0.110, 241, 109, HA1.7 A MHC CLASS II RESTRICTED TCR SPECIFIC FOR HAEMAGGLUTININ
4294, 4d9qE, 0.5206, 3.99, 0.080, 212, 113, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4295, 3qnxA, 0.5206, 3.89, 0.139, 219, 108, ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
4296, 3pqyS, 0.5206, 3.55, 0.160, 174, 106, CRYSTAL STRUCTURE OF 6218 TCR IN COMPLEX WITH THE H2DB-PA224
4297, 3lrsA, 0.5206, 4.06, 0.079, 221, 114, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4298, 3lh8A, 0.5206, 3.78, 0.076, 283, 105, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
4299, 3i9gL, 0.5206, 3.93, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
4300, 3gnmL, 0.5206, 4.01, 0.138, 217, 109, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
4301, 2vxtH, 0.5206, 3.93, 0.080, 207, 112, CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
4302, 2pcpC, 0.5206, 4.04, 0.138, 216, 109, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
4303, 2ianO, 0.5206, 3.79, 0.074, 238, 108, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4304, 2gj6E, 0.5206, 3.70, 0.075, 243, 107, THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS I MHC HLA-A2 WITH THE MODIFIED HTLV-1 TAX (Y5K-4-[3-INDOLYL]-BUTYRIC ACID) PEPTIDE
4305, 2bnuB, 0.5206, 3.74, 0.083, 241, 108, STRUCTURAL AND KINETIC BASIS FOR HEIGHTENED IMMUNOGENICITY OF T CELL VACCINES
4306, 2bipA, 0.5206, 3.76, 0.028, 185, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-H168R-V203A-N239Y-R249S- N268D
4307, 2ak4J, 0.5206, 3.83, 0.093, 241, 108, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
4308, 2ahiC, 0.5206, 3.77, 0.038, 193, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
4309, 2ac0C, 0.5206, 3.76, 0.038, 195, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
4310, 1hxmA, 0.5206, 3.70, 0.084, 206, 107, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
4311, 1h3pL, 0.5206, 3.98, 0.130, 219, 108, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
4312, 1cicC, 0.5206, 3.91, 0.112, 214, 107, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
4313, 1bfoH, 0.5206, 4.07, 0.105, 216, 114, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4314, 6igoA, 0.5205, 3.95, 0.107, 120, 112, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
4315, 6ggcA, 0.5205, 3.75, 0.028, 197, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9320 
4316, 6dlbH, 0.5205, 3.99, 0.062, 227, 113, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:1203D4 CHIMERA 
4317, 6anaH, 0.5205, 3.87, 0.107, 208, 112, LL2 FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
4318, 5udcL, 0.5205, 3.85, 0.093, 211, 107, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4319, 5myoD, 0.5205, 4.02, 0.071, 219, 113, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
4320, 5mv3S, 0.5205, 3.86, 0.120, 218, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4321, 5hyqB, 0.5205, 3.85, 0.081, 220, 111, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4322, 5eukB, 0.5205, 3.85, 0.081, 220, 111, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4323, 5dmiH, 0.5205, 3.96, 0.088, 223, 113, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB
4324, 5cgyC, 0.5205, 4.13, 0.087, 222, 115, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
4325, 4xcnH, 0.5205, 3.91, 0.080, 230, 112, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4326, 4xcnA, 0.5205, 4.01, 0.080, 227, 113, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4327, 4rgnL, 0.5205, 3.81, 0.121, 213, 107, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
4328, 4qtiH, 0.5205, 4.08, 0.096, 218, 114, CRYSTAL STRUCTURE OF HUMAN UPAR IN COMPLEX WITH ANTI-UPAR FAB 8B12
4329, 4pb9L, 0.5205, 3.90, 0.111, 216, 108, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64
4330, 4okvB, 0.5205, 4.01, 0.138, 218, 109, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4331, 4odwA, 0.5205, 3.92, 0.080, 208, 112, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY A6
4332, 4laqL, 0.5205, 4.04, 0.157, 118, 108, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
4333, 4imlH, 0.5205, 3.96, 0.071, 234, 113, CROSSFAB BINDING TO HUMAN ANGIOPOIETIN 2
4334, 4guoL, 0.5205, 3.73, 0.066, 201, 106, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4335, 4ei5H, 0.5205, 3.87, 0.130, 230, 108, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
4336, 4d9rH, 0.5205, 3.99, 0.080, 218, 113, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4337, 3zkmL, 0.5205, 3.86, 0.111, 217, 108, BACE2 FAB COMPLEX
4338, 3tt3L, 0.5205, 3.97, 0.119, 216, 109, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4339, 3tn0D, 0.5205, 3.73, 0.075, 235, 107, STRUCTURE OF MOUSE VA14VB8.2NKT TCR-MOUSE CD1D-A-C-GALACTOSYLCERAMIDE COMPLEX
4340, 3tn0C, 0.5205, 3.72, 0.156, 203, 109, STRUCTURE OF MOUSE VA14VB8.2NKT TCR-MOUSE CD1D-A-C-GALACTOSYLCERAMIDE COMPLEX
4341, 3mugH, 0.5205, 3.90, 0.080, 237, 112, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4342, 3mbeH, 0.5205, 3.80, 0.074, 236, 108, TCR 21.30 IN COMPLEX WITH MHC CLASS II I-AG7HEL(11-27)
4343, 2xwrA, 0.5205, 3.79, 0.038, 199, 106, CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF HUMAN P53 WITH EXTENDED N TERMINUS
4344, 2wbjH, 0.5205, 3.93, 0.091, 260, 110, TCR COMPLEX
4345, 2v7hA, 0.5205, 3.87, 0.093, 214, 107, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
4346, 2r29L, 0.5205, 3.87, 0.120, 204, 108, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
4347, 2gsiG, 0.5205, 4.00, 0.119, 215, 109, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4348, 2gsiD, 0.5205, 3.96, 0.071, 215, 112, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
4349, 2g5bC, 0.5205, 3.86, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4350, 2fjgA, 0.5205, 3.90, 0.103, 211, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4351, 2ak4E, 0.5205, 3.83, 0.093, 241, 108, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH HLA-B*3508- 13MER PEPTIDE
4352, 1yedA, 0.5205, 3.89, 0.148, 219, 108, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
4353, 1sbsL, 0.5205, 3.97, 0.130, 220, 108, CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
4354, 1q9oC, 0.5205, 3.85, 0.176, 219, 108, S45-18 FAB UNLIGANDED
4355, 1pkqF, 0.5205, 3.94, 0.111, 216, 108, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
4356, 1pkqA, 0.5205, 3.95, 0.111, 219, 108, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
4357, 1op3M, 0.5205, 3.89, 0.089, 224, 112, CRYSTAL STRUCTURE OF FAB 2G12 BOUND TO MAN1->2MAN
4358, 1nd0A, 0.5205, 3.88, 0.111, 219, 108, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4359, 1mrfL, 0.5205, 3.91, 0.139, 216, 108, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
4360, 1i8mH, 0.5205, 4.01, 0.088, 213, 113, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
4361, 1bfoF, 0.5205, 3.97, 0.080, 216, 113, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4362, 6idgH, 0.5204, 3.97, 0.106, 221, 113, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
4363, 6ff9B, 0.5204, 3.78, 0.038, 193, 106, MUTANT R280K OF HUMAN P53 
4364, 6eynD, 0.5204, 3.89, 0.080, 194, 112, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
4365, 6eljB, 0.5204, 3.85, 0.103, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4366, 6dfwH, 0.5204, 3.75, 0.065, 235, 107, TCR 8F10 IN COMPLEX WITH IAG7-P8G9E 
4367, 6c6zH, 0.5204, 3.84, 0.072, 224, 111, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
4368, 5tztB, 0.5204, 4.05, 0.128, 218, 109, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
4369, 5t5fL, 0.5204, 4.00, 0.111, 216, 108, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
4370, 5t1kA, 0.5204, 3.88, 0.103, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
4371, 5ob5L, 0.5204, 3.87, 0.103, 213, 107, FAB COMPLEX WITH GROBETA. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
4372, 5o1cA, 0.5204, 3.74, 0.028, 197, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB184 
4373, 5n2kK, 0.5204, 3.72, 0.094, 214, 106, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4374, 5myxC, 0.5204, 3.89, 0.139, 218, 108, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
4375, 5mp5A, 0.5204, 3.89, 0.089, 217, 112, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
4376, 5l0qB, 0.5204, 3.88, 0.121, 212, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
4377, 5k9jL, 0.5204, 3.90, 0.111, 212, 108, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.
4378, 5ir1D, 0.5204, 3.84, 0.081, 220, 111, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4379, 5imlB, 0.5204, 3.82, 0.073, 125, 109, NANOBODY TARGETING HUMAN VSIG4 IN SPACEGROUP P212121
4380, 5hysD, 0.5204, 3.98, 0.110, 217, 109, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4381, 5ff6D, 0.5204, 3.83, 0.081, 214, 111, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4382, 5ff6A, 0.5204, 3.87, 0.103, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4383, 5fc9C, 0.5204, 2.19, 0.159, 95, 88, NOVEL PURPLE CUPREDOXIN FROM NITROSOPUMILUS MARITIMUS
4384, 5euoG, 0.5204, 3.63, 0.133, 191, 105, PF6-M1-HLA-A2
4385, 5dumH, 0.5204, 4.03, 0.062, 219, 112, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 65C6
4386, 5dmgD, 0.5204, 3.94, 0.120, 217, 108, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
4387, 4q6iF, 0.5204, 3.89, 0.139, 218, 108, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
4388, 4q6iA, 0.5204, 3.89, 0.139, 218, 108, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
4389, 4nnpL, 0.5204, 3.88, 0.103, 213, 107, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
4390, 4njaH, 0.5204, 3.95, 0.071, 221, 112, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
4391, 4eupJ, 0.5204, 3.72, 0.103, 240, 107, THE COMPLEX BETWEEN TCR JKF6 AND HUMAN CLASS I MHC HLA-A2 PRESENTING THE MART-1(27-35)(A27L) PEPTIDE
4392, 4agnA, 0.5204, 3.75, 0.028, 197, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5116
4393, 4agmA, 0.5204, 3.75, 0.028, 197, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5086
4394, 3sknA, 0.5204, 3.74, 0.103, 197, 107, CRYSTAL STRUCTURE OF THE RL42 TCR UNLIGANDED
4395, 3mmeH, 0.5204, 4.05, 0.079, 235, 114, STRUCTURE AND FUNCTIONAL DISSECTION OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4396, 3cxdL, 0.5204, 3.91, 0.131, 213, 107, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE
4397, 3c60B, 0.5204, 3.76, 0.103, 236, 107, CRYSTAL STRUCTURE OF MOUSE MHC CLASS II I-AB/3K PEPTIDE COMPLEXED WITH MOUSE TCR YAE62
4398, 2v17H, 0.5204, 4.01, 0.071, 222, 113, STRUCTURE OF THE COMPLEX OF ANTIBODY MN423 WITH A FRAGMENT OF TAU PROTEIN
4399, 2r6pG, 0.5204, 3.87, 0.120, 206, 108, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
4400, 2r6pE, 0.5204, 3.87, 0.120, 206, 108, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
4401, 2nr6C, 0.5204, 3.81, 0.140, 211, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
4402, 2jelL, 0.5204, 4.04, 0.138, 217, 109, JEL42 FAB/HPR COMPLEX
4403, 2g2rH, 0.5204, 3.91, 0.072, 219, 111, GREEN-FLUORESCENT ANTIBODY 11G10 IN COMPLEX WITH ITS HAPTEN (NITRO-STILBENE DERIVATIVE)
4404, 2bimB, 0.5204, 3.78, 0.028, 195, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273H
4405, 2ahiD, 0.5204, 3.76, 0.038, 196, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
4406, 1npuA, 0.5204, 3.80, 0.093, 116, 107, CRYSTAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MURINE PD-1
4407, 1ngxL, 0.5204, 3.91, 0.112, 213, 107, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
4408, 1mjjB, 0.5204, 3.95, 0.107, 210, 112, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
4409, 1igyC, 0.5204, 3.86, 0.113, 213, 106, STRUCTURE OF IMMUNOGLOBULIN
4410, 1fskK, 0.5204, 3.95, 0.140, 214, 107, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
4411, 1fskH, 0.5204, 3.95, 0.140, 214, 107, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
4412, 1fskE, 0.5204, 3.95, 0.140, 214, 107, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
4413, 1fskB, 0.5204, 3.95, 0.140, 214, 107, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
4414, 1ad9B, 0.5204, 4.10, 0.088, 219, 114, IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
4415, 1ac6A, 0.5204, 3.58, 0.105, 110, 105, CRYSTAL STRUCTURE OF A VARIABLE DOMAIN MUTANT OF A T-CELL RECEPTOR ALPHA CHAIN
4416, 6mamA, 0.5203, 3.97, 0.124, 226, 113, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
4417, 6ggbA, 0.5203, 3.76, 0.028, 198, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9318 
4418, 6fr8B, 0.5203, 3.73, 0.103, 241, 107, HA1.7 HUMAN T-CELL RECEPTOR SPECIFIC FOR INFLUENZA VIRUS EPITOPE PKYVKQNTLKLAT PRESENTED BY HUMAN LEUKOCYTE ANTIGEN HLA-DR0101 
4419, 6dfwF, 0.5203, 3.76, 0.065, 237, 107, TCR 8F10 IN COMPLEX WITH IAG7-P8G9E 
4420, 6c9wB, 0.5203, 3.75, 0.081, 125, 111, CRYSTAL STRUCTURE OF A LIGAND BOUND LACY/NANOBODY COMPLEX 
4421, 6c5kL, 0.5203, 3.91, 0.130, 219, 108, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
4422, 5wkoG, 0.5203, 3.90, 0.089, 225, 112, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4423, 5vm6A, 0.5203, 3.99, 0.072, 129, 111, THE HAPTEN TRICLOCARBAN BOUND TO THE SINGLE DOMAIN CAMELID NANOBODY VHH T10 
4424, 5uqyG, 0.5203, 3.90, 0.093, 210, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4425, 5o1hA, 0.5203, 3.74, 0.028, 196, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB539 
4426, 5o1dA, 0.5203, 3.74, 0.028, 197, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB481 
4427, 5o1bA, 0.5203, 3.74, 0.028, 197, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB84 
4428, 5nivA, 0.5203, 3.91, 0.112, 212, 107, CRYSTAL STRUCTURE OF 5D3 FAB
4429, 5nb5L, 0.5203, 3.88, 0.130, 218, 108, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
4430, 5mubS, 0.5203, 3.87, 0.120, 217, 108, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4431, 5lgyB, 0.5203, 3.75, 0.038, 197, 106, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
4432, 5icyA, 0.5203, 3.88, 0.103, 212, 107, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
4433, 5hpmA, 0.5203, 3.87, 0.103, 213, 107, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
4434, 5eukD, 0.5203, 3.84, 0.081, 213, 111, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4435, 5eukA, 0.5203, 3.88, 0.103, 212, 107, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4436, 4zypG, 0.5203, 3.84, 0.093, 213, 107, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
4437, 4r7dP, 0.5203, 3.82, 0.093, 211, 107, FAB HU 15C1
4438, 4pb0L, 0.5203, 3.89, 0.139, 216, 108, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53
4439, 4p46B, 0.5203, 3.77, 0.093, 238, 107, J809.B5 Y31A TCR BOUND TO IAB3K
4440, 4oz4B, 0.5203, 3.85, 0.130, 218, 108, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
4441, 4ouuL, 0.5203, 4.05, 0.147, 217, 109, ANTI-MT1-MMP MONOCLONAL ANTIBODY
4442, 4olwH, 0.5203, 3.97, 0.080, 228, 113, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54H IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
4443, 4odsL, 0.5203, 3.88, 0.111, 218, 108, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3
4444, 4ma3A, 0.5203, 3.87, 0.103, 218, 107, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
4445, 4jhwL, 0.5203, 3.87, 0.093, 211, 107, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
4446, 4dvbB, 0.5203, 3.96, 0.111, 215, 108, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
4447, 3zkmD, 0.5203, 3.87, 0.111, 217, 108, BACE2 FAB COMPLEX
4448, 3t0eC, 0.5203, 3.56, 0.123, 193, 106, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX OF T CELL RECEPTOR PEPTIDE-MHC AND CD4
4449, 3qcvI, 0.5203, 4.16, 0.087, 219, 115, CRYSTAL STRUCTURE OF THE LT3015 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LYSOPHOSPHATIDIC ACID (18:2)
4450, 3o2vH, 0.5203, 3.94, 0.071, 219, 113, CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY
4451, 3lrsC, 0.5203, 4.13, 0.070, 228, 114, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4452, 3lh2H, 0.5203, 3.87, 0.080, 127, 112, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_1VI7A_S0_002_N 4E10 FV COMPLEX
4453, 3iy3A, 0.5203, 3.85, 0.121, 113, 107, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 8 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 8 COMPLEX
4454, 3hi1L, 0.5203, 3.89, 0.120, 215, 108, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
4455, 3eobA, 0.5203, 3.86, 0.103, 214, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
4456, 3chnO, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4457, 3chnN, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4458, 3chnM, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4459, 3chnL, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4460, 2qtjO, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4461, 2qtjN, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4462, 2qtjM, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4463, 2qtjL, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4464, 2ny4D, 0.5203, 4.01, 0.080, 222, 113, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (K231C T257S E268C S334A S375W) COMPLEXED WITH CD4 AND ANTIBODY 17B
4465, 2h1lQ, 0.5203, 3.77, 0.038, 199, 106, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4466, 2h1lM, 0.5203, 3.75, 0.038, 199, 106, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4467, 2g5bG, 0.5203, 3.95, 0.139, 217, 108, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4468, 2esgM, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4469, 2esgL, 0.5203, 3.89, 0.093, 214, 107, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4470, 2bmkH, 0.5203, 4.07, 0.070, 221, 114, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-D-ALANINE
4471, 1yjdL, 0.5203, 3.88, 0.103, 212, 107, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
4472, 1vgeL, 0.5203, 3.89, 0.093, 214, 107, TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
4473, 1q9kA, 0.5203, 3.98, 0.130, 219, 108, S25-2 FAB UNLIGANDED 1
4474, 1ngxA, 0.5203, 3.91, 0.112, 213, 107, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
4475, 1mfcH, 0.5203, 3.96, 0.097, 211, 113, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
4476, 1igaD, 0.5203, 3.89, 0.093, 214, 107, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4477, 1igaC, 0.5203, 3.89, 0.093, 214, 107, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4478, 1a6vJ, 0.5203, 3.95, 0.082, 120, 110, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-3-NITROPHENYL) ACETATE COMPOUND
4479, 6gs4H, 0.5202, 3.80, 0.065, 125, 108, CRYSTAL STRUCTURE OF PEPTIDE TRANSPORTER DTPA-NANOBODY IN COMPLEX WITH VALGANCICLOVIR 
4480, 6fxnM, 0.5202, 3.88, 0.062, 215, 112, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
4481, 6emjL, 0.5202, 3.86, 0.103, 211, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4482, 6c5kB, 0.5202, 3.90, 0.130, 219, 108, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
4483, 5vh4B, 0.5202, 3.89, 0.103, 213, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
4484, 5th2B, 0.5202, 3.83, 0.081, 216, 111, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
4485, 5nhtB, 0.5202, 3.75, 0.074, 242, 108, HUMAN 199.54-16 TCR IN COMPLEX WITH MELAN-A/MART-1 (26-35) PEPTIDE AND HLA-A2 
4486, 5mhsD, 0.5202, 3.99, 0.101, 214, 109, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
4487, 5jqdD, 0.5202, 4.06, 0.070, 214, 115, ANTIBODY FAB FRAGMENT
4488, 5iopD, 0.5202, 3.84, 0.081, 213, 111, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4489, 5i2iB, 0.5202, 3.84, 0.081, 220, 111, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4490, 5i1aL, 0.5202, 3.87, 0.084, 212, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
4491, 5i19L, 0.5202, 3.88, 0.103, 213, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39
4492, 5dlmL, 0.5202, 4.04, 0.147, 217, 109, COMPLEX OF INFLUENZA M2E AND ANTIBODY
4493, 5b4mD, 0.5202, 4.02, 0.128, 218, 109, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
4494, 5aolB, 0.5202, 3.78, 0.028, 197, 106, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND 3-BROMO-5- (TRIFLUOROMETHYL)BENZENE-12-DIAMINE
4495, 4yhnL, 0.5202, 4.03, 0.138, 218, 109, DABIGATRAN REVERSAL AGENT
4496, 4x6bD, 0.5202, 3.77, 0.083, 240, 108, BK6 TCR APO STRUCTURE
4497, 4r96A, 0.5202, 3.99, 0.102, 219, 108, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
4498, 4qxuL, 0.5202, 4.04, 0.147, 219, 109, NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY
4499, 4om0H, 0.5202, 3.97, 0.071, 228, 113, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54Y IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
4500, 4olzH, 0.5202, 3.97, 0.080, 228, 113, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54W IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
4501, 4nkoF, 0.5202, 3.86, 0.091, 121, 110, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4502, 4n5eD, 0.5202, 3.75, 0.083, 239, 108, 42F3 TCR PCPA12/H-2LD COMPLEX
4503, 4mhjW, 0.5202, 3.90, 0.089, 221, 112, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4504, 4mhjT, 0.5202, 3.90, 0.089, 220, 112, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4505, 4mhjR, 0.5202, 3.90, 0.089, 221, 112, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4506, 4mhjK, 0.5202, 3.90, 0.089, 221, 112, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4507, 4mhjH, 0.5202, 3.90, 0.089, 221, 112, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4508, 4mhjF, 0.5202, 3.90, 0.089, 221, 112, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4509, 4mhhK, 0.5202, 3.91, 0.130, 217, 108, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4510, 4mhhH, 0.5202, 3.90, 0.089, 222, 112, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4511, 4agpA, 0.5202, 3.76, 0.028, 196, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5176
4512, 3zmeA, 0.5202, 3.74, 0.028, 195, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE SMALL MOLECULE PHIKAN7242
4513, 3qnzA, 0.5202, 4.01, 0.120, 219, 108, ORTHORHOMBIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC TUBULIN PEPTIDE) SHARING SAME FV AS IGA
4514, 3mugB, 0.5202, 3.97, 0.080, 237, 113, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4515, 3iu3H, 0.5202, 3.87, 0.117, 215, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4516, 3i75A, 0.5202, 3.87, 0.093, 212, 107, ANTIBODY STRUCTURE
4517, 3et9F, 0.5202, 3.72, 0.073, 226, 109, CRYSTAL STRUCTURE OF THE ENGINEERED NEUTRALIZING ANTIBODY 1H
4518, 3au0A, 0.5202, 4.22, 0.080, 339, 112, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF CLFB:LIGAND INTERACTIONS
4519, 2nxyD, 0.5202, 4.01, 0.080, 227, 113, HIV-1 GP120 ENVELOPE GLYCOPROTEIN(S334A) COMPLEXED WITH CD4 AND ANTIBODY 17B
4520, 2ianT, 0.5202, 3.78, 0.074, 238, 108, STRUCTURAL BASIS FOR RECOGNITION OF MUTANT SELF BY A TUMOR- SPECIFIC MHC CLASS II-RESTRICTED TCR
4521, 2gk0L, 0.5202, 4.05, 0.147, 217, 109, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
4522, 2fgwL, 0.5202, 3.85, 0.103, 214, 107, X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
4523, 2biqA, 0.5202, 3.77, 0.028, 185, 106, HUMAN P53 CORE DOMAIN MUTANT T123A-M133L-H168R-V203A-N239Y- R249S-N268D
4524, 2a6dH, 0.5202, 3.89, 0.071, 218, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
4525, 1yedL, 0.5202, 3.89, 0.148, 219, 108, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
4526, 1wc7H, 0.5202, 4.06, 0.070, 223, 114, FAB FRAGMENT OF PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH PHOSPHOPYRIDOXYL-L-ALANINE
4527, 1q9wC, 0.5202, 3.87, 0.176, 219, 108, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
4528, 1nsnH, 0.5202, 3.99, 0.054, 210, 112, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
4529, 1nakL, 0.5202, 3.90, 0.148, 217, 108, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
4530, 1jnnL, 0.5202, 3.89, 0.140, 211, 107, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
4531, 1i7zD, 0.5202, 4.09, 0.114, 220, 114, ANTIBODY GNC92H2 BOUND TO LIGAND
4532, 1ghfH, 0.5202, 3.95, 0.071, 212, 113, ANTI-ANTI-IDIOTYPE GH1002 FAB FRAGMENT
4533, 6igoB, 0.5201, 3.90, 0.108, 119, 111, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
4534, 6emjB, 0.5201, 3.86, 0.103, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4535, 6dlaH, 0.5201, 4.00, 0.062, 226, 113, CRYSTAL STRUCTURES OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:7969D2 
4536, 6apbL, 0.5201, 3.86, 0.103, 212, 107, CRYSTAL STRUCTURE OF NON-NEUTRALIZING INFANT ANTIBODY ADI-14359 IN COMPLEX WITH POSTFUSION RSV F GLYCOPROTEIN
4537, 5wb9H, 0.5201, 4.02, 0.061, 220, 114, CRYSTAL STRUCTURE OF CD4 BINDING SITE ANTIBODY N60P23 IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 CORE 
4538, 5w0dB, 0.5201, 3.95, 0.062, 235, 113, INFERRED PRECURSOR (UCA) OF THE HUMAN ANTIBODY LINEAGE K03.12 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
4539, 5w08O, 0.5201, 4.03, 0.070, 235, 114, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4540, 5o1aA, 0.5201, 3.73, 0.028, 196, 106, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB240 
4541, 5lapB, 0.5201, 3.77, 0.028, 196, 106, P53 CANCER MUTANT Y220C WITH CYS182 ALKYLATION
4542, 5kvfL, 0.5201, 3.86, 0.148, 220, 108, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
4543, 5jofH, 0.5201, 4.09, 0.088, 224, 114, CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.
4544, 5hysB, 0.5201, 3.84, 0.102, 217, 108, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
4545, 5f9wB, 0.5201, 4.00, 0.071, 220, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4546, 5b3jE, 0.5201, 3.99, 0.088, 215, 113, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
4547, 4zs6H, 0.5201, 3.88, 0.109, 221, 110, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
4548, 4xbeL, 0.5201, 3.97, 0.083, 214, 108, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)).
4549, 4q6iL, 0.5201, 3.90, 0.139, 218, 108, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
4550, 4nkoC, 0.5201, 4.05, 0.128, 115, 109, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4551, 4kq4H, 0.5201, 3.96, 0.080, 225, 113, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
4552, 4hpoH, 0.5201, 4.04, 0.080, 217, 112, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 IN COMPLEX WITH V2 PEPTIDE
4553, 4guoK, 0.5201, 3.80, 0.075, 201, 106, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4554, 4guoJ, 0.5201, 3.76, 0.066, 199, 106, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4555, 4agqA, 0.5201, 3.76, 0.028, 195, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5196
4556, 4agoA, 0.5201, 3.76, 0.028, 196, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5174
4557, 3zknL, 0.5201, 3.86, 0.111, 217, 108, BACE2 FAB INHIBITOR COMPLEX
4558, 3sjvN, 0.5201, 3.65, 0.104, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
4559, 3sgeI, 0.5201, 4.01, 0.138, 219, 109, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
4560, 3s96B, 0.5201, 3.99, 0.117, 204, 111, CRYSTAL STRUCTURE OF 3B5H10
4561, 3qrgL, 0.5201, 3.90, 0.120, 217, 108, CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
4562, 3q01B, 0.5201, 3.74, 0.057, 233, 106, AN INDUCED FIT MECHANISM REGULATES P53 DNA BINDING KINETICS TO CONFER SEQUENCE SPECIFICITY
4563, 3q01A, 0.5201, 3.74, 0.057, 233, 106, AN INDUCED FIT MECHANISM REGULATES P53 DNA BINDING KINETICS TO CONFER SEQUENCE SPECIFICITY
4564, 3o2dH, 0.5201, 4.00, 0.097, 222, 113, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
4565, 3mo1A, 0.5201, 3.84, 0.139, 218, 108, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4566, 3lrsE, 0.5201, 4.12, 0.079, 221, 114, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4567, 3l95L, 0.5201, 3.85, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
4568, 3ijsD, 0.5201, 3.97, 0.071, 221, 113, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
4569, 3he6D, 0.5201, 3.79, 0.102, 236, 108, CRYSTAL STRUCTURE OF MOUSE CD1D-ALPHA-GALACTOSYLCERAMIDE WITH MOUSE VALPHA14-VBETA8.2 NKT TCR
4570, 3chnA, 0.5201, 4.01, 0.062, 475, 113, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4571, 2qtjC, 0.5201, 4.01, 0.062, 475, 113, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4572, 2qtjA, 0.5201, 4.01, 0.062, 475, 113, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4573, 2oqjK, 0.5201, 3.98, 0.080, 224, 113, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
4574, 2hffA, 0.5201, 3.87, 0.112, 213, 107, CRYSTAL STRUCTURE OF CB2 FAB
4575, 2esgA, 0.5201, 4.01, 0.062, 475, 113, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4576, 2adgA, 0.5201, 3.84, 0.123, 211, 106, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
4577, 2a6iB, 0.5201, 3.97, 0.088, 219, 113, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL
4578, 1zlvM, 0.5201, 3.90, 0.089, 217, 112, FAB 2G12 + MAN7
4579, 1xctC, 0.5201, 3.98, 0.156, 220, 109, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
4580, 1r70C, 0.5201, 3.89, 0.084, 214, 107, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
4581, 1q9wB, 0.5201, 4.04, 0.088, 226, 114, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
4582, 1kcvL, 0.5201, 3.88, 0.121, 214, 107, CRYSTAL STRUCTURE OF ANTIBODY PC282
4583, 1igaA, 0.5201, 4.01, 0.062, 475, 113, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4584, 1fl5A, 0.5201, 3.94, 0.139, 217, 108, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
4585, 6hjpG, 0.5200, 4.04, 0.080, 216, 113, STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
4586, 6csfB, 0.5200, 3.81, 0.121, 213, 107, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH D-ALANINE BOUND 
4587, 6ayzB, 0.5200, 4.05, 0.089, 220, 112, CRYSTAL STRUCTURE OF ASF1-FAB 12E COMPLEX
4588, 5tudB, 0.5200, 3.88, 0.104, 211, 106, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
4589, 5ivzA, 0.5200, 3.88, 0.103, 213, 107, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
4590, 5hyjI, 0.5200, 3.79, 0.103, 193, 107, 1E6 TCR IN COMPLEX WITH HLA-A02 CARRYING AQWGPDPAAA
4591, 5f9wH, 0.5200, 3.98, 0.071, 219, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4592, 5e08L, 0.5200, 3.86, 0.103, 215, 107, SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT
4593, 4qt5B, 0.5200, 3.96, 0.099, 207, 111, CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR
4594, 4plkG, 0.5200, 3.90, 0.112, 198, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4595, 4o5iQ, 0.5200, 3.97, 0.088, 226, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
4596, 4nwtH, 0.5200, 3.91, 0.062, 232, 113, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
4597, 4f9pD, 0.5200, 3.85, 0.090, 224, 111, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 103.2 SINGLE CHAIN ANTIBODY
4598, 4edwL, 0.5200, 3.86, 0.103, 214, 107, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
4599, 4bz1L, 0.5200, 3.84, 0.130, 218, 108, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
4600, 3u79C, 0.5200, 3.72, 0.114, 111, 105, AL-103 Y32F Y96F
4601, 3sn6N, 0.5200, 3.88, 0.092, 128, 109, CRYSTAL STRUCTURE OF THE BETA2 ADRENERGIC RECEPTOR-GS PROTEIN COMPLEX
4602, 3qjfA, 0.5200, 3.58, 0.135, 195, 104, CRYSTAL STRUCTURE OF THE 2B4 TCR
4603, 3o9wC, 0.5200, 3.76, 0.147, 203, 109, RECOGNITION OF A GLYCOLIPID ANTIGEN BY THE INKT CELL TCR
4604, 3k80B, 0.5200, 3.91, 0.064, 124, 110, STRUCTURE OF ESSENTIAL PROTEIN FROM TRYPANOSOMA BRUCEI
4605, 3ghbI, 0.5200, 4.08, 0.088, 235, 113, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
4606, 3cm9S, 0.5200, 3.81, 0.100, 585, 110, SOLUTION STRUCTURE OF HUMAN SIGA2
4607, 3c2aH, 0.5200, 4.02, 0.097, 231, 113, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
4608, 2q8aL, 0.5200, 3.90, 0.121, 214, 107, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
4609, 2ny6D, 0.5200, 3.92, 0.089, 222, 112, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T123C T257S V275CS334A S375W Q428C G431C) COMPLEXED WITH CD4 AND ANTIBODY 17B
4610, 2ny5H, 0.5200, 3.91, 0.089, 221, 112, HIV-1 GP120 ENVELOPE GLYCOPROTEIN (M95W W96C I109C T257S V275C S334A S375W Q428C A433M) COMPLEXED WITH CD4 AND ANTIBODY 17B
4611, 2h1pH, 0.5200, 4.09, 0.088, 220, 114, THE THREE-DIMENSIONAL STRUCTURES OF A POLYSACCHARIDE BINDING ANTIBODY TO CRYPTOCOCCUS NEOFORMANS AND ITS COMPLEX WITH A PEPTIDE FROM A PHAGE DISPLAY LIBRARY: IMPLICATIONS FOR THE IDENTIFICATION OF PEPTIDE MIMOTOPES
4612, 2fr4B, 0.5200, 4.10, 0.088, 214, 114, STRUCTURE OF FAB DNA-1 COMPLEXED WITH A STEM-LOOP DNA LIGAND
4613, 1yymR, 0.5200, 4.05, 0.088, 229, 114, CRYSTAL STRUCTURE OF F23 A SCORPION-TOXIN MIMIC OF CD4 IN COMPLEX WITH HIV-1 YU2 GP120 ENVELOPE GLYCOPROTEIN AND ANTI-HIV-1 ANTIBODY 17B
4614, 1xf3H, 0.5200, 3.93, 0.098, 216, 112, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4615, 1tupA, 0.5200, 3.77, 0.038, 196, 106, TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA
4616, 1tsrA, 0.5200, 3.77, 0.038, 196, 106, P53 CORE DOMAIN IN COMPLEX WITH DNA
4617, 1hu8A, 0.5200, 3.63, 0.019, 186, 105, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DNA-BINDING DOMAIN AT 2.7A RESOLUTION
4618, 6ewbJ, 0.5199, 4.11, 0.105, 207, 114, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
4619, 6dztM, 0.5199, 3.77, 0.109, 226, 110, CRYO-EM STRUCTURE OF NUCLEOSOME IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4620, 6dwiI, 0.5199, 3.97, 0.093, 211, 107, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4621, 5njdW, 0.5199, 3.71, 0.094, 214, 106, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
4622, 5ivzB, 0.5199, 3.85, 0.081, 216, 111, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
4623, 5ecgB, 0.5199, 3.79, 0.038, 183, 106, CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF 53BP1 IN COMPLEX WITH P53 AND H2AX-PSER139 (GAMMAH2AX)
4624, 5bjzD, 0.5199, 4.05, 0.080, 231, 113, CRYSTAL STRUCTURE OF MALTOSE BINDING PROTEIN IN COMPLEX WITH AN ALLOSTERIC SYNTHETIC ANTIBODY
4625, 4yhnB, 0.5199, 4.03, 0.138, 218, 109, DABIGATRAN REVERSAL AGENT
4626, 4q6iD, 0.5199, 3.89, 0.139, 218, 108, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
4627, 4fqrj, 0.5199, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4628, 4dvbL, 0.5199, 3.97, 0.111, 215, 108, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
4629, 3zknD, 0.5199, 3.87, 0.111, 217, 108, BACE2 FAB INHIBITOR COMPLEX
4630, 3vd1I, 0.5199, 3.72, 0.066, 199, 106, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4631, 3u46A, 0.5199, 4.02, 0.080, 225, 113, CH04H/CH02L P212121
4632, 3qnyA, 0.5199, 4.01, 0.120, 218, 108, MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
4633, 3l7fB, 0.5199, 3.82, 0.063, 220, 111, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
4634, 3i02A, 0.5199, 3.93, 0.157, 219, 108, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
4635, 3exjB, 0.5199, 3.78, 0.019, 194, 106, CRYSTAL STRUCTURE OF A P53 CORE TETRAMER BOUND TO DNA
4636, 32c2A, 0.5199, 3.79, 0.104, 217, 106, STRUCTURE OF AN ACTIVITY SUPPRESSING FAB FRAGMENT TO CYTOCHROME P450 AROMATASE
4637, 2xnaA, 0.5199, 3.72, 0.132, 199, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN T CELL RECEPTOR AND STAPHYLOCOCCAL ENTEROTOXIN
4638, 2r56L, 0.5199, 3.89, 0.103, 211, 107, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
4639, 2r2eB, 0.5199, 3.99, 0.088, 221, 113, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4640, 2icwL, 0.5199, 3.73, 0.084, 111, 107, CRYSTAL STRUCTURE OF A COMPLETE TERNARY COMPLEX BETWEEN TCR SUPERANTIGEN AND PEPTIDE-MHC CLASS II MOLECULE
4641, 2h1lX, 0.5199, 3.77, 0.038, 199, 106, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4642, 2adjA, 0.5199, 3.85, 0.103, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
4643, 1ymmE, 0.5199, 4.02, 0.081, 246, 111, TCR/HLA-DR2B/MBP-PEPTIDE COMPLEX
4644, 1rzjH, 0.5199, 3.96, 0.080, 229, 113, HIV-1 HXBC2 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH CD4 AND INDUCED NEUTRALIZING ANTIBODY 17B
4645, 1nd0E, 0.5199, 3.88, 0.111, 219, 108, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4646, 1hxmC, 0.5199, 3.70, 0.111, 206, 108, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
4647, 1bfoB, 0.5199, 3.97, 0.080, 216, 113, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4648, 6e0cN, 0.5198, 3.77, 0.109, 229, 110, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
4649, 6cqnE, 0.5198, 3.97, 0.110, 244, 109, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
4650, 6bdzH, 0.5198, 4.05, 0.062, 219, 113, ADAM10 EXTRACELLULAR DOMAIN BOUND BY THE 11G2 FAB
4651, 5w08G, 0.5198, 3.96, 0.062, 236, 113, A/TEXAS/50/2012(H3N2) INFLUENZA HEMAGGLUTININ IN COMPLEX WITH K03.12 FAB
4652, 5vh4L, 0.5198, 3.89, 0.103, 213, 107, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
4653, 5uqyO, 0.5198, 3.90, 0.093, 210, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4654, 5umiH, 0.5198, 3.92, 0.071, 213, 112, CLOSTRIDIUM DIFFICILE TCDA-CROPS BOUND TO PA50 FAB
4655, 5tl5H, 0.5198, 3.89, 0.098, 221, 112, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
4656, 5myoA, 0.5198, 3.92, 0.139, 219, 108, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
4657, 5kg9B, 0.5198, 4.07, 0.134, 218, 112, CRYSTAL STRUCTURE OF THE GP120 V2 ANTIBODY RE505-22 FAB FROM IGH- AND IGK-HUMANIZED MOUSE
4658, 5iv2A, 0.5198, 3.88, 0.103, 213, 107, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4659, 5ik3D, 0.5198, 3.99, 0.128, 218, 109, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E03 FAB FRAGMENT
4660, 5id1D, 0.5198, 3.85, 0.081, 212, 111, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
4661, 5f3bB, 0.5198, 3.85, 0.123, 213, 106, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
4662, 5d2lO, 0.5198, 3.78, 0.110, 187, 109, CRYSTAL STRUCTURE OF TCR C7 IN COMPLEX WITH HCMV NLV EPITOPE PRESENTED BY HLA-A2
4663, 5cp7E, 0.5198, 3.78, 0.150, 218, 107, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
4664, 5cipL, 0.5198, 3.84, 0.093, 212, 107, CRYSTAL STRUCTURE OF UNBOUND 4E10
4665, 5aokA, 0.5198, 3.65, 0.019, 195, 105, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE PHIKAN7099
4666, 4zs6C, 0.5198, 3.99, 0.098, 221, 112, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
4667, 4x7tA, 0.5198, 4.03, 0.062, 222, 113, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
4668, 4p23A, 0.5198, 3.67, 0.112, 199, 107, J809.B5 TCR BOUND TO IAB/3K
4669, 4jpkH, 0.5198, 4.09, 0.088, 221, 114, CRYSTAL STRUCTURE OF THE GERMLINE-TARGETING HIV-1 GP120 ENGINEERED OUTER DOMAIN EOD-GT6 IN COMPLEX WITH A PUTATIVE VRC01 GERMLINE PRECURSOR FAB
4670, 4g8fB, 0.5198, 3.80, 0.083, 243, 108, CRYSTAL STRUCTURE OF CLONE42 TCR
4671, 4fnlM, 0.5198, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4672, 3tzvB, 0.5198, 3.77, 0.103, 236, 107, CRYSTAL STRUCTURE OF AN INKT TCR IN COMPLEX WITH CD1D- LYSOPHOSPHATIDYLCHOLINE
4673, 3sjvD, 0.5198, 3.64, 0.104, 197, 106, CRYSTAL STRUCTURE OF THE RL42 TCR IN COMPLEX WITH HLA-B8-FLR
4674, 3qwoB, 0.5198, 3.85, 0.113, 210, 106, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
4675, 3o2wL, 0.5198, 3.90, 0.130, 218, 108, CRYSTAL STRUCTURE OF THE 1E9 PHEL89SER/LEUH47TRP/METH100BPHE FAB IN COMPLEX WITH A 39A11 TRANSITION STATE ANALOG
4676, 3lrsH, 0.5198, 4.09, 0.079, 220, 114, STRUCTURE OF PG16 AN ANTIBODY WITH BROAD AND POTENT NEUTRALIZATION OF HIV-1
4677, 3hi1A, 0.5198, 3.87, 0.111, 215, 108, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
4678, 3ghbH, 0.5198, 3.92, 0.107, 235, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
4679, 3bszL, 0.5198, 4.04, 0.119, 215, 109, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
4680, 2wgxB, 0.5198, 3.77, 0.038, 194, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I- N268D
4681, 2vlrE, 0.5198, 3.74, 0.075, 240, 107, THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN IMMUNODOMINANT T-CELL RECEPTOR ARE PROGRAMMED BY ITS VBETA DOMAIN
4682, 2oqjB, 0.5198, 3.88, 0.080, 224, 112, CRYSTAL STRUCTURE ANALYSIS OF FAB 2G12 IN COMPLEX WITH PEPTIDE 2G12.1
4683, 2mcpL, 0.5198, 3.97, 0.120, 220, 108, REFINED CRYSTAL STRUCTURE OF THE MC/PC603 FAB-PHOSPHOCHOLINE COMPLEX AT 3.1 ANGSTROMS RESOLUTION
4684, 2eh8L, 0.5198, 3.90, 0.130, 218, 108, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMANIZED KR127 FAB AND PRES1 PEPTIDE EPITOPE
4685, 1xedF, 0.5198, 3.59, 0.085, 111, 106, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
4686, 1kiuO, 0.5198, 2.93, 0.095, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
4687, 1kiuK, 0.5198, 2.93, 0.095, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
4688, 1kiuI, 0.5198, 2.93, 0.095, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
4689, 1igtC, 0.5198, 3.91, 0.093, 214, 107, STRUCTURE OF IMMUNOGLOBULIN
4690, 1forH, 0.5198, 3.90, 0.089, 219, 112, STRUCTURE DETERMINATION OF AN FAB FRAGMENT THAT NEUTRALIZES HUMAN RHINOVIRUS AND ANALYSIS OF THE FAB-VIRUS COMPLEX
4691, 6mngB, 0.5197, 3.77, 0.093, 239, 107, 4738 TCR BOUND TO IAB PADI4 
4692, 6igoD, 0.5197, 3.93, 0.107, 120, 112, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
4693, 6ff9A, 0.5197, 3.79, 0.038, 193, 106, MUTANT R280K OF HUMAN P53 
4694, 6erxM, 0.5197, 3.89, 0.062, 215, 112, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
4695, 6dl8A, 0.5197, 4.06, 0.079, 218, 114, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB VARIANT CH67:1203D4 CHIMERA 
4696, 6bj3D, 0.5197, 3.80, 0.119, 202, 109, TCR55 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
4697, 6a0zL, 0.5197, 3.96, 0.121, 212, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 BOUND TO H5N1 INFLUENZA HEMAGGLUTININ; HA HEAD REGION 
4698, 5xcvD, 0.5197, 3.85, 0.089, 167, 112, CRYSTAL STRUCTURE OF NZ-1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
4699, 5vsiL, 0.5197, 3.82, 0.094, 212, 106, CH1/CKAPPA FAB MUTANT 15.1
4700, 5vcoA, 0.5197, 3.92, 0.093, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4701, 5mx3B, 0.5197, 3.88, 0.176, 218, 108, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
4702, 5icyB, 0.5197, 3.75, 0.082, 219, 110, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
4703, 5e6iF, 0.5197, 3.68, 0.132, 198, 106, CRYSTAL STRUCTURE OF TCR PF8 IN COMPLEX WITH FLU MP(58-66) EPITOPE PRESENTED BY HLA-A2
4704, 5e2vL, 0.5197, 3.91, 0.093, 216, 108, ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE
4705, 5ab9B, 0.5197, 3.78, 0.028, 197, 106, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE 7-ETHYL-3-(PIPERIDIN-4-YL)-1H-INDOLE
4706, 4zezJ, 0.5197, 3.91, 0.092, 240, 109, CRYSTAL STRUCTURE OF HCV 1406 TCR/HCV NS3: 1406-1415/HLA-A2 COMPLEX
4707, 4yo0C, 0.5197, 3.89, 0.098, 198, 112, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
4708, 4x0kA, 0.5197, 3.99, 0.071, 235, 113, ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE
4709, 4pttB, 0.5197, 3.95, 0.081, 225, 111, CRYSTAL STRUCTURE OF ANTI-23F STREP FAB C05
4710, 4pp2A, 0.5197, 3.92, 0.093, 211, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4711, 4plkC, 0.5197, 3.85, 0.112, 198, 107, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4712, 4onhA, 0.5197, 3.60, 0.102, 201, 108, CRYSTAL STRUCTURE OF DN6 TCR
4713, 4mwfB, 0.5197, 3.84, 0.094, 211, 106, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
4714, 4lstH, 0.5197, 3.93, 0.071, 222, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 CLADE C STRAIN ZM176.66 GP120
4715, 4kxzQ, 0.5197, 3.97, 0.071, 217, 112, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4716, 4krpC, 0.5197, 3.88, 0.093, 211, 107, NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
4717, 4kphL, 0.5197, 3.84, 0.132, 209, 106, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
4718, 4fqrp, 0.5197, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4719, 4fp8M, 0.5197, 3.87, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4720, 4dtgL, 0.5197, 3.90, 0.130, 219, 108, HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
4721, 4dkeM, 0.5197, 3.83, 0.093, 212, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
4722, 3s96D, 0.5197, 4.04, 0.117, 203, 111, CRYSTAL STRUCTURE OF 3B5H10
4723, 3rugF, 0.5197, 3.77, 0.084, 236, 107, CRYSTAL STRUCTURE OF VALPHA10-VBETA8.1 NKT TCR IN COMPLEX WITH CD1D- ALPHAGLUCOSYLCERAMIDE (C20:2)
4724, 3mugD, 0.5197, 3.95, 0.080, 237, 112, CRYSTAL STRUCTURE OF HUMAN FAB PG16 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4725, 3lhaA, 0.5197, 3.79, 0.076, 283, 105, CRYSTAL STRUCTURE OF MOUSE VPS26B(R240S/G241A/E242S) IN SPACEGROUP P41 21 2
4726, 3hmwL, 0.5197, 3.81, 0.103, 214, 107, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
4727, 3fmgH, 0.5197, 4.10, 0.070, 221, 114, STRUCTURE OF ROTAVIRUS OUTER CAPSID PROTEIN VP7 TRIMER IN COMPLEX WITH A NEUTRALIZING FAB
4728, 2ymxH, 0.5197, 4.10, 0.079, 222, 114, CRYSTAL STRUCTURE OF INHIBITORY ANTI-ACHE FAB408
4729, 2p5eE, 0.5197, 3.78, 0.083, 241, 108, CRYSTAL STRUCTURES OF HIGH AFFINITY HUMAN T-CELL RECEPTORS BOUND TO PMHC REVEAL NATIVE DIAGONAL BINDING GEOMETRY
4730, 2j4wL, 0.5197, 3.91, 0.104, 212, 106, STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX
4731, 2j21B, 0.5197, 3.77, 0.028, 188, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R282W
4732, 2g5bA, 0.5197, 3.87, 0.120, 217, 108, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
4733, 2adfL, 0.5197, 3.90, 0.103, 209, 107, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
4734, 1rz8A, 0.5197, 3.87, 0.112, 214, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
4735, 1ncbL, 0.5197, 3.89, 0.150, 214, 107, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
4736, 1mreL, 0.5197, 3.92, 0.139, 218, 108, PREPARATION CHARACTERIZATION AND CRYSTALLIZATION OF AN ANTIBODY FAB FRAGMENT THAT RECOGNIZES RNA. CRYSTAL STRUCTURES OF NATIVE FAB AND THREE FAB-MONONUCLEOTIDE COMPLEXES
4737, 1mlcA, 0.5197, 3.95, 0.121, 214, 107, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
4738, 1kiuM, 0.5197, 2.93, 0.095, 205, 95, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
4739, 1jp5B, 0.5197, 3.99, 0.062, 232, 112, CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-1 PROTEASE
4740, 1jp5A, 0.5197, 3.99, 0.062, 232, 112, CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-1 PROTEASE
4741, 6fg1A, 0.5196, 4.01, 0.071, 236, 113, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA32. 
4742, 6dfvD, 0.5196, 3.81, 0.111, 240, 108, MOUSE DIABETOGENIC TCR 8F10 
4743, 5wkoC, 0.5196, 4.01, 0.088, 225, 113, CRYSTAL STRUCTURE OF ANTIBODY 27F3 RECOGNIZING THE HA FROM A/CALIFORNIA/04/2009 (H1N1) INFLUENZA VIRUS
4744, 5n2kM, 0.5196, 3.72, 0.094, 212, 106, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4745, 5id0B, 0.5196, 3.75, 0.082, 219, 110, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
4746, 5icxB, 0.5196, 3.84, 0.081, 220, 111, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
4747, 5i1iL, 0.5196, 4.02, 0.120, 219, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV4-1
4748, 5hhmJ, 0.5196, 3.85, 0.074, 240, 108, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-F5L
4749, 5ggsC, 0.5196, 4.04, 0.070, 220, 114, PD-1 IN COMPLEX WITH PEMBROLIZUMAB FAB
4750, 5ggrH, 0.5196, 3.96, 0.073, 207, 110, PD-1 IN COMPLEX WITH NIVOLUMAB FAB
4751, 5etuD, 0.5196, 3.85, 0.081, 214, 111, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
4752, 5ea0L, 0.5196, 3.99, 0.111, 219, 108, STRUCTURE OF THE ANTIBODY 7968 WITH HUMAN COMPLEMENT FACTOR H-DERIVED PEPTIDE
4753, 5dyoA, 0.5196, 3.81, 0.100, 205, 110, FAB43.1 COMPLEX WITH FLOURESCEIN
4754, 5ds8H, 0.5196, 3.75, 0.037, 203, 108, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH HYPUSINE
4755, 5dk3A, 0.5196, 3.88, 0.074, 218, 108, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
4756, 5cp3A, 0.5196, 4.02, 0.147, 218, 109, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
4757, 5cipB, 0.5196, 3.84, 0.093, 212, 107, CRYSTAL STRUCTURE OF UNBOUND 4E10
4758, 5a8hR, 0.5196, 3.85, 0.063, 224, 111, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4759, 5a8hL, 0.5196, 3.85, 0.063, 224, 111, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4760, 5a8hF, 0.5196, 3.85, 0.063, 224, 111, CRYO-ET SUBTOMOGRAM AVERAGING OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4761, 5a7xR, 0.5196, 3.85, 0.063, 224, 111, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4762, 5a7xP, 0.5196, 3.85, 0.063, 224, 111, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4763, 5a7xN, 0.5196, 3.85, 0.063, 224, 111, NEGATIVE STAIN EM OF BG505 SOSIP.664 IN COMPLEX WITH SCD4 17B AND 8ANC195
4764, 4p9mH, 0.5196, 3.85, 0.063, 224, 111, CRYSTAL STRUCTURE OF 8ANC195 FAB
4765, 4ouuA, 0.5196, 4.06, 0.147, 217, 109, ANTI-MT1-MMP MONOCLONAL ANTIBODY
4766, 4olvH, 0.5196, 4.03, 0.079, 228, 114, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54F IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
4767, 4o51A, 0.5196, 3.89, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE QAA VARIANT OF ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
4768, 4lsuH, 0.5196, 3.98, 0.080, 221, 113, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC- PG20 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4769, 4jkpH, 0.5196, 4.04, 0.080, 221, 113, RESTRICTING HIV-1 PATHWAYS FOR ESCAPE USING RATIONALLY-DESIGNED ANTI- HIV-1 ANTIBODIES
4770, 4ei6D, 0.5196, 3.70, 0.132, 241, 106, STRUCTURE OF XV19 VALPHA1-VBETA16 TYPE-II NATURAL KILLER T CELL RECEPTOR
4771, 4ei5D, 0.5196, 3.79, 0.131, 242, 107, CRYSTAL STRUCTURE OF XV19 TCR IN COMPLEX WITH CD1D-SULFATIDE C24:1
4772, 4dkeL, 0.5196, 3.87, 0.103, 214, 107, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
4773, 3qumB, 0.5196, 3.94, 0.062, 219, 113, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4774, 3ob0H, 0.5196, 3.93, 0.089, 220, 112, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4775, 3oazH, 0.5196, 3.99, 0.097, 223, 113, A NON-SELF SUGAR MIMIC OF THE HIV GLYCAN SHIELD SHOWS ENHANCED ANTIGENICITY
4776, 3o2vL, 0.5196, 3.91, 0.130, 218, 108, CRYSTAL STRUCTURE OF 1E9 PHEL89SER/LEUH47TRP/METH100BPHE AN ENGINEERED DIELS-ALDERASE FAB WITH MODIFIED SPECIFICITY AND CATALYTIC ACTIVITY
4777, 3mo1B, 0.5196, 4.00, 0.097, 215, 113, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4778, 3mnvC, 0.5196, 3.86, 0.139, 220, 108, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4779, 3j3pL, 0.5196, 3.84, 0.140, 219, 107, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 135S POLIOVIRUS AND C3-FAB COMPLEX
4780, 3ijhD, 0.5196, 3.98, 0.080, 221, 113, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4781, 3d09A, 0.5196, 3.78, 0.038, 188, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND-SITE SUPPRESSOR MUTATIONS H168R AND T123A
4782, 3bquD, 0.5196, 4.03, 0.080, 217, 113, CRYSTAL STRUCTURE OF THE 2F5 FAB -3H6 FAB COMPLEX
4783, 2znwB, 0.5196, 3.99, 0.071, 221, 112, CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
4784, 2xwrB, 0.5196, 3.80, 0.038, 200, 106, CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF HUMAN P53 WITH EXTENDED N TERMINUS
4785, 2hfgL, 0.5196, 3.81, 0.103, 213, 107, CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
4786, 1qrnE, 0.5196, 3.76, 0.083, 243, 108, CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED WITH HLA-A2 BOUND TO ALTERED HTLV-1 TAX PEPTIDE P6A
4787, 1nfdH, 0.5196, 3.94, 0.089, 222, 112, AN ALPHA-BETA T CELL RECEPTOR (TCR) HETERODIMER IN COMPLEX WITH AN ANTI-TCR FAB FRAGMENT DERIVED FROM A MITOGENIC ANTIBODY
4788, 1n4xH, 0.5196, 3.88, 0.064, 120, 110, STRUCTURE OF SCFV 1696 AT ACIDIC PH
4789, 1mh5L, 0.5196, 4.01, 0.093, 212, 108, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
4790, 1jckC, 0.5196, 3.82, 0.120, 238, 108, T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN
4791, 1jckA, 0.5196, 3.82, 0.120, 238, 108, T-CELL RECEPTOR BETA CHAIN COMPLEXED WITH SEC3 SUPERANTIGEN
4792, 1il1B, 0.5196, 3.86, 0.130, 219, 108, CRYSTAL STRUCTURE OF G3-519 AN ANTI-HIV MONOCLONAL ANTIBODY
4793, 1bfoD, 0.5196, 3.98, 0.080, 216, 113, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
4794, 1ap2B, 0.5196, 3.78, 0.064, 120, 109, SINGLE CHAIN FV OF C219
4795, 1ao7E, 0.5196, 3.71, 0.083, 209, 108, COMPLEX BETWEEN HUMAN T-CELL RECEPTOR VIRAL PEPTIDE (TAX) AND HLA-A 0201
4796, 6oikH, 0.5195, 3.96, 0.089, 236, 112, MUSCARINIC ACETYLCHOLINE RECEPTOR 2-GO COMPLEX 
4797, 6ff9D, 0.5195, 3.81, 0.038, 193, 106, MUTANT R280K OF HUMAN P53 
4798, 6dwiP, 0.5195, 3.92, 0.090, 204, 111, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4799, 6dfvB, 0.5195, 3.79, 0.093, 240, 108, MOUSE DIABETOGENIC TCR 8F10 
4800, 6cqrE, 0.5195, 3.97, 0.119, 245, 109, CRYSTAL STRUCTURE OF AN IMMUNE RECEPTOR 
4801, 6bpaB, 0.5195, 3.86, 0.089, 217, 112, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
4802, 6bj8D, 0.5195, 3.81, 0.119, 201, 109, TCR55 IN COMPLEX WITH PEP20/HLA-B35 
4803, 6apdD, 0.5195, 4.10, 0.079, 221, 114, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4804, 5xotD, 0.5195, 3.75, 0.119, 203, 109, CRYSTAL STRUCTURE OF PHLA-B35 IN COMPLEX WITH TU55 T CELL RECEPTOR
4805, 5wuxL, 0.5195, 3.89, 0.093, 213, 107, TNFALPHA-CERTOLIZUMAB FAB
4806, 5umnD, 0.5195, 3.89, 0.093, 213, 107, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4807, 5tdpC, 0.5195, 3.88, 0.112, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4808, 5t3xD, 0.5195, 3.86, 0.062, 229, 112, 3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.
4809, 5t1mD, 0.5195, 3.76, 0.082, 215, 110, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
4810, 5iw1E, 0.5195, 3.79, 0.101, 189, 109, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
4811, 5ifhH, 0.5195, 3.98, 0.071, 178, 112, CRYSTAL STRUCTURE OF THE BCR FAB FRAGMENT FROM SUBSET  2 CASE P11475
4812, 5i1gL, 0.5195, 3.83, 0.093, 211, 107, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-11
4813, 5fhxL, 0.5195, 3.89, 0.111, 334, 108, CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.
4814, 5fhcA, 0.5195, 3.97, 0.070, 221, 114, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
4815, 5dubH, 0.5195, 3.74, 0.046, 206, 108, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
4816, 5dubA, 0.5195, 3.87, 0.055, 208, 109, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
4817, 4yk4Y, 0.5195, 3.80, 0.112, 211, 107, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
4818, 4xakH, 0.5195, 3.94, 0.071, 227, 113, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD
4819, 4s1dF, 0.5195, 3.93, 0.140, 213, 107, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
4820, 4qt5H, 0.5195, 3.95, 0.099, 207, 111, CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR
4821, 4nylF, 0.5195, 3.80, 0.104, 124, 106, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
4822, 4jn1L, 0.5195, 4.04, 0.119, 219, 109, AN ANTIDOTE FOR DABIGATRAN
4823, 4hiiD, 0.5195, 4.03, 0.080, 203, 113, ANTI-STREPTOCOCCUS PNEUMONIAE 23F FAB 023.102 WITH BOUND RHAMNOSE- GALACTOSE
4824, 4hg4X, 0.5195, 4.01, 0.071, 164, 112, CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4825, 4fqrt, 0.5195, 3.87, 0.093, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4826, 4fqrd, 0.5195, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4827, 4cniL, 0.5195, 3.87, 0.104, 214, 106, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
4828, 3x2dO, 0.5195, 3.88, 0.103, 211, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4829, 3vd1J, 0.5195, 3.75, 0.066, 199, 106, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4830, 3vd0C, 0.5195, 3.73, 0.066, 202, 106, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4831, 3qo0A, 0.5195, 3.90, 0.121, 219, 107, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA
4832, 3nz8B, 0.5195, 3.89, 0.139, 217, 108, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
4833, 3fctC, 0.5195, 3.81, 0.103, 213, 107, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
4834, 3eo1K, 0.5195, 4.09, 0.053, 216, 114, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
4835, 3eo1H, 0.5195, 3.96, 0.062, 216, 113, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
4836, 3eo1E, 0.5195, 4.09, 0.053, 216, 114, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
4837, 3eo1B, 0.5195, 3.96, 0.062, 216, 113, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
4838, 3bszM, 0.5195, 4.04, 0.119, 215, 109, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
4839, 1z3gL, 0.5195, 3.85, 0.113, 213, 106, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
4840, 1wtlB, 0.5195, 3.77, 0.095, 108, 105, COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS
4841, 1uwgY, 0.5195, 3.79, 0.073, 208, 110, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
4842, 1lo4L, 0.5195, 3.88, 0.130, 217, 108, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
4843, 1jtpA, 0.5195, 3.93, 0.080, 135, 113, DEGENERATE INTERFACES IN ANTIGEN-ANTIBODY COMPLEXES
4844, 1iqdB, 0.5195, 4.11, 0.088, 200, 114, HUMAN FACTOR VIII C2 DOMAIN COMPLEXED TO HUMAN MONOCLONAL BO2C11 FAB.
4845, 1ce1L, 0.5195, 3.87, 0.093, 211, 107, 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
4846, 6ol6A, 0.5194, 3.94, 0.080, 216, 112, STRUCTURE OF IGLB12 SCFV IN COMPLEX WITH ANTI-IDIOTYPE IB2 FAB 
4847, 6mngA, 0.5194, 3.72, 0.120, 199, 108, 4738 TCR BOUND TO IAB PADI4 
4848, 6i53G, 0.5194, 3.88, 0.054, 123, 111, CRYO-EM STRUCTURE OF THE HUMAN SYNAPTIC ALPHA1-BETA3-GAMMA2 GABAA RECEPTOR IN COMPLEX WITH MEGABODY38 IN A LIPID NANODISC 
4849, 6ewbE, 0.5194, 4.12, 0.105, 195, 114, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
4850, 6eluH, 0.5194, 3.99, 0.088, 222, 113, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4851, 6dc3H, 0.5194, 4.03, 0.078, 229, 115, RSV PREFUSION F BOUND TO RSD5 FAB 
4852, 6cx9C, 0.5194, 3.80, 0.147, 201, 109, STRUCTURE OF ALPHA-GSA[16;6P] BOUND BY CD1D AND IN COMPLEX WITH THE VA14VB8.2 TCR 
4853, 6bf4C, 0.5194, 3.91, 0.120, 219, 108, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
4854, 6azmA, 0.5194, 3.85, 0.120, 219, 108, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
4855, 6apdO, 0.5194, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4856, 6apdL, 0.5194, 3.82, 0.104, 213, 106, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4857, 5wn9H, 0.5194, 3.87, 0.071, 236, 112, STRUCTURE OF ANTIBODY 2D10 BOUND TO THE CENTRAL CONSERVED REGION OF RSV G
4858, 5wl2A, 0.5194, 4.10, 0.079, 221, 114, VH1-69 GERMLINE ANTIBODY WITH CDR H3 SEQUENCE OF CR9114 
4859, 5w3pH, 0.5194, 4.00, 0.071, 214, 112, ANTIBODY C706 IN COMPLEX WTH BETA-AMYLOID PEPTIDE 1-16
4860, 5uddR, 0.5194, 3.85, 0.093, 211, 107, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4861, 5t1kD, 0.5194, 3.85, 0.081, 215, 111, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
4862, 5lgyD, 0.5194, 3.76, 0.038, 196, 106, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH THE BAX RESPONSE ELEMENT.
4863, 5jhlH, 0.5194, 3.90, 0.080, 216, 112, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
4864, 5iw1A, 0.5194, 3.77, 0.101, 189, 109, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR
4865, 5i71C, 0.5194, 3.84, 0.131, 214, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
4866, 5e1aB, 0.5194, 3.83, 0.131, 212, 107, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
4867, 4xcyE, 0.5194, 3.93, 0.080, 223, 112, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4868, 4uduB, 0.5194, 3.86, 0.120, 238, 108, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN E IN COMPLEX WITH A T CELL RECEPTOR
4869, 4okvD, 0.5194, 4.03, 0.138, 218, 109, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4870, 4lriA, 0.5194, 3.84, 0.102, 217, 108, ANTI CMV FAB FRAGMENT
4871, 4kvpD, 0.5194, 3.80, 0.038, 194, 106, HUMAN P53 CORE DOMAIN MUTANT V157F
4872, 4jn2L, 0.5194, 3.90, 0.120, 219, 108, AN ANTIDOTE FOR DABIGATRAN
4873, 4fp8L, 0.5194, 3.88, 0.093, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4874, 4agnB, 0.5194, 3.78, 0.028, 197, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5116
4875, 3vd1K, 0.5194, 3.79, 0.075, 202, 106, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4876, 3t4yA, 0.5194, 3.99, 0.147, 219, 109, S25-2- KDO MONOSACCHARIDE COMPLEX
4877, 3s37H, 0.5194, 3.95, 0.099, 209, 111, STRUCTURAL BASIS FOR THE FUNCTION OF TWO ANTI-VEGF RECEPTOR ANTIBODIES
4878, 3oklA, 0.5194, 3.84, 0.120, 219, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
4879, 3mclH, 0.5194, 3.92, 0.080, 227, 112, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21
4880, 3kxfE, 0.5194, 3.85, 0.093, 241, 108, CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX WITH THE  RESTRICTION TRIAD  MUTANT HLA-B*3508-13MER
4881, 3ikcD, 0.5194, 4.01, 0.080, 221, 113, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
4882, 3i02C, 0.5194, 3.83, 0.130, 196, 108, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
4883, 3hc3H, 0.5194, 3.99, 0.088, 212, 113, BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
4884, 3h3pI, 0.5194, 3.93, 0.098, 126, 112, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
4885, 1ypzG, 0.5194, 3.59, 0.125, 207, 104, IMMUNE RECEPTOR
4886, 1xf4L, 0.5194, 3.97, 0.140, 213, 107, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4887, 1nakM, 0.5194, 3.91, 0.148, 217, 108, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
4888, 1becA, 0.5194, 3.82, 0.120, 238, 108, BETA CHAIN OF A T CELL ANTIGEN RECEPTOR
4889, 6mnnB, 0.5193, 3.75, 0.103, 239, 107, 6236 TCR BOUND TO I-AB PADI4 
4890, 6mnmA, 0.5193, 3.73, 0.120, 196, 108, 6256 TCR BOUND TO I-AB PADI4 
4891, 6hjpK, 0.5193, 4.00, 0.080, 216, 113, STRUCTURE OF INFLUENZA HEMAGGLUTININ ECTODOMAIN (A/DUCK/ALBERTA/35/76) IN COMPLEX WITH FISW84 FAB FRAGMENT 
4892, 6eluB, 0.5193, 3.99, 0.088, 222, 113, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4893, 6e3hH, 0.5193, 4.00, 0.097, 226, 113, CRYSTAL STRUCTURE OF S9-3-37 BOUND TO H5 INFLUENZA HEMAGGLUTININ 
4894, 6bj2D, 0.5193, 3.73, 0.093, 202, 108, TCR589 IN COMPLEX WITH HIV(POL448-456)/HLA-B35 
4895, 6bf4L, 0.5193, 4.03, 0.119, 218, 109, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
4896, 5v52D, 0.5193, 4.01, 0.117, 127, 111, STRUCTURE OF TIGIT BOUND TO NECTIN-2 (CD112)
4897, 5jxeG, 0.5193, 4.09, 0.070, 218, 114, HUMAN PD-1 ECTODOMAIN COMPLEXED WITH PEMBROLIZUMAB FAB
4898, 5ivxF, 0.5193, 3.86, 0.119, 234, 109, CRYSTAL STRUCTURE OF B4.2.3 T-CELL RECEPTOR AND H2-DD P18-I10 COMPLEX
4899, 5i2iA, 0.5193, 3.88, 0.103, 213, 107, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4900, 5fuuM, 0.5193, 3.83, 0.090, 135, 111, ECTODOMAIN OF CLEAVED WILD TYPE JR-FL ENVDCT TRIMER IN COMPLEX WITH PGT151 FAB
4901, 5ff6B, 0.5193, 3.84, 0.081, 220, 111, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4902, 5fecH, 0.5193, 3.99, 0.071, 215, 113, CRYSTAL STRUCTURE OF 3BNC60 FAB GERMLINE PRECURSOR IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120
4903, 5etuB, 0.5193, 3.85, 0.081, 216, 111, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
4904, 5etuA, 0.5193, 3.89, 0.121, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
4905, 5aojA, 0.5193, 3.66, 0.019, 195, 105, STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH 2- HYDROXY-35-DIIODO-4-(1H-PYRROL-1-YL)BENZOIC ACID
4906, 4r3sA, 0.5193, 3.82, 0.090, 114, 111, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 11-23
4907, 4plkD, 0.5193, 3.84, 0.082, 218, 110, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4908, 4nztL, 0.5193, 3.84, 0.132, 212, 106, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4909, 4lmqH, 0.5193, 3.94, 0.062, 220, 112, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
4910, 4kxzM, 0.5193, 4.02, 0.093, 213, 108, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4911, 4ffzZ, 0.5193, 4.00, 0.080, 217, 113, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
4912, 3vd2B, 0.5193, 3.74, 0.066, 200, 106, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4913, 3qh3A, 0.5193, 3.74, 0.066, 194, 106, THE CRYSTAL STRUCTURE OF TCR A6
4914, 3n9gL, 0.5193, 3.87, 0.131, 220, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI- WEST NILE VIRUS MAB CR4354
4915, 3kj4B, 0.5193, 4.02, 0.138, 219, 109, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
4916, 3ck0L, 0.5193, 3.85, 0.120, 216, 108, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH HUMAN ANGIOTENSIN II
4917, 2znwA, 0.5193, 3.98, 0.062, 221, 112, CRYSTAL STRUCTURE OF SCFV10 IN COMPLEX WITH HEN EGG LYSOZYME
4918, 2vukB, 0.5193, 3.78, 0.028, 196, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL-MOLECULE DRUG PHIKAN083
4919, 2vq1E, 0.5193, 4.02, 0.128, 216, 109, ANTI TRIMERIC LEWIS X FAB54-5C10-A
4920, 2fr4H, 0.5193, 4.03, 0.080, 214, 113, STRUCTURE OF FAB DNA-1 COMPLEXED WITH A STEM-LOOP DNA LIGAND
4921, 2c1oB, 0.5193, 4.11, 0.096, 217, 114, ENAIIHIS FAB FRAGMENT IN THE FREE FORM
4922, 2adiA, 0.5193, 3.86, 0.103, 211, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
4923, 1xf2H, 0.5193, 3.99, 0.097, 213, 113, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
4924, 1wcbB, 0.5193, 4.00, 0.097, 224, 113, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
4925, 1nbvH, 0.5193, 4.04, 0.088, 219, 113, AN AUTOANTIBODY TO SINGLE-STRANDED DNA: COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF THE UNLIGANDED FAB AND A DEOXYNUCLEOTIDE-FAB COMPLEX
4926, 6mnoB, 0.5192, 3.77, 0.093, 239, 107, 6235 TCR BOUND TO I-AB PADI4 
4927, 6ff9C, 0.5192, 3.79, 0.038, 193, 106, MUTANT R280K OF HUMAN P53 
4928, 6eluE, 0.5192, 4.01, 0.088, 222, 113, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4929, 6eljL, 0.5192, 3.88, 0.103, 212, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4930, 6eleB, 0.5192, 3.87, 0.103, 213, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4931, 6cdih, 0.5192, 3.73, 0.092, 116, 109, CRYO-EM STRUCTURE AT 3.6 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4932, 6cdiH, 0.5192, 3.73, 0.092, 116, 109, CRYO-EM STRUCTURE AT 3.6 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4933, 6cdi3, 0.5192, 3.73, 0.092, 116, 109, CRYO-EM STRUCTURE AT 3.6 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4934, 6avgC, 0.5192, 3.58, 0.150, 196, 107, CRYSTAL STRUCTURE OF THE KFJ37 TCR-NY-ESO-1-HLA-B*07:02 COMPLEX
4935, 5vkkB, 0.5192, 3.85, 0.111, 219, 108, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
4936, 5te6H, 0.5192, 4.00, 0.097, 223, 113, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE
4937, 5tdoC, 0.5192, 3.91, 0.112, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4938, 5jofE, 0.5192, 3.92, 0.071, 224, 112, CRYSTAL STRUCTURE OF VRC03 GHVGLV ANTIGEN-BINDING FRAGMENT.
4939, 5immA, 0.5192, 3.96, 0.073, 120, 109, NANOBODY TARGETING MOUSE VSIG4 IN SPACEGROUP P212121
4940, 5id0A, 0.5192, 3.89, 0.103, 212, 107, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
4941, 5hhoE, 0.5192, 3.84, 0.074, 240, 108, CRYSTAL STRUCTURE OF THE JM22 TCR IN COMPLEX WITH HLA-A*0201 IN COMPLEX WITH M1-G4E
4942, 5fhbH, 0.5192, 3.90, 0.080, 228, 113, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 100
4943, 5epmB, 0.5192, 3.95, 0.148, 218, 108, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
4944, 5eoqL, 0.5192, 3.90, 0.130, 218, 108, STRUCTURE OF THE MURINE FAB 1G6 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 31-40
4945, 5a7bB, 0.5192, 3.78, 0.028, 197, 106, STRUCTURE OF THE P53 CANCER Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5211
4946, 4yzfL, 0.5192, 3.88, 0.102, 218, 108, CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3
4947, 4uokL, 0.5192, 3.89, 0.130, 215, 108, ELECTRON CRYO-MICROSCOPY OF VENEZUELAN EQUINE ENCEPHALITIS VIRUS TC-83 IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 3B4C-4
4948, 4s1dD, 0.5192, 3.92, 0.131, 211, 107, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
4949, 4pb9H, 0.5192, 3.93, 0.071, 216, 112, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64
4950, 4jpvH, 0.5192, 4.02, 0.070, 216, 114, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 3BNC117 IN COMPLEX WITH HIV-1 GP120
4951, 4ffzH, 0.5192, 4.00, 0.080, 217, 113, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
4952, 4eowL, 0.5192, 3.79, 0.113, 211, 106, CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
4953, 4elkC, 0.5192, 3.70, 0.093, 203, 108, CRYSTAL STRUCTURE OF THE HY19.3 TYPE II NKT TCR
4954, 3v0vA, 0.5192, 4.01, 0.080, 217, 113, FAB WN1 222-5 UNLIGANDED
4955, 3utpD, 0.5192, 3.77, 0.084, 199, 107, 1E6 TCR SPECIFIC FOR HLA-A*0201-ALWGPDPAAA
4956, 3qnyC, 0.5192, 4.01, 0.130, 219, 108, MONOCLINIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
4957, 3kykH, 0.5192, 3.90, 0.098, 220, 112, CRYSTAL STRUCTURE OF LI33 IGG1 FAB
4958, 3ixyG, 0.5192, 4.20, 0.070, 221, 115, THE PSEUDO-ATOMIC STRUCTURE OF DENGUE IMMATURE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF THE ANTI-FUSION LOOP ANTIBODY E53
4959, 3ijsC, 0.5192, 3.99, 0.165, 216, 109, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
4960, 3ijhC, 0.5192, 3.85, 0.120, 217, 108, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4961, 3ijhA, 0.5192, 4.02, 0.147, 217, 109, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4962, 3f58L, 0.5192, 3.93, 0.130, 215, 108, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120 (MN ISOLATE); H315S MUTATION
4963, 2zckL, 0.5192, 3.92, 0.130, 218, 108, CRYSTAL STRUCTURE OF A TERNARY COMPLEX BETWEEN PSA A SUBSTRAT-ACYL INTERMEDIATE AND AN ACTIVATING ANTIBODY
4964, 2nx5I, 0.5192, 3.58, 0.123, 188, 106, CRYSTAL STRUCTURE OF ELS4 TCR BOUND TO HLA-B*3501 PRESENTING EBV PEPTIDE EPLPQGQLTAY AT 1.7A
4965, 2h1lR, 0.5192, 3.77, 0.038, 199, 106, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4966, 1zluM, 0.5192, 3.89, 0.080, 212, 112, FAB 2G12 + MAN5
4967, 1za6E, 0.5192, 4.02, 0.111, 220, 108, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4968, 1t66L, 0.5192, 3.94, 0.139, 219, 108, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
4969, 1svzA, 0.5192, 3.98, 0.062, 232, 112, CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV FRAGMENT 1696 IN COMPLEX WITH THE EPITOPE PEPTIDE CORRESPONDING TO N- TERMINUS OF HIV-2 PROTEASE
4970, 1mjuH, 0.5192, 3.96, 0.116, 211, 112, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
4971, 1mj7L, 0.5192, 3.92, 0.102, 218, 108, CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393 AND A TRANSITION-STATE ANALOG
4972, 1a0qH, 0.5192, 3.92, 0.090, 205, 111, 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
4973, 6mkdB, 0.5191, 3.80, 0.093, 239, 107, 4699 TCR BOUND TO I-AB PADI4 
4974, 6c5hL, 0.5191, 4.03, 0.138, 216, 109, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
4975, 5xxyL, 0.5191, 3.82, 0.103, 211, 107, COMPLEX STRUCTURE OF PD-L1 WITH ATEZOLIZUMAB FAB
4976, 5xcuE, 0.5191, 4.00, 0.120, 157, 108, CRYSTAL STRUCTURE OF 12CA5 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
4977, 5v7uL, 0.5191, 3.92, 0.139, 219, 108, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-22.1 FAB
4978, 5uqyK, 0.5191, 3.91, 0.093, 210, 107, CRYSTAL STRUCTURE OF MARBURG VIRUS GP IN COMPLEX WITH THE HUMAN SURVIVOR ANTIBODY MR78
4979, 5th2C, 0.5191, 3.89, 0.121, 213, 107, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
4980, 5t3zD, 0.5191, 3.99, 0.062, 229, 113, 3.5 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074
4981, 5t1kB, 0.5191, 3.77, 0.082, 217, 110, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
4982, 5sv4B, 0.5191, 3.97, 0.090, 128, 111, ANTI-RICIN A-CHAIN SINGLE DOMAIN ANTIBODY A3C8
4983, 5icyD, 0.5191, 3.76, 0.082, 211, 110, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
4984, 5dfzE, 0.5191, 3.60, 0.076, 113, 105, STRUCTURE OF VPS34 COMPLEX II FROM S. CEREVISIAE.
4985, 5b4mL, 0.5191, 4.03, 0.128, 218, 109, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
4986, 4xbgH, 0.5191, 3.92, 0.080, 230, 112, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
4987, 4uv4L, 0.5191, 3.91, 0.111, 217, 108, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
4988, 4r9yN, 0.5191, 3.83, 0.089, 218, 112, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
4989, 4olxH, 0.5191, 3.99, 0.080, 228, 113, CRYSTAL STRUCTURE OF ANTIBODY VRC07-G54L IN COMPLEX WITH CLADE A/E 93TH057 HIV-1 GP120 CORE
4990, 4lo9A, 0.5191, 3.82, 0.038, 194, 106, HUMAN P53 CORE DOMAIN MUTANT N235K
4991, 4ibqA, 0.5191, 3.81, 0.038, 192, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C
4992, 4hxbL, 0.5191, 4.05, 0.138, 219, 109, CRYSTAL STRUCTURE OF 6B9 FAB
4993, 4gmtH, 0.5191, 3.94, 0.089, 212, 112, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
4994, 4fnlL, 0.5191, 3.85, 0.093, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4995, 4c56B, 0.5191, 3.81, 0.056, 240, 108, X-RAY STRUCTURE OF THE COMPLEX BETWEEN STAPHYLOCOCCAL ENTEROTOXIN B T CELL RECEPTOR AND MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II
4996, 3u79A, 0.5191, 3.75, 0.105, 111, 105, AL-103 Y32F Y96F
4997, 3okkA, 0.5191, 3.85, 0.120, 220, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
4998, 3l7fE, 0.5191, 3.82, 0.063, 220, 111, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
4999, 3j6lB, 0.5191, 3.96, 0.090, 121, 111, KINETIC AND STRUCTURAL ANALYSIS OF COXSACKIEVIRUS B3 RECEPTOR INTERACTIONS AND FORMATION OF THE A-PARTICLE
5000, 3c09B, 0.5191, 3.84, 0.094, 175, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
5001, 2xxcB, 0.5191, 3.93, 0.074, 114, 108, CRYSTAL STRUCTURE OF A CAMELID VHH RAISED AGAINST THE HIV-1 CAPSID PROTEIN C-TERMINAL DOMAIN.
